data_1a3p_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1a3p _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo . . . . . 0 N--CA 1.501 1.931 0 N-CA-C 110.093 -0.772 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.1 t -19.94 -43.56 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 126.252 2.22 . . . . 0.0 116.238 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 t -146.49 127.38 14.46 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -122.06 35.93 4.76 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.09 131.96 45.74 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.1 40.16 1.7 Allowed Glycine 0 N--CA 1.51 3.569 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.44 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 26.4 t80 -91.87 -15.2 28.47 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 125.756 1.504 . . . . 0.0 114.191 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.4 m -128.47 156.62 42.93 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.402 ' CD2' ' HA ' ' A' ' 43' ' ' GLN . 1.1 mp -104.49 -33.09 8.69 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.438 ' ND2' ' CD ' ' A' ' 45' ' ' ARG . 4.6 m-80 -144.92 -81.65 0.16 Allowed 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 120.109 3.374 . . . . 0.0 120.109 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.12 -29.6 65.76 Favored Glycine 0 N--CA 1.507 3.429 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.402 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 5.02 66.99 0.01 OUTLIER Glycine 0 N--CA 1.483 1.767 0 CA-C-N 110.085 -3.058 . . . . 0.0 119.809 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.301 -1.515 1 N-CA-C 99.175 -4.38 . . . . 0.0 99.175 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.553 ' SD ' HD11 ' A' ' 23' ' ' ILE . 2.5 ppp? . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 124.459 2.076 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -70.86 117.24 12.12 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 113.238 -1.801 . . . . 0.0 107.497 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.553 HD11 ' SD ' ' A' ' 21' ' ' MET . 0.1 OUTLIER -100.93 24.88 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.006 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 23' ' ' ILE . 1.3 tm-20 -32.71 -46.84 0.15 Allowed 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 123.607 1.67 . . . . 0.0 108.458 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -26.11 -48.47 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 108.605 -3.907 . . . . 0.0 113.067 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.08 -33.99 5.2 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 111.357 -2.656 . . . . 0.0 109.996 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -146.82 -81.5 0.14 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 23' ' ' ILE . 6.3 p -156.16 -127.73 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.108 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -101.15 137.06 40.01 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.544 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -146.87 -174.54 4.52 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 112.312 -2.222 . . . . 0.0 109.297 -179.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.402 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -125.34 156.28 38.95 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -108.47 117.9 35.36 Favored 'General case' 0 C--N 1.298 -1.633 1 N-CA-C 98.102 -4.777 . . . . 0.0 98.102 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.548 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 81.9 m -98.57 166.22 11.45 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.574 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 7.1 p -64.87 158.11 4.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 C-N-CA 117.67 -1.612 . . . . 0.0 112.707 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -42.38 -28.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 111.52 -2.582 . . . . 0.0 110.682 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -99.06 -17.24 28.07 Favored Glycine 0 C--O 1.203 -1.784 0 CA-C-N 114.198 -1.365 . . . . 0.0 115.484 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.574 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 6.0 m-30 -111.96 124.92 53.41 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 40' ' ' ASP . 47.0 t -133.71 -130.38 0.17 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.237 -1.385 . . . . 0.0 112.362 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.501 ' C ' ' NE2' ' A' ' 43' ' ' GLN . . . 65.75 -2.56 3.5 Favored Glycine 0 N--CA 1.483 1.77 0 CA-C-O 117.699 -1.611 . . . . 0.0 109.815 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 8.8 t70 92.78 -2.48 0.13 Allowed 'General case' 0 N--CA 1.517 2.916 0 CA-C-N 118.268 1.034 . . . . 0.0 113.662 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.477 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -141.38 2.41 1.65 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.548 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 61.13 33.95 19.21 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 -179.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.501 ' NE2' ' C ' ' A' ' 39' ' ' GLY . 0.8 OUTLIER -88.71 -24.27 22.76 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 111.731 -2.486 . . . . 0.0 108.305 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.417 ' O ' ' CG2' ' A' ' 44' ' ' THR . 6.1 t -112.33 83.92 1.88 Allowed 'General case' 0 C--N 1.297 -1.678 1 N-CA-C 99.07 -4.418 . . . . 0.0 99.07 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.487 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 16.6 mtm180 -79.84 91.49 5.36 Favored 'General case' 0 C--N 1.296 -1.731 1 N-CA-C 100.11 -4.033 . . . . 0.0 100.11 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 36' ' ' GLY . 5.6 t70 -86.79 64.98 8.79 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.498 1.957 0 N-CA-C 117.929 2.566 . . . . 0.0 117.929 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 N--CA 1.501 1.943 0 CA-C-O 120.867 0.278 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -19.89 -53.83 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 125.332 1.645 . . . . 0.0 114.634 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 t -143.75 144.2 31.72 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 104.23 -2.508 . . . . 0.0 104.23 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.423 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 3.2 p90 -127.19 26.4 6.06 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 124.868 1.355 . . . . 0.0 109.845 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -100.06 133.26 44.7 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.37 24.69 61.77 Favored Glycine 0 N--CA 1.505 3.243 0 N-CA-C 107.662 -2.175 . . . . 0.0 107.662 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.402 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 10.2 t80 -91.1 -18.04 25.19 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 113.47 -1.365 . . . . 0.0 112.208 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.1 m -132.83 147.51 52.3 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.459 ' HB3' ' ND2' ' A' ' 16' ' ' ASN . 0.2 OUTLIER -104.0 -34.7 8.36 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -179.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.459 ' ND2' ' HB3' ' A' ' 15' ' ' LEU . 53.9 m-80 -147.86 -76.02 0.18 Allowed 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 120.403 3.483 . . . . 0.0 120.403 -178.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.72 -26.35 69.82 Favored Glycine 0 N--CA 1.508 3.496 0 N-CA-C 108.155 -1.978 . . . . 0.0 108.155 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.421 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -1.25 68.56 0.0 OUTLIER Glycine 0 N--CA 1.485 1.911 0 N-CA-C 120.672 3.029 . . . . 0.0 120.672 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.3 -1.565 0 N-CA-C 100.322 -3.955 . . . . 0.0 100.322 179.316 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.475 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 5.5 ptp . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 123.207 1.479 . . . . 0.0 108.984 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -72.41 113.35 9.35 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 103.406 -2.812 . . . . 0.0 103.406 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -95.38 27.14 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.113 -179.289 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.467 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.8 OUTLIER -37.84 -37.65 0.25 Allowed 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 123.439 1.59 . . . . 0.0 109.288 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.4 ' N ' ' C ' ' A' ' 23' ' ' ILE . 0.7 OUTLIER -33.31 -44.38 0.13 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 110.388 -3.097 . . . . 0.0 111.579 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.5 -32.98 4.18 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 111.659 -2.519 . . . . 0.0 111.1 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -149.5 -80.04 0.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 118.124 2.639 . . . . 0.0 118.124 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.9 p -153.46 -133.52 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 119.098 -1.041 . . . . 0.0 109.834 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -100.09 135.95 40.73 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 179.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.526 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -147.65 -176.42 5.25 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 112.841 -1.981 . . . . 0.0 109.994 -179.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.421 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -125.18 150.07 47.32 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.475 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 14.5 t30 -106.36 123.71 48.47 Favored 'General case' 0 C--N 1.299 -1.599 1 N-CA-C 97.348 -5.056 . . . . 0.0 97.348 179.366 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 72.1 m -96.59 -117.73 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.582 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.575 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 7.4 p -149.52 166.84 3.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 117.815 -1.554 . . . . 0.0 111.151 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tt -50.74 -19.68 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 112.247 -2.251 . . . . 0.0 107.747 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -104.27 -14.11 25.02 Favored Glycine 0 C--O 1.202 -1.848 0 CA-C-N 113.521 -1.672 . . . . 0.0 115.285 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.575 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 1.9 m-85 -131.66 125.64 32.64 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.445 ' C ' ' H ' ' A' ' 40' ' ' ASP . 11.1 t -129.74 -148.27 0.36 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.82 -48.15 3.01 Favored Glycine 0 N--CA 1.502 3.049 0 N-CA-C 106.89 -2.484 . . . . 0.0 106.89 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.445 ' H ' ' C ' ' A' ' 38' ' ' SER . 0.5 OUTLIER 122.81 8.68 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 C-N-CA 129.788 3.235 . . . . 0.0 108.186 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -127.27 -7.18 5.88 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.366 0.603 . . . . 0.0 110.83 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.45 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 62.51 38.32 12.65 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 124.236 1.969 . . . . 0.0 107.564 -179.211 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.458 ' H ' ' HG3' ' A' ' 43' ' ' GLN . 0.5 OUTLIER -88.23 -38.26 15.4 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 109.236 -3.62 . . . . 0.0 105.76 -179.708 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 37' ' ' TYR . 1.9 t -96.35 85.33 3.91 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 102.048 -3.316 . . . . 0.0 102.048 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -82.61 84.69 7.18 Favored 'General case' 0 C--N 1.299 -1.626 1 N-CA-C 99.791 -4.152 . . . . 0.0 99.791 179.886 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 36' ' ' GLY . 30.1 t70 -55.49 -28.91 57.47 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 112.192 -2.276 . . . . 0.0 108.4 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 C-N-CA 127.068 2.147 . . . . 0.0 108.209 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.502 1.986 0 CA-C-O 122.411 0.921 . . . . 0.0 112.679 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.1 t -100.68 -25.15 14.24 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 113.391 -1.731 . . . . 0.0 106.406 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.9 t -155.88 133.82 11.28 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.481 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 3.0 p90 -124.09 19.59 9.13 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 122.896 1.331 . . . . 0.0 108.579 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.69 129.85 40.23 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.406 ' O ' ' NH1' ' A' ' 41' ' ' ARG . . . 36.36 50.6 1.31 Allowed Glycine 0 N--CA 1.501 2.972 0 O-C-N 125.415 1.697 . . . . 0.0 109.595 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.438 ' CD1' ' CZ ' ' A' ' 29' ' ' TYR . 48.4 t80 -92.45 -14.9 27.84 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.5 m -122.67 162.72 21.43 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -117.29 -37.31 3.55 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.458 ' ND2' ' HD3' ' A' ' 45' ' ' ARG . 18.0 m-80 -146.69 -67.63 0.27 Allowed 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 119.765 3.246 . . . . 0.0 119.765 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.75 -24.99 76.48 Favored Glycine 0 N--CA 1.506 3.325 0 N-CA-C 106.474 -2.651 . . . . 0.0 106.474 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.501 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 0.97 59.88 0.0 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 120.56 2.984 . . . . 0.0 120.56 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.304 -1.386 0 N-CA-C 101.22 -3.622 . . . . 0.0 101.22 179.319 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.417 ' SD ' ' ND2' ' A' ' 32' ' ' ASN . 14.6 ptt? . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.475 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -63.0 122.89 17.15 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 102.535 -3.135 . . . . 0.0 102.535 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.469 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -101.1 25.69 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 124.098 0.874 . . . . 0.0 109.96 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.475 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 1.1 tm-20 -34.15 -42.94 0.14 Allowed 'General case' 0 N--CA 1.509 2.518 0 CA-C-O 123.21 1.481 . . . . 0.0 109.516 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -29.93 -49.9 0.11 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 109.56 -3.473 . . . . 0.0 111.86 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.05 -28.45 6.99 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 111.383 -2.644 . . . . 0.0 112.122 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -149.89 -79.42 0.13 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 29' ' ' TYR . 3.5 p -156.05 -131.94 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.23 -1.804 . . . . 0.0 110.31 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.545 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -101.64 135.68 42.76 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 123.012 1.387 . . . . 0.0 109.697 179.708 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.545 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -148.37 -176.59 5.36 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 112.23 -2.259 . . . . 0.0 111.951 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.501 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -125.63 154.34 42.45 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.417 ' ND2' ' SD ' ' A' ' 21' ' ' MET . 6.2 t-20 -109.64 98.24 7.64 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 37' ' ' TYR . 55.8 m -93.07 150.33 20.6 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.564 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 9.9 p -59.51 169.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 111.758 -2.474 . . . . 0.0 117.143 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -21.07 17.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 111.497 -2.592 . . . . 0.0 107.146 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -94.56 -8.84 59.36 Favored Glycine 0 N--CA 1.482 1.733 0 CA-C-N 114.218 -1.355 . . . . 0.0 113.161 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.564 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 1.4 m-85 -141.19 126.25 18.34 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 116.496 -1.716 . . . . 0.0 107.799 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.412 ' O ' ' NE2' ' A' ' 43' ' ' GLN . 8.5 t -124.14 -144.43 0.33 Allowed 'General case' 0 N--CA 1.518 2.966 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 41' ' ' ARG . . . 35.97 69.81 0.23 Allowed Glycine 0 N--CA 1.501 2.999 0 C-N-CA 124.441 1.019 . . . . 0.0 114.237 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 29.92 8.91 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 119.547 3.165 . . . . 0.0 119.547 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -132.19 -25.16 2.02 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.794 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.446 ' HB3' ' CB ' ' A' ' 37' ' ' TYR . 1.8 m 76.8 40.53 0.2 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.492 HE22 ' CG2' ' A' ' 44' ' ' THR . 0.0 OUTLIER -88.74 -20.7 24.45 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 112.749 -2.023 . . . . 0.0 109.437 -179.464 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.492 ' CG2' HE22 ' A' ' 43' ' ' GLN . 0.6 OUTLIER -113.0 92.87 4.16 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 102.21 -3.255 . . . . 0.0 102.21 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.458 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 6.7 mtm180 -84.93 85.84 7.43 Favored 'General case' 0 C--N 1.299 -1.597 1 N-CA-C 99.238 -4.356 . . . . 0.0 99.238 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 36' ' ' GLY . 13.9 t0 -60.67 -12.97 11.9 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 112.531 -2.122 . . . . 0.0 109.264 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.413 ' H ' ' C ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.878 0 C-N-CA 128.156 2.582 . . . . 0.0 117.751 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo . . . . . 0 N--CA 1.492 1.403 0 CA-C-O 122.591 0.996 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 t -100.57 -29.0 12.58 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 113.682 -1.599 . . . . 0.0 106.824 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -166.46 152.75 8.8 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.478 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -129.55 14.58 6.01 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 124.659 1.224 . . . . 0.0 110.411 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -63.35 137.83 58.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.36 37.99 1.29 Allowed Glycine 0 N--CA 1.511 3.672 0 O-C-N 124.258 0.974 . . . . 0.0 111.133 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.489 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 30.5 t80 -90.4 -8.35 50.86 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 113.597 -1.301 . . . . 0.0 112.815 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.7 m -137.07 152.45 50.05 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.13 -72.75 0.6 Allowed 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.41 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.507 ' C ' ' H ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -121.81 -56.66 1.85 Allowed 'General case' 0 N--CA 1.512 2.674 0 N-CA-C 115.667 1.728 . . . . 0.0 115.667 -179.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 33' ' ' CYS . . . -86.81 44.29 3.31 Favored Glycine 0 N--CA 1.503 3.115 0 N-CA-C 105.913 -2.875 . . . . 0.0 105.913 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.533 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -68.82 67.39 0.45 Allowed Glycine 0 C--N 1.29 -2.019 0 CA-C-N 112.479 -1.861 . . . . 0.0 116.084 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.2 t . . . . . 0 C--N 1.302 -1.471 0 N-CA-C 103.52 -2.77 . . . . 0.0 103.52 179.673 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.0 ptm . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.469 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -111.7 126.5 55.1 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.194 -1.402 . . . . 0.0 107.696 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.484 ' N ' ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -106.78 23.11 3.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 124.189 0.931 . . . . 0.0 111.308 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.469 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.4 OUTLIER -38.1 -37.31 0.26 Allowed 'General case' 0 N--CA 1.515 2.816 0 CA-C-O 123.421 1.582 . . . . 0.0 110.157 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -33.26 -43.27 0.11 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 110.227 -3.17 . . . . 0.0 111.914 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.35 -34.66 3.77 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 111.335 -2.666 . . . . 0.0 111.3 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -147.28 -82.47 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 23' ' ' ILE . 26.7 p -154.52 -125.59 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.831 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.517 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -98.76 139.44 34.45 Favored 'General case' 0 N--CA 1.51 2.547 0 CA-C-O 122.394 1.092 . . . . 0.0 110.199 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.517 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -148.56 178.96 8.17 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 112.843 -1.98 . . . . 0.0 111.438 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.533 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -115.12 154.6 28.63 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 103.09 -2.93 . . . . 0.0 103.09 179.269 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.88 86.59 2.31 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.664 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 34.8 m -59.38 151.91 22.56 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.913 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.548 HG13 ' CD2' ' A' ' 37' ' ' TYR . 7.5 p -59.36 157.12 2.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 111.589 -2.55 . . . . 0.0 112.158 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tt -43.16 -25.61 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 112.344 -2.207 . . . . 0.0 110.063 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 34' ' ' VAL . . . -98.33 -24.1 11.78 Favored Glycine 0 N--CA 1.485 1.931 0 CA-C-N 114.6 -1.182 . . . . 0.0 115.256 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.548 ' CD2' HG13 ' A' ' 34' ' ' VAL . 1.3 m-30 -111.57 133.05 54.1 Favored 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 102.862 -3.014 . . . . 0.0 102.862 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.6 t -139.2 -137.04 0.13 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 118.403 -1.319 . . . . 0.0 111.175 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 75.74 -10.5 13.06 Favored Glycine 0 N--CA 1.48 1.621 0 CA-C-O 117.905 -1.497 . . . . 0.0 109.513 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 21.6 t70 102.06 -15.66 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.048 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.606 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -134.43 6.9 3.56 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.216 -179.285 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.664 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 59.48 32.51 21.76 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.261 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.606 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -88.13 5.55 40.76 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.256 -179.426 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.452 ' O ' ' C ' ' A' ' 45' ' ' ARG . 12.1 t -130.08 22.33 5.3 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.518 -1.674 . . . . 0.0 113.632 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.452 ' C ' ' O ' ' A' ' 44' ' ' THR . 1.0 OUTLIER -16.56 90.32 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 O-C-N 125.36 1.662 . . . . 0.0 112.252 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.79 2.62 9.69 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 117.844 -1.542 . . . . 0.0 111.002 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.907 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.423 ' HA ' ' HB3' ' A' ' 29' ' ' TYR . 8.4 Cg_endo . . . . . 0 N--CA 1.495 1.589 0 CA-C-O 119.878 -0.134 . . . . 0.0 111.882 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -19.86 -53.7 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 126.542 2.401 . . . . 0.0 115.172 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.55 125.38 22.54 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.392 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.424 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 1.4 p90 -110.51 4.42 20.41 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.851 1.31 . . . . 0.0 110.747 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.65 129.2 38.16 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 113.607 -1.633 . . . . 0.0 106.974 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 34.46 46.17 0.53 Allowed Glycine 0 N--CA 1.511 3.637 0 O-C-N 124.423 1.077 . . . . 0.0 111.414 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -91.44 -20.26 21.96 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 125.935 1.609 . . . . 0.0 112.611 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.8 m -116.92 153.82 31.91 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.407 ' CD2' ' HA ' ' A' ' 43' ' ' GLN . 0.3 OUTLIER -100.58 -36.53 9.13 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -144.67 -82.05 0.16 Allowed 'General case' 0 N--CA 1.51 2.572 1 N-CA-C 121.876 4.028 . . . . 0.0 121.876 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.25 -31.9 59.78 Favored Glycine 0 N--CA 1.515 3.924 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.474 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 7.8 69.47 0.01 OUTLIER Glycine 0 N--CA 1.486 1.969 0 CA-C-N 109.67 -3.265 . . . . 0.0 120.847 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.301 -1.518 1 N-CA-C 98.67 -4.567 . . . . 0.0 98.67 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 13.5 ptt? . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 122.974 1.369 . . . . 0.0 108.497 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -64.59 119.58 10.76 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.474 ' O ' ' C ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -101.18 20.93 2.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 123.513 0.508 . . . . 0.0 109.684 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -26.26 -50.51 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 123.097 1.427 . . . . 0.0 109.603 -179.457 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -25.9 -49.06 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 108.829 -3.805 . . . . 0.0 113.333 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.91 -33.82 5.95 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 111.476 -2.602 . . . . 0.0 110.405 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -146.84 -80.24 0.15 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.5 p -156.8 -132.13 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.762 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -99.02 137.94 36.82 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.564 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.267 0.6 OUTLIER -148.26 -174.73 4.66 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 112.863 -1.971 . . . . 0.0 109.419 -179.615 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.474 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -124.7 157.47 35.56 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -109.33 116.4 31.78 Favored 'General case' 0 C--N 1.298 -1.649 1 N-CA-C 96.069 -5.53 . . . . 0.0 96.069 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 37' ' ' TYR . 66.0 m -94.62 -124.71 0.11 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 118.601 -0.714 . . . . 0.0 111.023 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.54 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 5.7 p -139.64 160.28 27.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 117.787 -1.565 . . . . 0.0 109.095 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -47.51 -24.0 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 111.895 -2.411 . . . . 0.0 108.1 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -97.37 -20.25 23.25 Favored Glycine 0 C--O 1.203 -1.833 0 CA-C-O 117.716 -1.602 . . . . 0.0 114.814 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.54 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 2.1 m-30 -123.74 125.84 45.45 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 120.764 2.282 . . . . 0.0 106.805 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.426 ' C ' ' H ' ' A' ' 40' ' ' ASP . 47.8 t -138.17 -131.34 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.487 -1.285 . . . . 0.0 111.334 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 68.89 -6.54 3.68 Favored Glycine 0 N--CA 1.487 2.042 0 CA-C-O 117.988 -1.451 . . . . 0.0 111.513 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 11.8 t70 102.14 -12.7 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.036 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.514 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.2 OUTLIER -133.8 4.01 3.55 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.54 -178.656 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 62.72 32.07 16.29 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.514 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -89.18 -19.91 24.87 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 112.743 -2.026 . . . . 0.0 107.099 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.94 82.15 1.65 Allowed 'General case' 0 N--CA 1.488 1.461 1 N-CA-C 100.144 -4.021 . . . . 0.0 100.144 179.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.414 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 12.8 mtm180 -76.47 89.3 3.24 Favored 'General case' 0 C--N 1.296 -1.757 1 N-CA-C 99.129 -4.396 . . . . 0.0 99.129 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 36' ' ' GLY . 25.1 t70 -62.81 -25.6 68.33 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 117.344 -1.742 . . . . 0.0 108.832 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 46' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.502 2.129 0 C-N-CA 128.042 2.537 . . . . 0.0 108.436 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.408 ' HA ' ' HB3' ' A' ' 29' ' ' TYR . 5.5 Cg_exo . . . . . 0 N--CA 1.503 2.04 0 N-CA-C 108.147 -1.52 . . . . 0.0 108.147 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -19.93 -51.42 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 110.066 -3.243 . . . . 0.0 118.251 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.2 p -126.44 108.88 11.6 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.286 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -115.08 0.9 13.77 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -85.26 89.45 7.66 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.987 1.375 . . . . 0.0 110.173 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.35 28.81 4.47 Favored Glycine 0 N--CA 1.501 2.97 0 N-CA-C 106.958 -2.457 . . . . 0.0 106.958 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.451 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 20.6 t80 -90.57 -11.07 41.13 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.527 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 60.5 m -126.8 151.21 48.58 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.404 ' HB3' ' ND2' ' A' ' 16' ' ' ASN . 0.3 OUTLIER -104.38 -38.31 6.88 Favored 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.418 ' HB2' ' CD2' ' A' ' 37' ' ' TYR . 38.3 m-80 -147.07 -66.66 0.27 Allowed 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 120.621 3.563 . . . . 0.0 120.621 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.97 19.59 52.55 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.636 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -65.56 96.02 0.24 Allowed Glycine 0 C--N 1.295 -1.726 0 CA-C-O 124.39 2.106 . . . . 0.0 115.826 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.287 -2.126 0 N-CA-C 101.08 -3.674 . . . . 0.0 101.08 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.527 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 4.3 ptm . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 101.9 -3.37 . . . . 0.0 101.9 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -103.99 127.94 51.54 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.476 ' O ' ' C ' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -105.79 21.07 3.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 123.918 0.761 . . . . 0.0 109.718 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -29.58 -49.29 0.09 Allowed 'General case' 0 N--CA 1.509 2.478 0 CA-C-O 123.528 1.632 . . . . 0.0 109.645 -179.303 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -26.88 -48.48 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.676 1 CA-C-N 108.362 -4.017 . . . . 0.0 113.34 179.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.85 -34.12 5.87 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 111.036 -2.802 . . . . 0.0 110.673 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -147.74 -79.87 0.15 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 29' ' ' TYR . 1.7 p -156.67 -134.48 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.806 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.57 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -97.55 138.56 34.78 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.57 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.273 0.5 OUTLIER -149.3 -179.17 6.85 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 112.875 -1.966 . . . . 0.0 111.757 -179.197 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.636 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -116.1 151.91 34.65 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.527 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 43.8 t30 -104.13 76.81 1.37 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.543 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 33.5 m -64.1 152.39 40.59 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.678 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.513 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 7.4 p -59.67 160.99 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 111.811 -2.449 . . . . 0.0 114.441 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 tt -51.72 -21.6 2.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 111.51 -2.587 . . . . 0.0 108.784 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -95.34 -14.38 48.21 Favored Glycine 0 N--CA 1.491 2.366 0 CA-C-N 114.201 -1.363 . . . . 0.0 115.297 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.513 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 2.1 m-85 -131.89 127.41 36.4 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.3 t -136.81 -135.46 0.14 Allowed 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 118.304 -1.358 . . . . 0.0 108.744 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 69.52 0.94 26.83 Favored Glycine 0 N--CA 1.48 1.603 0 CA-C-O 116.707 -2.163 . . . . 0.0 111.701 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 5.1 t70 94.65 -11.7 0.11 Allowed 'General case' 0 N--CA 1.52 3.068 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.486 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -138.02 -2.65 1.86 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.543 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 67.85 31.47 5.75 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -179.462 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.486 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -89.04 -19.55 25.5 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 111.878 -2.419 . . . . 0.0 108.652 -179.755 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.407 ' O ' ' CG2' ' A' ' 44' ' ' THR 0.266 2.3 t -115.14 89.89 3.21 Favored 'General case' 0 C--N 1.296 -1.723 1 N-CA-C 98.541 -4.615 . . . . 0.0 98.541 179.863 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.5 mtm180 -87.61 93.25 9.37 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 101.77 -3.419 . . . . 0.0 101.77 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 36' ' ' GLY . 31.7 t70 -64.73 -20.31 66.27 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.0 -1.455 . . . . 0.0 108.114 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 N--CA 1.493 1.683 0 C-N-CA 126.414 1.886 . . . . 0.0 107.572 179.634 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 N--CA 1.488 1.176 0 CA-C-O 123.168 1.237 . . . . 0.0 108.943 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.6 t -100.99 -26.05 13.86 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.206 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.3 t -173.27 151.96 2.14 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.533 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -129.84 12.6 5.77 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 124.41 1.068 . . . . 0.0 110.744 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -62.27 136.33 57.88 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 37.95 41.54 0.97 Allowed Glycine 0 N--CA 1.512 3.741 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 29' ' ' TYR . 37.3 t80 -91.71 -13.77 31.12 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 125.591 1.406 . . . . 0.0 113.231 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.453 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 33.7 m -121.79 155.08 36.08 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -37.91 5.9 Favored 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.526 HD22 ' CZ ' ' A' ' 45' ' ' ARG . 25.7 m-80 -143.12 -80.57 0.2 Allowed 'General case' 0 N--CA 1.514 2.752 0 N-CA-C 119.471 3.137 . . . . 0.0 119.471 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.05 -24.6 63.19 Favored Glycine 0 N--CA 1.51 3.61 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.626 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 4.55 63.92 0.0 OUTLIER Glycine 0 N--CA 1.481 1.662 0 N-CA-C 120.823 3.089 . . . . 0.0 120.823 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.307 -1.254 0 N-CA-C 102.4 -3.185 . . . . 0.0 102.4 179.373 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.485 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 9.6 ptm . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.423 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -109.34 129.0 55.54 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.451 ' O ' ' C ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -106.09 13.94 7.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 124.039 0.837 . . . . 0.0 111.87 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -22.78 -54.88 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 124.815 1.322 . . . . 0.0 112.008 -179.41 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.6 m -26.52 -45.18 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 110.921 -2.854 . . . . 0.0 114.3 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.53 -36.98 5.61 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 111.361 -2.654 . . . . 0.0 109.939 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -147.96 -81.77 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.2 p -156.87 -133.25 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.436 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.533 ' CE2' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -96.25 139.48 32.33 Favored 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.474 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -147.92 178.72 8.28 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 113.073 -1.876 . . . . 0.0 109.95 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.626 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -118.15 146.64 44.03 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.485 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 56.9 t30 -99.55 104.61 16.42 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 101.558 -3.497 . . . . 0.0 101.558 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 61.6 m -84.13 177.38 8.25 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.988 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.576 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 14.5 p -80.3 159.54 4.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 123.003 1.383 . . . . 0.0 112.712 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -46.84 -22.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-N 111.618 -2.537 . . . . 0.0 108.99 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -97.2 -15.88 37.01 Favored Glycine 0 C--O 1.203 -1.783 0 CA-C-N 113.615 -1.63 . . . . 0.0 116.534 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.576 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 4.4 m-30 -123.52 121.41 35.59 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 103.535 -2.765 . . . . 0.0 103.535 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.408 ' C ' ' H ' ' A' ' 40' ' ' ASP . 15.2 t -130.1 -142.54 0.24 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.385 1.088 . . . . 0.0 113.306 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 40' ' ' ASP . . . 86.33 -47.84 3.82 Favored Glycine 0 C--N 1.301 -1.406 0 N-CA-C 106.514 -2.634 . . . . 0.0 106.514 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER 139.31 -6.68 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.983 0 O-C-N 126.807 2.122 . . . . 0.0 112.291 -179.569 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.651 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -134.58 -1.9 2.76 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.14 -178.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.54 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 69.64 35.36 2.45 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 104.991 -2.225 . . . . 0.0 104.991 -179.28 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.651 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -89.06 -13.74 37.98 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 112.599 -2.091 . . . . 0.0 108.846 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 t -122.54 92.62 3.75 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 103.07 -2.937 . . . . 0.0 103.07 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.526 ' CZ ' HD22 ' A' ' 16' ' ' ASN . 0.1 OUTLIER -83.94 97.18 9.1 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' GLY . 30.2 t70 -66.11 -29.58 69.92 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 116.633 -2.027 . . . . 0.0 108.474 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 mt . . . . . 0 N--CA 1.502 2.14 0 C-N-CA 127.523 2.329 . . . . 0.0 106.82 179.643 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 N--CA 1.496 1.674 0 N-CA-C 108.179 -1.508 . . . . 0.0 108.179 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.2 m -21.27 -41.58 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 111.597 -2.547 . . . . 0.0 117.614 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.2 m -145.06 119.93 9.94 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -114.48 15.48 17.84 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 122.379 1.085 . . . . 0.0 111.058 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.51 133.25 36.49 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.41 32.86 31.23 Favored Glycine 0 N--CA 1.506 3.347 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.481 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 23.9 t80 -90.37 -13.2 35.54 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 113.935 -1.133 . . . . 0.0 112.951 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.0 m -128.95 143.61 50.93 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.416 ' CD2' ' HA ' ' A' ' 43' ' ' GLN . 0.5 OUTLIER -97.62 -33.02 11.49 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 123.58 0.55 . . . . 0.0 112.41 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -149.08 -85.96 0.09 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 120.515 3.524 . . . . 0.0 120.515 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -48.7 -32.69 11.29 Favored Glycine 0 N--CA 1.513 3.785 0 CA-C-O 123.136 1.409 . . . . 0.0 109.684 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.5 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 8.11 64.84 0.01 OUTLIER Glycine 0 N--CA 1.48 1.599 0 CA-C-N 109.521 -3.339 . . . . 0.0 121.198 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.3 -1.578 1 N-CA-C 99.885 -4.117 . . . . 0.0 99.885 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.3 ptp . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -101.79 123.74 46.26 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.47 ' O ' ' CG2' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -102.54 22.78 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 124.757 1.286 . . . . 0.0 111.489 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.412 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -36.3 -37.55 0.12 Allowed 'General case' 0 N--CA 1.516 2.852 0 CA-C-O 123.79 1.757 . . . . 0.0 110.353 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.7 OUTLIER -34.91 -45.95 0.29 Allowed 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 110.077 -3.238 . . . . 0.0 111.44 179.172 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.59 -33.83 5.08 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 111.517 -2.583 . . . . 0.0 110.481 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.67 -79.97 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.0 OUTLIER -156.65 -135.47 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 118.38 -1.328 . . . . 0.0 109.855 -179.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -94.78 140.44 29.91 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.575 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -151.21 -174.5 4.83 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 113.097 -1.865 . . . . 0.0 110.712 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.5 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -125.42 153.45 43.43 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -105.9 118.47 36.68 Favored 'General case' 0 C--N 1.3 -1.548 1 N-CA-C 98.29 -4.707 . . . . 0.0 98.29 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.511 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 76.3 m -98.8 166.45 11.3 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.54 HG13 ' CD2' ' A' ' 37' ' ' TYR . 3.4 p -65.24 157.43 5.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 C-N-CA 118.141 -1.424 . . . . 0.0 111.064 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -41.78 -24.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 111.864 -2.426 . . . . 0.0 111.934 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -100.53 -27.39 7.63 Favored Glycine 0 N--CA 1.484 1.838 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.82 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.54 ' CD2' HG13 ' A' ' 34' ' ' VAL . 4.2 m-30 -98.91 120.58 39.6 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 104.019 -2.585 . . . . 0.0 104.019 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 40' ' ' ASP . 33.4 t -130.91 -135.54 0.2 Allowed 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 118.175 -1.41 . . . . 0.0 112.398 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.508 ' C ' ' NE2' ' A' ' 43' ' ' GLN . . . 69.99 -8.58 3.48 Favored Glycine 0 N--CA 1.483 1.802 0 CA-C-O 117.4 -1.778 . . . . 0.0 110.622 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 16.7 t70 100.11 -2.83 0.03 OUTLIER 'General case' 0 N--CA 1.523 3.209 0 C-N-CA 124.004 0.922 . . . . 0.0 113.184 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.521 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -140.66 1.41 1.72 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -178.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 64.39 33.91 10.86 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 -179.383 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.521 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -88.47 -23.86 23.14 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 111.993 -2.367 . . . . 0.0 110.737 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.41 ' O ' ' CG2' ' A' ' 44' ' ' THR . 5.9 t -112.23 86.6 2.38 Favored 'General case' 0 C--N 1.294 -1.806 1 N-CA-C 98.201 -4.741 . . . . 0.0 98.201 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.461 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 14.9 mtm180 -77.04 87.2 3.54 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 110.849 -2.887 . . . . 0.0 104.647 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 36' ' ' GLY . 5.9 t70 -83.7 67.05 9.33 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 mp . . . . . 0 N--CA 1.506 2.363 1 N-CA-C 122.885 4.402 . . . . 0.0 122.885 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.415 ' HA ' ' HB3' ' A' ' 29' ' ' TYR . 6.8 Cg_endo . . . . . 0 N--CA 1.502 2.026 0 N-CA-C 108.325 -1.452 . . . . 0.0 108.325 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m -20.15 -50.52 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 109.944 -3.298 . . . . 0.0 116.413 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.19 127.82 17.11 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.506 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 1.0 OUTLIER -117.14 8.97 13.42 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 124.02 0.825 . . . . 0.0 112.074 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -69.38 138.25 53.48 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 41.25 37.53 1.64 Allowed Glycine 0 N--CA 1.507 3.402 0 O-C-N 124.43 1.081 . . . . 0.0 110.775 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.426 ' CD1' ' CZ ' ' A' ' 29' ' ' TYR . 30.9 t80 -91.25 -17.22 26.35 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 114.063 -1.068 . . . . 0.0 113.813 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.434 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 41.5 m -116.85 154.68 30.34 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.428 ' CD2' ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -107.71 -37.97 6.0 Favored 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 115.086 1.514 . . . . 0.0 115.086 -179.65 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.455 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 3.8 m-80 -139.19 -83.21 0.27 Allowed 'General case' 0 N--CA 1.509 2.513 0 N-CA-C 120.133 3.383 . . . . 0.0 120.133 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.75 -24.22 64.14 Favored Glycine 0 N--CA 1.511 3.669 0 N-CA-C 108.849 -1.701 . . . . 0.0 108.849 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.577 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 5.38 65.39 0.01 OUTLIER Glycine 0 N--CA 1.478 1.495 0 N-CA-C 120.449 2.94 . . . . 0.0 120.449 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.306 -1.308 0 N-CA-C 100.734 -3.802 . . . . 0.0 100.734 179.28 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.56 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 7.2 ptm . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 123.073 1.416 . . . . 0.0 109.089 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -63.31 120.44 11.58 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 179.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -102.78 23.69 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 123.714 0.634 . . . . 0.0 110.367 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -33.5 -42.06 0.1 Allowed 'General case' 0 N--CA 1.511 2.607 0 CA-C-O 123.722 1.725 . . . . 0.0 109.696 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -30.89 -46.54 0.08 Allowed 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 109.632 -3.44 . . . . 0.0 111.992 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.49 -35.51 4.56 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 111.572 -2.558 . . . . 0.0 109.779 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -146.71 -82.82 0.13 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 117.419 2.377 . . . . 0.0 117.419 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.3 p -153.11 -131.39 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.594 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -100.3 135.84 41.11 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.531 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.25 0.6 OUTLIER -146.5 -179.05 6.5 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.103 -2.317 . . . . 0.0 109.119 -179.42 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.577 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -121.16 153.67 37.22 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.56 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 60.5 t30 -106.72 104.28 13.92 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 101.77 -3.419 . . . . 0.0 101.77 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 57.5 m -88.71 156.72 18.83 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.19 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.609 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 12.2 p -59.83 159.93 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 113.019 -1.9 . . . . 0.0 114.319 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -48.56 -22.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 110.884 -2.871 . . . . 0.0 109.126 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -98.39 -11.84 46.91 Favored Glycine 0 N--CA 1.485 1.933 0 CA-C-O 117.832 -1.538 . . . . 0.0 116.588 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.609 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 3.1 m-30 -126.8 121.7 32.66 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.452 ' C ' ' H ' ' A' ' 40' ' ' ASP . 48.2 t -132.32 -134.59 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.725 -1.19 . . . . 0.0 110.868 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 74.61 -13.12 5.31 Favored Glycine 0 N--CA 1.485 1.953 0 CA-C-O 117.894 -1.504 . . . . 0.0 110.166 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 27.9 t70 104.62 -7.57 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.884 0 C-N-CA 124.419 1.087 . . . . 0.0 113.672 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.563 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -137.28 -2.26 2.05 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.498 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 70.27 31.2 3.19 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 -179.248 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.563 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -88.38 -11.96 44.68 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 113.699 -1.592 . . . . 0.0 109.82 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . 0.253 5.3 t -121.54 85.95 2.49 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 101.545 -3.502 . . . . 0.0 101.545 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.2 mtm180 -78.35 88.68 4.37 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 36' ' ' GLY . 24.1 t70 -61.01 -20.61 62.7 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.247 -1.797 . . . . 0.0 108.544 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.499 1.976 0 O-C-N 124.905 1.378 . . . . 0.0 112.379 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo . . . . . 0 N--CA 1.496 1.625 0 CA-C-O 122.449 0.937 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.21 -21.62 17.19 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 113.381 -1.736 . . . . 0.0 109.071 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.0 t -150.09 121.21 7.75 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -121.38 29.03 7.45 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 123.291 1.519 . . . . 0.0 107.795 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -101.01 134.37 44.1 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.15 23.9 60.26 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -91.94 -26.12 18.57 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.786 -1.207 . . . . 0.0 113.252 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.522 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 33.8 m -124.23 150.34 45.4 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -111.07 -37.85 5.23 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -179.24 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.49 ' ND2' ' HD2' ' A' ' 45' ' ' ARG . 34.3 m-80 -149.82 -59.91 0.2 Allowed 'General case' 0 N--CA 1.509 2.508 0 N-CA-C 118.57 2.804 . . . . 0.0 118.57 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -107.2 18.71 35.79 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 106.875 -2.49 . . . . 0.0 106.875 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.615 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -72.46 94.73 0.66 Allowed Glycine 0 C--N 1.296 -1.661 0 CA-C-O 123.926 1.848 . . . . 0.0 113.631 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.294 -1.848 0 N-CA-C 102.779 -3.045 . . . . 0.0 102.779 179.412 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.466 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 21.8 ptt? . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 123.401 1.572 . . . . 0.0 108.863 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.8 OUTLIER -73.61 119.14 17.43 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.103 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.484 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -104.11 23.77 2.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 124.279 0.987 . . . . 0.0 111.025 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -38.84 -37.18 0.32 Allowed 'General case' 0 N--CA 1.514 2.755 0 CA-C-O 123.707 1.718 . . . . 0.0 109.262 -179.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.402 ' N ' ' C ' ' A' ' 23' ' ' ILE . 1.3 m -32.78 -43.42 0.09 Allowed 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 110.035 -3.257 . . . . 0.0 111.902 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.3 -36.58 3.34 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 111.358 -2.656 . . . . 0.0 110.949 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -144.49 -84.6 0.14 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 23' ' ' ILE . 11.2 p -149.8 -131.56 0.05 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.495 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.534 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -98.54 143.74 28.62 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 179.544 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.534 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.258 0.6 OUTLIER -151.13 175.01 12.55 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 125.776 1.923 . . . . 0.0 111.03 -179.374 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.615 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -118.95 136.61 54.0 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.466 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 50.5 t30 -93.16 77.23 4.6 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.108 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.434 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 65.9 m -61.26 146.67 47.07 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.516 1.15 . . . . 0.0 110.681 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.495 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 10.5 p -58.97 161.98 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 112.332 -2.213 . . . . 0.0 115.403 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tt -49.83 -20.12 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 111.541 -2.572 . . . . 0.0 109.315 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.59 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -98.98 -18.35 25.02 Favored Glycine 0 C--O 1.202 -1.851 0 CA-C-O 117.48 -1.733 . . . . 0.0 114.34 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.507 ' CE1' ' NH2' ' A' ' 45' ' ' ARG . 1.9 m-30 -123.31 129.81 51.86 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 120.27 2.035 . . . . 0.0 107.269 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.29 -159.46 0.89 Allowed 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 88.59 -47.82 3.48 Favored Glycine 0 N--CA 1.494 2.529 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.288 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 27.7 t70 124.28 -0.42 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.038 0 O-C-N 126.719 2.07 . . . . 0.0 109.198 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -117.95 -28.67 5.85 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.434 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 3.0 m 82.7 37.86 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.583 ' NE2' ' CG2' ' A' ' 44' ' ' THR . 2.6 pp0? -88.96 -21.43 23.55 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 110.665 -2.971 . . . . 0.0 107.425 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.583 ' CG2' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -110.01 83.34 1.74 Allowed 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 101.835 -3.394 . . . . 0.0 101.835 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.507 ' NH2' ' CE1' ' A' ' 37' ' ' TYR . 1.1 mtm180 -78.77 89.19 4.62 Favored 'General case' 0 C--N 1.299 -1.622 1 N-CA-C 98.906 -4.479 . . . . 0.0 98.906 179.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.59 ' N ' ' O ' ' A' ' 36' ' ' GLY . 29.2 t0 -58.51 -23.0 57.03 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 111.849 -2.432 . . . . 0.0 107.192 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 N--CA 1.497 1.908 0 CA-C-N 112.668 -2.06 . . . . 0.0 115.077 179.541 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo . . . . . 0 N--CA 1.498 1.77 0 CA-C-O 122.349 0.895 . . . . 0.0 111.478 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 t -100.99 -19.3 15.91 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.249 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.9 m -154.95 128.96 8.8 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.483 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 2.7 p90 -124.83 8.91 8.18 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -69.24 142.73 54.12 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 39.71 39.46 1.31 Allowed Glycine 0 N--CA 1.507 3.405 0 O-C-N 124.518 1.136 . . . . 0.0 110.87 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.463 ' CD1' ' CZ ' ' A' ' 29' ' ' TYR . 38.6 t80 -91.34 -15.81 28.46 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 125.383 1.284 . . . . 0.0 113.414 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.447 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 58.2 m -119.72 157.19 29.06 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.417 HD13 ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -110.72 -38.38 5.17 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -140.58 -77.84 0.3 Allowed 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 121.486 3.884 . . . . 0.0 121.486 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.54 -17.76 73.05 Favored Glycine 0 N--CA 1.507 3.377 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.611 ' HA2' ' SG ' ' A' ' 31' ' ' CYS . . . 2.71 62.92 0.0 OUTLIER Glycine 0 C--N 1.302 -1.352 0 N-CA-C 120.091 2.796 . . . . 0.0 120.091 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.31 -1.125 0 N-CA-C 101.762 -3.421 . . . . 0.0 101.762 179.376 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.7 ptm . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 102.525 -3.139 . . . . 0.0 102.525 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -102.4 129.51 48.9 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -105.19 19.47 4.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 124.053 0.846 . . . . 0.0 112.309 -179.556 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -29.11 -49.87 0.08 Allowed 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 122.811 1.291 . . . . 0.0 112.008 -179.408 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.4 m -31.44 -43.64 0.06 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 110.99 -2.823 . . . . 0.0 114.151 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.59 -32.68 6.1 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 112.063 -2.335 . . . . 0.0 111.094 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -149.61 -80.14 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.5 p -158.33 -133.2 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.879 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -97.04 139.36 33.16 Favored 'General case' 0 N--CA 1.51 2.554 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.538 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 1.2 t -147.34 -171.34 3.77 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.305 -1.771 . . . . 0.0 112.914 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.611 ' SG ' ' HA2' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -125.46 151.28 46.47 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 179.275 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -107.82 103.17 12.37 Favored 'General case' 0 C--N 1.3 -1.577 1 N-CA-C 99.53 -4.248 . . . . 0.0 99.53 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 83.4 m -87.69 170.74 10.99 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.415 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.523 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 14.2 p -67.69 163.6 2.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-O 123.304 1.526 . . . . 0.0 112.582 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tt -53.34 -18.11 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 112.044 -2.343 . . . . 0.0 108.851 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -100.03 -22.21 12.4 Favored Glycine 0 C--O 1.199 -2.081 0 CA-C-N 113.507 -1.679 . . . . 0.0 114.16 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.523 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 2.8 m-30 -118.96 130.21 55.58 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 121.149 2.475 . . . . 0.0 104.676 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.444 ' C ' ' H ' ' A' ' 40' ' ' ASP . 22.9 t -142.07 -136.24 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 117.545 -1.662 . . . . 0.0 113.767 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.64 -42.37 3.15 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 107.744 -2.142 . . . . 0.0 107.744 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 38' ' ' SER . 0.8 OUTLIER 137.68 -2.03 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.796 0 O-C-N 126.017 1.657 . . . . 0.0 110.135 -179.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.549 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -140.93 -7.06 1.08 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -178.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.49 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 73.79 35.07 0.85 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 -178.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.549 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -88.39 -17.68 30.0 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 112.015 -2.357 . . . . 0.0 107.727 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.451 ' O ' ' CG2' ' A' ' 44' ' ' THR . 5.1 t -120.02 88.36 2.92 Favored 'General case' 0 C--N 1.299 -1.588 1 N-CA-C 99.745 -4.168 . . . . 0.0 99.745 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -83.46 96.34 8.55 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 101.841 -3.392 . . . . 0.0 101.841 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 36' ' ' GLY . 28.1 t70 -83.93 69.75 10.33 Favored 'General case' 0 C--N 1.294 -1.81 1 N-CA-C 99.926 -4.102 . . . . 0.0 99.926 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.4 mp . . . . . 0 N--CA 1.49 1.551 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.457 -179.648 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 N--CA 1.496 1.631 0 CA-C-O 121.928 0.72 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.25 -23.82 20.06 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.778 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 t -153.25 126.77 8.7 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.524 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 4.1 p90 -121.38 20.01 11.29 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 122.146 0.974 . . . . 0.0 109.004 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -72.46 121.47 19.64 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.463 ' O ' ' NH2' ' A' ' 41' ' ' ARG . . . 53.13 40.99 60.16 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.428 ' OH ' ' HA ' ' A' ' 30' ' ' THR . 7.0 t80 -91.27 -16.17 28.0 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.7 m -122.61 161.49 23.66 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -115.63 -37.17 4.03 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 117.885 2.55 . . . . 0.0 117.885 -179.203 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.45 ' ND2' ' HD3' ' A' ' 45' ' ' ARG . 34.1 m-80 -146.22 -69.98 0.26 Allowed 'General case' 0 N--CA 1.515 2.82 0 N-CA-C 120.341 3.46 . . . . 0.0 120.341 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.11 -25.38 59.75 Favored Glycine 0 N--CA 1.506 3.352 0 N-CA-C 107.834 -2.107 . . . . 0.0 107.834 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.487 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -6.8 74.78 0.0 OUTLIER Glycine 0 N--CA 1.484 1.898 0 N-CA-C 118.842 2.297 . . . . 0.0 118.842 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.302 -1.46 0 N-CA-C 100.429 -3.915 . . . . 0.0 100.429 179.617 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.4 ptm . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 123.193 1.473 . . . . 0.0 108.93 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -76.2 113.67 14.01 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -94.8 21.85 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.174 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.456 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.6 OUTLIER -37.63 -38.94 0.29 Allowed 'General case' 0 N--CA 1.514 2.764 0 CA-C-O 123.117 1.437 . . . . 0.0 109.267 -179.71 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -31.09 -43.63 0.05 Allowed 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 109.927 -3.306 . . . . 0.0 111.477 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.95 -38.18 3.11 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 111.152 -2.749 . . . . 0.0 109.998 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -145.98 -82.44 0.14 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 119.432 3.123 . . . . 0.0 119.432 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.1 p -150.95 -139.63 0.09 Allowed 'General case' 0 N--CA 1.509 2.495 0 C-N-CA 118.639 -1.224 . . . . 0.0 110.732 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.524 ' CE2' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -95.36 138.74 32.64 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 179.39 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.5 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.331 0.4 OUTLIER -150.47 178.79 8.71 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 112.2 -2.273 . . . . 0.0 110.332 -179.403 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.487 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -122.68 142.46 50.65 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.06 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.84 110.75 22.79 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 100.867 -3.753 . . . . 0.0 100.867 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 37' ' ' TYR . 76.2 m -84.27 -119.86 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.413 -1.315 . . . . 0.0 112.792 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.555 HG13 ' CD2' ' A' ' 37' ' ' TYR . 9.1 p -144.07 165.05 14.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 122.646 1.212 . . . . 0.0 110.806 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -52.65 -18.83 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 CA-C-N 112.135 -2.302 . . . . 0.0 107.73 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -105.55 -15.17 19.8 Favored Glycine 0 N--CA 1.482 1.742 0 CA-C-O 117.563 -1.687 . . . . 0.0 115.716 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.555 ' CD2' HG13 ' A' ' 34' ' ' VAL . 3.9 m-85 -131.87 123.96 28.57 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.9 t -132.73 -147.57 0.31 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 87.48 -50.08 3.99 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.412 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER 136.59 -9.53 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.025 0 O-C-N 126.923 2.19 . . . . 0.0 109.002 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.463 ' NH2' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -114.31 -26.07 8.16 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.3 -178.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 1.2 m 79.82 35.88 0.14 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.537 ' NE2' ' CG2' ' A' ' 44' ' ' THR . 2.9 pp0? -88.82 -24.71 22.51 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 110.702 -2.954 . . . . 0.0 105.97 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.537 ' CG2' ' NE2' ' A' ' 43' ' ' GLN . 1.0 OUTLIER -106.31 89.73 3.14 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 102.469 -3.16 . . . . 0.0 102.469 179.749 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.45 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 4.3 mtm180 -84.93 90.8 7.89 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 101.572 -3.492 . . . . 0.0 101.572 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' GLY . 29.3 t70 -59.25 -20.1 51.42 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 111.693 -2.503 . . . . 0.0 107.882 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.881 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo . . . . . 0 N--CA 1.499 1.817 0 CA-C-O 121.004 0.335 . . . . 0.0 111.506 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.22 -20.87 47.18 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.829 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 t -158.08 133.25 8.69 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.501 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 3.4 p90 -128.5 36.99 4.19 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.742 1.258 . . . . 0.0 108.05 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -100.45 130.3 46.52 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 47.3 33.75 8.09 Favored Glycine 0 N--CA 1.506 3.338 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -91.77 -20.37 21.59 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 125.315 1.244 . . . . 0.0 112.315 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.2 m -118.56 158.31 25.65 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 103.318 -2.845 . . . . 0.0 103.318 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.424 HD13 ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -112.25 -36.69 5.24 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.427 ' ND2' ' HD3' ' A' ' 45' ' ' ARG . 39.8 m-80 -146.77 -77.05 0.18 Allowed 'General case' 0 N--CA 1.51 2.57 0 N-CA-C 119.053 2.983 . . . . 0.0 119.053 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.16 -23.56 69.86 Favored Glycine 0 N--CA 1.507 3.425 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.476 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -3.01 67.63 0.0 OUTLIER Glycine 0 N--CA 1.488 2.126 0 N-CA-C 122.1 3.6 . . . . 0.0 122.1 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.303 -1.451 1 N-CA-C 100.172 -4.01 . . . . 0.0 100.172 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.493 ' SD ' ' ND2' ' A' ' 32' ' ' ASN . 8.3 ptm . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 123.147 1.451 . . . . 0.0 109.166 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -68.16 117.56 10.15 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.486 ' O ' ' C ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -101.01 23.65 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.544 -179.532 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.486 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.7 OUTLIER -29.07 -49.25 0.08 Allowed 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 123.353 1.549 . . . . 0.0 109.034 -179.678 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -26.12 -49.29 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 108.656 -3.884 . . . . 0.0 113.165 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.51 -34.52 5.83 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 111.768 -2.469 . . . . 0.0 109.339 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -146.95 -81.12 0.14 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 23' ' ' ILE . 3.4 p -156.15 -132.07 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.468 -1.293 . . . . 0.0 110.129 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -98.45 137.17 37.53 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 179.67 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.541 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -148.57 -175.93 5.12 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 125.818 1.949 . . . . 0.0 110.246 -179.456 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.476 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -125.9 152.93 44.92 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.493 ' ND2' ' SD ' ' A' ' 21' ' ' MET . 4.0 t-20 -109.88 119.82 40.55 Favored 'General case' 0 C--N 1.298 -1.665 1 N-CA-C 96.346 -5.428 . . . . 0.0 96.346 179.612 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 37' ' ' TYR . 72.6 m -96.06 -111.89 0.14 Allowed 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 118.684 -1.206 . . . . 0.0 110.385 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.598 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 4.2 p -146.92 161.29 8.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 C-N-CA 118.617 -1.233 . . . . 0.0 108.139 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -46.62 -25.37 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 112.125 -2.307 . . . . 0.0 109.157 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -106.84 1.6 35.98 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 118.495 2.158 . . . . 0.0 118.495 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.598 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 5.5 m-30 -135.55 120.32 18.43 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 100.283 -3.969 . . . . 0.0 100.283 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.4 t -131.77 -150.41 0.42 Allowed 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.19 -40.12 3.0 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 122.59 4.23 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.563 0 C-N-CA 127.073 2.149 . . . . 0.0 107.945 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.442 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -127.69 -21.74 3.7 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.265 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER 77.0 35.79 0.35 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 -179.462 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.593 ' NE2' ' CG2' ' A' ' 44' ' ' THR . 2.7 pp0? -88.61 -21.47 23.99 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 111.423 -2.626 . . . . 0.0 107.307 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.593 ' CG2' ' NE2' ' A' ' 43' ' ' GLN . 1.7 t -113.5 87.85 2.7 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 102.117 -3.29 . . . . 0.0 102.117 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.427 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 8.3 mtm180 -84.3 88.31 7.24 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 101.504 -3.517 . . . . 0.0 101.504 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 36' ' ' GLY . 32.4 t70 -55.32 -27.35 46.42 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.787 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 75.5 mt . . . . . 0 N--CA 1.51 2.574 0 C-N-CA 128.101 2.56 . . . . 0.0 117.263 179.268 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 N--CA 1.504 2.112 0 N-CA-C 108.542 -1.368 . . . . 0.0 108.542 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -19.82 -54.81 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 110.801 -2.909 . . . . 0.0 117.621 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.89 116.71 19.05 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.582 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 2.7 p90 -114.5 2.47 14.62 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -70.38 140.47 52.12 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.34 42.37 2.48 Favored Glycine 0 N--CA 1.505 3.3 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.412 ' CD1' ' CZ ' ' A' ' 29' ' ' TYR . 35.9 t80 -91.17 -19.12 23.42 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 125.177 1.163 . . . . 0.0 113.258 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.406 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 35.6 m -116.21 154.85 29.35 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.14 -35.72 6.77 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.527 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 2.1 m-80 -141.35 -83.09 0.21 Allowed 'General case' 0 N--CA 1.51 2.571 0 N-CA-C 120.84 3.644 . . . . 0.0 120.84 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.87 -26.12 66.73 Favored Glycine 0 N--CA 1.508 3.48 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.61 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 6.97 65.68 0.01 OUTLIER Glycine 0 N--CA 1.481 1.649 0 CA-C-N 110.275 -2.963 . . . . 0.0 120.127 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.305 -1.33 0 N-CA-C 102.768 -3.049 . . . . 0.0 102.768 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.5 ptt? . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 102.815 -3.031 . . . . 0.0 102.815 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -111.16 127.73 55.68 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER -105.53 14.06 7.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 123.911 0.757 . . . . 0.0 110.644 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -20.12 -56.93 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.631 0 CA-C-O 123.893 1.806 . . . . 0.0 111.652 -179.028 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -26.26 -49.14 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.034 1 CA-C-N 108.259 -4.064 . . . . 0.0 113.723 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.37 -36.34 6.54 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 111.424 -2.625 . . . . 0.0 109.149 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -146.53 -81.14 0.15 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 23' ' ' ILE . 8.2 p -157.32 -132.7 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.951 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -97.21 140.56 31.52 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.551 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.264 0.5 OUTLIER -152.59 -177.89 6.51 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 112.753 -2.021 . . . . 0.0 109.578 -179.272 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.61 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -117.6 156.67 27.73 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -108.08 100.46 9.79 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 100.633 -3.84 . . . . 0.0 100.633 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.431 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 57.3 m -86.83 160.2 18.84 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.677 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.602 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 14.6 p -61.71 160.71 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-O 123.197 1.475 . . . . 0.0 111.658 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 tt -52.51 -19.49 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 111.423 -2.626 . . . . 0.0 109.946 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -101.91 -0.72 51.97 Favored Glycine 0 N--CA 1.491 2.328 0 CA-C-N 114.076 -1.42 . . . . 0.0 115.692 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.602 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 9.4 m-30 -133.67 118.59 18.34 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.421 ' C ' ' H ' ' A' ' 40' ' ' ASP . 35.3 t -132.44 -134.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.741 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 71.63 -10.81 3.65 Favored Glycine 0 N--CA 1.486 1.969 0 CA-C-O 117.709 -1.606 . . . . 0.0 111.634 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 17.7 t70 105.0 -8.24 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.144 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.561 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -138.35 -1.05 1.94 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.688 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 69.34 30.95 4.02 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 -179.199 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.561 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -89.04 -16.68 31.04 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.204 -1.816 . . . . 0.0 110.107 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . 0.258 5.1 t -118.4 92.9 3.94 Favored 'General case' 0 C--N 1.297 -1.692 1 N-CA-C 99.668 -4.197 . . . . 0.0 99.668 179.995 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 19.0 mtm180 -88.36 92.28 9.11 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 112.249 -2.25 . . . . 0.0 105.832 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 36' ' ' GLY . 28.6 t70 -56.2 -27.34 54.3 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 125.833 1.958 . . . . 0.0 109.914 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.498 1.937 0 O-C-N 126.066 2.104 . . . . 0.0 113.662 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo . . . . . 0 N--CA 1.495 1.585 0 CA-C-O 122.316 0.882 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.2 t -100.72 -21.84 15.08 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.977 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.5 t -156.53 125.84 6.13 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.451 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 9.3 p90 -123.49 30.82 6.12 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.688 1.232 . . . . 0.0 110.568 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -100.41 134.08 43.88 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.31 29.28 52.55 Favored Glycine 0 N--CA 1.506 3.327 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -91.25 -24.15 19.95 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.292 -1.454 . . . . 0.0 112.965 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.433 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 17.7 m -119.78 150.43 40.43 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -109.19 -37.5 5.77 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 -179.355 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -149.46 -67.71 0.21 Allowed 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.94 -20.41 79.73 Favored Glycine 0 N--CA 1.502 3.085 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.454 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -4.02 71.08 0.0 OUTLIER Glycine 0 N--CA 1.484 1.834 0 N-CA-C 121.748 3.459 . . . . 0.0 121.748 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 C--N 1.303 -1.42 0 N-CA-C 101.343 -3.577 . . . . 0.0 101.343 179.408 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.3 ptp . . . . . 0 N--CA 1.487 1.394 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.432 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 0.8 OUTLIER -108.2 123.14 48.29 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.472 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -103.2 18.61 4.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 124.635 1.21 . . . . 0.0 111.115 -179.741 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -25.94 -52.41 0.05 OUTLIER 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 123.8 1.762 . . . . 0.0 110.643 -179.402 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -25.83 -49.37 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 108.437 -3.983 . . . . 0.0 113.069 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.76 -34.91 6.12 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 111.233 -2.712 . . . . 0.0 110.246 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -147.2 -80.84 0.14 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 23' ' ' ILE . 9.6 p -159.34 -130.98 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.771 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -96.31 140.64 30.69 Favored 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.521 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -151.2 172.34 15.97 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.791 -179.217 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.454 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -116.32 131.45 56.94 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -89.49 121.83 32.09 Favored 'General case' 0 C--N 1.303 -1.443 1 N-CA-C 99.957 -4.09 . . . . 0.0 99.957 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 37' ' ' TYR . 82.2 m -90.95 -114.5 0.08 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 123.945 0.778 . . . . 0.0 112.215 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.535 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 7.2 p -153.77 164.58 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 C-N-CA 117.656 -1.618 . . . . 0.0 111.257 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -47.9 -24.26 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 112.052 -2.34 . . . . 0.0 107.41 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -99.92 -17.9 24.11 Favored Glycine 0 C--O 1.201 -1.951 0 CA-C-O 117.69 -1.616 . . . . 0.0 115.165 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.535 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 1.1 m-85 -128.46 128.56 44.65 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 121.697 2.749 . . . . 0.0 106.008 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 40' ' ' ASP . 12.6 t -130.77 -146.66 0.31 Allowed 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.95 -51.12 3.17 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 106.496 -2.642 . . . . 0.0 106.496 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 38' ' ' SER . 0.6 OUTLIER 128.32 4.97 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.663 0 O-C-N 127.958 2.799 . . . . 0.0 109.026 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.473 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -121.53 -27.98 4.67 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.651 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 1.9 m 85.54 37.73 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 104.327 -2.472 . . . . 0.0 104.327 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.547 ' NE2' ' CG2' ' A' ' 44' ' ' THR . 2.7 pp0? -88.17 -23.32 23.64 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 111.514 -2.585 . . . . 0.0 107.157 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.547 ' CG2' ' NE2' ' A' ' 43' ' ' GLN . 1.3 t -110.23 84.42 1.92 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 101.365 -3.569 . . . . 0.0 101.365 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -81.28 87.48 6.12 Favored 'General case' 0 C--N 1.299 -1.63 1 N-CA-C 99.28 -4.341 . . . . 0.0 99.28 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 36' ' ' GLY . 33.3 t70 -58.85 -25.66 63.46 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 112.111 -2.313 . . . . 0.0 107.355 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo . . . . . 0 N--CA 1.492 1.433 0 CA-C-O 122.031 0.763 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.9 t -100.47 -20.97 15.52 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.424 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.9 t -156.9 130.57 8.17 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.519 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 3.2 p90 -123.03 2.7 9.33 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.404 0.621 . . . . 0.0 111.82 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.29 122.57 13.55 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.11 36.95 93.13 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.722 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.52 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 22.4 t80 -91.24 -17.63 25.7 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.619 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.513 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 30.9 m -115.02 151.63 33.87 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.469 ' CD2' ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -108.31 -34.0 6.94 Favored 'General case' 0 N--CA 1.508 2.457 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.403 ' CB ' ' CD2' ' A' ' 37' ' ' TYR . 5.1 m-80 -142.07 -82.21 0.21 Allowed 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 120.355 3.465 . . . . 0.0 120.355 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.68 6.32 77.19 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 108.421 -1.871 . . . . 0.0 108.421 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.621 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -51.2 95.87 0.01 OUTLIER Glycine 0 C--N 1.303 -1.265 0 CA-C-N 112.847 -1.676 . . . . 0.0 113.508 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.291 -1.962 0 N-CA-C 102.85 -3.019 . . . . 0.0 102.85 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.534 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 4.3 ptm . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 102.343 -3.206 . . . . 0.0 102.343 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.438 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -110.3 126.56 54.33 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.46 ' O ' ' C ' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -104.51 14.19 7.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 124.329 1.018 . . . . 0.0 112.408 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -23.05 -56.81 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 122.889 1.328 . . . . 0.0 112.657 -179.095 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.7 m -28.03 -44.22 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 110.277 -3.147 . . . . 0.0 115.428 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.99 -37.0 5.5 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 111.428 -2.623 . . . . 0.0 109.834 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -145.19 -82.63 0.15 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 117.211 2.301 . . . . 0.0 117.211 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.475 ' OG ' ' N ' ' A' ' 29' ' ' TYR . 1.0 OUTLIER -156.3 -138.87 0.07 Allowed 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 119.259 -0.977 . . . . 0.0 109.953 -179.267 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.547 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -92.36 146.39 23.73 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 102.591 -3.115 . . . . 0.0 102.591 179.372 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.547 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -158.43 -176.43 5.89 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 125.793 1.933 . . . . 0.0 109.704 -179.607 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.621 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -121.37 153.41 37.82 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.772 -1.171 . . . . 0.0 108.446 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.534 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 53.5 t30 -106.85 85.45 2.15 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 59.5 m -60.72 167.27 2.82 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.513 -1.676 . . . . 0.0 112.04 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.513 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 11.1 p -71.98 161.64 4.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 117.804 -1.559 . . . . 0.0 108.92 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -51.68 -21.64 2.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-N 112.335 -2.211 . . . . 0.0 108.735 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -92.4 -27.55 15.04 Favored Glycine 0 C--O 1.2 -2.016 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.81 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.517 ' CD1' ' HA ' ' A' ' 45' ' ' ARG . 3.1 m-30 -110.57 142.4 42.44 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 121.476 2.638 . . . . 0.0 108.341 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.454 ' C ' ' H ' ' A' ' 40' ' ' ASP . 53.0 m -142.73 -137.18 0.1 Allowed 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.649 -1.22 . . . . 0.0 112.034 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 73.79 -16.98 2.31 Favored Glycine 0 N--CA 1.481 1.665 0 CA-C-O 116.623 -2.209 . . . . 0.0 110.356 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 17.6 t70 106.94 -6.83 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.133 0 O-C-N 125.126 1.133 . . . . 0.0 111.817 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.505 ' C ' ' SG ' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -135.52 -6.58 2.23 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -178.715 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.562 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 69.3 33.54 3.21 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 -179.325 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.481 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -88.1 -21.13 24.86 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 111.514 -2.584 . . . . 0.0 106.916 -179.669 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.401 ' CG2' ' O ' ' A' ' 44' ' ' THR . 10.9 t -114.87 114.27 25.29 Favored 'General case' 0 C--N 1.296 -1.754 1 N-CA-C 94.032 -6.285 . . . . 0.0 94.032 179.612 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.517 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 14.6 mtm180 -105.25 99.76 9.37 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 101.337 -3.579 . . . . 0.0 101.337 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 36' ' ' GLY . 44.5 t0 -85.54 70.34 10.75 Favored 'General case' 0 C--N 1.295 -1.769 1 N-CA-C 98.599 -4.593 . . . . 0.0 98.599 179.533 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.7 mt . . . . . 0 N--CA 1.496 1.85 0 N-CA-C 117.829 2.529 . . . . 0.0 117.829 -179.384 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo . . . . . 0 N--CA 1.493 1.46 0 CA-C-O 122.232 0.847 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 t -100.22 -22.14 15.25 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.983 -1.462 . . . . 0.0 107.827 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.5 p -151.63 121.53 7.08 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 118.092 -0.956 . . . . 0.0 108.809 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -116.11 -5.05 11.92 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.41 116.32 3.26 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.686 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.37 26.73 60.89 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.111 -1.519 . . . . 0.0 109.702 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.526 ' CE1' ' HA ' ' A' ' 30' ' ' THR . 26.3 t80 -91.28 -12.46 35.05 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 118.854 -1.139 . . . . 0.0 109.992 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.544 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 17.5 m -126.41 142.07 51.66 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.527 HD13 ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -100.83 -59.57 1.68 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -179.434 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.439 ' HB2' ' CD2' ' A' ' 37' ' ' TYR . 6.5 m-80 -134.72 -52.62 0.81 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 119.791 3.256 . . . . 0.0 119.791 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -100.85 -0.62 55.13 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.544 ' HA3' ' HB3' ' A' ' 14' ' ' CYS . . . -51.75 90.52 0.01 OUTLIER Glycine 0 N--CA 1.476 1.327 0 CA-C-O 123.976 1.876 . . . . 0.0 117.119 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.295 -1.785 1 N-CA-C 96.02 -5.548 . . . . 0.0 96.02 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.6 ptm . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.477 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -111.08 130.79 55.5 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 103.419 -2.808 . . . . 0.0 103.419 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.458 ' O ' ' C ' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -104.59 16.45 5.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 124.214 0.946 . . . . 0.0 112.084 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.477 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 1.0 OUTLIER -29.16 -50.91 0.1 Allowed 'General case' 0 N--CA 1.507 2.389 0 CA-C-O 122.582 1.182 . . . . 0.0 112.727 -179.161 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.8 m -31.31 -43.42 0.06 Allowed 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 111.087 -2.779 . . . . 0.0 113.804 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.61 -36.03 5.6 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 111.522 -2.581 . . . . 0.0 109.987 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -148.2 -83.55 0.11 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 118.846 2.906 . . . . 0.0 118.846 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 23' ' ' ILE . 5.1 p -148.92 -136.04 0.07 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.525 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.494 ' HE1' ' CG ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -101.4 147.87 25.83 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-N 118.584 0.629 . . . . 0.0 109.941 -179.593 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.526 ' HA ' ' CE1' ' A' ' 13' ' ' TYR . 0.7 OUTLIER -160.01 -173.72 4.21 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 118.587 2.81 . . . . 0.0 118.587 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.511 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -131.85 130.11 41.27 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.58 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -92.08 89.62 7.02 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 104.716 -2.328 . . . . 0.0 104.716 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 37' ' ' TYR . 30.2 m -72.72 -178.35 2.65 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.247 1.023 . . . . 0.0 108.922 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.495 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 10.9 p -89.81 166.81 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-O 123.979 1.847 . . . . 0.0 113.458 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 tt -56.29 -15.74 2.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-N 112.096 -2.32 . . . . 0.0 108.271 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -98.34 -12.63 44.57 Favored Glycine 0 N--CA 1.486 1.972 0 CA-C-N 113.929 -1.487 . . . . 0.0 113.716 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' A' ' 44' ' ' THR . 1.3 m-85 -135.24 130.51 35.32 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.436 ' O ' ' NE2' ' A' ' 43' ' ' GLN . 1.4 t -129.06 -161.23 1.09 Allowed 'General case' 0 N--CA 1.515 2.775 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 51.27 63.5 4.57 Favored Glycine 0 N--CA 1.499 2.865 0 N-CA-C 117.513 1.765 . . . . 0.0 117.513 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 43.71 -13.78 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.588 1 N-CA-C 122.16 4.133 . . . . 0.0 122.16 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.527 ' NE ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -113.82 -28.2 7.5 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.464 ' SG ' ' N ' ' A' ' 18' ' ' GLY . 2.7 m 82.01 43.86 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.436 ' NE2' ' O ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -88.8 -8.68 53.95 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 112.86 -1.973 . . . . 0.0 112.127 -179.235 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -120.83 94.12 4.25 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 102.121 -3.289 . . . . 0.0 102.121 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.429 ' C ' ' H ' ' A' ' 47' ' ' LEU . 7.2 mtm180 -83.78 86.52 7.13 Favored 'General case' 0 C--N 1.305 -1.329 1 N-CA-C 98.408 -4.664 . . . . 0.0 98.408 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 36' ' ' GLY . 1.3 t70 -59.96 -12.95 9.01 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 112.098 -2.319 . . . . 0.0 109.342 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' A' ' 45' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.903 0 C-N-CA 127.581 2.353 . . . . 0.0 116.709 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.503 2.059 0 N-CA-C 109.06 -1.169 . . . . 0.0 109.06 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -19.91 -49.84 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 111.061 -2.791 . . . . 0.0 116.555 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.2 t -139.78 127.41 21.73 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -123.57 34.06 5.19 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.05 130.9 46.25 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 104.678 -2.342 . . . . 0.0 104.678 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.81 40.31 2.17 Favored Glycine 0 N--CA 1.506 3.34 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.407 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 24.6 t80 -91.52 -22.08 20.55 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 126.098 1.705 . . . . 0.0 112.856 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.1 m -114.68 155.07 27.3 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -107.06 -37.14 6.39 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -179.575 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.499 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 3.5 m-80 -141.51 -85.54 0.18 Allowed 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 119.981 3.326 . . . . 0.0 119.981 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.98 -26.33 55.21 Favored Glycine 0 N--CA 1.512 3.716 0 N-CA-C 108.486 -1.845 . . . . 0.0 108.486 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.535 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 6.25 65.42 0.01 OUTLIER Glycine 0 N--CA 1.484 1.843 0 N-CA-C 121.504 3.362 . . . . 0.0 121.504 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.307 -1.261 0 N-CA-C 100.944 -3.725 . . . . 0.0 100.944 179.279 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.556 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 7.3 ptm . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 123.128 1.442 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -62.57 121.38 13.19 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 179.626 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -104.36 24.87 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 123.936 0.773 . . . . 0.0 110.31 -179.637 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.47 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.8 OUTLIER -34.77 -39.89 0.1 Allowed 'General case' 0 N--CA 1.509 2.487 0 CA-C-O 123.502 1.62 . . . . 0.0 110.195 -179.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.401 ' N ' ' C ' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -32.61 -46.26 0.13 Allowed 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 110.055 -3.248 . . . . 0.0 111.477 179.245 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.53 -34.53 4.86 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 111.672 -2.513 . . . . 0.0 110.396 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -148.09 -81.98 0.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 23' ' ' ILE . 2.5 p -152.76 -131.54 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.149 -1.02 . . . . 0.0 109.378 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.595 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -100.16 137.42 38.63 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.595 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -148.58 -176.34 5.28 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 112.449 -2.159 . . . . 0.0 110.266 -179.396 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.535 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -122.02 155.75 34.94 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.556 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 45.6 t30 -109.21 104.33 13.46 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 100.346 -3.946 . . . . 0.0 100.346 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 37' ' ' TYR . 60.8 m -89.22 169.86 11.09 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.499 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.583 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 8.9 p -68.79 159.56 5.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 123.264 1.507 . . . . 0.0 111.613 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tt -48.43 -21.71 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 111.177 -2.738 . . . . 0.0 109.914 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.554 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -106.64 3.73 36.72 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 118.026 1.971 . . . . 0.0 118.026 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.583 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 13.5 m-30 -133.44 116.81 16.47 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 100.461 -3.903 . . . . 0.0 100.461 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.425 ' C ' ' H ' ' A' ' 40' ' ' ASP . 39.9 t -132.54 -133.65 0.18 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 118.381 -1.328 . . . . 0.0 113.041 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 71.42 -9.87 4.12 Favored Glycine 0 N--CA 1.486 1.993 0 CA-C-O 117.764 -1.575 . . . . 0.0 111.293 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 19.6 t70 104.57 -5.24 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.073 0 O-C-N 124.967 1.039 . . . . 0.0 112.907 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.536 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -139.39 -2.96 1.56 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -178.754 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 71.17 30.9 2.56 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 -179.254 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.536 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -89.04 -15.02 35.09 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 113.119 -1.855 . . . . 0.0 110.191 -179.519 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . 0.26 6.0 t -118.99 83.07 1.96 Allowed 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 100.236 -3.987 . . . . 0.0 100.236 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -77.51 89.87 3.87 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 111.115 -2.766 . . . . 0.0 104.057 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 36' ' ' GLY . 0.9 OUTLIER -62.34 -16.89 57.09 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 113.017 -1.901 . . . . 0.0 109.773 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mt . . . . . 0 N--CA 1.507 2.388 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 179.205 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.496 1.626 0 N-CA-C 111.342 -0.292 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.5 t -20.14 -51.91 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 O-C-N 124.95 1.406 . . . . 0.0 113.535 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -156.31 154.83 31.26 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 102.421 -3.177 . . . . 0.0 102.421 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.486 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -125.32 10.77 8.03 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 124.768 1.292 . . . . 0.0 109.581 179.724 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.99 135.27 57.2 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 37.52 41.55 0.83 Allowed Glycine 0 N--CA 1.511 3.651 0 O-C-N 124.08 0.863 . . . . 0.0 111.511 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.412 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 20.9 t80 -91.24 -17.21 26.37 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 125.231 1.195 . . . . 0.0 112.589 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.432 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 44.6 m -116.92 154.13 31.36 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.15 -36.47 6.29 Favored 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.553 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 3.7 m-80 -140.58 -82.52 0.24 Allowed 'General case' 0 N--CA 1.51 2.555 0 N-CA-C 120.372 3.471 . . . . 0.0 120.372 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.82 -21.42 65.32 Favored Glycine 0 N--CA 1.508 3.462 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.575 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 2.95 67.46 0.0 OUTLIER Glycine 0 N--CA 1.481 1.696 0 N-CA-C 120.215 2.846 . . . . 0.0 120.215 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.305 -1.351 0 N-CA-C 101.423 -3.547 . . . . 0.0 101.423 179.332 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.43 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 8.2 ptm . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.411 ' CE1' ' HG2' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -102.71 126.71 49.92 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.487 ' O ' ' C ' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -106.6 18.92 5.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 124.412 1.07 . . . . 0.0 109.913 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.487 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -27.47 -52.96 0.07 Allowed 'General case' 0 N--CA 1.512 2.636 0 CA-C-O 123.405 1.574 . . . . 0.0 109.742 -179.421 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -25.08 -46.98 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 108.964 -3.743 . . . . 0.0 114.323 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.78 -35.52 5.45 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 110.916 -2.856 . . . . 0.0 110.026 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -147.03 -81.62 0.14 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 23' ' ' ILE . 4.5 p -157.44 -131.77 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.582 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -97.73 141.5 30.67 Favored 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.576 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.266 0.5 OUTLIER -153.31 -176.73 5.92 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.384 -1.735 . . . . 0.0 110.446 -179.277 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.575 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -120.48 148.95 43.15 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.43 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 43.3 t30 -101.61 101.0 11.47 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 101.417 -3.549 . . . . 0.0 101.417 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.511 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 59.5 m -86.71 156.6 19.9 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.116 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.583 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 12.5 p -59.94 160.38 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 112.591 -2.095 . . . . 0.0 114.266 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.7 tt -50.72 -21.85 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 CA-C-N 110.845 -2.889 . . . . 0.0 109.243 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -99.61 -6.83 54.49 Favored Glycine 0 N--CA 1.49 2.261 0 CA-C-N 114.202 -1.363 . . . . 0.0 115.929 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.583 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 5.9 m-85 -132.59 120.8 22.29 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.4 t -131.7 -137.98 0.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.629 -1.228 . . . . 0.0 111.087 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 74.88 -10.66 8.74 Favored Glycine 0 N--CA 1.481 1.688 0 CA-C-O 117.075 -1.958 . . . . 0.0 111.339 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 19.2 t70 105.07 -8.88 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.261 0 O-C-N 125.039 1.082 . . . . 0.0 113.065 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.553 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -137.86 -2.24 1.93 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -178.67 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 69.31 31.35 3.92 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 104.523 -2.399 . . . . 0.0 104.523 -179.254 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.553 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -88.81 -16.03 33.1 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 113.024 -1.898 . . . . 0.0 109.223 -179.39 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.4 t -119.45 88.84 3.01 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 101.397 -3.557 . . . . 0.0 101.397 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.9 mtp-105 -83.4 93.69 7.82 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 111.342 -2.663 . . . . 0.0 105.465 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 36' ' ' GLY . 26.0 t0 -62.07 -23.64 66.62 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 112.745 -2.025 . . . . 0.0 108.042 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-N 112.789 -2.005 . . . . 0.0 107.686 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo . . . . . 0 N--CA 1.498 1.747 0 CA-C-O 119.676 -0.218 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -19.81 -54.21 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 125.956 2.035 . . . . 0.0 113.177 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.8 t -146.99 154.47 41.28 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 103.669 -2.715 . . . . 0.0 103.669 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.524 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -127.06 12.12 7.13 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.183 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -55.81 129.7 40.51 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 35.35 46.04 0.71 Allowed Glycine 0 N--CA 1.508 3.487 0 O-C-N 124.744 1.277 . . . . 0.0 111.017 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.406 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 29.3 t80 -91.08 -17.6 25.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 125.752 1.501 . . . . 0.0 113.007 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.9 m -116.72 153.38 32.48 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.404 ' CD2' ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -106.28 -35.71 7.08 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -179.691 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.407 ' CB ' ' CD2' ' A' ' 37' ' ' TYR . 4.3 m-80 -144.12 -83.23 0.16 Allowed 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 119.107 3.003 . . . . 0.0 119.107 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -57.34 -27.0 57.48 Favored Glycine 0 N--CA 1.51 3.614 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.561 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 7.96 63.14 0.01 OUTLIER Glycine 0 N--CA 1.48 1.607 0 N-CA-C 120.304 2.882 . . . . 0.0 120.304 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.307 -1.262 0 N-CA-C 100.464 -3.902 . . . . 0.0 100.464 179.323 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.533 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 6.3 ptm . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 123.094 1.426 . . . . 0.0 108.807 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -63.78 118.36 8.22 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -99.98 26.18 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 123.751 0.657 . . . . 0.0 110.305 -179.448 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 23' ' ' ILE . 1.3 tm-20 -34.29 -41.86 0.12 Allowed 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 123.652 1.691 . . . . 0.0 109.713 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -31.19 -45.33 0.08 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 109.874 -3.33 . . . . 0.0 112.241 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.02 -33.73 4.63 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 111.841 -2.436 . . . . 0.0 110.305 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -149.32 -80.67 0.12 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 23' ' ' ILE . 2.4 p -153.86 -131.11 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 118.891 -1.124 . . . . 0.0 109.718 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -100.84 135.94 41.48 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.543 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -147.14 -177.56 5.74 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 112.333 -2.212 . . . . 0.0 109.705 -179.391 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.561 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -122.8 154.51 38.11 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 179.576 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.533 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 54.6 t30 -108.82 101.89 10.96 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 101.093 -3.669 . . . . 0.0 101.093 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 62.9 m -82.84 170.39 15.05 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 113.747 -1.57 . . . . 0.0 109.853 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.562 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 12.9 p -72.33 160.51 5.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 123.14 1.448 . . . . 0.0 111.859 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 tt -51.02 -19.03 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 111.657 -2.519 . . . . 0.0 108.94 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -94.3 -25.71 15.7 Favored Glycine 0 C--O 1.203 -1.839 0 CA-C-O 117.898 -1.501 . . . . 0.0 112.766 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.562 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 2.4 m-30 -115.1 124.64 52.05 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 119.428 1.614 . . . . 0.0 108.193 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 40' ' ' ASP . 23.1 t -131.62 -139.92 0.21 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.83 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 76.62 -12.62 10.08 Favored Glycine 0 N--CA 1.481 1.657 0 CA-C-O 117.555 -1.692 . . . . 0.0 110.1 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.522 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 31.0 t70 105.63 -6.11 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.062 0 O-C-N 125.04 1.082 . . . . 0.0 113.301 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.565 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -137.4 -4.17 1.88 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.515 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 72.2 32.4 1.73 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 -179.238 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.565 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -87.99 -20.07 26.34 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 113.328 -1.76 . . . . 0.0 110.575 -179.248 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . 0.256 6.1 t -113.67 83.5 1.86 Allowed 'General case' 0 C--N 1.295 -1.79 1 N-CA-C 98.893 -4.484 . . . . 0.0 98.893 179.955 . . . . . . . . 3 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.476 ' C ' ' H ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -76.0 89.34 2.97 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 101.944 -3.354 . . . . 0.0 101.944 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 36' ' ' GLY . 30.4 t70 -83.41 46.22 1.12 Allowed 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.476 ' H ' ' C ' ' A' ' 45' ' ' ARG . 41.1 mt . . . . . 0 N--CA 1.504 2.27 1 N-CA-C 122.114 4.116 . . . . 0.0 122.114 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo . . . . . 0 N--CA 1.493 1.474 0 N-CA-C 108.692 -1.311 . . . . 0.0 108.692 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.97 173.43 13.42 Favored Glycine 0 N--CA 1.498 2.807 0 C-N-CA 119.506 -1.331 . . . . 0.0 114.232 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ABA . . . . . 0.523 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.523 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 23.0 Cg_exo -58.2 -44.07 41.96 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 123.536 2.824 . . . . 0.0 110.093 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.1 t -19.94 -43.56 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 126.252 2.22 . . . . 0.0 116.238 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 t -146.49 127.38 14.46 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -122.06 35.93 4.76 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.09 131.96 45.74 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.1 40.16 1.7 Allowed Glycine 0 N--CA 1.51 3.569 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.44 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 26.4 t80 -91.87 -15.2 28.47 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 125.756 1.504 . . . . 0.0 114.191 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.4 m -128.47 156.62 42.93 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.402 ' CD2' ' HA ' ' A' ' 43' ' ' GLN . 1.1 mp -104.49 -33.09 8.69 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.438 ' ND2' ' CD ' ' A' ' 45' ' ' ARG . 4.6 m-80 -144.92 -81.65 0.16 Allowed 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 120.109 3.374 . . . . 0.0 120.109 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.12 -29.6 65.76 Favored Glycine 0 N--CA 1.507 3.429 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.402 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 5.02 66.99 0.01 OUTLIER Glycine 0 N--CA 1.483 1.767 0 CA-C-N 110.085 -3.058 . . . . 0.0 119.809 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 t -96.11 96.71 5.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 1 N-CA-C 99.175 -4.38 . . . . 0.0 99.175 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ABA . . . . . 0.502 ' CG ' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.553 ' SD ' HD11 ' A' ' 23' ' ' ILE . 2.5 ppp? -122.26 132.6 54.5 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 124.459 2.076 . . . . 0.0 109.964 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -70.86 117.24 12.12 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 113.238 -1.801 . . . . 0.0 107.497 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.553 HD11 ' SD ' ' A' ' 21' ' ' MET . 0.1 OUTLIER -100.93 24.88 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.006 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 23' ' ' ILE . 1.3 tm-20 -32.71 -46.84 0.15 Allowed 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 123.607 1.67 . . . . 0.0 108.458 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -26.11 -48.47 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 108.605 -3.907 . . . . 0.0 113.067 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.08 -33.99 5.2 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 111.357 -2.656 . . . . 0.0 109.996 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -146.82 -81.5 0.14 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 23' ' ' ILE . 6.3 p -156.16 -127.73 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.108 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -101.15 137.06 40.01 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.544 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -146.87 -174.54 4.52 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 112.312 -2.222 . . . . 0.0 109.297 -179.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.402 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -125.34 156.28 38.95 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -108.47 117.9 35.36 Favored 'General case' 0 C--N 1.298 -1.633 1 N-CA-C 98.102 -4.777 . . . . 0.0 98.102 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.548 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 81.9 m -98.57 166.22 11.45 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.574 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 7.1 p -64.87 158.11 4.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 C-N-CA 117.67 -1.612 . . . . 0.0 112.707 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -42.38 -28.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 111.52 -2.582 . . . . 0.0 110.682 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -99.06 -17.24 28.07 Favored Glycine 0 C--O 1.203 -1.784 0 CA-C-N 114.198 -1.365 . . . . 0.0 115.484 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.574 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 6.0 m-30 -111.96 124.92 53.41 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 40' ' ' ASP . 47.0 t -133.71 -130.38 0.17 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.237 -1.385 . . . . 0.0 112.362 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.501 ' C ' ' NE2' ' A' ' 43' ' ' GLN . . . 65.75 -2.56 3.5 Favored Glycine 0 N--CA 1.483 1.77 0 CA-C-O 117.699 -1.611 . . . . 0.0 109.815 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 8.8 t70 92.78 -2.48 0.13 Allowed 'General case' 0 N--CA 1.517 2.916 0 CA-C-N 118.268 1.034 . . . . 0.0 113.662 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.477 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -141.38 2.41 1.65 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.548 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 61.13 33.95 19.21 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 -179.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.501 ' NE2' ' C ' ' A' ' 39' ' ' GLY . 0.8 OUTLIER -88.71 -24.27 22.76 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 111.731 -2.486 . . . . 0.0 108.305 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.417 ' O ' ' CG2' ' A' ' 44' ' ' THR . 6.1 t -112.33 83.92 1.88 Allowed 'General case' 0 C--N 1.297 -1.678 1 N-CA-C 99.07 -4.418 . . . . 0.0 99.07 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.487 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 16.6 mtm180 -79.84 91.49 5.36 Favored 'General case' 0 C--N 1.296 -1.731 1 N-CA-C 100.11 -4.033 . . . . 0.0 100.11 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 36' ' ' GLY . 5.6 t70 -86.79 64.98 8.79 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -10.76 62.23 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 117.929 2.566 . . . . 0.0 117.929 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 46' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.264 -1.351 . . . . 0.0 112.575 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 0 N--CA 1.493 1.444 0 CA-C-O 121.643 0.601 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.34 164.53 9.92 Favored Glycine 0 N--CA 1.5 2.9 0 C-N-CA 119.999 -1.096 . . . . 0.0 113.202 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ABA . . . . . 0.448 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.448 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 7.9 Cg_exo -71.33 -35.08 8.9 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.944 2.43 . . . . 0.0 111.497 171.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -19.89 -53.83 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 125.332 1.645 . . . . 0.0 114.634 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 t -143.75 144.2 31.72 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 104.23 -2.508 . . . . 0.0 104.23 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.423 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 3.2 p90 -127.19 26.4 6.06 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 124.868 1.355 . . . . 0.0 109.845 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -100.06 133.26 44.7 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.37 24.69 61.77 Favored Glycine 0 N--CA 1.505 3.243 0 N-CA-C 107.662 -2.175 . . . . 0.0 107.662 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.402 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 10.2 t80 -91.1 -18.04 25.19 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 113.47 -1.365 . . . . 0.0 112.208 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.1 m -132.83 147.51 52.3 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.459 ' HB3' ' ND2' ' A' ' 16' ' ' ASN . 0.2 OUTLIER -104.0 -34.7 8.36 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -179.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.459 ' ND2' ' HB3' ' A' ' 15' ' ' LEU . 53.9 m-80 -147.86 -76.02 0.18 Allowed 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 120.403 3.483 . . . . 0.0 120.403 -178.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.72 -26.35 69.82 Favored Glycine 0 N--CA 1.508 3.496 0 N-CA-C 108.155 -1.978 . . . . 0.0 108.155 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.421 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -1.25 68.56 0.0 OUTLIER Glycine 0 N--CA 1.485 1.911 0 N-CA-C 120.672 3.029 . . . . 0.0 120.672 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.46 96.37 5.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 100.322 -3.955 . . . . 0.0 100.322 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ABA . . . . . 0.492 ' CG ' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.475 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 5.5 ptp -116.61 126.64 53.54 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 123.207 1.479 . . . . 0.0 108.984 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -72.41 113.35 9.35 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 103.406 -2.812 . . . . 0.0 103.406 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -95.38 27.14 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.113 -179.289 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.467 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.8 OUTLIER -37.84 -37.65 0.25 Allowed 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 123.439 1.59 . . . . 0.0 109.288 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.4 ' N ' ' C ' ' A' ' 23' ' ' ILE . 0.7 OUTLIER -33.31 -44.38 0.13 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 110.388 -3.097 . . . . 0.0 111.579 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.5 -32.98 4.18 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 111.659 -2.519 . . . . 0.0 111.1 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -149.5 -80.04 0.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 118.124 2.639 . . . . 0.0 118.124 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.9 p -153.46 -133.52 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 119.098 -1.041 . . . . 0.0 109.834 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -100.09 135.95 40.73 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 179.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.526 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -147.65 -176.42 5.25 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 112.841 -1.981 . . . . 0.0 109.994 -179.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.421 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -125.18 150.07 47.32 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.475 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 14.5 t30 -106.36 123.71 48.47 Favored 'General case' 0 C--N 1.299 -1.599 1 N-CA-C 97.348 -5.056 . . . . 0.0 97.348 179.366 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 72.1 m -96.59 -117.73 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.582 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.575 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 7.4 p -149.52 166.84 3.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 117.815 -1.554 . . . . 0.0 111.151 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tt -50.74 -19.68 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 112.247 -2.251 . . . . 0.0 107.747 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -104.27 -14.11 25.02 Favored Glycine 0 C--O 1.202 -1.848 0 CA-C-N 113.521 -1.672 . . . . 0.0 115.285 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.575 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 1.9 m-85 -131.66 125.64 32.64 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.445 ' C ' ' H ' ' A' ' 40' ' ' ASP . 11.1 t -129.74 -148.27 0.36 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.82 -48.15 3.01 Favored Glycine 0 N--CA 1.502 3.049 0 N-CA-C 106.89 -2.484 . . . . 0.0 106.89 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.445 ' H ' ' C ' ' A' ' 38' ' ' SER . 0.5 OUTLIER 122.81 8.68 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 C-N-CA 129.788 3.235 . . . . 0.0 108.186 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -127.27 -7.18 5.88 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.366 0.603 . . . . 0.0 110.83 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.45 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 62.51 38.32 12.65 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 124.236 1.969 . . . . 0.0 107.564 -179.211 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.458 ' H ' ' HG3' ' A' ' 43' ' ' GLN . 0.5 OUTLIER -88.23 -38.26 15.4 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 109.236 -3.62 . . . . 0.0 105.76 -179.708 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 37' ' ' TYR . 1.9 t -96.35 85.33 3.91 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 102.048 -3.316 . . . . 0.0 102.048 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -82.61 84.69 7.18 Favored 'General case' 0 C--N 1.299 -1.626 1 N-CA-C 99.791 -4.152 . . . . 0.0 99.791 179.886 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 36' ' ' GLY . 30.1 t70 -55.49 -28.91 57.47 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 112.192 -2.276 . . . . 0.0 108.4 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 88.32 -139.03 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 127.068 2.147 . . . . 0.0 108.209 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.7 ptm85 . . . . . 0 N--CA 1.509 2.511 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -179.829 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo . . . . . 0 N--CA 1.493 1.442 0 N-CA-C 107.441 -1.792 . . . . 0.0 107.441 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.07 177.6 15.12 Favored Glycine 0 N--CA 1.499 2.882 0 C-N-CA 119.054 -1.546 . . . . 0.0 112.26 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ABA . . . . . 0.577 ' C ' ' H ' ' A' ' 8' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 73.6 Cg_endo -76.47 23.09 0.49 Allowed 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 123.746 2.964 . . . . 0.0 112.679 -167.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.577 ' H ' ' C ' ' A' ' 6' ' ' ABA . 5.1 t -100.68 -25.15 14.24 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 113.391 -1.731 . . . . 0.0 106.406 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.9 t -155.88 133.82 11.28 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.481 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 3.0 p90 -124.09 19.59 9.13 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 122.896 1.331 . . . . 0.0 108.579 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.69 129.85 40.23 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.406 ' O ' ' NH1' ' A' ' 41' ' ' ARG . . . 36.36 50.6 1.31 Allowed Glycine 0 N--CA 1.501 2.972 0 O-C-N 125.415 1.697 . . . . 0.0 109.595 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.438 ' CD1' ' CZ ' ' A' ' 29' ' ' TYR . 48.4 t80 -92.45 -14.9 27.84 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.5 m -122.67 162.72 21.43 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -117.29 -37.31 3.55 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.458 ' ND2' ' HD3' ' A' ' 45' ' ' ARG . 18.0 m-80 -146.69 -67.63 0.27 Allowed 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 119.765 3.246 . . . . 0.0 119.765 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.75 -24.99 76.48 Favored Glycine 0 N--CA 1.506 3.325 0 N-CA-C 106.474 -2.651 . . . . 0.0 106.474 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.501 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 0.97 59.88 0.0 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 120.56 2.984 . . . . 0.0 120.56 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.1 95.21 5.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 101.22 -3.622 . . . . 0.0 101.22 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ABA . . . . . 0.419 ' CG ' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.417 ' SD ' ' ND2' ' A' ' 32' ' ' ASN . 14.6 ptt? -128.23 113.79 16.13 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.475 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -63.0 122.89 17.15 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 102.535 -3.135 . . . . 0.0 102.535 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.469 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -101.1 25.69 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 124.098 0.874 . . . . 0.0 109.96 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.475 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 1.1 tm-20 -34.15 -42.94 0.14 Allowed 'General case' 0 N--CA 1.509 2.518 0 CA-C-O 123.21 1.481 . . . . 0.0 109.516 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -29.93 -49.9 0.11 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 109.56 -3.473 . . . . 0.0 111.86 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.05 -28.45 6.99 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 111.383 -2.644 . . . . 0.0 112.122 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -149.89 -79.42 0.13 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 29' ' ' TYR . 3.5 p -156.05 -131.94 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.23 -1.804 . . . . 0.0 110.31 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.545 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -101.64 135.68 42.76 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 123.012 1.387 . . . . 0.0 109.697 179.708 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.545 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -148.37 -176.59 5.36 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 112.23 -2.259 . . . . 0.0 111.951 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.501 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -125.63 154.34 42.45 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.417 ' ND2' ' SD ' ' A' ' 21' ' ' MET . 6.2 t-20 -109.64 98.24 7.64 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 37' ' ' TYR . 55.8 m -93.07 150.33 20.6 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.564 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 9.9 p -59.51 169.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 111.758 -2.474 . . . . 0.0 117.143 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -21.07 17.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 111.497 -2.592 . . . . 0.0 107.146 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -94.56 -8.84 59.36 Favored Glycine 0 N--CA 1.482 1.733 0 CA-C-N 114.218 -1.355 . . . . 0.0 113.161 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.564 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 1.4 m-85 -141.19 126.25 18.34 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 116.496 -1.716 . . . . 0.0 107.799 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.412 ' O ' ' NE2' ' A' ' 43' ' ' GLN . 8.5 t -124.14 -144.43 0.33 Allowed 'General case' 0 N--CA 1.518 2.966 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 41' ' ' ARG . . . 35.97 69.81 0.23 Allowed Glycine 0 N--CA 1.501 2.999 0 C-N-CA 124.441 1.019 . . . . 0.0 114.237 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 29.92 8.91 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 119.547 3.165 . . . . 0.0 119.547 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -132.19 -25.16 2.02 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.794 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.446 ' HB3' ' CB ' ' A' ' 37' ' ' TYR . 1.8 m 76.8 40.53 0.2 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.492 HE22 ' CG2' ' A' ' 44' ' ' THR . 0.0 OUTLIER -88.74 -20.7 24.45 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 112.749 -2.023 . . . . 0.0 109.437 -179.464 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.492 ' CG2' HE22 ' A' ' 43' ' ' GLN . 0.6 OUTLIER -113.0 92.87 4.16 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 102.21 -3.255 . . . . 0.0 102.21 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.458 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 6.7 mtm180 -84.93 85.84 7.43 Favored 'General case' 0 C--N 1.299 -1.597 1 N-CA-C 99.238 -4.356 . . . . 0.0 99.238 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 36' ' ' GLY . 13.9 t0 -60.67 -12.97 11.9 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 112.531 -2.122 . . . . 0.0 109.264 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.413 ' H ' ' C ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER 70.17 -29.46 0.18 Allowed 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 128.156 2.582 . . . . 0.0 117.751 179.321 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.4 ' H ' ' C ' ' A' ' 46' ' ' ASP . 26.9 mtp180 . . . . . 0 N--CA 1.511 2.579 0 O-C-N 126.261 2.226 . . . . 0.0 114.112 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 N--CA 1.492 1.402 0 N-CA-C 108.882 -1.238 . . . . 0.0 108.882 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 124.97 -169.15 16.93 Favored Glycine 0 N--CA 1.499 2.843 0 C-N-CA 120.414 -0.898 . . . . 0.0 110.875 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ABA . . . . . 0.563 ' C ' ' H ' ' A' ' 8' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.536 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 39.2 Cg_endo -81.87 33.99 0.54 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.911 2.407 . . . . 0.0 110.274 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.563 ' H ' ' C ' ' A' ' 6' ' ' ABA . 5.4 t -100.57 -29.0 12.58 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 113.682 -1.599 . . . . 0.0 106.824 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -166.46 152.75 8.8 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.478 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -129.55 14.58 6.01 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 124.659 1.224 . . . . 0.0 110.411 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -63.35 137.83 58.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.36 37.99 1.29 Allowed Glycine 0 N--CA 1.511 3.672 0 O-C-N 124.258 0.974 . . . . 0.0 111.133 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.489 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 30.5 t80 -90.4 -8.35 50.86 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 113.597 -1.301 . . . . 0.0 112.815 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.7 m -137.07 152.45 50.05 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.13 -72.75 0.6 Allowed 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.41 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.507 ' C ' ' H ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -121.81 -56.66 1.85 Allowed 'General case' 0 N--CA 1.512 2.674 0 N-CA-C 115.667 1.728 . . . . 0.0 115.667 -179.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 33' ' ' CYS . . . -86.81 44.29 3.31 Favored Glycine 0 N--CA 1.503 3.115 0 N-CA-C 105.913 -2.875 . . . . 0.0 105.913 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.533 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -68.82 67.39 0.45 Allowed Glycine 0 C--N 1.29 -2.019 0 CA-C-N 112.479 -1.861 . . . . 0.0 116.084 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.2 t -90.67 85.27 2.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 103.52 -2.77 . . . . 0.0 103.52 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ABA . . . . . 0.48 ' CG ' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.0 ptm -120.25 -179.28 3.9 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.469 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -111.7 126.5 55.1 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.194 -1.402 . . . . 0.0 107.696 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.484 ' N ' ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -106.78 23.11 3.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 124.189 0.931 . . . . 0.0 111.308 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.469 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.4 OUTLIER -38.1 -37.31 0.26 Allowed 'General case' 0 N--CA 1.515 2.816 0 CA-C-O 123.421 1.582 . . . . 0.0 110.157 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -33.26 -43.27 0.11 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 110.227 -3.17 . . . . 0.0 111.914 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.35 -34.66 3.77 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 111.335 -2.666 . . . . 0.0 111.3 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -147.28 -82.47 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 23' ' ' ILE . 26.7 p -154.52 -125.59 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.831 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.517 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -98.76 139.44 34.45 Favored 'General case' 0 N--CA 1.51 2.547 0 CA-C-O 122.394 1.092 . . . . 0.0 110.199 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.517 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -148.56 178.96 8.17 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 112.843 -1.98 . . . . 0.0 111.438 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.533 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -115.12 154.6 28.63 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 103.09 -2.93 . . . . 0.0 103.09 179.269 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.88 86.59 2.31 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.664 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 34.8 m -59.38 151.91 22.56 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.913 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.548 HG13 ' CD2' ' A' ' 37' ' ' TYR . 7.5 p -59.36 157.12 2.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 111.589 -2.55 . . . . 0.0 112.158 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tt -43.16 -25.61 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 112.344 -2.207 . . . . 0.0 110.063 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 34' ' ' VAL . . . -98.33 -24.1 11.78 Favored Glycine 0 N--CA 1.485 1.931 0 CA-C-N 114.6 -1.182 . . . . 0.0 115.256 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.548 ' CD2' HG13 ' A' ' 34' ' ' VAL . 1.3 m-30 -111.57 133.05 54.1 Favored 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 102.862 -3.014 . . . . 0.0 102.862 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.6 t -139.2 -137.04 0.13 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 118.403 -1.319 . . . . 0.0 111.175 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 75.74 -10.5 13.06 Favored Glycine 0 N--CA 1.48 1.621 0 CA-C-O 117.905 -1.497 . . . . 0.0 109.513 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 21.6 t70 102.06 -15.66 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.048 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.606 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -134.43 6.9 3.56 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.216 -179.285 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.664 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 59.48 32.51 21.76 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.261 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.606 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -88.13 5.55 40.76 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.256 -179.426 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.452 ' O ' ' C ' ' A' ' 45' ' ' ARG . 12.1 t -130.08 22.33 5.3 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.518 -1.674 . . . . 0.0 113.632 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.452 ' C ' ' O ' ' A' ' 44' ' ' THR . 1.0 OUTLIER -16.56 90.32 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 O-C-N 125.36 1.662 . . . . 0.0 112.252 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.79 2.62 9.69 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 117.844 -1.542 . . . . 0.0 111.002 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 mt 67.63 -152.05 0.18 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.241 0 CA-C-O 114.14 -2.838 . . . . 0.0 113.112 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.493 1.496 0 N-CA-C 110.505 -0.613 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -119.99 161.79 14.29 Favored Glycine 0 N--CA 1.496 2.679 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.83 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ABA . . . . . 0.462 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 8.4 Cg_endo -73.39 -42.68 0.85 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.42 2.08 . . . . 0.0 111.882 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -19.86 -53.7 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 126.542 2.401 . . . . 0.0 115.172 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.55 125.38 22.54 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.392 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.424 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 1.4 p90 -110.51 4.42 20.41 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.851 1.31 . . . . 0.0 110.747 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.65 129.2 38.16 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 113.607 -1.633 . . . . 0.0 106.974 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 34.46 46.17 0.53 Allowed Glycine 0 N--CA 1.511 3.637 0 O-C-N 124.423 1.077 . . . . 0.0 111.414 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -91.44 -20.26 21.96 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 125.935 1.609 . . . . 0.0 112.611 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.8 m -116.92 153.82 31.91 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.407 ' CD2' ' HA ' ' A' ' 43' ' ' GLN . 0.3 OUTLIER -100.58 -36.53 9.13 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -144.67 -82.05 0.16 Allowed 'General case' 0 N--CA 1.51 2.572 1 N-CA-C 121.876 4.028 . . . . 0.0 121.876 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.25 -31.9 59.78 Favored Glycine 0 N--CA 1.515 3.924 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.474 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 7.8 69.47 0.01 OUTLIER Glycine 0 N--CA 1.486 1.969 0 CA-C-N 109.67 -3.265 . . . . 0.0 120.847 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.7 t -97.84 96.53 5.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 1 N-CA-C 98.67 -4.567 . . . . 0.0 98.67 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ABA . . . . . 0.532 ' CG ' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 13.5 ptt? -119.88 121.72 39.67 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 122.974 1.369 . . . . 0.0 108.497 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -64.59 119.58 10.76 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.474 ' O ' ' C ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -101.18 20.93 2.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 123.513 0.508 . . . . 0.0 109.684 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -26.26 -50.51 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 123.097 1.427 . . . . 0.0 109.603 -179.457 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -25.9 -49.06 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 108.829 -3.805 . . . . 0.0 113.333 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.91 -33.82 5.95 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 111.476 -2.602 . . . . 0.0 110.405 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -146.84 -80.24 0.15 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.5 p -156.8 -132.13 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.762 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -99.02 137.94 36.82 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.564 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.267 0.6 OUTLIER -148.26 -174.73 4.66 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 112.863 -1.971 . . . . 0.0 109.419 -179.615 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.474 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -124.7 157.47 35.56 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -109.33 116.4 31.78 Favored 'General case' 0 C--N 1.298 -1.649 1 N-CA-C 96.069 -5.53 . . . . 0.0 96.069 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 37' ' ' TYR . 66.0 m -94.62 -124.71 0.11 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 118.601 -0.714 . . . . 0.0 111.023 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.54 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 5.7 p -139.64 160.28 27.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 117.787 -1.565 . . . . 0.0 109.095 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -47.51 -24.0 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 111.895 -2.411 . . . . 0.0 108.1 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -97.37 -20.25 23.25 Favored Glycine 0 C--O 1.203 -1.833 0 CA-C-O 117.716 -1.602 . . . . 0.0 114.814 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.54 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 2.1 m-30 -123.74 125.84 45.45 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 120.764 2.282 . . . . 0.0 106.805 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.426 ' C ' ' H ' ' A' ' 40' ' ' ASP . 47.8 t -138.17 -131.34 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.487 -1.285 . . . . 0.0 111.334 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 68.89 -6.54 3.68 Favored Glycine 0 N--CA 1.487 2.042 0 CA-C-O 117.988 -1.451 . . . . 0.0 111.513 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 11.8 t70 102.14 -12.7 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.036 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.514 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.2 OUTLIER -133.8 4.01 3.55 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.54 -178.656 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 62.72 32.07 16.29 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.514 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -89.18 -19.91 24.87 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 112.743 -2.026 . . . . 0.0 107.099 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.94 82.15 1.65 Allowed 'General case' 0 N--CA 1.488 1.461 1 N-CA-C 100.144 -4.021 . . . . 0.0 100.144 179.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.414 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 12.8 mtm180 -76.47 89.3 3.24 Favored 'General case' 0 C--N 1.296 -1.757 1 N-CA-C 99.129 -4.396 . . . . 0.0 99.129 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 36' ' ' GLY . 25.1 t70 -62.81 -25.6 68.33 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 117.344 -1.742 . . . . 0.0 108.832 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 46' ' ' ASP . 0.2 OUTLIER 89.28 -157.71 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 128.042 2.537 . . . . 0.0 108.436 179.656 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.509 2.492 0 CA-C-O 116.054 -1.927 . . . . 0.0 110.541 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo . . . . . 0 N--CA 1.491 1.369 0 N-CA-C 109.265 -1.09 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -119.55 167.38 13.38 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 107.068 -2.413 . . . . 0.0 107.068 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ABA . . . . . 0.463 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 5.5 Cg_exo -65.91 -47.33 3.81 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 122.049 1.833 . . . . 0.0 108.147 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -19.93 -51.42 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 110.066 -3.243 . . . . 0.0 118.251 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.2 p -126.44 108.88 11.6 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.286 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -115.08 0.9 13.77 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -85.26 89.45 7.66 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.987 1.375 . . . . 0.0 110.173 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.35 28.81 4.47 Favored Glycine 0 N--CA 1.501 2.97 0 N-CA-C 106.958 -2.457 . . . . 0.0 106.958 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.451 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 20.6 t80 -90.57 -11.07 41.13 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.527 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 60.5 m -126.8 151.21 48.58 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.404 ' HB3' ' ND2' ' A' ' 16' ' ' ASN . 0.3 OUTLIER -104.38 -38.31 6.88 Favored 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.418 ' HB2' ' CD2' ' A' ' 37' ' ' TYR . 38.3 m-80 -147.07 -66.66 0.27 Allowed 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 120.621 3.563 . . . . 0.0 120.621 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.97 19.59 52.55 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.636 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -65.56 96.02 0.24 Allowed Glycine 0 C--N 1.295 -1.726 0 CA-C-O 124.39 2.106 . . . . 0.0 115.826 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.05 102.98 14.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 101.08 -3.674 . . . . 0.0 101.08 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ABA . . . . . 0.472 ' CG ' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.527 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 4.3 ptm -134.88 161.3 35.61 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 101.9 -3.37 . . . . 0.0 101.9 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -103.99 127.94 51.54 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.476 ' O ' ' C ' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -105.79 21.07 3.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 123.918 0.761 . . . . 0.0 109.718 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -29.58 -49.29 0.09 Allowed 'General case' 0 N--CA 1.509 2.478 0 CA-C-O 123.528 1.632 . . . . 0.0 109.645 -179.303 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -26.88 -48.48 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.676 1 CA-C-N 108.362 -4.017 . . . . 0.0 113.34 179.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.85 -34.12 5.87 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 111.036 -2.802 . . . . 0.0 110.673 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -147.74 -79.87 0.15 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 29' ' ' TYR . 1.7 p -156.67 -134.48 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.806 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.57 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -97.55 138.56 34.78 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.57 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.273 0.5 OUTLIER -149.3 -179.17 6.85 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 112.875 -1.966 . . . . 0.0 111.757 -179.197 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.636 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -116.1 151.91 34.65 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.527 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 43.8 t30 -104.13 76.81 1.37 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.543 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 33.5 m -64.1 152.39 40.59 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.678 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.513 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 7.4 p -59.67 160.99 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 111.811 -2.449 . . . . 0.0 114.441 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 tt -51.72 -21.6 2.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 111.51 -2.587 . . . . 0.0 108.784 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -95.34 -14.38 48.21 Favored Glycine 0 N--CA 1.491 2.366 0 CA-C-N 114.201 -1.363 . . . . 0.0 115.297 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.513 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 2.1 m-85 -131.89 127.41 36.4 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.3 t -136.81 -135.46 0.14 Allowed 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 118.304 -1.358 . . . . 0.0 108.744 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 69.52 0.94 26.83 Favored Glycine 0 N--CA 1.48 1.603 0 CA-C-O 116.707 -2.163 . . . . 0.0 111.701 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 5.1 t70 94.65 -11.7 0.11 Allowed 'General case' 0 N--CA 1.52 3.068 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.486 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -138.02 -2.65 1.86 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.543 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 67.85 31.47 5.75 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -179.462 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.486 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -89.04 -19.55 25.5 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 111.878 -2.419 . . . . 0.0 108.652 -179.755 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.407 ' O ' ' CG2' ' A' ' 44' ' ' THR 0.266 2.3 t -115.14 89.89 3.21 Favored 'General case' 0 C--N 1.296 -1.723 1 N-CA-C 98.541 -4.615 . . . . 0.0 98.541 179.863 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.5 mtm180 -87.61 93.25 9.37 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 101.77 -3.419 . . . . 0.0 101.77 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 36' ' ' GLY . 31.7 t70 -64.73 -20.31 66.27 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.0 -1.455 . . . . 0.0 108.114 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 mt 75.64 -145.51 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 126.414 1.886 . . . . 0.0 107.572 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.39 0 CA-C-O 113.645 -3.074 . . . . 0.0 113.676 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo . . . . . 0 N--CA 1.496 1.647 0 CA-C-O 122.111 0.796 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 124.35 -169.35 16.41 Favored Glycine 0 N--CA 1.499 2.859 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ABA . . . . . 0.554 ' C ' ' H ' ' A' ' 8' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 95.5 Cg_endo -85.68 36.68 0.54 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 123.323 2.682 . . . . 0.0 108.943 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.554 ' H ' ' C ' ' A' ' 6' ' ' ABA . 47.6 t -100.99 -26.05 13.86 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.206 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.3 t -173.27 151.96 2.14 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.533 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -129.84 12.6 5.77 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 124.41 1.068 . . . . 0.0 110.744 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -62.27 136.33 57.88 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 37.95 41.54 0.97 Allowed Glycine 0 N--CA 1.512 3.741 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 29' ' ' TYR . 37.3 t80 -91.71 -13.77 31.12 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 125.591 1.406 . . . . 0.0 113.231 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.453 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 33.7 m -121.79 155.08 36.08 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -37.91 5.9 Favored 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.526 HD22 ' CZ ' ' A' ' 45' ' ' ARG . 25.7 m-80 -143.12 -80.57 0.2 Allowed 'General case' 0 N--CA 1.514 2.752 0 N-CA-C 119.471 3.137 . . . . 0.0 119.471 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.05 -24.6 63.19 Favored Glycine 0 N--CA 1.51 3.61 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.626 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 4.55 63.92 0.0 OUTLIER Glycine 0 N--CA 1.481 1.662 0 N-CA-C 120.823 3.089 . . . . 0.0 120.823 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.8 t -94.24 96.32 5.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 102.4 -3.185 . . . . 0.0 102.4 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ABA . . . . . 0.486 ' CG ' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.485 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 9.6 ptm -122.08 172.92 7.89 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.423 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -109.34 129.0 55.54 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.451 ' O ' ' C ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -106.09 13.94 7.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 124.039 0.837 . . . . 0.0 111.87 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -22.78 -54.88 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 124.815 1.322 . . . . 0.0 112.008 -179.41 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.6 m -26.52 -45.18 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 110.921 -2.854 . . . . 0.0 114.3 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.53 -36.98 5.61 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 111.361 -2.654 . . . . 0.0 109.939 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -147.96 -81.77 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.2 p -156.87 -133.25 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.436 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.533 ' CE2' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -96.25 139.48 32.33 Favored 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.474 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -147.92 178.72 8.28 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 113.073 -1.876 . . . . 0.0 109.95 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.626 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -118.15 146.64 44.03 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.485 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 56.9 t30 -99.55 104.61 16.42 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 101.558 -3.497 . . . . 0.0 101.558 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 61.6 m -84.13 177.38 8.25 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.988 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.576 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 14.5 p -80.3 159.54 4.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 123.003 1.383 . . . . 0.0 112.712 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -46.84 -22.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-N 111.618 -2.537 . . . . 0.0 108.99 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -97.2 -15.88 37.01 Favored Glycine 0 C--O 1.203 -1.783 0 CA-C-N 113.615 -1.63 . . . . 0.0 116.534 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.576 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 4.4 m-30 -123.52 121.41 35.59 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 103.535 -2.765 . . . . 0.0 103.535 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.408 ' C ' ' H ' ' A' ' 40' ' ' ASP . 15.2 t -130.1 -142.54 0.24 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.385 1.088 . . . . 0.0 113.306 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 40' ' ' ASP . . . 86.33 -47.84 3.82 Favored Glycine 0 C--N 1.301 -1.406 0 N-CA-C 106.514 -2.634 . . . . 0.0 106.514 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER 139.31 -6.68 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.983 0 O-C-N 126.807 2.122 . . . . 0.0 112.291 -179.569 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.651 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -134.58 -1.9 2.76 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.14 -178.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.54 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 69.64 35.36 2.45 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 104.991 -2.225 . . . . 0.0 104.991 -179.28 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.651 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -89.06 -13.74 37.98 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 112.599 -2.091 . . . . 0.0 108.846 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 t -122.54 92.62 3.75 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 103.07 -2.937 . . . . 0.0 103.07 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.526 ' CZ ' HD22 ' A' ' 16' ' ' ASN . 0.1 OUTLIER -83.94 97.18 9.1 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' GLY . 30.2 t70 -66.11 -29.58 69.92 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 116.633 -2.027 . . . . 0.0 108.474 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 mt 96.64 -147.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 127.523 2.329 . . . . 0.0 106.82 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.506 2.355 0 CA-C-O 115.003 -2.427 . . . . 0.0 111.322 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.493 1.468 0 N-CA-C 110.25 -0.712 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.77 -179.8 16.05 Favored Glycine 0 N--CA 1.498 2.816 0 C-N-CA 120.031 -1.081 . . . . 0.0 110.473 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ABA . . . . . 0.444 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 1.1 Cg_endo -68.74 -47.97 1.15 Allowed 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.109 1.872 . . . . 0.0 108.179 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.2 m -21.27 -41.58 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 111.597 -2.547 . . . . 0.0 117.614 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.2 m -145.06 119.93 9.94 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -114.48 15.48 17.84 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 122.379 1.085 . . . . 0.0 111.058 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.51 133.25 36.49 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.41 32.86 31.23 Favored Glycine 0 N--CA 1.506 3.347 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.481 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 23.9 t80 -90.37 -13.2 35.54 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 113.935 -1.133 . . . . 0.0 112.951 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.0 m -128.95 143.61 50.93 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.416 ' CD2' ' HA ' ' A' ' 43' ' ' GLN . 0.5 OUTLIER -97.62 -33.02 11.49 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 123.58 0.55 . . . . 0.0 112.41 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -149.08 -85.96 0.09 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 120.515 3.524 . . . . 0.0 120.515 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -48.7 -32.69 11.29 Favored Glycine 0 N--CA 1.513 3.785 0 CA-C-O 123.136 1.409 . . . . 0.0 109.684 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.5 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 8.11 64.84 0.01 OUTLIER Glycine 0 N--CA 1.48 1.599 0 CA-C-N 109.521 -3.339 . . . . 0.0 121.198 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.3 t -95.14 95.02 4.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 1 N-CA-C 99.885 -4.117 . . . . 0.0 99.885 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ABA . . . . . 0.505 ' CG ' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.3 ptp -119.31 161.11 21.0 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -101.79 123.74 46.26 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.47 ' O ' ' CG2' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -102.54 22.78 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 124.757 1.286 . . . . 0.0 111.489 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -36.3 -37.55 0.12 Allowed 'General case' 0 N--CA 1.516 2.852 0 CA-C-O 123.79 1.757 . . . . 0.0 110.353 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.7 OUTLIER -34.91 -45.95 0.29 Allowed 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 110.077 -3.238 . . . . 0.0 111.44 179.172 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.59 -33.83 5.08 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 111.517 -2.583 . . . . 0.0 110.481 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.67 -79.97 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.0 OUTLIER -156.65 -135.47 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 118.38 -1.328 . . . . 0.0 109.855 -179.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -94.78 140.44 29.91 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.575 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -151.21 -174.5 4.83 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 113.097 -1.865 . . . . 0.0 110.712 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.5 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -125.42 153.45 43.43 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -105.9 118.47 36.68 Favored 'General case' 0 C--N 1.3 -1.548 1 N-CA-C 98.29 -4.707 . . . . 0.0 98.29 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.511 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 76.3 m -98.8 166.45 11.3 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.54 HG13 ' CD2' ' A' ' 37' ' ' TYR . 3.4 p -65.24 157.43 5.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 C-N-CA 118.141 -1.424 . . . . 0.0 111.064 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -41.78 -24.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 111.864 -2.426 . . . . 0.0 111.934 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -100.53 -27.39 7.63 Favored Glycine 0 N--CA 1.484 1.838 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.82 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.54 ' CD2' HG13 ' A' ' 34' ' ' VAL . 4.2 m-30 -98.91 120.58 39.6 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 104.019 -2.585 . . . . 0.0 104.019 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 40' ' ' ASP . 33.4 t -130.91 -135.54 0.2 Allowed 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 118.175 -1.41 . . . . 0.0 112.398 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.508 ' C ' ' NE2' ' A' ' 43' ' ' GLN . . . 69.99 -8.58 3.48 Favored Glycine 0 N--CA 1.483 1.802 0 CA-C-O 117.4 -1.778 . . . . 0.0 110.622 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 16.7 t70 100.11 -2.83 0.03 OUTLIER 'General case' 0 N--CA 1.523 3.209 0 C-N-CA 124.004 0.922 . . . . 0.0 113.184 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.521 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -140.66 1.41 1.72 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -178.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 64.39 33.91 10.86 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 -179.383 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.521 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -88.47 -23.86 23.14 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 111.993 -2.367 . . . . 0.0 110.737 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.41 ' O ' ' CG2' ' A' ' 44' ' ' THR . 5.9 t -112.23 86.6 2.38 Favored 'General case' 0 C--N 1.294 -1.806 1 N-CA-C 98.201 -4.741 . . . . 0.0 98.201 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.461 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 14.9 mtm180 -77.04 87.2 3.54 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 110.849 -2.887 . . . . 0.0 104.647 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 48' ' ' ARG . 5.9 t70 -83.7 67.05 9.33 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 mp -2.64 31.02 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 1 N-CA-C 122.885 4.402 . . . . 0.0 122.885 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.474 ' N ' ' O ' ' A' ' 46' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 116.494 -1.717 . . . . 0.0 113.179 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo . . . . . 0 N--CA 1.49 1.293 0 N-CA-C 108.026 -1.567 . . . . 0.0 108.026 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.32 -170.01 13.84 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ABA . . . . . 0.453 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.453 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 6.8 Cg_endo -68.82 -41.77 5.28 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 122.529 2.152 . . . . 0.0 108.325 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m -20.15 -50.52 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 109.944 -3.298 . . . . 0.0 116.413 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.19 127.82 17.11 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.506 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 1.0 OUTLIER -117.14 8.97 13.42 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 124.02 0.825 . . . . 0.0 112.074 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -69.38 138.25 53.48 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 41.25 37.53 1.64 Allowed Glycine 0 N--CA 1.507 3.402 0 O-C-N 124.43 1.081 . . . . 0.0 110.775 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.426 ' CD1' ' CZ ' ' A' ' 29' ' ' TYR . 30.9 t80 -91.25 -17.22 26.35 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 114.063 -1.068 . . . . 0.0 113.813 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.434 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 41.5 m -116.85 154.68 30.34 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.428 ' CD2' ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -107.71 -37.97 6.0 Favored 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 115.086 1.514 . . . . 0.0 115.086 -179.65 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.455 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 3.8 m-80 -139.19 -83.21 0.27 Allowed 'General case' 0 N--CA 1.509 2.513 0 N-CA-C 120.133 3.383 . . . . 0.0 120.133 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.75 -24.22 64.14 Favored Glycine 0 N--CA 1.511 3.669 0 N-CA-C 108.849 -1.701 . . . . 0.0 108.849 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.577 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 5.38 65.39 0.01 OUTLIER Glycine 0 N--CA 1.478 1.495 0 N-CA-C 120.449 2.94 . . . . 0.0 120.449 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.73 96.5 5.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 100.734 -3.802 . . . . 0.0 100.734 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ABA . . . . . 0.498 ' CG ' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.56 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 7.2 ptm -121.25 121.2 37.21 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 123.073 1.416 . . . . 0.0 109.089 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -63.31 120.44 11.58 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 179.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -102.78 23.69 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 123.714 0.634 . . . . 0.0 110.367 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -33.5 -42.06 0.1 Allowed 'General case' 0 N--CA 1.511 2.607 0 CA-C-O 123.722 1.725 . . . . 0.0 109.696 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -30.89 -46.54 0.08 Allowed 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 109.632 -3.44 . . . . 0.0 111.992 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.49 -35.51 4.56 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 111.572 -2.558 . . . . 0.0 109.779 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -146.71 -82.82 0.13 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 117.419 2.377 . . . . 0.0 117.419 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.3 p -153.11 -131.39 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.594 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -100.3 135.84 41.11 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.531 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.25 0.6 OUTLIER -146.5 -179.05 6.5 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.103 -2.317 . . . . 0.0 109.119 -179.42 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.577 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -121.16 153.67 37.22 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.56 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 60.5 t30 -106.72 104.28 13.92 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 101.77 -3.419 . . . . 0.0 101.77 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 57.5 m -88.71 156.72 18.83 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.19 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.609 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 12.2 p -59.83 159.93 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 113.019 -1.9 . . . . 0.0 114.319 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -48.56 -22.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 110.884 -2.871 . . . . 0.0 109.126 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -98.39 -11.84 46.91 Favored Glycine 0 N--CA 1.485 1.933 0 CA-C-O 117.832 -1.538 . . . . 0.0 116.588 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.609 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 3.1 m-30 -126.8 121.7 32.66 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.452 ' C ' ' H ' ' A' ' 40' ' ' ASP . 48.2 t -132.32 -134.59 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.725 -1.19 . . . . 0.0 110.868 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 74.61 -13.12 5.31 Favored Glycine 0 N--CA 1.485 1.953 0 CA-C-O 117.894 -1.504 . . . . 0.0 110.166 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 27.9 t70 104.62 -7.57 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.884 0 C-N-CA 124.419 1.087 . . . . 0.0 113.672 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.563 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -137.28 -2.26 2.05 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.498 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 70.27 31.2 3.19 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 -179.248 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.563 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -88.38 -11.96 44.68 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 113.699 -1.592 . . . . 0.0 109.82 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . 0.253 5.3 t -121.54 85.95 2.49 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 101.545 -3.502 . . . . 0.0 101.545 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.2 mtm180 -78.35 88.68 4.37 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 36' ' ' GLY . 24.1 t70 -61.01 -20.61 62.7 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.247 -1.797 . . . . 0.0 108.544 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 72.49 25.59 2.69 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 124.905 1.378 . . . . 0.0 112.379 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.429 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo . . . . . 0 N--CA 1.493 1.463 0 N-CA-C 110.642 -0.561 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.54 157.0 7.13 Favored Glycine 0 N--CA 1.497 2.726 0 C-N-CA 119.979 -1.105 . . . . 0.0 111.937 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ABA . . . . . 0.494 ' C ' ' H ' ' A' ' 8' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 62.3 Cg_endo -84.18 18.03 1.61 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.377 2.718 . . . . 0.0 110.058 -172.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 6' ' ' ABA . 0.5 OUTLIER -97.21 -21.62 17.19 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 113.381 -1.736 . . . . 0.0 109.071 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.0 t -150.09 121.21 7.75 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -121.38 29.03 7.45 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 123.291 1.519 . . . . 0.0 107.795 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -101.01 134.37 44.1 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.15 23.9 60.26 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -91.94 -26.12 18.57 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.786 -1.207 . . . . 0.0 113.252 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.522 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 33.8 m -124.23 150.34 45.4 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -111.07 -37.85 5.23 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -179.24 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.49 ' ND2' ' HD2' ' A' ' 45' ' ' ARG . 34.3 m-80 -149.82 -59.91 0.2 Allowed 'General case' 0 N--CA 1.509 2.508 0 N-CA-C 118.57 2.804 . . . . 0.0 118.57 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -107.2 18.71 35.79 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 106.875 -2.49 . . . . 0.0 106.875 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.615 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -72.46 94.73 0.66 Allowed Glycine 0 C--N 1.296 -1.661 0 CA-C-O 123.926 1.848 . . . . 0.0 113.631 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.6 t -91.88 103.1 14.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 102.779 -3.045 . . . . 0.0 102.779 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ABA . . . . . 0.479 ' CG ' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.466 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 21.8 ptt? -116.57 129.69 56.32 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 123.401 1.572 . . . . 0.0 108.863 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.8 OUTLIER -73.61 119.14 17.43 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.103 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.484 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -104.11 23.77 2.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 124.279 0.987 . . . . 0.0 111.025 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -38.84 -37.18 0.32 Allowed 'General case' 0 N--CA 1.514 2.755 0 CA-C-O 123.707 1.718 . . . . 0.0 109.262 -179.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.402 ' N ' ' C ' ' A' ' 23' ' ' ILE . 1.3 m -32.78 -43.42 0.09 Allowed 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 110.035 -3.257 . . . . 0.0 111.902 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.3 -36.58 3.34 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 111.358 -2.656 . . . . 0.0 110.949 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -144.49 -84.6 0.14 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 23' ' ' ILE . 11.2 p -149.8 -131.56 0.05 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.495 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.534 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -98.54 143.74 28.62 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 179.544 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.534 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.258 0.6 OUTLIER -151.13 175.01 12.55 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 125.776 1.923 . . . . 0.0 111.03 -179.374 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.615 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -118.95 136.61 54.0 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.466 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 50.5 t30 -93.16 77.23 4.6 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.108 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.434 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 65.9 m -61.26 146.67 47.07 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.516 1.15 . . . . 0.0 110.681 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.495 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 10.5 p -58.97 161.98 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 112.332 -2.213 . . . . 0.0 115.403 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tt -49.83 -20.12 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 111.541 -2.572 . . . . 0.0 109.315 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.59 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -98.98 -18.35 25.02 Favored Glycine 0 C--O 1.202 -1.851 0 CA-C-O 117.48 -1.733 . . . . 0.0 114.34 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.507 ' CE1' ' NH2' ' A' ' 45' ' ' ARG . 1.9 m-30 -123.31 129.81 51.86 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 120.27 2.035 . . . . 0.0 107.269 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.29 -159.46 0.89 Allowed 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 88.59 -47.82 3.48 Favored Glycine 0 N--CA 1.494 2.529 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.288 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 27.7 t70 124.28 -0.42 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.038 0 O-C-N 126.719 2.07 . . . . 0.0 109.198 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -117.95 -28.67 5.85 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.434 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 3.0 m 82.7 37.86 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.583 ' NE2' ' CG2' ' A' ' 44' ' ' THR . 2.6 pp0? -88.96 -21.43 23.55 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 110.665 -2.971 . . . . 0.0 107.425 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.583 ' CG2' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -110.01 83.34 1.74 Allowed 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 101.835 -3.394 . . . . 0.0 101.835 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.507 ' NH2' ' CE1' ' A' ' 37' ' ' TYR . 1.1 mtm180 -78.77 89.19 4.62 Favored 'General case' 0 C--N 1.299 -1.622 1 N-CA-C 98.906 -4.479 . . . . 0.0 98.906 179.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.59 ' N ' ' O ' ' A' ' 36' ' ' GLY . 29.2 t0 -58.51 -23.0 57.03 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 111.849 -2.432 . . . . 0.0 107.192 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 mt 62.98 6.17 2.12 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 112.668 -2.06 . . . . 0.0 115.077 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.588 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.42 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 N--CA 1.496 1.624 0 N-CA-C 110.197 -0.732 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.54 -178.56 19.55 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 119.564 -1.303 . . . . 0.0 112.597 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ABA . . . . . 0.552 ' C ' ' H ' ' A' ' 8' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.413 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 69.1 Cg_endo -78.21 16.76 1.14 Allowed 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.708 2.272 . . . . 0.0 111.478 -173.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.552 ' H ' ' C ' ' A' ' 6' ' ' ABA . 6.0 t -100.99 -19.3 15.91 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.249 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.9 m -154.95 128.96 8.8 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.483 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 2.7 p90 -124.83 8.91 8.18 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -69.24 142.73 54.12 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 39.71 39.46 1.31 Allowed Glycine 0 N--CA 1.507 3.405 0 O-C-N 124.518 1.136 . . . . 0.0 110.87 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.463 ' CD1' ' CZ ' ' A' ' 29' ' ' TYR . 38.6 t80 -91.34 -15.81 28.46 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 125.383 1.284 . . . . 0.0 113.414 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.447 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 58.2 m -119.72 157.19 29.06 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.417 HD13 ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -110.72 -38.38 5.17 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -140.58 -77.84 0.3 Allowed 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 121.486 3.884 . . . . 0.0 121.486 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.54 -17.76 73.05 Favored Glycine 0 N--CA 1.507 3.377 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.611 ' HA2' ' SG ' ' A' ' 31' ' ' CYS . . . 2.71 62.92 0.0 OUTLIER Glycine 0 C--N 1.302 -1.352 0 N-CA-C 120.091 2.796 . . . . 0.0 120.091 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.6 t -91.6 96.56 6.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 101.762 -3.421 . . . . 0.0 101.762 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ABA . . . . . 0.437 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.7 ptm -137.51 159.87 40.74 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 102.525 -3.139 . . . . 0.0 102.525 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -102.4 129.51 48.9 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -105.19 19.47 4.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 124.053 0.846 . . . . 0.0 112.309 -179.556 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -29.11 -49.87 0.08 Allowed 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 122.811 1.291 . . . . 0.0 112.008 -179.408 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.4 m -31.44 -43.64 0.06 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 110.99 -2.823 . . . . 0.0 114.151 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.59 -32.68 6.1 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 112.063 -2.335 . . . . 0.0 111.094 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -149.61 -80.14 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.5 p -158.33 -133.2 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.879 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -97.04 139.36 33.16 Favored 'General case' 0 N--CA 1.51 2.554 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.538 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 1.2 t -147.34 -171.34 3.77 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.305 -1.771 . . . . 0.0 112.914 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.611 ' SG ' ' HA2' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -125.46 151.28 46.47 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 179.275 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -107.82 103.17 12.37 Favored 'General case' 0 C--N 1.3 -1.577 1 N-CA-C 99.53 -4.248 . . . . 0.0 99.53 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 83.4 m -87.69 170.74 10.99 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.415 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.523 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 14.2 p -67.69 163.6 2.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-O 123.304 1.526 . . . . 0.0 112.582 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tt -53.34 -18.11 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 112.044 -2.343 . . . . 0.0 108.851 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -100.03 -22.21 12.4 Favored Glycine 0 C--O 1.199 -2.081 0 CA-C-N 113.507 -1.679 . . . . 0.0 114.16 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.523 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 2.8 m-30 -118.96 130.21 55.58 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 121.149 2.475 . . . . 0.0 104.676 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.444 ' C ' ' H ' ' A' ' 40' ' ' ASP . 22.9 t -142.07 -136.24 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 117.545 -1.662 . . . . 0.0 113.767 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.64 -42.37 3.15 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 107.744 -2.142 . . . . 0.0 107.744 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 38' ' ' SER . 0.8 OUTLIER 137.68 -2.03 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.796 0 O-C-N 126.017 1.657 . . . . 0.0 110.135 -179.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.549 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -140.93 -7.06 1.08 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -178.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.49 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 73.79 35.07 0.85 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 -178.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.549 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -88.39 -17.68 30.0 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 112.015 -2.357 . . . . 0.0 107.727 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.451 ' O ' ' CG2' ' A' ' 44' ' ' THR . 5.1 t -120.02 88.36 2.92 Favored 'General case' 0 C--N 1.299 -1.588 1 N-CA-C 99.745 -4.168 . . . . 0.0 99.745 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -83.46 96.34 8.55 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 101.841 -3.392 . . . . 0.0 101.841 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 36' ' ' GLY . 28.1 t70 -83.93 69.75 10.33 Favored 'General case' 0 C--N 1.294 -1.81 1 N-CA-C 99.926 -4.102 . . . . 0.0 99.926 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.4 mp -44.37 120.25 2.13 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.457 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 116.792 -1.575 . . . . 0.0 111.483 179.936 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 N--CA 1.499 1.823 0 CA-C-O 120.386 0.078 . . . . 0.0 111.951 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.424 ' HA3' ' CB ' ' A' ' 28' ' ' SER . . . 124.65 175.21 14.23 Favored Glycine 0 N--CA 1.505 3.286 0 CA-C-O 119.01 -0.883 . . . . 0.0 112.689 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ABA . . . . . 0.527 ' C ' ' H ' ' A' ' 8' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 95.2 Cg_endo -76.41 11.86 1.74 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 123.591 2.861 . . . . 0.0 111.777 -159.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.527 ' H ' ' C ' ' A' ' 6' ' ' ABA . 0.1 OUTLIER -91.25 -23.82 20.06 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.778 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 t -153.25 126.77 8.7 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.524 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 4.1 p90 -121.38 20.01 11.29 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 122.146 0.974 . . . . 0.0 109.004 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -72.46 121.47 19.64 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.463 ' O ' ' NH2' ' A' ' 41' ' ' ARG . . . 53.13 40.99 60.16 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.428 ' OH ' ' HA ' ' A' ' 30' ' ' THR . 7.0 t80 -91.27 -16.17 28.0 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.7 m -122.61 161.49 23.66 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -115.63 -37.17 4.03 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 117.885 2.55 . . . . 0.0 117.885 -179.203 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.45 ' ND2' ' HD3' ' A' ' 45' ' ' ARG . 34.1 m-80 -146.22 -69.98 0.26 Allowed 'General case' 0 N--CA 1.515 2.82 0 N-CA-C 120.341 3.46 . . . . 0.0 120.341 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.11 -25.38 59.75 Favored Glycine 0 N--CA 1.506 3.352 0 N-CA-C 107.834 -2.107 . . . . 0.0 107.834 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.487 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -6.8 74.78 0.0 OUTLIER Glycine 0 N--CA 1.484 1.898 0 N-CA-C 118.842 2.297 . . . . 0.0 118.842 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 t -90.5 102.2 13.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 100.429 -3.915 . . . . 0.0 100.429 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ABA . . . . . 0.465 ' CG ' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.4 ptm -117.04 131.59 56.9 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 113.011 -1.904 . . . . 0.0 108.93 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -76.2 113.67 14.01 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -94.8 21.85 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.174 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.456 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.6 OUTLIER -37.63 -38.94 0.29 Allowed 'General case' 0 N--CA 1.514 2.764 0 CA-C-O 123.117 1.437 . . . . 0.0 109.267 -179.71 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -31.09 -43.63 0.05 Allowed 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 109.927 -3.306 . . . . 0.0 111.477 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.95 -38.18 3.11 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 111.152 -2.749 . . . . 0.0 109.998 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -145.98 -82.44 0.14 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 119.432 3.123 . . . . 0.0 119.432 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.1 p -150.95 -139.63 0.09 Allowed 'General case' 0 N--CA 1.509 2.495 0 C-N-CA 118.639 -1.224 . . . . 0.0 110.732 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.524 ' CE2' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -95.36 138.74 32.64 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 179.39 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.5 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.331 0.4 OUTLIER -150.47 178.79 8.71 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 112.2 -2.273 . . . . 0.0 110.332 -179.403 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.487 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -122.68 142.46 50.65 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.06 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.84 110.75 22.79 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 100.867 -3.753 . . . . 0.0 100.867 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 37' ' ' TYR . 76.2 m -84.27 -119.86 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.413 -1.315 . . . . 0.0 112.792 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.555 HG13 ' CD2' ' A' ' 37' ' ' TYR . 9.1 p -144.07 165.05 14.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 122.646 1.212 . . . . 0.0 110.806 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -52.65 -18.83 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 CA-C-N 112.135 -2.302 . . . . 0.0 107.73 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -105.55 -15.17 19.8 Favored Glycine 0 N--CA 1.482 1.742 0 CA-C-O 117.563 -1.687 . . . . 0.0 115.716 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.555 ' CD2' HG13 ' A' ' 34' ' ' VAL . 3.9 m-85 -131.87 123.96 28.57 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.9 t -132.73 -147.57 0.31 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 87.48 -50.08 3.99 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.412 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER 136.59 -9.53 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.025 0 O-C-N 126.923 2.19 . . . . 0.0 109.002 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.463 ' NH2' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -114.31 -26.07 8.16 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.3 -178.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 1.2 m 79.82 35.88 0.14 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.537 ' NE2' ' CG2' ' A' ' 44' ' ' THR . 2.9 pp0? -88.82 -24.71 22.51 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 110.702 -2.954 . . . . 0.0 105.97 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.537 ' CG2' ' NE2' ' A' ' 43' ' ' GLN . 1.0 OUTLIER -106.31 89.73 3.14 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 102.469 -3.16 . . . . 0.0 102.469 179.749 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.45 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 4.3 mtm180 -84.93 90.8 7.89 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 101.572 -3.492 . . . . 0.0 101.572 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' GLY . 29.3 t70 -59.25 -20.1 51.42 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 111.693 -2.503 . . . . 0.0 107.882 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 65.47 49.29 1.88 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.881 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.462 ' H ' ' CA ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 115.934 -1.984 . . . . 0.0 111.249 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.493 1.46 0 N-CA-C 109.835 -0.871 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 145.8 172.78 16.46 Favored Glycine 0 N--CA 1.499 2.858 0 C-N-CA 118.987 -1.578 . . . . 0.0 115.238 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ABA . . . . . 0.448 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.448 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 63.4 Cg_endo -83.07 9.62 4.01 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 123.647 2.898 . . . . 0.0 111.506 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.22 -20.87 47.18 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.829 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 t -158.08 133.25 8.69 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.501 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 3.4 p90 -128.5 36.99 4.19 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.742 1.258 . . . . 0.0 108.05 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -100.45 130.3 46.52 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 47.3 33.75 8.09 Favored Glycine 0 N--CA 1.506 3.338 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -91.77 -20.37 21.59 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 125.315 1.244 . . . . 0.0 112.315 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.2 m -118.56 158.31 25.65 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 103.318 -2.845 . . . . 0.0 103.318 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.424 HD13 ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -112.25 -36.69 5.24 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.427 ' ND2' ' HD3' ' A' ' 45' ' ' ARG . 39.8 m-80 -146.77 -77.05 0.18 Allowed 'General case' 0 N--CA 1.51 2.57 0 N-CA-C 119.053 2.983 . . . . 0.0 119.053 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.16 -23.56 69.86 Favored Glycine 0 N--CA 1.507 3.425 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.476 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -3.01 67.63 0.0 OUTLIER Glycine 0 N--CA 1.488 2.126 0 N-CA-C 122.1 3.6 . . . . 0.0 122.1 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.44 95.26 5.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 1 N-CA-C 100.172 -4.01 . . . . 0.0 100.172 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ABA . . . . . 0.501 ' CG ' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.493 ' SD ' ' ND2' ' A' ' 32' ' ' ASN . 8.3 ptm -122.49 126.89 48.8 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 123.147 1.451 . . . . 0.0 109.166 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -68.16 117.56 10.15 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.486 ' O ' ' C ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -101.01 23.65 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.544 -179.532 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.486 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.7 OUTLIER -29.07 -49.25 0.08 Allowed 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 123.353 1.549 . . . . 0.0 109.034 -179.678 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -26.12 -49.29 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 108.656 -3.884 . . . . 0.0 113.165 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.51 -34.52 5.83 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 111.768 -2.469 . . . . 0.0 109.339 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -146.95 -81.12 0.14 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 23' ' ' ILE . 3.4 p -156.15 -132.07 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.468 -1.293 . . . . 0.0 110.129 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -98.45 137.17 37.53 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 179.67 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.541 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -148.57 -175.93 5.12 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 125.818 1.949 . . . . 0.0 110.246 -179.456 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.476 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -125.9 152.93 44.92 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.493 ' ND2' ' SD ' ' A' ' 21' ' ' MET . 4.0 t-20 -109.88 119.82 40.55 Favored 'General case' 0 C--N 1.298 -1.665 1 N-CA-C 96.346 -5.428 . . . . 0.0 96.346 179.612 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 37' ' ' TYR . 72.6 m -96.06 -111.89 0.14 Allowed 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 118.684 -1.206 . . . . 0.0 110.385 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.598 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 4.2 p -146.92 161.29 8.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 C-N-CA 118.617 -1.233 . . . . 0.0 108.139 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -46.62 -25.37 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 112.125 -2.307 . . . . 0.0 109.157 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -106.84 1.6 35.98 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 118.495 2.158 . . . . 0.0 118.495 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.598 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 5.5 m-30 -135.55 120.32 18.43 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 100.283 -3.969 . . . . 0.0 100.283 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.4 t -131.77 -150.41 0.42 Allowed 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.19 -40.12 3.0 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 122.59 4.23 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.563 0 C-N-CA 127.073 2.149 . . . . 0.0 107.945 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.442 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -127.69 -21.74 3.7 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.265 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER 77.0 35.79 0.35 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 -179.462 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.593 ' NE2' ' CG2' ' A' ' 44' ' ' THR . 2.7 pp0? -88.61 -21.47 23.99 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 111.423 -2.626 . . . . 0.0 107.307 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.593 ' CG2' ' NE2' ' A' ' 43' ' ' GLN . 1.7 t -113.5 87.85 2.7 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 102.117 -3.29 . . . . 0.0 102.117 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.427 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 8.3 mtm180 -84.3 88.31 7.24 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 101.504 -3.517 . . . . 0.0 101.504 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 36' ' ' GLY . 32.4 t70 -55.32 -27.35 46.42 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.787 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 75.5 mt 91.48 64.16 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.574 0 C-N-CA 128.101 2.56 . . . . 0.0 117.263 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.442 ' H ' ' HA3' ' A' ' 36' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 116.295 -1.812 . . . . 0.0 109.906 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.493 1.476 0 CA-C-O 123.329 1.304 . . . . 0.0 108.717 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -120.44 168.25 13.87 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 107.037 -2.425 . . . . 0.0 107.037 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ABA . . . . . 0.414 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.414 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 7.7 Cg_exo -68.37 -44.61 3.27 Favored 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 122.134 1.889 . . . . 0.0 108.542 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -19.82 -54.81 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 110.801 -2.909 . . . . 0.0 117.621 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.89 116.71 19.05 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.582 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 2.7 p90 -114.5 2.47 14.62 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -70.38 140.47 52.12 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.34 42.37 2.48 Favored Glycine 0 N--CA 1.505 3.3 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.412 ' CD1' ' CZ ' ' A' ' 29' ' ' TYR . 35.9 t80 -91.17 -19.12 23.42 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 125.177 1.163 . . . . 0.0 113.258 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.406 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 35.6 m -116.21 154.85 29.35 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.14 -35.72 6.77 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.527 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 2.1 m-80 -141.35 -83.09 0.21 Allowed 'General case' 0 N--CA 1.51 2.571 0 N-CA-C 120.84 3.644 . . . . 0.0 120.84 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.87 -26.12 66.73 Favored Glycine 0 N--CA 1.508 3.48 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.61 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 6.97 65.68 0.01 OUTLIER Glycine 0 N--CA 1.481 1.649 0 CA-C-N 110.275 -2.963 . . . . 0.0 120.127 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -94.17 97.09 6.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 102.768 -3.049 . . . . 0.0 102.768 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ABA . . . . . 0.461 ' CG ' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.5 ptt? -137.6 171.85 13.84 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 102.815 -3.031 . . . . 0.0 102.815 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -111.16 127.73 55.68 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER -105.53 14.06 7.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 123.911 0.757 . . . . 0.0 110.644 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -20.12 -56.93 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.631 0 CA-C-O 123.893 1.806 . . . . 0.0 111.652 -179.028 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -26.26 -49.14 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.034 1 CA-C-N 108.259 -4.064 . . . . 0.0 113.723 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.37 -36.34 6.54 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 111.424 -2.625 . . . . 0.0 109.149 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -146.53 -81.14 0.15 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 23' ' ' ILE . 8.2 p -157.32 -132.7 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.951 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -97.21 140.56 31.52 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.551 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.264 0.5 OUTLIER -152.59 -177.89 6.51 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 112.753 -2.021 . . . . 0.0 109.578 -179.272 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.61 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -117.6 156.67 27.73 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -108.08 100.46 9.79 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 100.633 -3.84 . . . . 0.0 100.633 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.431 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 57.3 m -86.83 160.2 18.84 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.677 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.602 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 14.6 p -61.71 160.71 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-O 123.197 1.475 . . . . 0.0 111.658 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 tt -52.51 -19.49 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 111.423 -2.626 . . . . 0.0 109.946 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -101.91 -0.72 51.97 Favored Glycine 0 N--CA 1.491 2.328 0 CA-C-N 114.076 -1.42 . . . . 0.0 115.692 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.602 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 9.4 m-30 -133.67 118.59 18.34 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.421 ' C ' ' H ' ' A' ' 40' ' ' ASP . 35.3 t -132.44 -134.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.741 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 71.63 -10.81 3.65 Favored Glycine 0 N--CA 1.486 1.969 0 CA-C-O 117.709 -1.606 . . . . 0.0 111.634 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 17.7 t70 105.0 -8.24 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.144 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.561 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -138.35 -1.05 1.94 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.688 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 69.34 30.95 4.02 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 -179.199 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.561 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -89.04 -16.68 31.04 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.204 -1.816 . . . . 0.0 110.107 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . 0.258 5.1 t -118.4 92.9 3.94 Favored 'General case' 0 C--N 1.297 -1.692 1 N-CA-C 99.668 -4.197 . . . . 0.0 99.668 179.995 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 19.0 mtm180 -88.36 92.28 9.11 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 112.249 -2.25 . . . . 0.0 105.832 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 36' ' ' GLY . 28.6 t70 -56.2 -27.34 54.3 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 125.833 1.958 . . . . 0.0 109.914 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 76.81 117.59 0.06 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 126.066 2.104 . . . . 0.0 113.662 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 115.802 -2.047 . . . . 0.0 110.41 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo . . . . . 0 N--CA 1.492 1.424 0 N-CA-C 109.778 -0.893 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.67 -173.41 19.71 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.925 -1.131 . . . . 0.0 112.553 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ABA . . . . . 0.52 ' C ' ' H ' ' A' ' 8' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 52.5 Cg_endo -83.85 28.08 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 124.265 3.31 . . . . 0.0 110.505 173.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.52 ' H ' ' C ' ' A' ' 6' ' ' ABA . 33.2 t -100.72 -21.84 15.08 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.977 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.5 t -156.53 125.84 6.13 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.451 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 9.3 p90 -123.49 30.82 6.12 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.688 1.232 . . . . 0.0 110.568 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -100.41 134.08 43.88 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.31 29.28 52.55 Favored Glycine 0 N--CA 1.506 3.327 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -91.25 -24.15 19.95 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.292 -1.454 . . . . 0.0 112.965 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.433 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 17.7 m -119.78 150.43 40.43 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -109.19 -37.5 5.77 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 -179.355 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -149.46 -67.71 0.21 Allowed 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.94 -20.41 79.73 Favored Glycine 0 N--CA 1.502 3.085 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.454 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -4.02 71.08 0.0 OUTLIER Glycine 0 N--CA 1.484 1.834 0 N-CA-C 121.748 3.459 . . . . 0.0 121.748 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.6 t -96.18 93.62 3.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 101.343 -3.577 . . . . 0.0 101.343 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ABA . . . . . 0.514 ' CG ' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.3 ptp -114.47 170.38 8.35 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.432 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 0.8 OUTLIER -108.2 123.14 48.29 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.472 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -103.2 18.61 4.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 124.635 1.21 . . . . 0.0 111.115 -179.741 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -25.94 -52.41 0.05 OUTLIER 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 123.8 1.762 . . . . 0.0 110.643 -179.402 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -25.83 -49.37 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 108.437 -3.983 . . . . 0.0 113.069 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.76 -34.91 6.12 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 111.233 -2.712 . . . . 0.0 110.246 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -147.2 -80.84 0.14 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 23' ' ' ILE . 9.6 p -159.34 -130.98 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.771 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -96.31 140.64 30.69 Favored 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.521 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -151.2 172.34 15.97 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.791 -179.217 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.454 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -116.32 131.45 56.94 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -89.49 121.83 32.09 Favored 'General case' 0 C--N 1.303 -1.443 1 N-CA-C 99.957 -4.09 . . . . 0.0 99.957 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 37' ' ' TYR . 82.2 m -90.95 -114.5 0.08 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 123.945 0.778 . . . . 0.0 112.215 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.535 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 7.2 p -153.77 164.58 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 C-N-CA 117.656 -1.618 . . . . 0.0 111.257 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -47.9 -24.26 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 112.052 -2.34 . . . . 0.0 107.41 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -99.92 -17.9 24.11 Favored Glycine 0 C--O 1.201 -1.951 0 CA-C-O 117.69 -1.616 . . . . 0.0 115.165 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.535 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 1.1 m-85 -128.46 128.56 44.65 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 121.697 2.749 . . . . 0.0 106.008 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 40' ' ' ASP . 12.6 t -130.77 -146.66 0.31 Allowed 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.95 -51.12 3.17 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 106.496 -2.642 . . . . 0.0 106.496 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 38' ' ' SER . 0.6 OUTLIER 128.32 4.97 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.663 0 O-C-N 127.958 2.799 . . . . 0.0 109.026 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.473 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -121.53 -27.98 4.67 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.651 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 1.9 m 85.54 37.73 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 104.327 -2.472 . . . . 0.0 104.327 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.547 ' NE2' ' CG2' ' A' ' 44' ' ' THR . 2.7 pp0? -88.17 -23.32 23.64 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 111.514 -2.585 . . . . 0.0 107.157 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.547 ' CG2' ' NE2' ' A' ' 43' ' ' GLN . 1.3 t -110.23 84.42 1.92 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 101.365 -3.569 . . . . 0.0 101.365 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -81.28 87.48 6.12 Favored 'General case' 0 C--N 1.299 -1.63 1 N-CA-C 99.28 -4.341 . . . . 0.0 99.28 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 36' ' ' GLY . 33.3 t70 -58.85 -25.66 63.46 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 112.111 -2.313 . . . . 0.0 107.355 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 80.58 -148.5 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.498 ' NH1' ' O ' ' A' ' 46' ' ' ASP . 8.7 mtt180 . . . . . 0 N--CA 1.504 2.256 0 CA-C-N 119.447 1.021 . . . . 0.0 110.572 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 N--CA 1.493 1.446 0 N-CA-C 108.551 -1.365 . . . . 0.0 108.551 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.26 147.5 19.12 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ABA . . . . . 0.53 ' C ' ' H ' ' A' ' 8' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.507 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 69.2 Cg_endo -77.09 19.1 0.71 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 123.551 2.834 . . . . 0.0 112.368 -163.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.53 ' H ' ' C ' ' A' ' 6' ' ' ABA . 35.9 t -100.47 -20.97 15.52 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.424 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.9 t -156.9 130.57 8.17 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.519 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 3.2 p90 -123.03 2.7 9.33 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.404 0.621 . . . . 0.0 111.82 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.29 122.57 13.55 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.11 36.95 93.13 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.722 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.52 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 22.4 t80 -91.24 -17.63 25.7 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.619 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.513 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 30.9 m -115.02 151.63 33.87 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.469 ' CD2' ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -108.31 -34.0 6.94 Favored 'General case' 0 N--CA 1.508 2.457 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.403 ' CB ' ' CD2' ' A' ' 37' ' ' TYR . 5.1 m-80 -142.07 -82.21 0.21 Allowed 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 120.355 3.465 . . . . 0.0 120.355 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.68 6.32 77.19 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 108.421 -1.871 . . . . 0.0 108.421 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.621 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -51.2 95.87 0.01 OUTLIER Glycine 0 C--N 1.303 -1.265 0 CA-C-N 112.847 -1.676 . . . . 0.0 113.508 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.73 106.63 17.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 102.85 -3.019 . . . . 0.0 102.85 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ABA . . . . . 0.463 ' CG ' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.534 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 4.3 ptm -134.12 167.61 20.34 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 102.343 -3.206 . . . . 0.0 102.343 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.438 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -110.3 126.56 54.33 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.46 ' O ' ' C ' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -104.51 14.19 7.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 124.329 1.018 . . . . 0.0 112.408 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -23.05 -56.81 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 122.889 1.328 . . . . 0.0 112.657 -179.095 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.7 m -28.03 -44.22 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 110.277 -3.147 . . . . 0.0 115.428 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.99 -37.0 5.5 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 111.428 -2.623 . . . . 0.0 109.834 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -145.19 -82.63 0.15 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 117.211 2.301 . . . . 0.0 117.211 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.475 ' OG ' ' N ' ' A' ' 29' ' ' TYR . 1.0 OUTLIER -156.3 -138.87 0.07 Allowed 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 119.259 -0.977 . . . . 0.0 109.953 -179.267 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.547 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -92.36 146.39 23.73 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 102.591 -3.115 . . . . 0.0 102.591 179.372 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.547 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -158.43 -176.43 5.89 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 125.793 1.933 . . . . 0.0 109.704 -179.607 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.621 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -121.37 153.41 37.82 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.772 -1.171 . . . . 0.0 108.446 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.534 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 53.5 t30 -106.85 85.45 2.15 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 59.5 m -60.72 167.27 2.82 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.513 -1.676 . . . . 0.0 112.04 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.513 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 11.1 p -71.98 161.64 4.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 117.804 -1.559 . . . . 0.0 108.92 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -51.68 -21.64 2.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-N 112.335 -2.211 . . . . 0.0 108.735 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -92.4 -27.55 15.04 Favored Glycine 0 C--O 1.2 -2.016 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.81 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.517 ' CD1' ' HA ' ' A' ' 45' ' ' ARG . 3.1 m-30 -110.57 142.4 42.44 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 121.476 2.638 . . . . 0.0 108.341 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.454 ' C ' ' H ' ' A' ' 40' ' ' ASP . 53.0 m -142.73 -137.18 0.1 Allowed 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.649 -1.22 . . . . 0.0 112.034 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 73.79 -16.98 2.31 Favored Glycine 0 N--CA 1.481 1.665 0 CA-C-O 116.623 -2.209 . . . . 0.0 110.356 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 17.6 t70 106.94 -6.83 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.133 0 O-C-N 125.126 1.133 . . . . 0.0 111.817 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.505 ' C ' ' SG ' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -135.52 -6.58 2.23 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -178.715 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.562 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 69.3 33.54 3.21 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 -179.325 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.481 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -88.1 -21.13 24.86 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 111.514 -2.584 . . . . 0.0 106.916 -179.669 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.401 ' CG2' ' O ' ' A' ' 44' ' ' THR . 10.9 t -114.87 114.27 25.29 Favored 'General case' 0 C--N 1.296 -1.754 1 N-CA-C 94.032 -6.285 . . . . 0.0 94.032 179.612 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.517 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 14.6 mtm180 -105.25 99.76 9.37 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 101.337 -3.579 . . . . 0.0 101.337 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 36' ' ' GLY . 44.5 t0 -85.54 70.34 10.75 Favored 'General case' 0 C--N 1.295 -1.769 1 N-CA-C 98.599 -4.593 . . . . 0.0 98.599 179.533 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.7 mt -46.72 70.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 117.829 2.529 . . . . 0.0 117.829 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 116.455 -1.736 . . . . 0.0 109.333 179.523 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo . . . . . 0 N--CA 1.494 1.515 0 N-CA-C 110.066 -0.782 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.516 ' HA3' ' CB ' ' A' ' 28' ' ' SER . . . 105.21 -146.83 16.13 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ABA . . . . . 0.567 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 93.9 Cg_endo -78.93 14.89 1.6 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 123.196 2.598 . . . . 0.0 109.973 -163.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.545 ' H ' ' C ' ' A' ' 6' ' ' ABA . 1.3 t -100.22 -22.14 15.25 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.983 -1.462 . . . . 0.0 107.827 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.5 p -151.63 121.53 7.08 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 118.092 -0.956 . . . . 0.0 108.809 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -116.11 -5.05 11.92 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.41 116.32 3.26 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.686 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.37 26.73 60.89 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.111 -1.519 . . . . 0.0 109.702 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.526 ' CE1' ' HA ' ' A' ' 30' ' ' THR . 26.3 t80 -91.28 -12.46 35.05 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 118.854 -1.139 . . . . 0.0 109.992 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.544 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 17.5 m -126.41 142.07 51.66 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.527 HD13 ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -100.83 -59.57 1.68 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -179.434 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.439 ' HB2' ' CD2' ' A' ' 37' ' ' TYR . 6.5 m-80 -134.72 -52.62 0.81 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 119.791 3.256 . . . . 0.0 119.791 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -100.85 -0.62 55.13 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.544 ' HA3' ' HB3' ' A' ' 14' ' ' CYS . . . -51.75 90.52 0.01 OUTLIER Glycine 0 N--CA 1.476 1.327 0 CA-C-O 123.976 1.876 . . . . 0.0 117.119 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -87.82 99.98 9.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 1 N-CA-C 96.02 -5.548 . . . . 0.0 96.02 179.237 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ABA . . . . . 0.471 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.6 ptm -138.71 170.06 16.68 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.477 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -111.08 130.79 55.5 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 103.419 -2.808 . . . . 0.0 103.419 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.458 ' O ' ' C ' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -104.59 16.45 5.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 124.214 0.946 . . . . 0.0 112.084 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.477 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 1.0 OUTLIER -29.16 -50.91 0.1 Allowed 'General case' 0 N--CA 1.507 2.389 0 CA-C-O 122.582 1.182 . . . . 0.0 112.727 -179.161 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.8 m -31.31 -43.42 0.06 Allowed 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 111.087 -2.779 . . . . 0.0 113.804 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.61 -36.03 5.6 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 111.522 -2.581 . . . . 0.0 109.987 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -148.2 -83.55 0.11 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 118.846 2.906 . . . . 0.0 118.846 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.516 ' CB ' ' HA3' ' A' ' 5' ' ' GLY . 5.1 p -148.92 -136.04 0.07 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.525 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.494 ' HE1' ' CG ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -101.4 147.87 25.83 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-N 118.584 0.629 . . . . 0.0 109.941 -179.593 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.526 ' HA ' ' CE1' ' A' ' 13' ' ' TYR . 0.7 OUTLIER -160.01 -173.72 4.21 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 118.587 2.81 . . . . 0.0 118.587 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.511 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -131.85 130.11 41.27 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.58 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -92.08 89.62 7.02 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 104.716 -2.328 . . . . 0.0 104.716 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 37' ' ' TYR . 30.2 m -72.72 -178.35 2.65 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.247 1.023 . . . . 0.0 108.922 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.495 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 10.9 p -89.81 166.81 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-O 123.979 1.847 . . . . 0.0 113.458 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 tt -56.29 -15.74 2.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-N 112.096 -2.32 . . . . 0.0 108.271 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -98.34 -12.63 44.57 Favored Glycine 0 N--CA 1.486 1.972 0 CA-C-N 113.929 -1.487 . . . . 0.0 113.716 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' A' ' 44' ' ' THR . 1.3 m-85 -135.24 130.51 35.32 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.436 ' O ' ' NE2' ' A' ' 43' ' ' GLN . 1.4 t -129.06 -161.23 1.09 Allowed 'General case' 0 N--CA 1.515 2.775 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 51.27 63.5 4.57 Favored Glycine 0 N--CA 1.499 2.865 0 N-CA-C 117.513 1.765 . . . . 0.0 117.513 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 43.71 -13.78 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.588 1 N-CA-C 122.16 4.133 . . . . 0.0 122.16 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.527 ' NE ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -113.82 -28.2 7.5 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.464 ' SG ' ' N ' ' A' ' 18' ' ' GLY . 2.7 m 82.01 43.86 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.436 ' NE2' ' O ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -88.8 -8.68 53.95 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 112.86 -1.973 . . . . 0.0 112.127 -179.235 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -120.83 94.12 4.25 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 102.121 -3.289 . . . . 0.0 102.121 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.429 ' C ' ' H ' ' A' ' 47' ' ' LEU . 7.2 mtm180 -83.78 86.52 7.13 Favored 'General case' 0 C--N 1.305 -1.329 1 N-CA-C 98.408 -4.664 . . . . 0.0 98.408 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 36' ' ' GLY . 1.3 t70 -59.96 -12.95 9.01 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 112.098 -2.319 . . . . 0.0 109.342 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' A' ' 45' ' ' ARG . 0.4 OUTLIER 57.91 12.96 1.92 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 127.581 2.353 . . . . 0.0 116.709 179.474 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.7 ptm85 . . . . . 0 N--CA 1.5 2.072 0 CA-C-O 117.271 -1.347 . . . . 0.0 113.818 -179.949 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 N--CA 1.492 1.421 0 N-CA-C 107.865 -1.629 . . . . 0.0 107.865 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.72 -170.31 14.06 Favored Glycine 0 N--CA 1.497 2.748 0 C-N-CA 120.151 -1.023 . . . . 0.0 110.569 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ABA . . . . . 0.482 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.482 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 2.9 Cg_exo -70.02 -41.55 3.86 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.87 2.38 . . . . 0.0 109.06 173.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -19.91 -49.84 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 111.061 -2.791 . . . . 0.0 116.555 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.2 t -139.78 127.41 21.73 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -123.57 34.06 5.19 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.05 130.9 46.25 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 104.678 -2.342 . . . . 0.0 104.678 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.81 40.31 2.17 Favored Glycine 0 N--CA 1.506 3.34 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.407 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 24.6 t80 -91.52 -22.08 20.55 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 126.098 1.705 . . . . 0.0 112.856 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.1 m -114.68 155.07 27.3 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -107.06 -37.14 6.39 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -179.575 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.499 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 3.5 m-80 -141.51 -85.54 0.18 Allowed 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 119.981 3.326 . . . . 0.0 119.981 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.98 -26.33 55.21 Favored Glycine 0 N--CA 1.512 3.716 0 N-CA-C 108.486 -1.845 . . . . 0.0 108.486 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.535 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 6.25 65.42 0.01 OUTLIER Glycine 0 N--CA 1.484 1.843 0 N-CA-C 121.504 3.362 . . . . 0.0 121.504 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.33 97.4 6.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 100.944 -3.725 . . . . 0.0 100.944 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ABA . . . . . 0.507 ' CG ' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.556 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 7.3 ptm -121.9 122.28 39.05 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 123.128 1.442 . . . . 0.0 109.379 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -62.57 121.38 13.19 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 179.626 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -104.36 24.87 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 123.936 0.773 . . . . 0.0 110.31 -179.637 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.47 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.8 OUTLIER -34.77 -39.89 0.1 Allowed 'General case' 0 N--CA 1.509 2.487 0 CA-C-O 123.502 1.62 . . . . 0.0 110.195 -179.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.401 ' N ' ' C ' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -32.61 -46.26 0.13 Allowed 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 110.055 -3.248 . . . . 0.0 111.477 179.245 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.53 -34.53 4.86 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 111.672 -2.513 . . . . 0.0 110.396 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -148.09 -81.98 0.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 23' ' ' ILE . 2.5 p -152.76 -131.54 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.149 -1.02 . . . . 0.0 109.378 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.595 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -100.16 137.42 38.63 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.595 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -148.58 -176.34 5.28 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 112.449 -2.159 . . . . 0.0 110.266 -179.396 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.535 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -122.02 155.75 34.94 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.556 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 45.6 t30 -109.21 104.33 13.46 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 100.346 -3.946 . . . . 0.0 100.346 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 37' ' ' TYR . 60.8 m -89.22 169.86 11.09 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.499 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.583 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 8.9 p -68.79 159.56 5.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 123.264 1.507 . . . . 0.0 111.613 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tt -48.43 -21.71 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 111.177 -2.738 . . . . 0.0 109.914 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.554 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -106.64 3.73 36.72 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 118.026 1.971 . . . . 0.0 118.026 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.583 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 13.5 m-30 -133.44 116.81 16.47 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 100.461 -3.903 . . . . 0.0 100.461 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.425 ' C ' ' H ' ' A' ' 40' ' ' ASP . 39.9 t -132.54 -133.65 0.18 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 118.381 -1.328 . . . . 0.0 113.041 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 71.42 -9.87 4.12 Favored Glycine 0 N--CA 1.486 1.993 0 CA-C-O 117.764 -1.575 . . . . 0.0 111.293 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 19.6 t70 104.57 -5.24 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.073 0 O-C-N 124.967 1.039 . . . . 0.0 112.907 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.536 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -139.39 -2.96 1.56 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -178.754 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 71.17 30.9 2.56 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 -179.254 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.536 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -89.04 -15.02 35.09 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 113.119 -1.855 . . . . 0.0 110.191 -179.519 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . 0.26 6.0 t -118.99 83.07 1.96 Allowed 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 100.236 -3.987 . . . . 0.0 100.236 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -77.51 89.87 3.87 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 111.115 -2.766 . . . . 0.0 104.057 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 36' ' ' GLY . 0.9 OUTLIER -62.34 -16.89 57.09 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 113.017 -1.901 . . . . 0.0 109.773 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mt 78.55 47.86 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.418 ' H ' ' HA3' ' A' ' 36' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 116.469 -1.729 . . . . 0.0 112.617 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 N--CA 1.493 1.447 0 N-CA-C 108.141 -1.523 . . . . 0.0 108.141 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.27 -178.95 19.16 Favored Glycine 0 N--CA 1.491 2.305 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.128 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ABA . . . . . 0.52 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 3.2 Cg_exo -74.33 -23.75 15.05 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.762 2.308 . . . . 0.0 111.342 173.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.5 t -20.14 -51.91 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 O-C-N 124.95 1.406 . . . . 0.0 113.535 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -156.31 154.83 31.26 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 102.421 -3.177 . . . . 0.0 102.421 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.486 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -125.32 10.77 8.03 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 124.768 1.292 . . . . 0.0 109.581 179.724 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.99 135.27 57.2 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 37.52 41.55 0.83 Allowed Glycine 0 N--CA 1.511 3.651 0 O-C-N 124.08 0.863 . . . . 0.0 111.511 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.412 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 20.9 t80 -91.24 -17.21 26.37 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 125.231 1.195 . . . . 0.0 112.589 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.432 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 44.6 m -116.92 154.13 31.36 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.15 -36.47 6.29 Favored 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.553 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 3.7 m-80 -140.58 -82.52 0.24 Allowed 'General case' 0 N--CA 1.51 2.555 0 N-CA-C 120.372 3.471 . . . . 0.0 120.372 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.82 -21.42 65.32 Favored Glycine 0 N--CA 1.508 3.462 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.575 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 2.95 67.46 0.0 OUTLIER Glycine 0 N--CA 1.481 1.696 0 N-CA-C 120.215 2.846 . . . . 0.0 120.215 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.0 t -95.72 94.58 4.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 101.423 -3.547 . . . . 0.0 101.423 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ABA . . . . . 0.514 ' CG ' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.43 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 8.2 ptm -115.84 165.66 12.83 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.411 ' CE1' ' HG2' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -102.71 126.71 49.92 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.487 ' O ' ' C ' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -106.6 18.92 5.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 124.412 1.07 . . . . 0.0 109.913 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.487 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -27.47 -52.96 0.07 Allowed 'General case' 0 N--CA 1.512 2.636 0 CA-C-O 123.405 1.574 . . . . 0.0 109.742 -179.421 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -25.08 -46.98 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 108.964 -3.743 . . . . 0.0 114.323 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.78 -35.52 5.45 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 110.916 -2.856 . . . . 0.0 110.026 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -147.03 -81.62 0.14 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 23' ' ' ILE . 4.5 p -157.44 -131.77 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.582 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -97.73 141.5 30.67 Favored 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.576 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.266 0.5 OUTLIER -153.31 -176.73 5.92 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.384 -1.735 . . . . 0.0 110.446 -179.277 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.575 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -120.48 148.95 43.15 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.43 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 43.3 t30 -101.61 101.0 11.47 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 101.417 -3.549 . . . . 0.0 101.417 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.511 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 59.5 m -86.71 156.6 19.9 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.116 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.583 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 12.5 p -59.94 160.38 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 112.591 -2.095 . . . . 0.0 114.266 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.7 tt -50.72 -21.85 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 CA-C-N 110.845 -2.889 . . . . 0.0 109.243 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -99.61 -6.83 54.49 Favored Glycine 0 N--CA 1.49 2.261 0 CA-C-N 114.202 -1.363 . . . . 0.0 115.929 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.583 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 5.9 m-85 -132.59 120.8 22.29 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.4 t -131.7 -137.98 0.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.629 -1.228 . . . . 0.0 111.087 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 74.88 -10.66 8.74 Favored Glycine 0 N--CA 1.481 1.688 0 CA-C-O 117.075 -1.958 . . . . 0.0 111.339 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 19.2 t70 105.07 -8.88 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.261 0 O-C-N 125.039 1.082 . . . . 0.0 113.065 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.553 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -137.86 -2.24 1.93 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -178.67 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 69.31 31.35 3.92 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 104.523 -2.399 . . . . 0.0 104.523 -179.254 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.553 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -88.81 -16.03 33.1 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 113.024 -1.898 . . . . 0.0 109.223 -179.39 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.4 t -119.45 88.84 3.01 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 101.397 -3.557 . . . . 0.0 101.397 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.9 mtp-105 -83.4 93.69 7.82 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 111.342 -2.663 . . . . 0.0 105.465 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 36' ' ' GLY . 26.0 t0 -62.07 -23.64 66.62 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 112.745 -2.025 . . . . 0.0 108.042 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 80.61 -144.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 112.789 -2.005 . . . . 0.0 107.686 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.312 0 O-C-N 124.334 1.021 . . . . 0.0 113.607 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 N--CA 1.494 1.526 0 N-CA-C 107.929 -1.604 . . . . 0.0 107.929 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.59 179.58 16.62 Favored Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.208 -1.472 . . . . 0.0 113.408 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ABA . . . . . 0.488 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 1.5 Cg_endo -76.45 -35.5 2.15 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.753 2.302 . . . . 0.0 112.548 177.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -19.81 -54.21 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 125.956 2.035 . . . . 0.0 113.177 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.8 t -146.99 154.47 41.28 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 103.669 -2.715 . . . . 0.0 103.669 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.524 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -127.06 12.12 7.13 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.183 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -55.81 129.7 40.51 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 35.35 46.04 0.71 Allowed Glycine 0 N--CA 1.508 3.487 0 O-C-N 124.744 1.277 . . . . 0.0 111.017 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.406 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 29.3 t80 -91.08 -17.6 25.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 125.752 1.501 . . . . 0.0 113.007 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.9 m -116.72 153.38 32.48 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.404 ' CD2' ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -106.28 -35.71 7.08 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -179.691 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.407 ' CB ' ' CD2' ' A' ' 37' ' ' TYR . 4.3 m-80 -144.12 -83.23 0.16 Allowed 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 119.107 3.003 . . . . 0.0 119.107 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -57.34 -27.0 57.48 Favored Glycine 0 N--CA 1.51 3.614 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.561 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 7.96 63.14 0.01 OUTLIER Glycine 0 N--CA 1.48 1.607 0 N-CA-C 120.304 2.882 . . . . 0.0 120.304 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.93 94.92 4.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 100.464 -3.902 . . . . 0.0 100.464 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ABA . . . . . 0.503 ' CG ' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.533 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 6.3 ptm -122.03 121.28 36.65 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 123.094 1.426 . . . . 0.0 108.807 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -63.78 118.36 8.22 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -99.98 26.18 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 123.751 0.657 . . . . 0.0 110.305 -179.448 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 23' ' ' ILE . 1.3 tm-20 -34.29 -41.86 0.12 Allowed 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 123.652 1.691 . . . . 0.0 109.713 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -31.19 -45.33 0.08 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 109.874 -3.33 . . . . 0.0 112.241 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.02 -33.73 4.63 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 111.841 -2.436 . . . . 0.0 110.305 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -149.32 -80.67 0.12 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 23' ' ' ILE . 2.4 p -153.86 -131.11 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 118.891 -1.124 . . . . 0.0 109.718 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -100.84 135.94 41.48 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.543 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -147.14 -177.56 5.74 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 112.333 -2.212 . . . . 0.0 109.705 -179.391 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.561 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -122.8 154.51 38.11 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 179.576 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.533 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 54.6 t30 -108.82 101.89 10.96 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 101.093 -3.669 . . . . 0.0 101.093 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 62.9 m -82.84 170.39 15.05 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 113.747 -1.57 . . . . 0.0 109.853 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.562 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 12.9 p -72.33 160.51 5.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 123.14 1.448 . . . . 0.0 111.859 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 tt -51.02 -19.03 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 111.657 -2.519 . . . . 0.0 108.94 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -94.3 -25.71 15.7 Favored Glycine 0 C--O 1.203 -1.839 0 CA-C-O 117.898 -1.501 . . . . 0.0 112.766 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.562 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 2.4 m-30 -115.1 124.64 52.05 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 119.428 1.614 . . . . 0.0 108.193 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 40' ' ' ASP . 23.1 t -131.62 -139.92 0.21 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.83 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 76.62 -12.62 10.08 Favored Glycine 0 N--CA 1.481 1.657 0 CA-C-O 117.555 -1.692 . . . . 0.0 110.1 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.522 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 31.0 t70 105.63 -6.11 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.062 0 O-C-N 125.04 1.082 . . . . 0.0 113.301 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.565 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -137.4 -4.17 1.88 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.515 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 72.2 32.4 1.73 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 -179.238 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.565 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -87.99 -20.07 26.34 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 113.328 -1.76 . . . . 0.0 110.575 -179.248 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . 0.256 6.1 t -113.67 83.5 1.86 Allowed 'General case' 0 C--N 1.295 -1.79 1 N-CA-C 98.893 -4.484 . . . . 0.0 98.893 179.955 . . . . . . . . 3 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.476 ' C ' ' H ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -76.0 89.34 2.97 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 101.944 -3.354 . . . . 0.0 101.944 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 36' ' ' GLY . 30.4 t70 -83.41 46.22 1.12 Allowed 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.476 ' H ' ' C ' ' A' ' 45' ' ' ARG . 41.1 mt 13.1 25.27 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 1 N-CA-C 122.114 4.116 . . . . 0.0 122.114 -179.584 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 46' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 115.168 -2.349 . . . . 0.0 109.845 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo . . . . . 0 N--CA 1.501 1.931 0 N-CA-C 110.093 -0.772 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.1 t -19.94 -43.56 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 126.252 2.22 . . . . 0.0 116.238 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 t -146.49 127.38 14.46 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.4 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 7.0 p90 -122.06 35.93 4.76 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.09 131.96 45.74 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.1 40.16 1.7 Allowed Glycine 0 N--CA 1.51 3.569 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.44 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 26.4 t80 -91.87 -15.2 28.47 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 125.756 1.504 . . . . 0.0 114.191 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.4 m -128.47 156.62 42.93 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.934 HD22 ' HA ' ' A' ' 43' ' ' GLN . 1.1 mp -104.49 -33.09 8.69 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.414 ' CB ' ' CD2' ' A' ' 37' ' ' TYR . 5.2 m120 -144.92 -81.65 0.16 Allowed 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 120.109 3.374 . . . . 0.0 120.109 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.12 -29.6 65.76 Favored Glycine 0 N--CA 1.507 3.429 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.402 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 5.02 66.99 0.01 OUTLIER Glycine 0 N--CA 1.483 1.767 0 CA-C-N 110.085 -3.058 . . . . 0.0 119.809 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.301 -1.515 1 N-CA-C 99.175 -4.38 . . . . 0.0 99.175 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.943 ' SD ' HD12 ' A' ' 23' ' ' ILE . 2.5 ppp? . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 124.459 2.076 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -70.86 117.24 12.12 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 113.238 -1.801 . . . . 0.0 107.497 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.943 HD12 ' SD ' ' A' ' 21' ' ' MET . 0.1 OUTLIER -100.93 24.88 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.006 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.482 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 1.3 tm-20 -32.71 -46.84 0.15 Allowed 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 123.607 1.67 . . . . 0.0 108.458 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -26.11 -48.47 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 108.605 -3.907 . . . . 0.0 113.067 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.449 ' CD1' HG12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -115.08 -33.99 5.2 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 111.357 -2.656 . . . . 0.0 109.996 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -146.82 -81.5 0.14 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 23' ' ' ILE . 6.3 p -156.16 -127.73 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.108 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -101.15 137.06 40.01 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.544 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -146.87 -174.54 4.52 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 112.312 -2.222 . . . . 0.0 109.297 -179.504 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.402 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -125.34 156.28 38.95 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -108.47 117.9 35.36 Favored 'General case' 0 C--N 1.298 -1.633 1 N-CA-C 98.102 -4.777 . . . . 0.0 98.102 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.548 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 81.9 m -98.57 166.22 11.45 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.61 HG12 ' CD2' ' A' ' 37' ' ' TYR . 7.1 p -64.87 158.11 4.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 C-N-CA 117.67 -1.612 . . . . 0.0 112.707 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -42.38 -28.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 111.52 -2.582 . . . . 0.0 110.682 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -99.06 -17.24 28.07 Favored Glycine 0 C--O 1.203 -1.784 0 CA-C-N 114.198 -1.365 . . . . 0.0 115.484 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.61 ' CD2' HG12 ' A' ' 34' ' ' VAL . 6.0 m-30 -111.96 124.92 53.41 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.43 ' C ' ' H ' ' A' ' 40' ' ' ASP . 47.0 t -133.71 -130.38 0.17 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.237 -1.385 . . . . 0.0 112.362 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.5 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 65.75 -2.56 3.5 Favored Glycine 0 N--CA 1.483 1.77 0 CA-C-O 117.699 -1.611 . . . . 0.0 109.815 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 8.8 t70 92.78 -2.48 0.13 Allowed 'General case' 0 N--CA 1.517 2.916 0 CA-C-N 118.268 1.034 . . . . 0.0 113.662 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.423 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -141.38 2.41 1.65 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.917 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.548 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 61.13 33.95 19.21 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 -179.26 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.934 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -88.71 -24.27 22.76 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 111.731 -2.486 . . . . 0.0 108.305 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 44' ' ' THR . 6.1 t -112.33 83.92 1.88 Allowed 'General case' 0 C--N 1.297 -1.678 1 N-CA-C 99.07 -4.418 . . . . 0.0 99.07 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.609 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 16.6 mtm180 -79.84 91.49 5.36 Favored 'General case' 0 C--N 1.296 -1.731 1 N-CA-C 100.11 -4.033 . . . . 0.0 100.11 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 36' ' ' GLY . 5.6 t70 -86.79 64.98 8.79 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.498 1.957 0 N-CA-C 117.929 2.566 . . . . 0.0 117.929 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 N--CA 1.501 1.943 0 CA-C-O 120.867 0.278 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -19.89 -53.83 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 125.332 1.645 . . . . 0.0 114.634 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 t -143.75 144.2 31.72 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 104.23 -2.508 . . . . 0.0 104.23 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.457 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 3.2 p90 -127.19 26.4 6.06 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 124.868 1.355 . . . . 0.0 109.845 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -100.06 133.26 44.7 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.37 24.69 61.77 Favored Glycine 0 N--CA 1.505 3.243 0 N-CA-C 107.662 -2.175 . . . . 0.0 107.662 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.428 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 10.2 t80 -91.1 -18.04 25.19 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 113.47 -1.365 . . . . 0.0 112.208 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.471 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 10.1 m -132.83 147.51 52.3 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.757 HD12 ' HD2' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -104.0 -34.7 8.36 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -179.636 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.401 ' HB3' ' CE2' ' A' ' 37' ' ' TYR . 23.0 m120 -147.86 -76.02 0.18 Allowed 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 120.403 3.483 . . . . 0.0 120.403 -178.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.469 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -63.72 -26.35 69.82 Favored Glycine 0 N--CA 1.508 3.496 0 N-CA-C 108.155 -1.978 . . . . 0.0 108.155 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 14' ' ' CYS . . . -1.25 68.56 0.0 OUTLIER Glycine 0 N--CA 1.485 1.911 0 N-CA-C 120.672 3.029 . . . . 0.0 120.672 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 17' ' ' GLY . 2.8 t . . . . . 0 C--N 1.3 -1.565 0 N-CA-C 100.322 -3.955 . . . . 0.0 100.322 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.503 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 5.5 ptp . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 123.207 1.479 . . . . 0.0 108.984 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.668 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -72.41 113.35 9.35 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 103.406 -2.812 . . . . 0.0 103.406 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.67 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -95.38 27.14 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.113 -179.289 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.496 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.8 OUTLIER -37.84 -37.65 0.25 Allowed 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 123.439 1.59 . . . . 0.0 109.288 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.4 ' N ' ' C ' ' A' ' 23' ' ' ILE . 0.7 OUTLIER -33.31 -44.38 0.13 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 110.388 -3.097 . . . . 0.0 111.579 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.5 -32.98 4.18 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 111.659 -2.519 . . . . 0.0 111.1 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -149.5 -80.04 0.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 118.124 2.639 . . . . 0.0 118.124 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.9 p -153.46 -133.52 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 119.098 -1.041 . . . . 0.0 109.834 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.668 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -100.09 135.95 40.73 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 179.739 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.526 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -147.65 -176.42 5.25 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 112.841 -1.981 . . . . 0.0 109.994 -179.511 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.421 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -125.18 150.07 47.32 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.503 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 14.5 t30 -106.36 123.71 48.47 Favored 'General case' 0 C--N 1.299 -1.599 1 N-CA-C 97.348 -5.056 . . . . 0.0 97.348 179.366 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 37' ' ' TYR . 72.1 m -96.59 -117.73 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.582 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.606 HG12 ' CD2' ' A' ' 37' ' ' TYR . 7.4 p -149.52 166.84 3.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 117.815 -1.554 . . . . 0.0 111.151 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tt -50.74 -19.68 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 112.247 -2.251 . . . . 0.0 107.747 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -104.27 -14.11 25.02 Favored Glycine 0 C--O 1.202 -1.848 0 CA-C-N 113.521 -1.672 . . . . 0.0 115.285 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.606 ' CD2' HG12 ' A' ' 34' ' ' VAL . 1.9 m-85 -131.66 125.64 32.64 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.609 ' H ' HG23 ' A' ' 44' ' ' THR . 11.1 t -129.74 -148.27 0.36 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 40' ' ' ASP . . . 90.82 -48.15 3.01 Favored Glycine 0 N--CA 1.502 3.049 0 N-CA-C 106.89 -2.484 . . . . 0.0 106.89 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 0.5 OUTLIER 122.81 8.68 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 C-N-CA 129.788 3.235 . . . . 0.0 108.186 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.757 ' HD2' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -127.27 -7.18 5.88 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.366 0.603 . . . . 0.0 110.83 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.45 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 62.51 38.32 12.65 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 124.236 1.969 . . . . 0.0 107.564 -179.211 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.591 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -88.23 -38.26 15.4 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 109.236 -3.62 . . . . 0.0 105.76 -179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.609 HG23 ' H ' ' A' ' 38' ' ' SER . 1.9 t -96.35 85.33 3.91 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 102.048 -3.316 . . . . 0.0 102.048 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.487 ' CZ ' ' HB2' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -82.61 84.69 7.18 Favored 'General case' 0 C--N 1.299 -1.626 1 N-CA-C 99.791 -4.152 . . . . 0.0 99.791 179.886 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 36' ' ' GLY . 30.1 t70 -55.49 -28.91 57.47 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 112.192 -2.276 . . . . 0.0 108.4 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 C-N-CA 127.068 2.147 . . . . 0.0 108.209 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.502 1.986 0 CA-C-O 122.411 0.921 . . . . 0.0 112.679 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.1 t -100.68 -25.15 14.24 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 113.391 -1.731 . . . . 0.0 106.406 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.9 t -155.88 133.82 11.28 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.507 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 3.0 p90 -124.09 19.59 9.13 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 122.896 1.331 . . . . 0.0 108.579 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.69 129.85 40.23 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.406 ' O ' ' NH1' ' A' ' 41' ' ' ARG . . . 36.36 50.6 1.31 Allowed Glycine 0 N--CA 1.501 2.972 0 O-C-N 125.415 1.697 . . . . 0.0 109.595 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.614 ' HD1' ' HH ' ' A' ' 29' ' ' TYR . 48.4 t80 -92.45 -14.9 27.84 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.5 m -122.67 162.72 21.43 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.622 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -117.29 -37.31 3.55 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.524 ' ND2' ' HD3' ' A' ' 45' ' ' ARG . 18.0 m-80 -146.69 -67.63 0.27 Allowed 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 119.765 3.246 . . . . 0.0 119.765 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.75 -24.99 76.48 Favored Glycine 0 N--CA 1.506 3.325 0 N-CA-C 106.474 -2.651 . . . . 0.0 106.474 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.501 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 0.97 59.88 0.0 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 120.56 2.984 . . . . 0.0 120.56 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.304 -1.386 0 N-CA-C 101.22 -3.622 . . . . 0.0 101.22 179.319 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.536 ' HE3' HD13 ' A' ' 23' ' ' ILE . 14.6 ptt? . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -63.0 122.89 17.15 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 102.535 -3.135 . . . . 0.0 102.535 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.643 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -101.1 25.69 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 124.098 0.874 . . . . 0.0 109.96 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.494 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 1.1 tm-20 -34.15 -42.94 0.14 Allowed 'General case' 0 N--CA 1.509 2.518 0 CA-C-O 123.21 1.481 . . . . 0.0 109.516 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -29.93 -49.9 0.11 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 109.56 -3.473 . . . . 0.0 111.86 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.05 -28.45 6.99 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 111.383 -2.644 . . . . 0.0 112.122 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -149.89 -79.42 0.13 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 29' ' ' TYR . 3.5 p -156.05 -131.94 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.23 -1.804 . . . . 0.0 110.31 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.614 ' HH ' ' HD1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -101.64 135.68 42.76 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 123.012 1.387 . . . . 0.0 109.697 179.708 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.545 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -148.37 -176.59 5.36 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 112.23 -2.259 . . . . 0.0 111.951 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.501 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -125.63 154.34 42.45 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.446 ' CA ' ' HE2' ' A' ' 21' ' ' MET . 6.2 t-20 -109.64 98.24 7.64 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 37' ' ' TYR . 55.8 m -93.07 150.33 20.6 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.751 HG12 ' CD2' ' A' ' 37' ' ' TYR . 9.9 p -59.51 169.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 111.758 -2.474 . . . . 0.0 117.143 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.447 ' H ' HG22 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -58.42 -21.07 17.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 111.497 -2.592 . . . . 0.0 107.146 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -94.56 -8.84 59.36 Favored Glycine 0 N--CA 1.482 1.733 0 CA-C-N 114.218 -1.355 . . . . 0.0 113.161 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.751 ' CD2' HG12 ' A' ' 34' ' ' VAL . 1.4 m-85 -141.19 126.25 18.34 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 116.496 -1.716 . . . . 0.0 107.799 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.612 ' H ' HG23 ' A' ' 44' ' ' THR . 8.5 t -124.14 -144.43 0.33 Allowed 'General case' 0 N--CA 1.518 2.966 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 41' ' ' ARG . . . 35.97 69.81 0.23 Allowed Glycine 0 N--CA 1.501 2.999 0 C-N-CA 124.441 1.019 . . . . 0.0 114.237 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 29.92 8.91 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 119.547 3.165 . . . . 0.0 119.547 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -132.19 -25.16 2.02 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.794 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.447 ' HB3' ' CB ' ' A' ' 37' ' ' TYR . 1.8 m 76.8 40.53 0.2 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.873 ' NE2' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -88.74 -20.7 24.45 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 112.749 -2.023 . . . . 0.0 109.437 -179.464 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.873 HG22 ' NE2' ' A' ' 43' ' ' GLN . 0.6 OUTLIER -113.0 92.87 4.16 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 102.21 -3.255 . . . . 0.0 102.21 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.524 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 6.7 mtm180 -84.93 85.84 7.43 Favored 'General case' 0 C--N 1.299 -1.597 1 N-CA-C 99.238 -4.356 . . . . 0.0 99.238 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 36' ' ' GLY . 13.9 t0 -60.67 -12.97 11.9 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 112.531 -2.122 . . . . 0.0 109.264 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.878 0 C-N-CA 128.156 2.582 . . . . 0.0 117.751 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo . . . . . 0 N--CA 1.492 1.403 0 CA-C-O 122.591 0.996 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 t -100.57 -29.0 12.58 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 113.682 -1.599 . . . . 0.0 106.824 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -166.46 152.75 8.8 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.508 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -129.55 14.58 6.01 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 124.659 1.224 . . . . 0.0 110.411 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -63.35 137.83 58.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.36 37.99 1.29 Allowed Glycine 0 N--CA 1.511 3.672 0 O-C-N 124.258 0.974 . . . . 0.0 111.133 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.576 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 30.5 t80 -90.4 -8.35 50.86 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 113.597 -1.301 . . . . 0.0 112.815 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.7 m -137.07 152.45 50.05 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.64 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.3 OUTLIER -94.13 -72.75 0.6 Allowed 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.41 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.454 ' C ' ' H ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -121.81 -56.66 1.85 Allowed 'General case' 0 N--CA 1.512 2.674 0 N-CA-C 115.667 1.728 . . . . 0.0 115.667 -179.551 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.81 44.29 3.31 Favored Glycine 0 N--CA 1.503 3.115 0 N-CA-C 105.913 -2.875 . . . . 0.0 105.913 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.533 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -68.82 67.39 0.45 Allowed Glycine 0 C--N 1.29 -2.019 0 CA-C-N 112.479 -1.861 . . . . 0.0 116.084 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.2 t . . . . . 0 C--N 1.302 -1.471 0 N-CA-C 103.52 -2.77 . . . . 0.0 103.52 179.673 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.0 ptm . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.485 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -111.7 126.5 55.1 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.194 -1.402 . . . . 0.0 107.696 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.638 ' O ' HG23 ' A' ' 23' ' ' ILE . 1.0 OUTLIER -106.78 23.11 3.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 124.189 0.931 . . . . 0.0 111.308 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.485 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.4 OUTLIER -38.1 -37.31 0.26 Allowed 'General case' 0 N--CA 1.515 2.816 0 CA-C-O 123.421 1.582 . . . . 0.0 110.157 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -33.26 -43.27 0.11 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 110.227 -3.17 . . . . 0.0 111.914 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.35 -34.66 3.77 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 111.335 -2.666 . . . . 0.0 111.3 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -147.28 -82.47 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 23' ' ' ILE . 26.7 p -154.52 -125.59 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.831 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.517 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -98.76 139.44 34.45 Favored 'General case' 0 N--CA 1.51 2.547 0 CA-C-O 122.394 1.092 . . . . 0.0 110.199 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.517 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -148.56 178.96 8.17 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 112.843 -1.98 . . . . 0.0 111.438 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.533 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -115.12 154.6 28.63 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 103.09 -2.93 . . . . 0.0 103.09 179.269 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -108.88 86.59 2.31 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.664 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 34.8 m -59.38 151.91 22.56 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.913 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.608 HG13 ' H ' ' A' ' 37' ' ' TYR . 7.5 p -59.36 157.12 2.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 111.589 -2.55 . . . . 0.0 112.158 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tt -43.16 -25.61 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 112.344 -2.207 . . . . 0.0 110.063 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 34' ' ' VAL . . . -98.33 -24.1 11.78 Favored Glycine 0 N--CA 1.485 1.931 0 CA-C-N 114.6 -1.182 . . . . 0.0 115.256 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.608 ' H ' HG13 ' A' ' 34' ' ' VAL . 1.3 m-30 -111.57 133.05 54.1 Favored 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 102.862 -3.014 . . . . 0.0 102.862 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.6 t -139.2 -137.04 0.13 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 118.403 -1.319 . . . . 0.0 111.175 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 75.74 -10.5 13.06 Favored Glycine 0 N--CA 1.48 1.621 0 CA-C-O 117.905 -1.497 . . . . 0.0 109.513 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 21.6 t70 102.06 -15.66 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.048 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -134.43 6.9 3.56 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.216 -179.285 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.664 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 59.48 32.51 21.76 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.261 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.64 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -88.13 5.55 40.76 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.256 -179.426 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.452 ' O ' ' C ' ' A' ' 45' ' ' ARG . 12.1 t -130.08 22.33 5.3 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.518 -1.674 . . . . 0.0 113.632 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.452 ' C ' ' O ' ' A' ' 44' ' ' THR . 1.0 OUTLIER -16.56 90.32 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 O-C-N 125.36 1.662 . . . . 0.0 112.252 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 36' ' ' GLY . 23.3 t70 -74.79 2.62 9.69 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 117.844 -1.542 . . . . 0.0 111.002 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.907 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 29' ' ' TYR . 8.4 Cg_endo . . . . . 0 N--CA 1.495 1.589 0 CA-C-O 119.878 -0.134 . . . . 0.0 111.882 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -19.86 -53.7 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 126.542 2.401 . . . . 0.0 115.172 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.55 125.38 22.54 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.392 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.459 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 1.4 p90 -110.51 4.42 20.41 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.851 1.31 . . . . 0.0 110.747 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.65 129.2 38.16 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 113.607 -1.633 . . . . 0.0 106.974 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 34.46 46.17 0.53 Allowed Glycine 0 N--CA 1.511 3.637 0 O-C-N 124.423 1.077 . . . . 0.0 111.414 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.402 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 26.7 t80 -91.44 -20.26 21.96 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 125.935 1.609 . . . . 0.0 112.611 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.8 m -116.92 153.82 31.91 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.884 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.3 OUTLIER -100.58 -36.53 9.13 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -144.67 -82.05 0.16 Allowed 'General case' 0 N--CA 1.51 2.572 1 N-CA-C 121.876 4.028 . . . . 0.0 121.876 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.25 -31.9 59.78 Favored Glycine 0 N--CA 1.515 3.924 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.474 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 7.8 69.47 0.01 OUTLIER Glycine 0 N--CA 1.486 1.969 0 CA-C-N 109.67 -3.265 . . . . 0.0 120.847 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.301 -1.518 1 N-CA-C 98.67 -4.567 . . . . 0.0 98.67 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 13.5 ptt? . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 122.974 1.369 . . . . 0.0 108.497 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -64.59 119.58 10.76 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.638 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -101.18 20.93 2.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 123.513 0.508 . . . . 0.0 109.684 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -26.26 -50.51 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 123.097 1.427 . . . . 0.0 109.603 -179.457 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -25.9 -49.06 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 108.829 -3.805 . . . . 0.0 113.333 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.91 -33.82 5.95 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 111.476 -2.602 . . . . 0.0 110.405 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -146.84 -80.24 0.15 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.5 p -156.8 -132.13 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.762 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -99.02 137.94 36.82 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.564 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.267 0.6 OUTLIER -148.26 -174.73 4.66 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 112.863 -1.971 . . . . 0.0 109.419 -179.615 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.474 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -124.7 157.47 35.56 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -109.33 116.4 31.78 Favored 'General case' 0 C--N 1.298 -1.649 1 N-CA-C 96.069 -5.53 . . . . 0.0 96.069 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 66.0 m -94.62 -124.71 0.11 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 118.601 -0.714 . . . . 0.0 111.023 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.54 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 5.7 p -139.64 160.28 27.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 117.787 -1.565 . . . . 0.0 109.095 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -47.51 -24.0 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 111.895 -2.411 . . . . 0.0 108.1 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -97.37 -20.25 23.25 Favored Glycine 0 C--O 1.203 -1.833 0 CA-C-O 117.716 -1.602 . . . . 0.0 114.814 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.55 ' CD1' ' HA ' ' A' ' 45' ' ' ARG . 2.1 m-30 -123.74 125.84 45.45 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 120.764 2.282 . . . . 0.0 106.805 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.527 ' H ' HG23 ' A' ' 44' ' ' THR . 47.8 t -138.17 -131.34 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.487 -1.285 . . . . 0.0 111.334 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 68.89 -6.54 3.68 Favored Glycine 0 N--CA 1.487 2.042 0 CA-C-O 117.988 -1.451 . . . . 0.0 111.513 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 11.8 t70 102.14 -12.7 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.036 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.439 ' HD2' HD13 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -133.8 4.01 3.55 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.54 -178.656 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 62.72 32.07 16.29 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.884 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -89.18 -19.91 24.87 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 112.743 -2.026 . . . . 0.0 107.099 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.527 HG23 ' H ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -106.94 82.15 1.65 Allowed 'General case' 0 N--CA 1.488 1.461 1 N-CA-C 100.144 -4.021 . . . . 0.0 100.144 179.543 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.55 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 12.8 mtm180 -76.47 89.3 3.24 Favored 'General case' 0 C--N 1.296 -1.757 1 N-CA-C 99.129 -4.396 . . . . 0.0 99.129 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 36' ' ' GLY . 25.1 t70 -62.81 -25.6 68.33 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 117.344 -1.742 . . . . 0.0 108.832 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 46' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.502 2.129 0 C-N-CA 128.042 2.537 . . . . 0.0 108.436 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.449 ' HA ' ' HB3' ' A' ' 29' ' ' TYR . 5.5 Cg_exo . . . . . 0 N--CA 1.503 2.04 0 N-CA-C 108.147 -1.52 . . . . 0.0 108.147 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -19.93 -51.42 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 110.066 -3.243 . . . . 0.0 118.251 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.2 p -126.44 108.88 11.6 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.286 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.535 ' HA ' ' HB2' ' A' ' 13' ' ' TYR . 18.4 p90 -115.08 0.9 13.77 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -85.26 89.45 7.66 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.987 1.375 . . . . 0.0 110.173 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.35 28.81 4.47 Favored Glycine 0 N--CA 1.501 2.97 0 N-CA-C 106.958 -2.457 . . . . 0.0 106.958 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.535 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 20.6 t80 -90.57 -11.07 41.13 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.579 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 60.5 m -126.8 151.21 48.58 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.943 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.3 OUTLIER -104.38 -38.31 6.88 Favored 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.435 ' HB2' ' CD2' ' A' ' 37' ' ' TYR . 18.9 m120 -147.07 -66.66 0.27 Allowed 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 120.621 3.563 . . . . 0.0 120.621 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.97 19.59 52.55 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.636 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -65.56 96.02 0.24 Allowed Glycine 0 C--N 1.295 -1.726 0 CA-C-O 124.39 2.106 . . . . 0.0 115.826 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.287 -2.126 0 N-CA-C 101.08 -3.674 . . . . 0.0 101.08 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.52 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 4.3 ptm . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 101.9 -3.37 . . . . 0.0 101.9 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -103.99 127.94 51.54 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -105.79 21.07 3.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 123.918 0.761 . . . . 0.0 109.718 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -29.58 -49.29 0.09 Allowed 'General case' 0 N--CA 1.509 2.478 0 CA-C-O 123.528 1.632 . . . . 0.0 109.645 -179.303 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -26.88 -48.48 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.676 1 CA-C-N 108.362 -4.017 . . . . 0.0 113.34 179.353 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.85 -34.12 5.87 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 111.036 -2.802 . . . . 0.0 110.673 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -147.74 -79.87 0.15 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 29' ' ' TYR . 1.7 p -156.67 -134.48 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.806 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.57 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -97.55 138.56 34.78 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.57 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.273 0.5 OUTLIER -149.3 -179.17 6.85 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 112.875 -1.966 . . . . 0.0 111.757 -179.197 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.636 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -116.1 151.91 34.65 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.52 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 43.8 t30 -104.13 76.81 1.37 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.543 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 33.5 m -64.1 152.39 40.59 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.678 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.671 HG12 ' CD2' ' A' ' 37' ' ' TYR . 7.4 p -59.67 160.99 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 111.811 -2.449 . . . . 0.0 114.441 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.421 ' H ' HG22 ' A' ' 35' ' ' ILE . 1.6 tt -51.72 -21.6 2.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 111.51 -2.587 . . . . 0.0 108.784 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -95.34 -14.38 48.21 Favored Glycine 0 N--CA 1.491 2.366 0 CA-C-N 114.201 -1.363 . . . . 0.0 115.297 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.671 ' CD2' HG12 ' A' ' 34' ' ' VAL . 2.1 m-85 -131.89 127.41 36.4 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.443 ' C ' HG22 ' A' ' 44' ' ' THR . 47.3 t -136.81 -135.46 0.14 Allowed 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 118.304 -1.358 . . . . 0.0 108.744 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 69.52 0.94 26.83 Favored Glycine 0 N--CA 1.48 1.603 0 CA-C-O 116.707 -2.163 . . . . 0.0 111.701 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 5.1 t70 94.65 -11.7 0.11 Allowed 'General case' 0 N--CA 1.52 3.068 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.473 ' NH1' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -138.02 -2.65 1.86 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.743 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.543 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 67.85 31.47 5.75 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -179.462 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.943 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -89.04 -19.55 25.5 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 111.878 -2.419 . . . . 0.0 108.652 -179.755 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 44' ' ' THR 0.266 2.3 t -115.14 89.89 3.21 Favored 'General case' 0 C--N 1.296 -1.723 1 N-CA-C 98.541 -4.615 . . . . 0.0 98.541 179.863 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 16.5 mtm180 -87.61 93.25 9.37 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 101.77 -3.419 . . . . 0.0 101.77 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 36' ' ' GLY . 31.7 t70 -64.73 -20.31 66.27 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.0 -1.455 . . . . 0.0 108.114 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 N--CA 1.493 1.683 0 C-N-CA 126.414 1.886 . . . . 0.0 107.572 179.634 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 N--CA 1.488 1.176 0 CA-C-O 123.168 1.237 . . . . 0.0 108.943 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.6 t -100.99 -26.05 13.86 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.206 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.3 t -173.27 151.96 2.14 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.57 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -129.84 12.6 5.77 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 124.41 1.068 . . . . 0.0 110.744 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -62.27 136.33 57.88 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 37.95 41.54 0.97 Allowed Glycine 0 N--CA 1.512 3.741 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 29' ' ' TYR . 37.3 t80 -91.71 -13.77 31.12 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 125.591 1.406 . . . . 0.0 113.231 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.483 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 33.7 m -121.79 155.08 36.08 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.857 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -108.2 -37.91 5.9 Favored 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.629 HD22 ' NH1' ' A' ' 45' ' ' ARG . 14.8 m120 -143.12 -80.57 0.2 Allowed 'General case' 0 N--CA 1.514 2.752 0 N-CA-C 119.471 3.137 . . . . 0.0 119.471 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.05 -24.6 63.19 Favored Glycine 0 N--CA 1.51 3.61 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.626 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 4.55 63.92 0.0 OUTLIER Glycine 0 N--CA 1.481 1.662 0 N-CA-C 120.823 3.089 . . . . 0.0 120.823 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 19' ' ' VAL . 1.8 t . . . . . 0 C--N 1.307 -1.254 0 N-CA-C 102.4 -3.185 . . . . 0.0 102.4 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.487 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 9.6 ptm . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.439 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -109.34 129.0 55.54 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.58 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -106.09 13.94 7.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 124.039 0.837 . . . . 0.0 111.87 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -22.78 -54.88 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 124.815 1.322 . . . . 0.0 112.008 -179.41 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.6 m -26.52 -45.18 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 110.921 -2.854 . . . . 0.0 114.3 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.53 -36.98 5.61 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 111.361 -2.654 . . . . 0.0 109.939 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -147.96 -81.77 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.2 p -156.87 -133.25 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.436 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.57 ' CE2' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -96.25 139.48 32.33 Favored 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.474 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -147.92 178.72 8.28 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 113.073 -1.876 . . . . 0.0 109.95 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.626 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -118.15 146.64 44.03 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.487 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 56.9 t30 -99.55 104.61 16.42 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 101.558 -3.497 . . . . 0.0 101.558 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 61.6 m -84.13 177.38 8.25 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.988 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.644 HG12 ' CD2' ' A' ' 37' ' ' TYR . 14.5 p -80.3 159.54 4.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 123.003 1.383 . . . . 0.0 112.712 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -46.84 -22.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-N 111.618 -2.537 . . . . 0.0 108.99 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -97.2 -15.88 37.01 Favored Glycine 0 C--O 1.203 -1.783 0 CA-C-N 113.615 -1.63 . . . . 0.0 116.534 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.644 ' CD2' HG12 ' A' ' 34' ' ' VAL . 4.4 m-30 -123.52 121.41 35.59 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 103.535 -2.765 . . . . 0.0 103.535 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.444 ' C ' HG22 ' A' ' 44' ' ' THR . 15.2 t -130.1 -142.54 0.24 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.385 1.088 . . . . 0.0 113.306 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 40' ' ' ASP . . . 86.33 -47.84 3.82 Favored Glycine 0 C--N 1.301 -1.406 0 N-CA-C 106.514 -2.634 . . . . 0.0 106.514 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER 139.31 -6.68 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.983 0 O-C-N 126.807 2.122 . . . . 0.0 112.291 -179.569 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.483 ' HD3' ' CA ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -134.58 -1.9 2.76 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.14 -178.846 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.54 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 69.64 35.36 2.45 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 104.991 -2.225 . . . . 0.0 104.991 -179.28 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.857 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -89.06 -13.74 37.98 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 112.599 -2.091 . . . . 0.0 108.846 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.512 ' O ' HG23 ' A' ' 44' ' ' THR . 5.0 t -122.54 92.62 3.75 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 103.07 -2.937 . . . . 0.0 103.07 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.629 ' NH1' HD22 ' A' ' 16' ' ' ASN . 0.1 OUTLIER -83.94 97.18 9.1 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' GLY . 30.2 t70 -66.11 -29.58 69.92 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 116.633 -2.027 . . . . 0.0 108.474 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 mt . . . . . 0 N--CA 1.502 2.14 0 C-N-CA 127.523 2.329 . . . . 0.0 106.82 179.643 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.438 ' HA ' ' HB3' ' A' ' 29' ' ' TYR . 1.1 Cg_endo . . . . . 0 N--CA 1.496 1.674 0 N-CA-C 108.179 -1.508 . . . . 0.0 108.179 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.2 m -21.27 -41.58 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 111.597 -2.547 . . . . 0.0 117.614 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.2 m -145.06 119.93 9.94 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.428 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 4.0 p90 -114.48 15.48 17.84 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 122.379 1.085 . . . . 0.0 111.058 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.51 133.25 36.49 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.41 32.86 31.23 Favored Glycine 0 N--CA 1.506 3.347 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.481 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 23.9 t80 -90.37 -13.2 35.54 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 113.935 -1.133 . . . . 0.0 112.951 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.405 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 16.0 m -128.95 143.61 50.93 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.941 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.5 OUTLIER -97.62 -33.02 11.49 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 123.58 0.55 . . . . 0.0 112.41 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -149.08 -85.96 0.09 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 120.515 3.524 . . . . 0.0 120.515 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 33' ' ' CYS . . . -48.7 -32.69 11.29 Favored Glycine 0 N--CA 1.513 3.785 0 CA-C-O 123.136 1.409 . . . . 0.0 109.684 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.5 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 8.11 64.84 0.01 OUTLIER Glycine 0 N--CA 1.48 1.599 0 CA-C-N 109.521 -3.339 . . . . 0.0 121.198 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 19' ' ' VAL . 1.3 t . . . . . 0 C--N 1.3 -1.578 1 N-CA-C 99.885 -4.117 . . . . 0.0 99.885 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.3 ptp . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -101.79 123.74 46.26 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.628 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -102.54 22.78 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 124.757 1.286 . . . . 0.0 111.489 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -36.3 -37.55 0.12 Allowed 'General case' 0 N--CA 1.516 2.852 0 CA-C-O 123.79 1.757 . . . . 0.0 110.353 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.7 OUTLIER -34.91 -45.95 0.29 Allowed 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 110.077 -3.238 . . . . 0.0 111.44 179.172 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.59 -33.83 5.08 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 111.517 -2.583 . . . . 0.0 110.481 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.67 -79.97 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.0 OUTLIER -156.65 -135.47 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 118.38 -1.328 . . . . 0.0 109.855 -179.416 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -94.78 140.44 29.91 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.575 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -151.21 -174.5 4.83 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 113.097 -1.865 . . . . 0.0 110.712 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.5 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -125.42 153.45 43.43 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.569 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -105.9 118.47 36.68 Favored 'General case' 0 C--N 1.3 -1.548 1 N-CA-C 98.29 -4.707 . . . . 0.0 98.29 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.511 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 76.3 m -98.8 166.45 11.3 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.634 HG13 ' H ' ' A' ' 37' ' ' TYR . 3.4 p -65.24 157.43 5.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 C-N-CA 118.141 -1.424 . . . . 0.0 111.064 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -41.78 -24.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 111.864 -2.426 . . . . 0.0 111.934 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.413 ' H ' HG22 ' A' ' 34' ' ' VAL . . . -100.53 -27.39 7.63 Favored Glycine 0 N--CA 1.484 1.838 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.82 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.634 ' H ' HG13 ' A' ' 34' ' ' VAL . 4.2 m-30 -98.91 120.58 39.6 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 104.019 -2.585 . . . . 0.0 104.019 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.4 t -130.91 -135.54 0.2 Allowed 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 118.175 -1.41 . . . . 0.0 112.398 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.505 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 69.99 -8.58 3.48 Favored Glycine 0 N--CA 1.483 1.802 0 CA-C-O 117.4 -1.778 . . . . 0.0 110.622 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 16.7 t70 100.11 -2.83 0.03 OUTLIER 'General case' 0 N--CA 1.523 3.209 0 C-N-CA 124.004 0.922 . . . . 0.0 113.184 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.451 ' NH1' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -140.66 1.41 1.72 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -178.773 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 64.39 33.91 10.86 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 -179.383 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.941 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -88.47 -23.86 23.14 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 111.993 -2.367 . . . . 0.0 110.737 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.494 ' O ' HG23 ' A' ' 44' ' ' THR . 5.9 t -112.23 86.6 2.38 Favored 'General case' 0 C--N 1.294 -1.806 1 N-CA-C 98.201 -4.741 . . . . 0.0 98.201 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 14.9 mtm180 -77.04 87.2 3.54 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 110.849 -2.887 . . . . 0.0 104.647 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 36' ' ' GLY . 5.9 t70 -83.7 67.05 9.33 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 mp . . . . . 0 N--CA 1.506 2.363 1 N-CA-C 122.885 4.402 . . . . 0.0 122.885 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.473 ' HA ' ' HB3' ' A' ' 29' ' ' TYR . 6.8 Cg_endo . . . . . 0 N--CA 1.502 2.026 0 N-CA-C 108.325 -1.452 . . . . 0.0 108.325 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m -20.15 -50.52 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 109.944 -3.298 . . . . 0.0 116.413 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.19 127.82 17.11 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.543 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 1.0 OUTLIER -117.14 8.97 13.42 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 124.02 0.825 . . . . 0.0 112.074 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -69.38 138.25 53.48 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 41.25 37.53 1.64 Allowed Glycine 0 N--CA 1.507 3.402 0 O-C-N 124.43 1.081 . . . . 0.0 110.775 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.426 ' CD1' ' CZ ' ' A' ' 29' ' ' TYR . 30.9 t80 -91.25 -17.22 26.35 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 114.063 -1.068 . . . . 0.0 113.813 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.455 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 41.5 m -116.85 154.68 30.34 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.983 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -107.71 -37.97 6.0 Favored 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 115.086 1.514 . . . . 0.0 115.086 -179.65 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.553 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 4.8 m120 -139.19 -83.21 0.27 Allowed 'General case' 0 N--CA 1.509 2.513 0 N-CA-C 120.133 3.383 . . . . 0.0 120.133 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.75 -24.22 64.14 Favored Glycine 0 N--CA 1.511 3.669 0 N-CA-C 108.849 -1.701 . . . . 0.0 108.849 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.577 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 5.38 65.39 0.01 OUTLIER Glycine 0 N--CA 1.478 1.495 0 N-CA-C 120.449 2.94 . . . . 0.0 120.449 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.306 -1.308 0 N-CA-C 100.734 -3.802 . . . . 0.0 100.734 179.28 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.56 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 7.2 ptm . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 123.073 1.416 . . . . 0.0 109.089 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -63.31 120.44 11.58 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 179.643 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.647 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -102.78 23.69 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 123.714 0.634 . . . . 0.0 110.367 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.5 OUTLIER -33.5 -42.06 0.1 Allowed 'General case' 0 N--CA 1.511 2.607 0 CA-C-O 123.722 1.725 . . . . 0.0 109.696 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -30.89 -46.54 0.08 Allowed 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 109.632 -3.44 . . . . 0.0 111.992 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.49 -35.51 4.56 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 111.572 -2.558 . . . . 0.0 109.779 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -146.71 -82.82 0.13 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 117.419 2.377 . . . . 0.0 117.419 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.3 p -153.11 -131.39 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.594 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -100.3 135.84 41.11 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.531 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.25 0.6 OUTLIER -146.5 -179.05 6.5 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.103 -2.317 . . . . 0.0 109.119 -179.42 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.577 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -121.16 153.67 37.22 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.56 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 60.5 t30 -106.72 104.28 13.92 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 101.77 -3.419 . . . . 0.0 101.77 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 57.5 m -88.71 156.72 18.83 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.19 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.65 HG12 ' CD2' ' A' ' 37' ' ' TYR . 12.2 p -59.83 159.93 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 113.019 -1.9 . . . . 0.0 114.319 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -48.56 -22.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 110.884 -2.871 . . . . 0.0 109.126 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -98.39 -11.84 46.91 Favored Glycine 0 N--CA 1.485 1.933 0 CA-C-O 117.832 -1.538 . . . . 0.0 116.588 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.65 ' CD2' HG12 ' A' ' 34' ' ' VAL . 3.1 m-30 -126.8 121.7 32.66 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.451 ' C ' HG22 ' A' ' 44' ' ' THR . 48.2 t -132.32 -134.59 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.725 -1.19 . . . . 0.0 110.868 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 74.61 -13.12 5.31 Favored Glycine 0 N--CA 1.485 1.953 0 CA-C-O 117.894 -1.504 . . . . 0.0 110.166 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 27.9 t70 104.62 -7.57 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.884 0 C-N-CA 124.419 1.087 . . . . 0.0 113.672 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.457 ' NH1' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -137.28 -2.26 2.05 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.498 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 70.27 31.2 3.19 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 -179.248 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.983 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -88.38 -11.96 44.68 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 113.699 -1.592 . . . . 0.0 109.82 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 44' ' ' THR 0.253 5.3 t -121.54 85.95 2.49 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 101.545 -3.502 . . . . 0.0 101.545 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.45 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 1.2 mtm180 -78.35 88.68 4.37 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 36' ' ' GLY . 24.1 t70 -61.01 -20.61 62.7 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.247 -1.797 . . . . 0.0 108.544 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.499 1.976 0 O-C-N 124.905 1.378 . . . . 0.0 112.379 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo . . . . . 0 N--CA 1.496 1.625 0 CA-C-O 122.449 0.937 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.21 -21.62 17.19 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 113.381 -1.736 . . . . 0.0 109.071 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.0 t -150.09 121.21 7.75 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -121.38 29.03 7.45 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 123.291 1.519 . . . . 0.0 107.795 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -101.01 134.37 44.1 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.15 23.9 60.26 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -91.94 -26.12 18.57 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.786 -1.207 . . . . 0.0 113.252 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.589 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 33.8 m -124.23 150.34 45.4 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -111.07 -37.85 5.23 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -179.24 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.539 ' ND2' ' HD2' ' A' ' 45' ' ' ARG . 34.3 m-80 -149.82 -59.91 0.2 Allowed 'General case' 0 N--CA 1.509 2.508 0 N-CA-C 118.57 2.804 . . . . 0.0 118.57 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -107.2 18.71 35.79 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 106.875 -2.49 . . . . 0.0 106.875 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.615 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -72.46 94.73 0.66 Allowed Glycine 0 C--N 1.296 -1.661 0 CA-C-O 123.926 1.848 . . . . 0.0 113.631 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.294 -1.848 0 N-CA-C 102.779 -3.045 . . . . 0.0 102.779 179.412 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.474 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 21.8 ptt? . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 123.401 1.572 . . . . 0.0 108.863 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.8 OUTLIER -73.61 119.14 17.43 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.103 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.643 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -104.11 23.77 2.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 124.279 0.987 . . . . 0.0 111.025 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -38.84 -37.18 0.32 Allowed 'General case' 0 N--CA 1.514 2.755 0 CA-C-O 123.707 1.718 . . . . 0.0 109.262 -179.744 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.402 ' N ' ' C ' ' A' ' 23' ' ' ILE . 1.3 m -32.78 -43.42 0.09 Allowed 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 110.035 -3.257 . . . . 0.0 111.902 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.454 HD11 HG12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -119.3 -36.58 3.34 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 111.358 -2.656 . . . . 0.0 110.949 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -144.49 -84.6 0.14 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 23' ' ' ILE . 11.2 p -149.8 -131.56 0.05 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.495 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -98.54 143.74 28.62 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 179.544 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.534 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.258 0.6 OUTLIER -151.13 175.01 12.55 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 125.776 1.923 . . . . 0.0 111.03 -179.374 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.615 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -118.95 136.61 54.0 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.474 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 50.5 t30 -93.16 77.23 4.6 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.108 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.434 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 65.9 m -61.26 146.67 47.07 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.516 1.15 . . . . 0.0 110.681 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.621 HG12 ' CD2' ' A' ' 37' ' ' TYR . 10.5 p -58.97 161.98 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 112.332 -2.213 . . . . 0.0 115.403 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tt -49.83 -20.12 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 111.541 -2.572 . . . . 0.0 109.315 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.59 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -98.98 -18.35 25.02 Favored Glycine 0 C--O 1.202 -1.851 0 CA-C-O 117.48 -1.733 . . . . 0.0 114.34 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.621 ' CD2' HG12 ' A' ' 34' ' ' VAL . 1.9 m-30 -123.31 129.81 51.86 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 120.27 2.035 . . . . 0.0 107.269 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.634 ' H ' HG23 ' A' ' 44' ' ' THR . 0.3 OUTLIER -125.29 -159.46 0.89 Allowed 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -179.308 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 88.59 -47.82 3.48 Favored Glycine 0 N--CA 1.494 2.529 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.288 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 27.7 t70 124.28 -0.42 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.038 0 O-C-N 126.719 2.07 . . . . 0.0 109.198 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -117.95 -28.67 5.85 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.434 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 3.0 m 82.7 37.86 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.781 ' OE1' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -88.96 -21.43 23.55 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 110.665 -2.971 . . . . 0.0 107.425 -179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.781 HG22 ' OE1' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -110.01 83.34 1.74 Allowed 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 101.835 -3.394 . . . . 0.0 101.835 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.539 ' HD2' ' ND2' ' A' ' 16' ' ' ASN . 1.1 mtm180 -78.77 89.19 4.62 Favored 'General case' 0 C--N 1.299 -1.622 1 N-CA-C 98.906 -4.479 . . . . 0.0 98.906 179.682 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.59 ' N ' ' O ' ' A' ' 36' ' ' GLY . 29.2 t0 -58.51 -23.0 57.03 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 111.849 -2.432 . . . . 0.0 107.192 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 N--CA 1.497 1.908 0 CA-C-N 112.668 -2.06 . . . . 0.0 115.077 179.541 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo . . . . . 0 N--CA 1.498 1.77 0 CA-C-O 122.349 0.895 . . . . 0.0 111.478 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 t -100.99 -19.3 15.91 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.249 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.9 m -154.95 128.96 8.8 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.516 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 2.7 p90 -124.83 8.91 8.18 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -69.24 142.73 54.12 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 39.71 39.46 1.31 Allowed Glycine 0 N--CA 1.507 3.405 0 O-C-N 124.518 1.136 . . . . 0.0 110.87 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.477 ' HD1' ' HH ' ' A' ' 29' ' ' TYR . 38.6 t80 -91.34 -15.81 28.46 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 125.383 1.284 . . . . 0.0 113.414 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.484 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 58.2 m -119.72 157.19 29.06 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.902 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -110.72 -38.38 5.17 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.457 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 8.5 m120 -140.58 -77.84 0.3 Allowed 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 121.486 3.884 . . . . 0.0 121.486 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.54 -17.76 73.05 Favored Glycine 0 N--CA 1.507 3.377 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.627 ' HA2' ' SG ' ' A' ' 31' ' ' CYS . . . 2.71 62.92 0.0 OUTLIER Glycine 0 C--N 1.302 -1.352 0 N-CA-C 120.091 2.796 . . . . 0.0 120.091 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 19' ' ' VAL . 1.6 t . . . . . 0 C--N 1.31 -1.125 0 N-CA-C 101.762 -3.421 . . . . 0.0 101.762 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.7 ptm . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 102.525 -3.139 . . . . 0.0 102.525 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -102.4 129.51 48.9 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.615 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -105.19 19.47 4.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 124.053 0.846 . . . . 0.0 112.309 -179.556 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -29.11 -49.87 0.08 Allowed 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 122.811 1.291 . . . . 0.0 112.008 -179.408 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.4 m -31.44 -43.64 0.06 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 110.99 -2.823 . . . . 0.0 114.151 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.59 -32.68 6.1 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 112.063 -2.335 . . . . 0.0 111.094 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -149.61 -80.14 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.5 p -158.33 -133.2 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.879 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -97.04 139.36 33.16 Favored 'General case' 0 N--CA 1.51 2.554 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.538 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 1.2 t -147.34 -171.34 3.77 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.305 -1.771 . . . . 0.0 112.914 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.627 ' SG ' ' HA2' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -125.46 151.28 46.47 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 179.275 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -107.82 103.17 12.37 Favored 'General case' 0 C--N 1.3 -1.577 1 N-CA-C 99.53 -4.248 . . . . 0.0 99.53 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 83.4 m -87.69 170.74 10.99 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.415 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.596 HG12 ' CD2' ' A' ' 37' ' ' TYR . 14.2 p -67.69 163.6 2.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-O 123.304 1.526 . . . . 0.0 112.582 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.463 ' H ' HG22 ' A' ' 35' ' ' ILE . 1.2 tt -53.34 -18.11 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 112.044 -2.343 . . . . 0.0 108.851 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -100.03 -22.21 12.4 Favored Glycine 0 C--O 1.199 -2.081 0 CA-C-N 113.507 -1.679 . . . . 0.0 114.16 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.596 ' CD2' HG12 ' A' ' 34' ' ' VAL . 2.8 m-30 -118.96 130.21 55.58 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 121.149 2.475 . . . . 0.0 104.676 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.404 ' C ' ' H ' ' A' ' 40' ' ' ASP . 22.9 t -142.07 -136.24 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 117.545 -1.662 . . . . 0.0 113.767 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 40' ' ' ASP . . . 86.64 -42.37 3.15 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 107.744 -2.142 . . . . 0.0 107.744 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 0.8 OUTLIER 137.68 -2.03 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.796 0 O-C-N 126.017 1.657 . . . . 0.0 110.135 -179.568 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.484 ' HD3' ' CA ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -140.93 -7.06 1.08 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -178.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.49 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 73.79 35.07 0.85 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 -178.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.902 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -88.39 -17.68 30.0 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 112.015 -2.357 . . . . 0.0 107.727 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.538 ' O ' HG23 ' A' ' 44' ' ' THR . 5.1 t -120.02 88.36 2.92 Favored 'General case' 0 C--N 1.299 -1.588 1 N-CA-C 99.745 -4.168 . . . . 0.0 99.745 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.412 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 13.7 mtm180 -83.46 96.34 8.55 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 101.841 -3.392 . . . . 0.0 101.841 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 36' ' ' GLY . 28.1 t70 -83.93 69.75 10.33 Favored 'General case' 0 C--N 1.294 -1.81 1 N-CA-C 99.926 -4.102 . . . . 0.0 99.926 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.405 HD12 ' CE1' ' A' ' 37' ' ' TYR . 3.4 mp . . . . . 0 N--CA 1.49 1.551 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.457 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 N--CA 1.496 1.631 0 CA-C-O 121.928 0.72 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.25 -23.82 20.06 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.778 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 t -153.25 126.77 8.7 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.567 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 4.1 p90 -121.38 20.01 11.29 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 122.146 0.974 . . . . 0.0 109.004 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -72.46 121.47 19.64 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.463 ' O ' ' NH2' ' A' ' 41' ' ' ARG . . . 53.13 40.99 60.16 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.433 ' OH ' ' HA ' ' A' ' 30' ' ' THR . 7.0 t80 -91.27 -16.17 28.0 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.546 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 4.7 m -122.61 161.49 23.66 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.522 HD12 ' HD2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -115.63 -37.17 4.03 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 117.885 2.55 . . . . 0.0 117.885 -179.203 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.514 ' ND2' ' HD3' ' A' ' 45' ' ' ARG . 34.1 m-80 -146.22 -69.98 0.26 Allowed 'General case' 0 N--CA 1.515 2.82 0 N-CA-C 120.341 3.46 . . . . 0.0 120.341 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.11 -25.38 59.75 Favored Glycine 0 N--CA 1.506 3.352 0 N-CA-C 107.834 -2.107 . . . . 0.0 107.834 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.546 ' HA3' ' HB3' ' A' ' 14' ' ' CYS . . . -6.8 74.78 0.0 OUTLIER Glycine 0 N--CA 1.484 1.898 0 N-CA-C 118.842 2.297 . . . . 0.0 118.842 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.302 -1.46 0 N-CA-C 100.429 -3.915 . . . . 0.0 100.429 179.617 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.42 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 4.4 ptm . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 123.193 1.473 . . . . 0.0 108.93 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -76.2 113.67 14.01 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -94.8 21.85 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.174 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.47 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.6 OUTLIER -37.63 -38.94 0.29 Allowed 'General case' 0 N--CA 1.514 2.764 0 CA-C-O 123.117 1.437 . . . . 0.0 109.267 -179.71 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -31.09 -43.63 0.05 Allowed 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 109.927 -3.306 . . . . 0.0 111.477 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.95 -38.18 3.11 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 111.152 -2.749 . . . . 0.0 109.998 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -145.98 -82.44 0.14 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 119.432 3.123 . . . . 0.0 119.432 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.1 p -150.95 -139.63 0.09 Allowed 'General case' 0 N--CA 1.509 2.495 0 C-N-CA 118.639 -1.224 . . . . 0.0 110.732 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -95.36 138.74 32.64 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 179.39 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.5 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.331 0.4 OUTLIER -150.47 178.79 8.71 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 112.2 -2.273 . . . . 0.0 110.332 -179.403 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.487 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -122.68 142.46 50.65 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.06 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.42 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 2.5 t-20 -102.84 110.75 22.79 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 100.867 -3.753 . . . . 0.0 100.867 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 76.2 m -84.27 -119.86 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.413 -1.315 . . . . 0.0 112.792 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.519 HG13 ' N ' ' A' ' 37' ' ' TYR . 9.1 p -144.07 165.05 14.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 122.646 1.212 . . . . 0.0 110.806 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -52.65 -18.83 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 CA-C-N 112.135 -2.302 . . . . 0.0 107.73 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -105.55 -15.17 19.8 Favored Glycine 0 N--CA 1.482 1.742 0 CA-C-O 117.563 -1.687 . . . . 0.0 115.716 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.519 ' N ' HG13 ' A' ' 34' ' ' VAL . 3.9 m-85 -131.87 123.96 28.57 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.587 ' H ' HG23 ' A' ' 44' ' ' THR . 7.9 t -132.73 -147.57 0.31 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 87.48 -50.08 3.99 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.412 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER 136.59 -9.53 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.025 0 O-C-N 126.923 2.19 . . . . 0.0 109.002 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.522 ' HD2' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -114.31 -26.07 8.16 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.3 -178.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 1.2 m 79.82 35.88 0.14 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.594 ' OE1' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -88.82 -24.71 22.51 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 110.702 -2.954 . . . . 0.0 105.97 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.594 HG22 ' OE1' ' A' ' 43' ' ' GLN . 1.0 OUTLIER -106.31 89.73 3.14 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 102.469 -3.16 . . . . 0.0 102.469 179.749 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.514 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 4.3 mtm180 -84.93 90.8 7.89 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 101.572 -3.492 . . . . 0.0 101.572 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' GLY . 29.3 t70 -59.25 -20.1 51.42 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 111.693 -2.503 . . . . 0.0 107.882 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.881 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo . . . . . 0 N--CA 1.499 1.817 0 CA-C-O 121.004 0.335 . . . . 0.0 111.506 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.22 -20.87 47.18 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.829 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 t -158.08 133.25 8.69 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.537 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 3.4 p90 -128.5 36.99 4.19 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.742 1.258 . . . . 0.0 108.05 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -100.45 130.3 46.52 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 47.3 33.75 8.09 Favored Glycine 0 N--CA 1.506 3.338 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -91.77 -20.37 21.59 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 125.315 1.244 . . . . 0.0 112.315 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.462 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 34.2 m -118.56 158.31 25.65 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 103.318 -2.845 . . . . 0.0 103.318 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.525 HD12 ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -112.25 -36.69 5.24 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -146.77 -77.05 0.18 Allowed 'General case' 0 N--CA 1.51 2.57 0 N-CA-C 119.053 2.983 . . . . 0.0 119.053 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.16 -23.56 69.86 Favored Glycine 0 N--CA 1.507 3.425 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.476 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -3.01 67.63 0.0 OUTLIER Glycine 0 N--CA 1.488 2.126 0 N-CA-C 122.1 3.6 . . . . 0.0 122.1 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.303 -1.451 1 N-CA-C 100.172 -4.01 . . . . 0.0 100.172 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.493 ' SD ' ' ND2' ' A' ' 32' ' ' ASN . 8.3 ptm . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 123.147 1.451 . . . . 0.0 109.166 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.675 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -68.16 117.56 10.15 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.647 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -101.01 23.65 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.544 -179.532 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.486 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.7 OUTLIER -29.07 -49.25 0.08 Allowed 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 123.353 1.549 . . . . 0.0 109.034 -179.678 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -26.12 -49.29 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 108.656 -3.884 . . . . 0.0 113.165 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.51 -34.52 5.83 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 111.768 -2.469 . . . . 0.0 109.339 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -146.95 -81.12 0.14 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 23' ' ' ILE . 3.4 p -156.15 -132.07 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.468 -1.293 . . . . 0.0 110.129 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.675 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -98.45 137.17 37.53 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 179.67 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.541 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -148.57 -175.93 5.12 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 125.818 1.949 . . . . 0.0 110.246 -179.456 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.476 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -125.9 152.93 44.92 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.493 ' ND2' ' SD ' ' A' ' 21' ' ' MET . 4.0 t-20 -109.88 119.82 40.55 Favored 'General case' 0 C--N 1.298 -1.665 1 N-CA-C 96.346 -5.428 . . . . 0.0 96.346 179.612 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 37' ' ' TYR . 72.6 m -96.06 -111.89 0.14 Allowed 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 118.684 -1.206 . . . . 0.0 110.385 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.598 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 4.2 p -146.92 161.29 8.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 C-N-CA 118.617 -1.233 . . . . 0.0 108.139 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.419 ' H ' HG22 ' A' ' 35' ' ' ILE . 0.6 OUTLIER -46.62 -25.37 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 112.125 -2.307 . . . . 0.0 109.157 179.5 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -106.84 1.6 35.98 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 118.495 2.158 . . . . 0.0 118.495 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.598 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 5.5 m-30 -135.55 120.32 18.43 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 100.283 -3.969 . . . . 0.0 100.283 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.624 ' H ' HG23 ' A' ' 44' ' ' THR . 7.4 t -131.77 -150.41 0.42 Allowed 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.19 -40.12 3.0 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 122.59 4.23 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.563 0 C-N-CA 127.073 2.149 . . . . 0.0 107.945 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.525 ' NE ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -127.69 -21.74 3.7 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.265 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER 77.0 35.79 0.35 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 -179.462 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.651 ' OE1' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -88.61 -21.47 23.99 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 111.423 -2.626 . . . . 0.0 107.307 -179.606 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.651 HG22 ' OE1' ' A' ' 43' ' ' GLN . 1.7 t -113.5 87.85 2.7 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 102.117 -3.29 . . . . 0.0 102.117 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 8.3 mtm180 -84.3 88.31 7.24 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 101.504 -3.517 . . . . 0.0 101.504 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 36' ' ' GLY . 32.4 t70 -55.32 -27.35 46.42 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.787 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 75.5 mt . . . . . 0 N--CA 1.51 2.574 0 C-N-CA 128.101 2.56 . . . . 0.0 117.263 179.268 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 N--CA 1.504 2.112 0 N-CA-C 108.542 -1.368 . . . . 0.0 108.542 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -19.82 -54.81 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 110.801 -2.909 . . . . 0.0 117.621 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.89 116.71 19.05 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.582 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 2.7 p90 -114.5 2.47 14.62 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -70.38 140.47 52.12 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.34 42.37 2.48 Favored Glycine 0 N--CA 1.505 3.3 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.412 ' CD1' ' CZ ' ' A' ' 29' ' ' TYR . 35.9 t80 -91.17 -19.12 23.42 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 125.177 1.163 . . . . 0.0 113.258 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.437 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 35.6 m -116.21 154.85 29.35 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.861 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -107.14 -35.72 6.77 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.642 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 3.5 m120 -141.35 -83.09 0.21 Allowed 'General case' 0 N--CA 1.51 2.571 0 N-CA-C 120.84 3.644 . . . . 0.0 120.84 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.87 -26.12 66.73 Favored Glycine 0 N--CA 1.508 3.48 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.61 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 6.97 65.68 0.01 OUTLIER Glycine 0 N--CA 1.481 1.649 0 CA-C-N 110.275 -2.963 . . . . 0.0 120.127 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.305 -1.33 0 N-CA-C 102.768 -3.049 . . . . 0.0 102.768 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.57 ' HE3' HD13 ' A' ' 23' ' ' ILE . 5.5 ptt? . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 102.815 -3.031 . . . . 0.0 102.815 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.432 ' CE1' ' HG2' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -111.16 127.73 55.68 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.602 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -105.53 14.06 7.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 123.911 0.757 . . . . 0.0 110.644 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -20.12 -56.93 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.631 0 CA-C-O 123.893 1.806 . . . . 0.0 111.652 -179.028 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -26.26 -49.14 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.034 1 CA-C-N 108.259 -4.064 . . . . 0.0 113.723 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.37 -36.34 6.54 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 111.424 -2.625 . . . . 0.0 109.149 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -146.53 -81.14 0.15 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.455 ' H ' HG22 ' A' ' 23' ' ' ILE . 8.2 p -157.32 -132.7 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.951 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -97.21 140.56 31.52 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.551 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.264 0.5 OUTLIER -152.59 -177.89 6.51 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 112.753 -2.021 . . . . 0.0 109.578 -179.272 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.61 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -117.6 156.67 27.73 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -108.08 100.46 9.79 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 100.633 -3.84 . . . . 0.0 100.633 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.431 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 57.3 m -86.83 160.2 18.84 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.677 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.796 HG12 ' CD2' ' A' ' 37' ' ' TYR . 14.6 p -61.71 160.71 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-O 123.197 1.475 . . . . 0.0 111.658 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.415 HG22 ' H ' ' A' ' 35' ' ' ILE . 2.0 tt -52.51 -19.49 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 111.423 -2.626 . . . . 0.0 109.946 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -101.91 -0.72 51.97 Favored Glycine 0 N--CA 1.491 2.328 0 CA-C-N 114.076 -1.42 . . . . 0.0 115.692 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.796 ' CD2' HG12 ' A' ' 34' ' ' VAL . 9.4 m-30 -133.67 118.59 18.34 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.459 ' C ' HG22 ' A' ' 44' ' ' THR . 35.3 t -132.44 -134.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.741 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 71.63 -10.81 3.65 Favored Glycine 0 N--CA 1.486 1.969 0 CA-C-O 117.709 -1.606 . . . . 0.0 111.634 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 17.7 t70 105.0 -8.24 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.144 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.443 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -138.35 -1.05 1.94 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.688 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 69.34 30.95 4.02 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 -179.199 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.861 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -89.04 -16.68 31.04 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.204 -1.816 . . . . 0.0 110.107 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.465 ' O ' HG23 ' A' ' 44' ' ' THR 0.258 5.1 t -118.4 92.9 3.94 Favored 'General case' 0 C--N 1.297 -1.692 1 N-CA-C 99.668 -4.197 . . . . 0.0 99.668 179.995 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 19.0 mtm180 -88.36 92.28 9.11 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 112.249 -2.25 . . . . 0.0 105.832 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 36' ' ' GLY . 28.6 t70 -56.2 -27.34 54.3 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 125.833 1.958 . . . . 0.0 109.914 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.498 1.937 0 O-C-N 126.066 2.104 . . . . 0.0 113.662 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo . . . . . 0 N--CA 1.495 1.585 0 CA-C-O 122.316 0.882 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.2 t -100.72 -21.84 15.08 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.977 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.5 t -156.53 125.84 6.13 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.474 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 9.3 p90 -123.49 30.82 6.12 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.688 1.232 . . . . 0.0 110.568 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -100.41 134.08 43.88 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.31 29.28 52.55 Favored Glycine 0 N--CA 1.506 3.327 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -91.25 -24.15 19.95 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.292 -1.454 . . . . 0.0 112.965 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.565 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 17.7 m -119.78 150.43 40.43 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.788 HD12 ' HD2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -109.19 -37.5 5.77 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 -179.355 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -149.46 -67.71 0.21 Allowed 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.94 -20.41 79.73 Favored Glycine 0 N--CA 1.502 3.085 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.565 ' HA3' ' HB3' ' A' ' 14' ' ' CYS . . . -4.02 71.08 0.0 OUTLIER Glycine 0 N--CA 1.484 1.834 0 N-CA-C 121.748 3.459 . . . . 0.0 121.748 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 C--N 1.303 -1.42 0 N-CA-C 101.343 -3.577 . . . . 0.0 101.343 179.408 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.3 ptp . . . . . 0 N--CA 1.487 1.394 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.8 OUTLIER -108.2 123.14 48.29 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -103.2 18.61 4.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 124.635 1.21 . . . . 0.0 111.115 -179.741 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -25.94 -52.41 0.05 OUTLIER 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 123.8 1.762 . . . . 0.0 110.643 -179.402 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -25.83 -49.37 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 108.437 -3.983 . . . . 0.0 113.069 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.76 -34.91 6.12 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 111.233 -2.712 . . . . 0.0 110.246 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -147.2 -80.84 0.14 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 23' ' ' ILE . 9.6 p -159.34 -130.98 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.771 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -96.31 140.64 30.69 Favored 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.521 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -151.2 172.34 15.97 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.791 -179.217 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.454 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -116.32 131.45 56.94 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -89.49 121.83 32.09 Favored 'General case' 0 C--N 1.303 -1.443 1 N-CA-C 99.957 -4.09 . . . . 0.0 99.957 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 37' ' ' TYR . 82.2 m -90.95 -114.5 0.08 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 123.945 0.778 . . . . 0.0 112.215 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.555 HG12 ' CD2' ' A' ' 37' ' ' TYR . 7.2 p -153.77 164.58 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 C-N-CA 117.656 -1.618 . . . . 0.0 111.257 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -47.9 -24.26 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 112.052 -2.34 . . . . 0.0 107.41 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -99.92 -17.9 24.11 Favored Glycine 0 C--O 1.201 -1.951 0 CA-C-O 117.69 -1.616 . . . . 0.0 115.165 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.555 ' CD2' HG12 ' A' ' 34' ' ' VAL . 1.1 m-85 -128.46 128.56 44.65 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 121.697 2.749 . . . . 0.0 106.008 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.64 ' H ' HG23 ' A' ' 44' ' ' THR . 12.6 t -130.77 -146.66 0.31 Allowed 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 40' ' ' ASP . . . 90.95 -51.12 3.17 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 106.496 -2.642 . . . . 0.0 106.496 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER 128.32 4.97 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.663 0 O-C-N 127.958 2.799 . . . . 0.0 109.026 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.788 ' HD2' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -121.53 -27.98 4.67 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.651 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 1.9 m 85.54 37.73 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 104.327 -2.472 . . . . 0.0 104.327 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.624 ' HA ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -88.17 -23.32 23.64 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 111.514 -2.585 . . . . 0.0 107.157 -179.621 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.64 HG23 ' H ' ' A' ' 38' ' ' SER . 1.3 t -110.23 84.42 1.92 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 101.365 -3.569 . . . . 0.0 101.365 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -81.28 87.48 6.12 Favored 'General case' 0 C--N 1.299 -1.63 1 N-CA-C 99.28 -4.341 . . . . 0.0 99.28 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 36' ' ' GLY . 33.3 t70 -58.85 -25.66 63.46 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 112.111 -2.313 . . . . 0.0 107.355 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.423 ' HB3' ' HB3' ' A' ' 29' ' ' TYR . 69.2 Cg_endo . . . . . 0 N--CA 1.492 1.433 0 CA-C-O 122.031 0.763 . . . . 0.0 112.368 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.9 t -100.47 -20.97 15.52 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.424 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.9 t -156.9 130.57 8.17 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.56 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 3.2 p90 -123.03 2.7 9.33 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.404 0.621 . . . . 0.0 111.82 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.29 122.57 13.55 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.11 36.95 93.13 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.722 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.52 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 22.4 t80 -91.24 -17.63 25.7 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.619 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.555 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 30.9 m -115.02 151.63 33.87 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.981 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -108.31 -34.0 6.94 Favored 'General case' 0 N--CA 1.508 2.457 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.491 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 4.3 m120 -142.07 -82.21 0.21 Allowed 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 120.355 3.465 . . . . 0.0 120.355 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.68 6.32 77.19 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 108.421 -1.871 . . . . 0.0 108.421 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.621 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -51.2 95.87 0.01 OUTLIER Glycine 0 C--N 1.303 -1.265 0 CA-C-N 112.847 -1.676 . . . . 0.0 113.508 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.291 -1.962 0 N-CA-C 102.85 -3.019 . . . . 0.0 102.85 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.532 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 4.3 ptm . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 102.343 -3.206 . . . . 0.0 102.343 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -110.3 126.56 54.33 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.548 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -104.51 14.19 7.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 124.329 1.018 . . . . 0.0 112.408 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -23.05 -56.81 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 122.889 1.328 . . . . 0.0 112.657 -179.095 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.7 m -28.03 -44.22 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 110.277 -3.147 . . . . 0.0 115.428 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.99 -37.0 5.5 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 111.428 -2.623 . . . . 0.0 109.834 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -145.19 -82.63 0.15 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 117.211 2.301 . . . . 0.0 117.211 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.544 ' H ' HG22 ' A' ' 23' ' ' ILE . 1.0 OUTLIER -156.3 -138.87 0.07 Allowed 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 119.259 -0.977 . . . . 0.0 109.953 -179.267 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.56 ' CE2' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -92.36 146.39 23.73 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 102.591 -3.115 . . . . 0.0 102.591 179.372 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.547 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -158.43 -176.43 5.89 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 125.793 1.933 . . . . 0.0 109.704 -179.607 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.621 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -121.37 153.41 37.82 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.772 -1.171 . . . . 0.0 108.446 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.532 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 53.5 t30 -106.85 85.45 2.15 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 59.5 m -60.72 167.27 2.82 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.513 -1.676 . . . . 0.0 112.04 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.669 HG12 ' CD2' ' A' ' 37' ' ' TYR . 11.1 p -71.98 161.64 4.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 117.804 -1.559 . . . . 0.0 108.92 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.428 ' H ' HG22 ' A' ' 35' ' ' ILE . 1.9 tt -51.68 -21.64 2.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-N 112.335 -2.211 . . . . 0.0 108.735 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -92.4 -27.55 15.04 Favored Glycine 0 C--O 1.2 -2.016 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.81 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.669 ' CD2' HG12 ' A' ' 34' ' ' VAL . 3.1 m-30 -110.57 142.4 42.44 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 121.476 2.638 . . . . 0.0 108.341 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.433 ' C ' ' H ' ' A' ' 40' ' ' ASP . 53.0 m -142.73 -137.18 0.1 Allowed 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.649 -1.22 . . . . 0.0 112.034 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 73.79 -16.98 2.31 Favored Glycine 0 N--CA 1.481 1.665 0 CA-C-O 116.623 -2.209 . . . . 0.0 110.356 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 17.6 t70 106.94 -6.83 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.133 0 O-C-N 125.126 1.133 . . . . 0.0 111.817 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.505 ' C ' ' SG ' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -135.52 -6.58 2.23 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -178.715 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.562 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 69.3 33.54 3.21 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 -179.325 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.981 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -88.1 -21.13 24.86 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 111.514 -2.584 . . . . 0.0 106.916 -179.669 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.401 ' O ' ' CG2' ' A' ' 44' ' ' THR . 10.9 t -114.87 114.27 25.29 Favored 'General case' 0 C--N 1.296 -1.754 1 N-CA-C 94.032 -6.285 . . . . 0.0 94.032 179.612 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.609 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 14.6 mtm180 -105.25 99.76 9.37 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 101.337 -3.579 . . . . 0.0 101.337 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 36' ' ' GLY . 44.5 t0 -85.54 70.34 10.75 Favored 'General case' 0 C--N 1.295 -1.769 1 N-CA-C 98.599 -4.593 . . . . 0.0 98.599 179.533 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.7 mt . . . . . 0 N--CA 1.496 1.85 0 N-CA-C 117.829 2.529 . . . . 0.0 117.829 -179.384 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo . . . . . 0 N--CA 1.493 1.46 0 CA-C-O 122.232 0.847 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 t -100.22 -22.14 15.25 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.983 -1.462 . . . . 0.0 107.827 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.5 p -151.63 121.53 7.08 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 118.092 -0.956 . . . . 0.0 108.809 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 29' ' ' TYR . 4.3 p90 -116.11 -5.05 11.92 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.41 116.32 3.26 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.686 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.37 26.73 60.89 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.111 -1.519 . . . . 0.0 109.702 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.597 ' CE1' ' HA ' ' A' ' 30' ' ' THR . 26.3 t80 -91.28 -12.46 35.05 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 118.854 -1.139 . . . . 0.0 109.992 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.62 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 17.5 m -126.41 142.07 51.66 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.763 HD12 ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -100.83 -59.57 1.68 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -179.434 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.469 ' HB2' ' CD2' ' A' ' 37' ' ' TYR . 6.4 m120 -134.72 -52.62 0.81 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 119.791 3.256 . . . . 0.0 119.791 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -100.85 -0.62 55.13 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.62 ' HA3' ' HB3' ' A' ' 14' ' ' CYS . . . -51.75 90.52 0.01 OUTLIER Glycine 0 N--CA 1.476 1.327 0 CA-C-O 123.976 1.876 . . . . 0.0 117.119 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.295 -1.785 1 N-CA-C 96.02 -5.548 . . . . 0.0 96.02 179.237 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.6 ptm . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.496 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -111.08 130.79 55.5 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 103.419 -2.808 . . . . 0.0 103.419 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.635 HD13 ' CG2' ' A' ' 30' ' ' THR . 0.4 OUTLIER -104.59 16.45 5.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 124.214 0.946 . . . . 0.0 112.084 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.496 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 1.0 OUTLIER -29.16 -50.91 0.1 Allowed 'General case' 0 N--CA 1.507 2.389 0 CA-C-O 122.582 1.182 . . . . 0.0 112.727 -179.161 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.8 m -31.31 -43.42 0.06 Allowed 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 111.087 -2.779 . . . . 0.0 113.804 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.61 -36.03 5.6 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 111.522 -2.581 . . . . 0.0 109.987 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -148.2 -83.55 0.11 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 118.846 2.906 . . . . 0.0 118.846 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.492 ' H ' HG22 ' A' ' 23' ' ' ILE . 5.1 p -148.92 -136.04 0.07 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.525 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.51 ' HE1' ' CG ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -101.4 147.87 25.83 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-N 118.584 0.629 . . . . 0.0 109.941 -179.593 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.635 ' CG2' HD13 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -160.01 -173.72 4.21 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 118.587 2.81 . . . . 0.0 118.587 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.511 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -131.85 130.11 41.27 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.58 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -92.08 89.62 7.02 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 104.716 -2.328 . . . . 0.0 104.716 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.2 m -72.72 -178.35 2.65 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.247 1.023 . . . . 0.0 108.922 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.779 HG12 ' CD2' ' A' ' 37' ' ' TYR . 10.9 p -89.81 166.81 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-O 123.979 1.847 . . . . 0.0 113.458 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.43 ' H ' HG22 ' A' ' 35' ' ' ILE . 2.5 tt -56.29 -15.74 2.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-N 112.096 -2.32 . . . . 0.0 108.271 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.586 ' H ' HG13 ' A' ' 34' ' ' VAL . . . -98.34 -12.63 44.57 Favored Glycine 0 N--CA 1.486 1.972 0 CA-C-N 113.929 -1.487 . . . . 0.0 113.716 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.779 ' CD2' HG12 ' A' ' 34' ' ' VAL . 1.3 m-85 -135.24 130.51 35.32 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.57 ' H ' HG23 ' A' ' 44' ' ' THR . 1.4 t -129.06 -161.23 1.09 Allowed 'General case' 0 N--CA 1.515 2.775 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 51.27 63.5 4.57 Favored Glycine 0 N--CA 1.499 2.865 0 N-CA-C 117.513 1.765 . . . . 0.0 117.513 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 43.71 -13.78 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.588 1 N-CA-C 122.16 4.133 . . . . 0.0 122.16 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.763 ' NE ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -113.82 -28.2 7.5 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.464 ' SG ' ' N ' ' A' ' 18' ' ' GLY . 2.7 m 82.01 43.86 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.728 ' NE2' HG22 ' A' ' 44' ' ' THR . 0.1 OUTLIER -88.8 -8.68 53.95 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 112.86 -1.973 . . . . 0.0 112.127 -179.235 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.728 HG22 ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -120.83 94.12 4.25 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 102.121 -3.289 . . . . 0.0 102.121 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.4 ' HA ' ' HD1' ' A' ' 37' ' ' TYR . 7.2 mtm180 -83.78 86.52 7.13 Favored 'General case' 0 C--N 1.305 -1.329 1 N-CA-C 98.408 -4.664 . . . . 0.0 98.408 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 36' ' ' GLY . 1.3 t70 -59.96 -12.95 9.01 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 112.098 -2.319 . . . . 0.0 109.342 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.903 0 C-N-CA 127.581 2.353 . . . . 0.0 116.709 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.503 2.059 0 N-CA-C 109.06 -1.169 . . . . 0.0 109.06 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -19.91 -49.84 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 111.061 -2.791 . . . . 0.0 116.555 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.2 t -139.78 127.41 21.73 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -123.57 34.06 5.19 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.05 130.9 46.25 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 104.678 -2.342 . . . . 0.0 104.678 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.81 40.31 2.17 Favored Glycine 0 N--CA 1.506 3.34 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.407 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 24.6 t80 -91.52 -22.08 20.55 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 126.098 1.705 . . . . 0.0 112.856 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.41 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 38.1 m -114.68 155.07 27.3 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.964 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -107.06 -37.14 6.39 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -179.575 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.609 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 4.7 m120 -141.51 -85.54 0.18 Allowed 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 119.981 3.326 . . . . 0.0 119.981 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.98 -26.33 55.21 Favored Glycine 0 N--CA 1.512 3.716 0 N-CA-C 108.486 -1.845 . . . . 0.0 108.486 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.535 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 6.25 65.42 0.01 OUTLIER Glycine 0 N--CA 1.484 1.843 0 N-CA-C 121.504 3.362 . . . . 0.0 121.504 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.307 -1.261 0 N-CA-C 100.944 -3.725 . . . . 0.0 100.944 179.279 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.55 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 7.3 ptm . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 123.128 1.442 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.641 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -62.57 121.38 13.19 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 179.626 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.653 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -104.36 24.87 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 123.936 0.773 . . . . 0.0 110.31 -179.637 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.498 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.8 OUTLIER -34.77 -39.89 0.1 Allowed 'General case' 0 N--CA 1.509 2.487 0 CA-C-O 123.502 1.62 . . . . 0.0 110.195 -179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.401 ' N ' ' C ' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -32.61 -46.26 0.13 Allowed 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 110.055 -3.248 . . . . 0.0 111.477 179.245 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.53 -34.53 4.86 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 111.672 -2.513 . . . . 0.0 110.396 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -148.09 -81.98 0.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 23' ' ' ILE . 2.5 p -152.76 -131.54 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.149 -1.02 . . . . 0.0 109.378 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -100.16 137.42 38.63 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.595 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -148.58 -176.34 5.28 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 112.449 -2.159 . . . . 0.0 110.266 -179.396 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.535 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -122.02 155.75 34.94 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.55 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 45.6 t30 -109.21 104.33 13.46 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 100.346 -3.946 . . . . 0.0 100.346 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.449 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 60.8 m -89.22 169.86 11.09 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.499 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.707 HG12 ' CD2' ' A' ' 37' ' ' TYR . 8.9 p -68.79 159.56 5.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 123.264 1.507 . . . . 0.0 111.613 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.402 ' H ' HG22 ' A' ' 35' ' ' ILE . 1.2 tt -48.43 -21.71 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 111.177 -2.738 . . . . 0.0 109.914 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.554 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -106.64 3.73 36.72 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 118.026 1.971 . . . . 0.0 118.026 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.707 ' CD2' HG12 ' A' ' 34' ' ' VAL . 13.5 m-30 -133.44 116.81 16.47 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 100.461 -3.903 . . . . 0.0 100.461 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.493 ' C ' HG22 ' A' ' 44' ' ' THR . 39.9 t -132.54 -133.65 0.18 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 118.381 -1.328 . . . . 0.0 113.041 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 71.42 -9.87 4.12 Favored Glycine 0 N--CA 1.486 1.993 0 CA-C-O 117.764 -1.575 . . . . 0.0 111.293 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 19.6 t70 104.57 -5.24 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.073 0 O-C-N 124.967 1.039 . . . . 0.0 112.907 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.463 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -139.39 -2.96 1.56 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -178.754 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 71.17 30.9 2.56 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 -179.254 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.964 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -89.04 -15.02 35.09 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 113.119 -1.855 . . . . 0.0 110.191 -179.519 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.493 HG22 ' C ' ' A' ' 38' ' ' SER 0.26 6.0 t -118.99 83.07 1.96 Allowed 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 100.236 -3.987 . . . . 0.0 100.236 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 8.8 mtm-85 -77.51 89.87 3.87 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 111.115 -2.766 . . . . 0.0 104.057 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 36' ' ' GLY . 0.9 OUTLIER -62.34 -16.89 57.09 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 113.017 -1.901 . . . . 0.0 109.773 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mt . . . . . 0 N--CA 1.507 2.388 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 179.205 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.496 1.626 0 N-CA-C 111.342 -0.292 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.5 t -20.14 -51.91 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 O-C-N 124.95 1.406 . . . . 0.0 113.535 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -156.31 154.83 31.26 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 102.421 -3.177 . . . . 0.0 102.421 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.521 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -125.32 10.77 8.03 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 124.768 1.292 . . . . 0.0 109.581 179.724 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.99 135.27 57.2 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 37.52 41.55 0.83 Allowed Glycine 0 N--CA 1.511 3.651 0 O-C-N 124.08 0.863 . . . . 0.0 111.511 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.412 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 20.9 t80 -91.24 -17.21 26.37 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 125.231 1.195 . . . . 0.0 112.589 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.455 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 44.6 m -116.92 154.13 31.36 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.933 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -108.15 -36.47 6.29 Favored 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -179.666 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.674 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 4.5 m120 -140.58 -82.52 0.24 Allowed 'General case' 0 N--CA 1.51 2.555 0 N-CA-C 120.372 3.471 . . . . 0.0 120.372 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.82 -21.42 65.32 Favored Glycine 0 N--CA 1.508 3.462 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.575 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 2.95 67.46 0.0 OUTLIER Glycine 0 N--CA 1.481 1.696 0 N-CA-C 120.215 2.846 . . . . 0.0 120.215 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 19' ' ' VAL . 2.0 t . . . . . 0 C--N 1.305 -1.351 0 N-CA-C 101.423 -3.547 . . . . 0.0 101.423 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.418 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 8.2 ptm . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.445 ' CE1' ' HG2' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -102.71 126.71 49.92 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.611 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -106.6 18.92 5.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 124.412 1.07 . . . . 0.0 109.913 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.487 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -27.47 -52.96 0.07 Allowed 'General case' 0 N--CA 1.512 2.636 0 CA-C-O 123.405 1.574 . . . . 0.0 109.742 -179.421 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -25.08 -46.98 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 108.964 -3.743 . . . . 0.0 114.323 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.78 -35.52 5.45 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 110.916 -2.856 . . . . 0.0 110.026 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -147.03 -81.62 0.14 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 23' ' ' ILE . 4.5 p -157.44 -131.77 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.582 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -97.73 141.5 30.67 Favored 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.576 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.266 0.5 OUTLIER -153.31 -176.73 5.92 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.384 -1.735 . . . . 0.0 110.446 -179.277 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.575 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -120.48 148.95 43.15 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.727 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.418 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 43.3 t30 -101.61 101.0 11.47 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 101.417 -3.549 . . . . 0.0 101.417 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.511 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 59.5 m -86.71 156.6 19.9 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.116 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.696 HG12 ' CD2' ' A' ' 37' ' ' TYR . 12.5 p -59.94 160.38 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 112.591 -2.095 . . . . 0.0 114.266 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.7 tt -50.72 -21.85 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 CA-C-N 110.845 -2.889 . . . . 0.0 109.243 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -99.61 -6.83 54.49 Favored Glycine 0 N--CA 1.49 2.261 0 CA-C-N 114.202 -1.363 . . . . 0.0 115.929 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.696 ' CD2' HG12 ' A' ' 34' ' ' VAL . 5.9 m-85 -132.59 120.8 22.29 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.497 ' C ' HG22 ' A' ' 44' ' ' THR . 26.4 t -131.7 -137.98 0.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.629 -1.228 . . . . 0.0 111.087 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 74.88 -10.66 8.74 Favored Glycine 0 N--CA 1.481 1.688 0 CA-C-O 117.075 -1.958 . . . . 0.0 111.339 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 19.2 t70 105.07 -8.88 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.261 0 O-C-N 125.039 1.082 . . . . 0.0 113.065 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.455 ' HD3' ' CA ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -137.86 -2.24 1.93 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -178.67 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 69.31 31.35 3.92 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 104.523 -2.399 . . . . 0.0 104.523 -179.254 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.933 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -88.81 -16.03 33.1 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 113.024 -1.898 . . . . 0.0 109.223 -179.39 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.497 HG22 ' C ' ' A' ' 38' ' ' SER . 3.4 t -119.45 88.84 3.01 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 101.397 -3.557 . . . . 0.0 101.397 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 24.9 mtp-105 -83.4 93.69 7.82 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 111.342 -2.663 . . . . 0.0 105.465 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 36' ' ' GLY . 26.0 t0 -62.07 -23.64 66.62 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 112.745 -2.025 . . . . 0.0 108.042 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-N 112.789 -2.005 . . . . 0.0 107.686 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo . . . . . 0 N--CA 1.498 1.747 0 CA-C-O 119.676 -0.218 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -19.81 -54.21 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 125.956 2.035 . . . . 0.0 113.177 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.8 t -146.99 154.47 41.28 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 103.669 -2.715 . . . . 0.0 103.669 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.561 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -127.06 12.12 7.13 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.183 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -55.81 129.7 40.51 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 35.35 46.04 0.71 Allowed Glycine 0 N--CA 1.508 3.487 0 O-C-N 124.744 1.277 . . . . 0.0 111.017 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.411 ' HD1' ' HH ' ' A' ' 29' ' ' TYR . 29.3 t80 -91.08 -17.6 25.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 125.752 1.501 . . . . 0.0 113.007 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.411 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 50.9 m -116.72 153.38 32.48 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.941 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -106.28 -35.71 7.08 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -179.691 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.49 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 4.9 m120 -144.12 -83.23 0.16 Allowed 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 119.107 3.003 . . . . 0.0 119.107 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -57.34 -27.0 57.48 Favored Glycine 0 N--CA 1.51 3.614 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.561 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 7.96 63.14 0.01 OUTLIER Glycine 0 N--CA 1.48 1.607 0 N-CA-C 120.304 2.882 . . . . 0.0 120.304 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.307 -1.262 0 N-CA-C 100.464 -3.902 . . . . 0.0 100.464 179.323 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 6.3 ptm . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 123.094 1.426 . . . . 0.0 108.807 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.661 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -63.78 118.36 8.22 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.67 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -99.98 26.18 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 123.751 0.657 . . . . 0.0 110.305 -179.448 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.487 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 1.3 tm-20 -34.29 -41.86 0.12 Allowed 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 123.652 1.691 . . . . 0.0 109.713 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -31.19 -45.33 0.08 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 109.874 -3.33 . . . . 0.0 112.241 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.02 -33.73 4.63 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 111.841 -2.436 . . . . 0.0 110.305 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -149.32 -80.67 0.12 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 23' ' ' ILE . 2.4 p -153.86 -131.11 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 118.891 -1.124 . . . . 0.0 109.718 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.661 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -100.84 135.94 41.48 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.543 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -147.14 -177.56 5.74 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 112.333 -2.212 . . . . 0.0 109.705 -179.391 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.561 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -122.8 154.51 38.11 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 179.576 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.535 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 54.6 t30 -108.82 101.89 10.96 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 101.093 -3.669 . . . . 0.0 101.093 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 62.9 m -82.84 170.39 15.05 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 113.747 -1.57 . . . . 0.0 109.853 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.69 HG12 ' CD2' ' A' ' 37' ' ' TYR . 12.9 p -72.33 160.51 5.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 123.14 1.448 . . . . 0.0 111.859 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.432 HG22 HG22 ' A' ' 34' ' ' VAL . 3.0 tt -51.02 -19.03 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 111.657 -2.519 . . . . 0.0 108.94 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -94.3 -25.71 15.7 Favored Glycine 0 C--O 1.203 -1.839 0 CA-C-O 117.898 -1.501 . . . . 0.0 112.766 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.69 ' CD2' HG12 ' A' ' 34' ' ' VAL . 2.4 m-30 -115.1 124.64 52.05 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 119.428 1.614 . . . . 0.0 108.193 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.415 ' C ' HG22 ' A' ' 44' ' ' THR . 23.1 t -131.62 -139.92 0.21 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.83 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 76.62 -12.62 10.08 Favored Glycine 0 N--CA 1.481 1.657 0 CA-C-O 117.555 -1.692 . . . . 0.0 110.1 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.522 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 31.0 t70 105.63 -6.11 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.062 0 O-C-N 125.04 1.082 . . . . 0.0 113.301 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.468 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -137.4 -4.17 1.88 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.814 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.515 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 72.2 32.4 1.73 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 -179.238 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.941 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -87.99 -20.07 26.34 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 113.328 -1.76 . . . . 0.0 110.575 -179.248 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.493 ' O ' HG23 ' A' ' 44' ' ' THR 0.256 6.1 t -113.67 83.5 1.86 Allowed 'General case' 0 C--N 1.295 -1.79 1 N-CA-C 98.893 -4.484 . . . . 0.0 98.893 179.955 . . . . . . . . 4 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.58 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -76.0 89.34 2.97 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 101.944 -3.354 . . . . 0.0 101.944 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 36' ' ' GLY . 30.4 t70 -83.41 46.22 1.12 Allowed 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 45' ' ' ARG . 41.1 mt . . . . . 0 N--CA 1.504 2.27 1 N-CA-C 122.114 4.116 . . . . 0.0 122.114 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo . . . . . 0 N--CA 1.493 1.474 0 N-CA-C 108.692 -1.311 . . . . 0.0 108.692 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.97 173.43 13.42 Favored Glycine 0 N--CA 1.498 2.807 0 C-N-CA 119.506 -1.331 . . . . 0.0 114.232 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ABA . . . . . 0.776 ' H ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.776 ' HD3' ' H ' ' A' ' 6' ' ' ABA . 23.0 Cg_exo -58.2 -44.07 41.96 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 123.536 2.824 . . . . 0.0 110.093 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.1 t -19.94 -43.56 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 126.252 2.22 . . . . 0.0 116.238 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 t -146.49 127.38 14.46 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.4 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 7.0 p90 -122.06 35.93 4.76 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.09 131.96 45.74 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.1 40.16 1.7 Allowed Glycine 0 N--CA 1.51 3.569 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.44 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 26.4 t80 -91.87 -15.2 28.47 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 125.756 1.504 . . . . 0.0 114.191 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.4 m -128.47 156.62 42.93 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.934 HD22 ' HA ' ' A' ' 43' ' ' GLN . 1.1 mp -104.49 -33.09 8.69 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.414 ' CB ' ' CD2' ' A' ' 37' ' ' TYR . 5.2 m120 -144.92 -81.65 0.16 Allowed 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 120.109 3.374 . . . . 0.0 120.109 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.12 -29.6 65.76 Favored Glycine 0 N--CA 1.507 3.429 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.402 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 5.02 66.99 0.01 OUTLIER Glycine 0 N--CA 1.483 1.767 0 CA-C-N 110.085 -3.058 . . . . 0.0 119.809 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 t -96.11 96.71 5.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 1 N-CA-C 99.175 -4.38 . . . . 0.0 99.175 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ABA . . . . . 1.055 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.943 ' SD ' HD12 ' A' ' 23' ' ' ILE . 2.5 ppp? -122.26 132.6 54.5 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 124.459 2.076 . . . . 0.0 109.964 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -70.86 117.24 12.12 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 113.238 -1.801 . . . . 0.0 107.497 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.943 HD12 ' SD ' ' A' ' 21' ' ' MET . 0.1 OUTLIER -100.93 24.88 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.006 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.482 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 1.3 tm-20 -32.71 -46.84 0.15 Allowed 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 123.607 1.67 . . . . 0.0 108.458 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -26.11 -48.47 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 108.605 -3.907 . . . . 0.0 113.067 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.449 ' CD1' HG12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -115.08 -33.99 5.2 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 111.357 -2.656 . . . . 0.0 109.996 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -146.82 -81.5 0.14 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 23' ' ' ILE . 6.3 p -156.16 -127.73 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.108 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.055 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -101.15 137.06 40.01 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.544 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -146.87 -174.54 4.52 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 112.312 -2.222 . . . . 0.0 109.297 -179.504 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.402 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -125.34 156.28 38.95 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -108.47 117.9 35.36 Favored 'General case' 0 C--N 1.298 -1.633 1 N-CA-C 98.102 -4.777 . . . . 0.0 98.102 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.548 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 81.9 m -98.57 166.22 11.45 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.61 HG12 ' CD2' ' A' ' 37' ' ' TYR . 7.1 p -64.87 158.11 4.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 C-N-CA 117.67 -1.612 . . . . 0.0 112.707 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -42.38 -28.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 111.52 -2.582 . . . . 0.0 110.682 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -99.06 -17.24 28.07 Favored Glycine 0 C--O 1.203 -1.784 0 CA-C-N 114.198 -1.365 . . . . 0.0 115.484 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.61 ' CD2' HG12 ' A' ' 34' ' ' VAL . 6.0 m-30 -111.96 124.92 53.41 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.43 ' C ' ' H ' ' A' ' 40' ' ' ASP . 47.0 t -133.71 -130.38 0.17 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.237 -1.385 . . . . 0.0 112.362 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.5 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 65.75 -2.56 3.5 Favored Glycine 0 N--CA 1.483 1.77 0 CA-C-O 117.699 -1.611 . . . . 0.0 109.815 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 8.8 t70 92.78 -2.48 0.13 Allowed 'General case' 0 N--CA 1.517 2.916 0 CA-C-N 118.268 1.034 . . . . 0.0 113.662 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.423 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -141.38 2.41 1.65 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.548 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 61.13 33.95 19.21 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 -179.26 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.934 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -88.71 -24.27 22.76 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 111.731 -2.486 . . . . 0.0 108.305 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 44' ' ' THR . 6.1 t -112.33 83.92 1.88 Allowed 'General case' 0 C--N 1.297 -1.678 1 N-CA-C 99.07 -4.418 . . . . 0.0 99.07 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.609 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 16.6 mtm180 -79.84 91.49 5.36 Favored 'General case' 0 C--N 1.296 -1.731 1 N-CA-C 100.11 -4.033 . . . . 0.0 100.11 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 36' ' ' GLY . 5.6 t70 -86.79 64.98 8.79 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -10.76 62.23 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 117.929 2.566 . . . . 0.0 117.929 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 46' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.264 -1.351 . . . . 0.0 112.575 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 0 N--CA 1.493 1.444 0 CA-C-O 121.643 0.601 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.34 164.53 9.92 Favored Glycine 0 N--CA 1.5 2.9 0 C-N-CA 119.999 -1.096 . . . . 0.0 113.202 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ABA . . . . . 0.46 ' H ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.46 ' HD3' ' H ' ' A' ' 6' ' ' ABA . 7.9 Cg_exo -71.33 -35.08 8.9 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.944 2.43 . . . . 0.0 111.497 171.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -19.89 -53.83 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 125.332 1.645 . . . . 0.0 114.634 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 t -143.75 144.2 31.72 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 104.23 -2.508 . . . . 0.0 104.23 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.457 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 3.2 p90 -127.19 26.4 6.06 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 124.868 1.355 . . . . 0.0 109.845 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -100.06 133.26 44.7 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.37 24.69 61.77 Favored Glycine 0 N--CA 1.505 3.243 0 N-CA-C 107.662 -2.175 . . . . 0.0 107.662 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.428 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 10.2 t80 -91.1 -18.04 25.19 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 113.47 -1.365 . . . . 0.0 112.208 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.471 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 10.1 m -132.83 147.51 52.3 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.757 HD12 ' HD2' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -104.0 -34.7 8.36 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -179.636 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.401 ' HB3' ' CE2' ' A' ' 37' ' ' TYR . 23.0 m120 -147.86 -76.02 0.18 Allowed 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 120.403 3.483 . . . . 0.0 120.403 -178.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.469 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -63.72 -26.35 69.82 Favored Glycine 0 N--CA 1.508 3.496 0 N-CA-C 108.155 -1.978 . . . . 0.0 108.155 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 14' ' ' CYS . . . -1.25 68.56 0.0 OUTLIER Glycine 0 N--CA 1.485 1.911 0 N-CA-C 120.672 3.029 . . . . 0.0 120.672 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 17' ' ' GLY . 2.8 t -95.46 96.37 5.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 100.322 -3.955 . . . . 0.0 100.322 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ABA . . . . . 1.043 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.503 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 5.5 ptp -116.61 126.64 53.54 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 123.207 1.479 . . . . 0.0 108.984 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.668 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -72.41 113.35 9.35 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 103.406 -2.812 . . . . 0.0 103.406 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.67 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -95.38 27.14 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.113 -179.289 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.496 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.8 OUTLIER -37.84 -37.65 0.25 Allowed 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 123.439 1.59 . . . . 0.0 109.288 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.4 ' N ' ' C ' ' A' ' 23' ' ' ILE . 0.7 OUTLIER -33.31 -44.38 0.13 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 110.388 -3.097 . . . . 0.0 111.579 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.5 -32.98 4.18 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 111.659 -2.519 . . . . 0.0 111.1 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -149.5 -80.04 0.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 118.124 2.639 . . . . 0.0 118.124 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.9 p -153.46 -133.52 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 119.098 -1.041 . . . . 0.0 109.834 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.043 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -100.09 135.95 40.73 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 179.739 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.526 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -147.65 -176.42 5.25 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 112.841 -1.981 . . . . 0.0 109.994 -179.511 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.421 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -125.18 150.07 47.32 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.503 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 14.5 t30 -106.36 123.71 48.47 Favored 'General case' 0 C--N 1.299 -1.599 1 N-CA-C 97.348 -5.056 . . . . 0.0 97.348 179.366 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 37' ' ' TYR . 72.1 m -96.59 -117.73 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.582 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.606 HG12 ' CD2' ' A' ' 37' ' ' TYR . 7.4 p -149.52 166.84 3.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 117.815 -1.554 . . . . 0.0 111.151 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tt -50.74 -19.68 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 112.247 -2.251 . . . . 0.0 107.747 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -104.27 -14.11 25.02 Favored Glycine 0 C--O 1.202 -1.848 0 CA-C-N 113.521 -1.672 . . . . 0.0 115.285 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.606 ' CD2' HG12 ' A' ' 34' ' ' VAL . 1.9 m-85 -131.66 125.64 32.64 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.609 ' H ' HG23 ' A' ' 44' ' ' THR . 11.1 t -129.74 -148.27 0.36 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 40' ' ' ASP . . . 90.82 -48.15 3.01 Favored Glycine 0 N--CA 1.502 3.049 0 N-CA-C 106.89 -2.484 . . . . 0.0 106.89 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 0.5 OUTLIER 122.81 8.68 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 C-N-CA 129.788 3.235 . . . . 0.0 108.186 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.757 ' HD2' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -127.27 -7.18 5.88 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.366 0.603 . . . . 0.0 110.83 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.45 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 62.51 38.32 12.65 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 124.236 1.969 . . . . 0.0 107.564 -179.211 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.591 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -88.23 -38.26 15.4 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 109.236 -3.62 . . . . 0.0 105.76 -179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.609 HG23 ' H ' ' A' ' 38' ' ' SER . 1.9 t -96.35 85.33 3.91 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 102.048 -3.316 . . . . 0.0 102.048 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.487 ' CZ ' ' HB2' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -82.61 84.69 7.18 Favored 'General case' 0 C--N 1.299 -1.626 1 N-CA-C 99.791 -4.152 . . . . 0.0 99.791 179.886 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 36' ' ' GLY . 30.1 t70 -55.49 -28.91 57.47 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 112.192 -2.276 . . . . 0.0 108.4 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 88.32 -139.03 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 127.068 2.147 . . . . 0.0 108.209 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.7 ptm85 . . . . . 0 N--CA 1.509 2.511 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -179.829 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo . . . . . 0 N--CA 1.493 1.442 0 N-CA-C 107.441 -1.792 . . . . 0.0 107.441 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.07 177.6 15.12 Favored Glycine 0 N--CA 1.499 2.882 0 C-N-CA 119.054 -1.546 . . . . 0.0 112.26 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ABA . . . . . 0.587 ' H ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.587 ' HD3' ' H ' ' A' ' 6' ' ' ABA . 73.6 Cg_endo -76.47 23.09 0.49 Allowed 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 123.746 2.964 . . . . 0.0 112.679 -167.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.523 ' H ' ' C ' ' A' ' 6' ' ' ABA . 5.1 t -100.68 -25.15 14.24 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 113.391 -1.731 . . . . 0.0 106.406 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.9 t -155.88 133.82 11.28 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.507 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 3.0 p90 -124.09 19.59 9.13 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 122.896 1.331 . . . . 0.0 108.579 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.69 129.85 40.23 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.406 ' O ' ' NH1' ' A' ' 41' ' ' ARG . . . 36.36 50.6 1.31 Allowed Glycine 0 N--CA 1.501 2.972 0 O-C-N 125.415 1.697 . . . . 0.0 109.595 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.614 ' HD1' ' HH ' ' A' ' 29' ' ' TYR . 48.4 t80 -92.45 -14.9 27.84 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.5 m -122.67 162.72 21.43 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.622 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -117.29 -37.31 3.55 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.524 ' ND2' ' HD3' ' A' ' 45' ' ' ARG . 18.0 m-80 -146.69 -67.63 0.27 Allowed 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 119.765 3.246 . . . . 0.0 119.765 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.75 -24.99 76.48 Favored Glycine 0 N--CA 1.506 3.325 0 N-CA-C 106.474 -2.651 . . . . 0.0 106.474 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.501 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 0.97 59.88 0.0 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 120.56 2.984 . . . . 0.0 120.56 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.1 95.21 5.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 101.22 -3.622 . . . . 0.0 101.22 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ABA . . . . . 0.962 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.536 ' HE3' HD13 ' A' ' 23' ' ' ILE . 14.6 ptt? -128.23 113.79 16.13 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -63.0 122.89 17.15 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 102.535 -3.135 . . . . 0.0 102.535 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.643 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -101.1 25.69 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 124.098 0.874 . . . . 0.0 109.96 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.494 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 1.1 tm-20 -34.15 -42.94 0.14 Allowed 'General case' 0 N--CA 1.509 2.518 0 CA-C-O 123.21 1.481 . . . . 0.0 109.516 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -29.93 -49.9 0.11 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 109.56 -3.473 . . . . 0.0 111.86 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.05 -28.45 6.99 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 111.383 -2.644 . . . . 0.0 112.122 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -149.89 -79.42 0.13 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 29' ' ' TYR . 3.5 p -156.05 -131.94 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.23 -1.804 . . . . 0.0 110.31 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.962 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.5 OUTLIER -101.64 135.68 42.76 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 123.012 1.387 . . . . 0.0 109.697 179.708 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.545 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -148.37 -176.59 5.36 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 112.23 -2.259 . . . . 0.0 111.951 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.501 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -125.63 154.34 42.45 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.446 ' CA ' ' HE2' ' A' ' 21' ' ' MET . 6.2 t-20 -109.64 98.24 7.64 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 37' ' ' TYR . 55.8 m -93.07 150.33 20.6 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.751 HG12 ' CD2' ' A' ' 37' ' ' TYR . 9.9 p -59.51 169.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 111.758 -2.474 . . . . 0.0 117.143 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.447 ' H ' HG22 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -58.42 -21.07 17.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 111.497 -2.592 . . . . 0.0 107.146 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -94.56 -8.84 59.36 Favored Glycine 0 N--CA 1.482 1.733 0 CA-C-N 114.218 -1.355 . . . . 0.0 113.161 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.751 ' CD2' HG12 ' A' ' 34' ' ' VAL . 1.4 m-85 -141.19 126.25 18.34 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 116.496 -1.716 . . . . 0.0 107.799 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.612 ' H ' HG23 ' A' ' 44' ' ' THR . 8.5 t -124.14 -144.43 0.33 Allowed 'General case' 0 N--CA 1.518 2.966 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 41' ' ' ARG . . . 35.97 69.81 0.23 Allowed Glycine 0 N--CA 1.501 2.999 0 C-N-CA 124.441 1.019 . . . . 0.0 114.237 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 29.92 8.91 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 119.547 3.165 . . . . 0.0 119.547 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -132.19 -25.16 2.02 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.794 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.447 ' HB3' ' CB ' ' A' ' 37' ' ' TYR . 1.8 m 76.8 40.53 0.2 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.873 ' NE2' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -88.74 -20.7 24.45 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 112.749 -2.023 . . . . 0.0 109.437 -179.464 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.873 HG22 ' NE2' ' A' ' 43' ' ' GLN . 0.6 OUTLIER -113.0 92.87 4.16 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 102.21 -3.255 . . . . 0.0 102.21 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.524 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 6.7 mtm180 -84.93 85.84 7.43 Favored 'General case' 0 C--N 1.299 -1.597 1 N-CA-C 99.238 -4.356 . . . . 0.0 99.238 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 36' ' ' GLY . 13.9 t0 -60.67 -12.97 11.9 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 112.531 -2.122 . . . . 0.0 109.264 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.17 -29.46 0.18 Allowed 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 128.156 2.582 . . . . 0.0 117.751 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 . . . . . 0 N--CA 1.511 2.579 0 O-C-N 126.261 2.226 . . . . 0.0 114.112 179.894 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 N--CA 1.492 1.402 0 N-CA-C 108.882 -1.238 . . . . 0.0 108.882 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 124.97 -169.15 16.93 Favored Glycine 0 N--CA 1.499 2.843 0 C-N-CA 120.414 -0.898 . . . . 0.0 110.875 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ABA . . . . . 0.534 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 39.2 Cg_endo -81.87 33.99 0.54 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.911 2.407 . . . . 0.0 110.274 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.517 ' H ' ' C ' ' A' ' 6' ' ' ABA . 5.4 t -100.57 -29.0 12.58 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 113.682 -1.599 . . . . 0.0 106.824 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -166.46 152.75 8.8 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.508 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -129.55 14.58 6.01 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 124.659 1.224 . . . . 0.0 110.411 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -63.35 137.83 58.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.36 37.99 1.29 Allowed Glycine 0 N--CA 1.511 3.672 0 O-C-N 124.258 0.974 . . . . 0.0 111.133 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.576 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 30.5 t80 -90.4 -8.35 50.86 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 113.597 -1.301 . . . . 0.0 112.815 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.7 m -137.07 152.45 50.05 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.64 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.3 OUTLIER -94.13 -72.75 0.6 Allowed 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.41 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.454 ' C ' ' H ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -121.81 -56.66 1.85 Allowed 'General case' 0 N--CA 1.512 2.674 0 N-CA-C 115.667 1.728 . . . . 0.0 115.667 -179.551 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.81 44.29 3.31 Favored Glycine 0 N--CA 1.503 3.115 0 N-CA-C 105.913 -2.875 . . . . 0.0 105.913 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.533 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -68.82 67.39 0.45 Allowed Glycine 0 C--N 1.29 -2.019 0 CA-C-N 112.479 -1.861 . . . . 0.0 116.084 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.2 t -90.67 85.27 2.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 103.52 -2.77 . . . . 0.0 103.52 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ABA . . . . . 1.009 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.0 ptm -120.25 -179.28 3.9 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.485 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -111.7 126.5 55.1 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.194 -1.402 . . . . 0.0 107.696 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.638 ' O ' HG23 ' A' ' 23' ' ' ILE . 1.0 OUTLIER -106.78 23.11 3.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 124.189 0.931 . . . . 0.0 111.308 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.485 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.4 OUTLIER -38.1 -37.31 0.26 Allowed 'General case' 0 N--CA 1.515 2.816 0 CA-C-O 123.421 1.582 . . . . 0.0 110.157 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -33.26 -43.27 0.11 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 110.227 -3.17 . . . . 0.0 111.914 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.35 -34.66 3.77 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 111.335 -2.666 . . . . 0.0 111.3 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -147.28 -82.47 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 23' ' ' ILE . 26.7 p -154.52 -125.59 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.831 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.009 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -98.76 139.44 34.45 Favored 'General case' 0 N--CA 1.51 2.547 0 CA-C-O 122.394 1.092 . . . . 0.0 110.199 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.517 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -148.56 178.96 8.17 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 112.843 -1.98 . . . . 0.0 111.438 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.533 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -115.12 154.6 28.63 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 103.09 -2.93 . . . . 0.0 103.09 179.269 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -108.88 86.59 2.31 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.664 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 34.8 m -59.38 151.91 22.56 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.913 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.608 HG13 ' H ' ' A' ' 37' ' ' TYR . 7.5 p -59.36 157.12 2.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 111.589 -2.55 . . . . 0.0 112.158 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tt -43.16 -25.61 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 112.344 -2.207 . . . . 0.0 110.063 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 34' ' ' VAL . . . -98.33 -24.1 11.78 Favored Glycine 0 N--CA 1.485 1.931 0 CA-C-N 114.6 -1.182 . . . . 0.0 115.256 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.608 ' H ' HG13 ' A' ' 34' ' ' VAL . 1.3 m-30 -111.57 133.05 54.1 Favored 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 102.862 -3.014 . . . . 0.0 102.862 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.6 t -139.2 -137.04 0.13 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 118.403 -1.319 . . . . 0.0 111.175 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 75.74 -10.5 13.06 Favored Glycine 0 N--CA 1.48 1.621 0 CA-C-O 117.905 -1.497 . . . . 0.0 109.513 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 21.6 t70 102.06 -15.66 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.048 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -134.43 6.9 3.56 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.216 -179.285 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.664 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 59.48 32.51 21.76 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.261 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.64 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -88.13 5.55 40.76 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.256 -179.426 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.452 ' O ' ' C ' ' A' ' 45' ' ' ARG . 12.1 t -130.08 22.33 5.3 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.518 -1.674 . . . . 0.0 113.632 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.452 ' C ' ' O ' ' A' ' 44' ' ' THR . 1.0 OUTLIER -16.56 90.32 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 O-C-N 125.36 1.662 . . . . 0.0 112.252 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 36' ' ' GLY . 23.3 t70 -74.79 2.62 9.69 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 117.844 -1.542 . . . . 0.0 111.002 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 mt 67.63 -152.05 0.18 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.241 0 CA-C-O 114.14 -2.838 . . . . 0.0 113.112 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.493 1.496 0 N-CA-C 110.505 -0.613 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -119.99 161.79 14.29 Favored Glycine 0 N--CA 1.496 2.679 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.83 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ABA . . . . . 0.478 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 29' ' ' TYR . 8.4 Cg_endo -73.39 -42.68 0.85 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.42 2.08 . . . . 0.0 111.882 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -19.86 -53.7 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 126.542 2.401 . . . . 0.0 115.172 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.55 125.38 22.54 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.392 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.459 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 1.4 p90 -110.51 4.42 20.41 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.851 1.31 . . . . 0.0 110.747 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.65 129.2 38.16 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 113.607 -1.633 . . . . 0.0 106.974 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 34.46 46.17 0.53 Allowed Glycine 0 N--CA 1.511 3.637 0 O-C-N 124.423 1.077 . . . . 0.0 111.414 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.402 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 26.7 t80 -91.44 -20.26 21.96 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 125.935 1.609 . . . . 0.0 112.611 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.8 m -116.92 153.82 31.91 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.884 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.3 OUTLIER -100.58 -36.53 9.13 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -144.67 -82.05 0.16 Allowed 'General case' 0 N--CA 1.51 2.572 1 N-CA-C 121.876 4.028 . . . . 0.0 121.876 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.25 -31.9 59.78 Favored Glycine 0 N--CA 1.515 3.924 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.474 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 7.8 69.47 0.01 OUTLIER Glycine 0 N--CA 1.486 1.969 0 CA-C-N 109.67 -3.265 . . . . 0.0 120.847 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.7 t -97.84 96.53 5.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 1 N-CA-C 98.67 -4.567 . . . . 0.0 98.67 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ABA . . . . . 1.081 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 13.5 ptt? -119.88 121.72 39.67 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 122.974 1.369 . . . . 0.0 108.497 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -64.59 119.58 10.76 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.638 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -101.18 20.93 2.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 123.513 0.508 . . . . 0.0 109.684 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -26.26 -50.51 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 123.097 1.427 . . . . 0.0 109.603 -179.457 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -25.9 -49.06 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 108.829 -3.805 . . . . 0.0 113.333 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.91 -33.82 5.95 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 111.476 -2.602 . . . . 0.0 110.405 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -146.84 -80.24 0.15 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.5 p -156.8 -132.13 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.762 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.081 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -99.02 137.94 36.82 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.564 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.267 0.6 OUTLIER -148.26 -174.73 4.66 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 112.863 -1.971 . . . . 0.0 109.419 -179.615 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.474 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -124.7 157.47 35.56 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -109.33 116.4 31.78 Favored 'General case' 0 C--N 1.298 -1.649 1 N-CA-C 96.069 -5.53 . . . . 0.0 96.069 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 66.0 m -94.62 -124.71 0.11 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 118.601 -0.714 . . . . 0.0 111.023 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.54 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 5.7 p -139.64 160.28 27.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 117.787 -1.565 . . . . 0.0 109.095 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -47.51 -24.0 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 111.895 -2.411 . . . . 0.0 108.1 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -97.37 -20.25 23.25 Favored Glycine 0 C--O 1.203 -1.833 0 CA-C-O 117.716 -1.602 . . . . 0.0 114.814 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.55 ' CD1' ' HA ' ' A' ' 45' ' ' ARG . 2.1 m-30 -123.74 125.84 45.45 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 120.764 2.282 . . . . 0.0 106.805 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.527 ' H ' HG23 ' A' ' 44' ' ' THR . 47.8 t -138.17 -131.34 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.487 -1.285 . . . . 0.0 111.334 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 68.89 -6.54 3.68 Favored Glycine 0 N--CA 1.487 2.042 0 CA-C-O 117.988 -1.451 . . . . 0.0 111.513 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 11.8 t70 102.14 -12.7 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.036 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.439 ' HD2' HD13 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -133.8 4.01 3.55 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.54 -178.656 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 62.72 32.07 16.29 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.884 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -89.18 -19.91 24.87 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 112.743 -2.026 . . . . 0.0 107.099 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.527 HG23 ' H ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -106.94 82.15 1.65 Allowed 'General case' 0 N--CA 1.488 1.461 1 N-CA-C 100.144 -4.021 . . . . 0.0 100.144 179.543 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.55 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 12.8 mtm180 -76.47 89.3 3.24 Favored 'General case' 0 C--N 1.296 -1.757 1 N-CA-C 99.129 -4.396 . . . . 0.0 99.129 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 36' ' ' GLY . 25.1 t70 -62.81 -25.6 68.33 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 117.344 -1.742 . . . . 0.0 108.832 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 46' ' ' ASP . 0.2 OUTLIER 89.28 -157.71 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 128.042 2.537 . . . . 0.0 108.436 179.656 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.509 2.492 0 CA-C-O 116.054 -1.927 . . . . 0.0 110.541 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo . . . . . 0 N--CA 1.491 1.369 0 N-CA-C 109.265 -1.09 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -119.55 167.38 13.38 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 107.068 -2.413 . . . . 0.0 107.068 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ABA . . . . . 0.593 ' H ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.593 ' HD3' ' H ' ' A' ' 6' ' ' ABA . 5.5 Cg_exo -65.91 -47.33 3.81 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 122.049 1.833 . . . . 0.0 108.147 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -19.93 -51.42 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 110.066 -3.243 . . . . 0.0 118.251 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.2 p -126.44 108.88 11.6 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.286 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.535 ' HA ' ' HB2' ' A' ' 13' ' ' TYR . 18.4 p90 -115.08 0.9 13.77 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -85.26 89.45 7.66 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.987 1.375 . . . . 0.0 110.173 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.35 28.81 4.47 Favored Glycine 0 N--CA 1.501 2.97 0 N-CA-C 106.958 -2.457 . . . . 0.0 106.958 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.535 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 20.6 t80 -90.57 -11.07 41.13 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.579 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 60.5 m -126.8 151.21 48.58 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.943 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.3 OUTLIER -104.38 -38.31 6.88 Favored 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.435 ' HB2' ' CD2' ' A' ' 37' ' ' TYR . 18.9 m120 -147.07 -66.66 0.27 Allowed 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 120.621 3.563 . . . . 0.0 120.621 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.97 19.59 52.55 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.636 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -65.56 96.02 0.24 Allowed Glycine 0 C--N 1.295 -1.726 0 CA-C-O 124.39 2.106 . . . . 0.0 115.826 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER -92.05 102.98 14.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 101.08 -3.674 . . . . 0.0 101.08 179.199 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ABA . . . . . 0.976 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.52 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 4.3 ptm -134.88 161.3 35.61 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 101.9 -3.37 . . . . 0.0 101.9 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -103.99 127.94 51.54 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -105.79 21.07 3.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 123.918 0.761 . . . . 0.0 109.718 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -29.58 -49.29 0.09 Allowed 'General case' 0 N--CA 1.509 2.478 0 CA-C-O 123.528 1.632 . . . . 0.0 109.645 -179.303 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -26.88 -48.48 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.676 1 CA-C-N 108.362 -4.017 . . . . 0.0 113.34 179.353 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.85 -34.12 5.87 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 111.036 -2.802 . . . . 0.0 110.673 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -147.74 -79.87 0.15 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 29' ' ' TYR . 1.7 p -156.67 -134.48 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.806 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.976 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -97.55 138.56 34.78 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.57 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.273 0.5 OUTLIER -149.3 -179.17 6.85 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 112.875 -1.966 . . . . 0.0 111.757 -179.197 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.636 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -116.1 151.91 34.65 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.52 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 43.8 t30 -104.13 76.81 1.37 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.543 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 33.5 m -64.1 152.39 40.59 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.678 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.671 HG12 ' CD2' ' A' ' 37' ' ' TYR . 7.4 p -59.67 160.99 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 111.811 -2.449 . . . . 0.0 114.441 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.421 ' H ' HG22 ' A' ' 35' ' ' ILE . 1.6 tt -51.72 -21.6 2.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 111.51 -2.587 . . . . 0.0 108.784 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -95.34 -14.38 48.21 Favored Glycine 0 N--CA 1.491 2.366 0 CA-C-N 114.201 -1.363 . . . . 0.0 115.297 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.671 ' CD2' HG12 ' A' ' 34' ' ' VAL . 2.1 m-85 -131.89 127.41 36.4 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.443 ' C ' HG22 ' A' ' 44' ' ' THR . 47.3 t -136.81 -135.46 0.14 Allowed 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 118.304 -1.358 . . . . 0.0 108.744 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 69.52 0.94 26.83 Favored Glycine 0 N--CA 1.48 1.603 0 CA-C-O 116.707 -2.163 . . . . 0.0 111.701 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 5.1 t70 94.65 -11.7 0.11 Allowed 'General case' 0 N--CA 1.52 3.068 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.473 ' NH1' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -138.02 -2.65 1.86 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.743 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.543 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 67.85 31.47 5.75 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -179.462 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.943 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -89.04 -19.55 25.5 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 111.878 -2.419 . . . . 0.0 108.652 -179.755 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 44' ' ' THR 0.266 2.3 t -115.14 89.89 3.21 Favored 'General case' 0 C--N 1.296 -1.723 1 N-CA-C 98.541 -4.615 . . . . 0.0 98.541 179.863 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 16.5 mtm180 -87.61 93.25 9.37 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 101.77 -3.419 . . . . 0.0 101.77 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 36' ' ' GLY . 31.7 t70 -64.73 -20.31 66.27 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.0 -1.455 . . . . 0.0 108.114 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 mt 75.64 -145.51 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 126.414 1.886 . . . . 0.0 107.572 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.39 0 CA-C-O 113.645 -3.074 . . . . 0.0 113.676 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo . . . . . 0 N--CA 1.496 1.647 0 CA-C-O 122.111 0.796 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 124.35 -169.35 16.41 Favored Glycine 0 N--CA 1.499 2.859 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ABA . . . . . 0.514 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.514 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 95.5 Cg_endo -85.68 36.68 0.54 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 123.323 2.682 . . . . 0.0 108.943 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 6' ' ' ABA . 47.6 t -100.99 -26.05 13.86 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.206 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.3 t -173.27 151.96 2.14 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.57 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -129.84 12.6 5.77 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 124.41 1.068 . . . . 0.0 110.744 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -62.27 136.33 57.88 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 37.95 41.54 0.97 Allowed Glycine 0 N--CA 1.512 3.741 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 29' ' ' TYR . 37.3 t80 -91.71 -13.77 31.12 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 125.591 1.406 . . . . 0.0 113.231 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.483 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 33.7 m -121.79 155.08 36.08 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.857 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -108.2 -37.91 5.9 Favored 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.629 HD22 ' NH1' ' A' ' 45' ' ' ARG . 14.8 m120 -143.12 -80.57 0.2 Allowed 'General case' 0 N--CA 1.514 2.752 0 N-CA-C 119.471 3.137 . . . . 0.0 119.471 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.05 -24.6 63.19 Favored Glycine 0 N--CA 1.51 3.61 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.626 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 4.55 63.92 0.0 OUTLIER Glycine 0 N--CA 1.481 1.662 0 N-CA-C 120.823 3.089 . . . . 0.0 120.823 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 19' ' ' VAL . 1.8 t -94.24 96.32 5.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 102.4 -3.185 . . . . 0.0 102.4 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ABA . . . . . 1.043 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.487 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 9.6 ptm -122.08 172.92 7.89 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.439 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -109.34 129.0 55.54 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.58 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -106.09 13.94 7.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 124.039 0.837 . . . . 0.0 111.87 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -22.78 -54.88 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 124.815 1.322 . . . . 0.0 112.008 -179.41 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.6 m -26.52 -45.18 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 110.921 -2.854 . . . . 0.0 114.3 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.53 -36.98 5.61 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 111.361 -2.654 . . . . 0.0 109.939 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -147.96 -81.77 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.2 p -156.87 -133.25 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.436 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.043 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -96.25 139.48 32.33 Favored 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.474 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -147.92 178.72 8.28 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 113.073 -1.876 . . . . 0.0 109.95 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.626 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -118.15 146.64 44.03 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.487 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 56.9 t30 -99.55 104.61 16.42 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 101.558 -3.497 . . . . 0.0 101.558 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 61.6 m -84.13 177.38 8.25 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.988 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.644 HG12 ' CD2' ' A' ' 37' ' ' TYR . 14.5 p -80.3 159.54 4.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 123.003 1.383 . . . . 0.0 112.712 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -46.84 -22.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-N 111.618 -2.537 . . . . 0.0 108.99 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -97.2 -15.88 37.01 Favored Glycine 0 C--O 1.203 -1.783 0 CA-C-N 113.615 -1.63 . . . . 0.0 116.534 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.644 ' CD2' HG12 ' A' ' 34' ' ' VAL . 4.4 m-30 -123.52 121.41 35.59 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 103.535 -2.765 . . . . 0.0 103.535 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.444 ' C ' HG22 ' A' ' 44' ' ' THR . 15.2 t -130.1 -142.54 0.24 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.385 1.088 . . . . 0.0 113.306 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 40' ' ' ASP . . . 86.33 -47.84 3.82 Favored Glycine 0 C--N 1.301 -1.406 0 N-CA-C 106.514 -2.634 . . . . 0.0 106.514 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER 139.31 -6.68 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.983 0 O-C-N 126.807 2.122 . . . . 0.0 112.291 -179.569 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.483 ' HD3' ' CA ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -134.58 -1.9 2.76 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.14 -178.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.54 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 69.64 35.36 2.45 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 104.991 -2.225 . . . . 0.0 104.991 -179.28 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.857 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -89.06 -13.74 37.98 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 112.599 -2.091 . . . . 0.0 108.846 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.512 ' O ' HG23 ' A' ' 44' ' ' THR . 5.0 t -122.54 92.62 3.75 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 103.07 -2.937 . . . . 0.0 103.07 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.629 ' NH1' HD22 ' A' ' 16' ' ' ASN . 0.1 OUTLIER -83.94 97.18 9.1 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' GLY . 30.2 t70 -66.11 -29.58 69.92 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 116.633 -2.027 . . . . 0.0 108.474 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 mt 96.64 -147.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 127.523 2.329 . . . . 0.0 106.82 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.506 2.355 0 CA-C-O 115.003 -2.427 . . . . 0.0 111.322 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.493 1.468 0 N-CA-C 110.25 -0.712 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.77 -179.8 16.05 Favored Glycine 0 N--CA 1.498 2.816 0 C-N-CA 120.031 -1.081 . . . . 0.0 110.473 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ABA . . . . . 0.619 ' H ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.619 ' HD3' ' H ' ' A' ' 6' ' ' ABA . 1.1 Cg_endo -68.74 -47.97 1.15 Allowed 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.109 1.872 . . . . 0.0 108.179 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.2 m -21.27 -41.58 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 111.597 -2.547 . . . . 0.0 117.614 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.2 m -145.06 119.93 9.94 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.428 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 4.0 p90 -114.48 15.48 17.84 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 122.379 1.085 . . . . 0.0 111.058 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.51 133.25 36.49 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.41 32.86 31.23 Favored Glycine 0 N--CA 1.506 3.347 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.481 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 23.9 t80 -90.37 -13.2 35.54 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 113.935 -1.133 . . . . 0.0 112.951 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.405 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 16.0 m -128.95 143.61 50.93 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.941 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.5 OUTLIER -97.62 -33.02 11.49 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 123.58 0.55 . . . . 0.0 112.41 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -149.08 -85.96 0.09 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 120.515 3.524 . . . . 0.0 120.515 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 33' ' ' CYS . . . -48.7 -32.69 11.29 Favored Glycine 0 N--CA 1.513 3.785 0 CA-C-O 123.136 1.409 . . . . 0.0 109.684 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.5 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 8.11 64.84 0.01 OUTLIER Glycine 0 N--CA 1.48 1.599 0 CA-C-N 109.521 -3.339 . . . . 0.0 121.198 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 19' ' ' VAL . 1.3 t -95.14 95.02 4.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 1 N-CA-C 99.885 -4.117 . . . . 0.0 99.885 179.273 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ABA . . . . . 1.039 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.3 ptp -119.31 161.11 21.0 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -101.79 123.74 46.26 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.628 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -102.54 22.78 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 124.757 1.286 . . . . 0.0 111.489 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -36.3 -37.55 0.12 Allowed 'General case' 0 N--CA 1.516 2.852 0 CA-C-O 123.79 1.757 . . . . 0.0 110.353 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.7 OUTLIER -34.91 -45.95 0.29 Allowed 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 110.077 -3.238 . . . . 0.0 111.44 179.172 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.59 -33.83 5.08 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 111.517 -2.583 . . . . 0.0 110.481 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.67 -79.97 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.0 OUTLIER -156.65 -135.47 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 118.38 -1.328 . . . . 0.0 109.855 -179.416 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.039 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.2 OUTLIER -94.78 140.44 29.91 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.575 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -151.21 -174.5 4.83 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 113.097 -1.865 . . . . 0.0 110.712 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.5 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -125.42 153.45 43.43 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.569 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -105.9 118.47 36.68 Favored 'General case' 0 C--N 1.3 -1.548 1 N-CA-C 98.29 -4.707 . . . . 0.0 98.29 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.511 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 76.3 m -98.8 166.45 11.3 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.634 HG13 ' H ' ' A' ' 37' ' ' TYR . 3.4 p -65.24 157.43 5.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 C-N-CA 118.141 -1.424 . . . . 0.0 111.064 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -41.78 -24.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 111.864 -2.426 . . . . 0.0 111.934 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.413 ' H ' HG22 ' A' ' 34' ' ' VAL . . . -100.53 -27.39 7.63 Favored Glycine 0 N--CA 1.484 1.838 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.82 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.634 ' H ' HG13 ' A' ' 34' ' ' VAL . 4.2 m-30 -98.91 120.58 39.6 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 104.019 -2.585 . . . . 0.0 104.019 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.4 t -130.91 -135.54 0.2 Allowed 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 118.175 -1.41 . . . . 0.0 112.398 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.505 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 69.99 -8.58 3.48 Favored Glycine 0 N--CA 1.483 1.802 0 CA-C-O 117.4 -1.778 . . . . 0.0 110.622 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 16.7 t70 100.11 -2.83 0.03 OUTLIER 'General case' 0 N--CA 1.523 3.209 0 C-N-CA 124.004 0.922 . . . . 0.0 113.184 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.451 ' NH1' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -140.66 1.41 1.72 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -178.773 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 64.39 33.91 10.86 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 -179.383 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.941 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -88.47 -23.86 23.14 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 111.993 -2.367 . . . . 0.0 110.737 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.494 ' O ' HG23 ' A' ' 44' ' ' THR . 5.9 t -112.23 86.6 2.38 Favored 'General case' 0 C--N 1.294 -1.806 1 N-CA-C 98.201 -4.741 . . . . 0.0 98.201 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 14.9 mtm180 -77.04 87.2 3.54 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 110.849 -2.887 . . . . 0.0 104.647 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 48' ' ' ARG . 5.9 t70 -83.7 67.05 9.33 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 mp -2.64 31.02 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 1 N-CA-C 122.885 4.402 . . . . 0.0 122.885 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.474 ' N ' ' O ' ' A' ' 46' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 116.494 -1.717 . . . . 0.0 113.179 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo . . . . . 0 N--CA 1.49 1.293 0 N-CA-C 108.026 -1.567 . . . . 0.0 108.026 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.32 -170.01 13.84 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ABA . . . . . 0.663 ' H ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.663 ' HD3' ' H ' ' A' ' 6' ' ' ABA . 6.8 Cg_endo -68.82 -41.77 5.28 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 122.529 2.152 . . . . 0.0 108.325 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m -20.15 -50.52 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 109.944 -3.298 . . . . 0.0 116.413 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.19 127.82 17.11 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.543 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 1.0 OUTLIER -117.14 8.97 13.42 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 124.02 0.825 . . . . 0.0 112.074 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -69.38 138.25 53.48 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 41.25 37.53 1.64 Allowed Glycine 0 N--CA 1.507 3.402 0 O-C-N 124.43 1.081 . . . . 0.0 110.775 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.426 ' CD1' ' CZ ' ' A' ' 29' ' ' TYR . 30.9 t80 -91.25 -17.22 26.35 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 114.063 -1.068 . . . . 0.0 113.813 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.455 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 41.5 m -116.85 154.68 30.34 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.983 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -107.71 -37.97 6.0 Favored 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 115.086 1.514 . . . . 0.0 115.086 -179.65 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.553 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 4.8 m120 -139.19 -83.21 0.27 Allowed 'General case' 0 N--CA 1.509 2.513 0 N-CA-C 120.133 3.383 . . . . 0.0 120.133 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.75 -24.22 64.14 Favored Glycine 0 N--CA 1.511 3.669 0 N-CA-C 108.849 -1.701 . . . . 0.0 108.849 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.577 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 5.38 65.39 0.01 OUTLIER Glycine 0 N--CA 1.478 1.495 0 N-CA-C 120.449 2.94 . . . . 0.0 120.449 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.73 96.5 5.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 100.734 -3.802 . . . . 0.0 100.734 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ABA . . . . . 1.055 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.56 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 7.2 ptm -121.25 121.2 37.21 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 123.073 1.416 . . . . 0.0 109.089 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -63.31 120.44 11.58 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 179.643 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.647 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -102.78 23.69 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 123.714 0.634 . . . . 0.0 110.367 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.5 OUTLIER -33.5 -42.06 0.1 Allowed 'General case' 0 N--CA 1.511 2.607 0 CA-C-O 123.722 1.725 . . . . 0.0 109.696 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -30.89 -46.54 0.08 Allowed 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 109.632 -3.44 . . . . 0.0 111.992 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.49 -35.51 4.56 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 111.572 -2.558 . . . . 0.0 109.779 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -146.71 -82.82 0.13 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 117.419 2.377 . . . . 0.0 117.419 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.3 p -153.11 -131.39 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.594 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.055 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -100.3 135.84 41.11 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.531 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.25 0.6 OUTLIER -146.5 -179.05 6.5 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.103 -2.317 . . . . 0.0 109.119 -179.42 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.577 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -121.16 153.67 37.22 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.56 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 60.5 t30 -106.72 104.28 13.92 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 101.77 -3.419 . . . . 0.0 101.77 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 57.5 m -88.71 156.72 18.83 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.19 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.65 HG12 ' CD2' ' A' ' 37' ' ' TYR . 12.2 p -59.83 159.93 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 113.019 -1.9 . . . . 0.0 114.319 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -48.56 -22.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 110.884 -2.871 . . . . 0.0 109.126 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -98.39 -11.84 46.91 Favored Glycine 0 N--CA 1.485 1.933 0 CA-C-O 117.832 -1.538 . . . . 0.0 116.588 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.65 ' CD2' HG12 ' A' ' 34' ' ' VAL . 3.1 m-30 -126.8 121.7 32.66 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.451 ' C ' HG22 ' A' ' 44' ' ' THR . 48.2 t -132.32 -134.59 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.725 -1.19 . . . . 0.0 110.868 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 74.61 -13.12 5.31 Favored Glycine 0 N--CA 1.485 1.953 0 CA-C-O 117.894 -1.504 . . . . 0.0 110.166 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 27.9 t70 104.62 -7.57 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.884 0 C-N-CA 124.419 1.087 . . . . 0.0 113.672 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.457 ' NH1' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -137.28 -2.26 2.05 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.498 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 70.27 31.2 3.19 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 -179.248 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.983 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -88.38 -11.96 44.68 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 113.699 -1.592 . . . . 0.0 109.82 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 44' ' ' THR 0.253 5.3 t -121.54 85.95 2.49 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 101.545 -3.502 . . . . 0.0 101.545 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.45 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 1.2 mtm180 -78.35 88.68 4.37 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 36' ' ' GLY . 24.1 t70 -61.01 -20.61 62.7 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.247 -1.797 . . . . 0.0 108.544 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 72.49 25.59 2.69 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 124.905 1.378 . . . . 0.0 112.379 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.429 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo . . . . . 0 N--CA 1.493 1.463 0 N-CA-C 110.642 -0.561 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.54 157.0 7.13 Favored Glycine 0 N--CA 1.497 2.726 0 C-N-CA 119.979 -1.105 . . . . 0.0 111.937 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ABA . . . . . 0.466 ' C ' ' H ' ' A' ' 8' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 62.3 Cg_endo -84.18 18.03 1.61 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.377 2.718 . . . . 0.0 110.058 -172.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 6' ' ' ABA . 0.5 OUTLIER -97.21 -21.62 17.19 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 113.381 -1.736 . . . . 0.0 109.071 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.0 t -150.09 121.21 7.75 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -121.38 29.03 7.45 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 123.291 1.519 . . . . 0.0 107.795 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -101.01 134.37 44.1 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.15 23.9 60.26 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -91.94 -26.12 18.57 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.786 -1.207 . . . . 0.0 113.252 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.589 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 33.8 m -124.23 150.34 45.4 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -111.07 -37.85 5.23 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -179.24 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.539 ' ND2' ' HD2' ' A' ' 45' ' ' ARG . 34.3 m-80 -149.82 -59.91 0.2 Allowed 'General case' 0 N--CA 1.509 2.508 0 N-CA-C 118.57 2.804 . . . . 0.0 118.57 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -107.2 18.71 35.79 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 106.875 -2.49 . . . . 0.0 106.875 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.615 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -72.46 94.73 0.66 Allowed Glycine 0 C--N 1.296 -1.661 0 CA-C-O 123.926 1.848 . . . . 0.0 113.631 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.6 t -91.88 103.1 14.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 102.779 -3.045 . . . . 0.0 102.779 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ABA . . . . . 0.995 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.474 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 21.8 ptt? -116.57 129.69 56.32 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 123.401 1.572 . . . . 0.0 108.863 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.8 OUTLIER -73.61 119.14 17.43 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.103 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.643 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -104.11 23.77 2.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 124.279 0.987 . . . . 0.0 111.025 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -38.84 -37.18 0.32 Allowed 'General case' 0 N--CA 1.514 2.755 0 CA-C-O 123.707 1.718 . . . . 0.0 109.262 -179.744 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.402 ' N ' ' C ' ' A' ' 23' ' ' ILE . 1.3 m -32.78 -43.42 0.09 Allowed 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 110.035 -3.257 . . . . 0.0 111.902 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.454 HD11 HG12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -119.3 -36.58 3.34 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 111.358 -2.656 . . . . 0.0 110.949 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -144.49 -84.6 0.14 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 23' ' ' ILE . 11.2 p -149.8 -131.56 0.05 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.495 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.995 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -98.54 143.74 28.62 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 179.544 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.534 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.258 0.6 OUTLIER -151.13 175.01 12.55 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 125.776 1.923 . . . . 0.0 111.03 -179.374 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.615 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -118.95 136.61 54.0 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.474 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 50.5 t30 -93.16 77.23 4.6 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.108 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.434 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 65.9 m -61.26 146.67 47.07 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.516 1.15 . . . . 0.0 110.681 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.621 HG12 ' CD2' ' A' ' 37' ' ' TYR . 10.5 p -58.97 161.98 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 112.332 -2.213 . . . . 0.0 115.403 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tt -49.83 -20.12 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 111.541 -2.572 . . . . 0.0 109.315 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.59 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -98.98 -18.35 25.02 Favored Glycine 0 C--O 1.202 -1.851 0 CA-C-O 117.48 -1.733 . . . . 0.0 114.34 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.621 ' CD2' HG12 ' A' ' 34' ' ' VAL . 1.9 m-30 -123.31 129.81 51.86 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 120.27 2.035 . . . . 0.0 107.269 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.634 ' H ' HG23 ' A' ' 44' ' ' THR . 0.3 OUTLIER -125.29 -159.46 0.89 Allowed 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -179.308 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 88.59 -47.82 3.48 Favored Glycine 0 N--CA 1.494 2.529 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.288 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 27.7 t70 124.28 -0.42 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.038 0 O-C-N 126.719 2.07 . . . . 0.0 109.198 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -117.95 -28.67 5.85 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.434 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 3.0 m 82.7 37.86 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.781 ' OE1' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -88.96 -21.43 23.55 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 110.665 -2.971 . . . . 0.0 107.425 -179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.781 HG22 ' OE1' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -110.01 83.34 1.74 Allowed 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 101.835 -3.394 . . . . 0.0 101.835 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.539 ' HD2' ' ND2' ' A' ' 16' ' ' ASN . 1.1 mtm180 -78.77 89.19 4.62 Favored 'General case' 0 C--N 1.299 -1.622 1 N-CA-C 98.906 -4.479 . . . . 0.0 98.906 179.682 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.59 ' N ' ' O ' ' A' ' 36' ' ' GLY . 29.2 t0 -58.51 -23.0 57.03 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 111.849 -2.432 . . . . 0.0 107.192 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 mt 62.98 6.17 2.12 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 112.668 -2.06 . . . . 0.0 115.077 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.588 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.42 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 N--CA 1.496 1.624 0 N-CA-C 110.197 -0.732 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' A' ' 28' ' ' SER . . . 139.54 -178.56 19.55 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 119.564 -1.303 . . . . 0.0 112.597 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ABA . . . . . 0.632 ' H ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.632 ' HD3' ' H ' ' A' ' 6' ' ' ABA . 69.1 Cg_endo -78.21 16.76 1.14 Allowed 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.708 2.272 . . . . 0.0 111.478 -173.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.522 ' H ' ' C ' ' A' ' 6' ' ' ABA . 6.0 t -100.99 -19.3 15.91 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.249 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.9 m -154.95 128.96 8.8 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.516 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 2.7 p90 -124.83 8.91 8.18 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -69.24 142.73 54.12 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 39.71 39.46 1.31 Allowed Glycine 0 N--CA 1.507 3.405 0 O-C-N 124.518 1.136 . . . . 0.0 110.87 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.477 ' HD1' ' HH ' ' A' ' 29' ' ' TYR . 38.6 t80 -91.34 -15.81 28.46 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 125.383 1.284 . . . . 0.0 113.414 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.484 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 58.2 m -119.72 157.19 29.06 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.902 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -110.72 -38.38 5.17 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.457 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 8.5 m120 -140.58 -77.84 0.3 Allowed 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 121.486 3.884 . . . . 0.0 121.486 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.54 -17.76 73.05 Favored Glycine 0 N--CA 1.507 3.377 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.627 ' HA2' ' SG ' ' A' ' 31' ' ' CYS . . . 2.71 62.92 0.0 OUTLIER Glycine 0 C--N 1.302 -1.352 0 N-CA-C 120.091 2.796 . . . . 0.0 120.091 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 19' ' ' VAL . 1.6 t -91.6 96.56 6.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 101.762 -3.421 . . . . 0.0 101.762 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ABA . . . . . 0.923 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.7 ptm -137.51 159.87 40.74 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 102.525 -3.139 . . . . 0.0 102.525 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -102.4 129.51 48.9 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.615 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -105.19 19.47 4.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 124.053 0.846 . . . . 0.0 112.309 -179.556 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -29.11 -49.87 0.08 Allowed 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 122.811 1.291 . . . . 0.0 112.008 -179.408 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.4 m -31.44 -43.64 0.06 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 110.99 -2.823 . . . . 0.0 114.151 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.59 -32.68 6.1 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 112.063 -2.335 . . . . 0.0 111.094 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -149.61 -80.14 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.43 ' CB ' ' HA3' ' A' ' 5' ' ' GLY . 1.5 p -158.33 -133.2 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.879 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.923 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -97.04 139.36 33.16 Favored 'General case' 0 N--CA 1.51 2.554 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.538 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 1.2 t -147.34 -171.34 3.77 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.305 -1.771 . . . . 0.0 112.914 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.627 ' SG ' ' HA2' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -125.46 151.28 46.47 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 179.275 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -107.82 103.17 12.37 Favored 'General case' 0 C--N 1.3 -1.577 1 N-CA-C 99.53 -4.248 . . . . 0.0 99.53 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 83.4 m -87.69 170.74 10.99 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.415 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.596 HG12 ' CD2' ' A' ' 37' ' ' TYR . 14.2 p -67.69 163.6 2.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-O 123.304 1.526 . . . . 0.0 112.582 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.463 ' H ' HG22 ' A' ' 35' ' ' ILE . 1.2 tt -53.34 -18.11 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 112.044 -2.343 . . . . 0.0 108.851 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -100.03 -22.21 12.4 Favored Glycine 0 C--O 1.199 -2.081 0 CA-C-N 113.507 -1.679 . . . . 0.0 114.16 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.596 ' CD2' HG12 ' A' ' 34' ' ' VAL . 2.8 m-30 -118.96 130.21 55.58 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 121.149 2.475 . . . . 0.0 104.676 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.404 ' C ' ' H ' ' A' ' 40' ' ' ASP . 22.9 t -142.07 -136.24 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 117.545 -1.662 . . . . 0.0 113.767 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 40' ' ' ASP . . . 86.64 -42.37 3.15 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 107.744 -2.142 . . . . 0.0 107.744 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 0.8 OUTLIER 137.68 -2.03 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.796 0 O-C-N 126.017 1.657 . . . . 0.0 110.135 -179.568 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.484 ' HD3' ' CA ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -140.93 -7.06 1.08 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -178.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.49 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 73.79 35.07 0.85 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 -178.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.902 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -88.39 -17.68 30.0 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 112.015 -2.357 . . . . 0.0 107.727 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.538 ' O ' HG23 ' A' ' 44' ' ' THR . 5.1 t -120.02 88.36 2.92 Favored 'General case' 0 C--N 1.299 -1.588 1 N-CA-C 99.745 -4.168 . . . . 0.0 99.745 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.412 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 13.7 mtm180 -83.46 96.34 8.55 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 101.841 -3.392 . . . . 0.0 101.841 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 36' ' ' GLY . 28.1 t70 -83.93 69.75 10.33 Favored 'General case' 0 C--N 1.294 -1.81 1 N-CA-C 99.926 -4.102 . . . . 0.0 99.926 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.405 HD12 ' CE1' ' A' ' 37' ' ' TYR . 3.4 mp -44.37 120.25 2.13 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.457 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 116.792 -1.575 . . . . 0.0 111.483 179.936 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 N--CA 1.499 1.823 0 CA-C-O 120.386 0.078 . . . . 0.0 111.951 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.47 ' HA3' ' CB ' ' A' ' 28' ' ' SER . . . 124.65 175.21 14.23 Favored Glycine 0 N--CA 1.505 3.286 0 CA-C-O 119.01 -0.883 . . . . 0.0 112.689 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ABA . . . . . 0.682 ' H ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.682 ' HD3' ' H ' ' A' ' 6' ' ' ABA . 95.2 Cg_endo -76.41 11.86 1.74 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 123.591 2.861 . . . . 0.0 111.777 -159.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.476 ' H ' ' C ' ' A' ' 6' ' ' ABA . 0.1 OUTLIER -91.25 -23.82 20.06 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.778 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 t -153.25 126.77 8.7 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.567 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 4.1 p90 -121.38 20.01 11.29 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 122.146 0.974 . . . . 0.0 109.004 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -72.46 121.47 19.64 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.463 ' O ' ' NH2' ' A' ' 41' ' ' ARG . . . 53.13 40.99 60.16 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.433 ' OH ' ' HA ' ' A' ' 30' ' ' THR . 7.0 t80 -91.27 -16.17 28.0 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.546 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 4.7 m -122.61 161.49 23.66 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.522 HD12 ' HD2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -115.63 -37.17 4.03 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 117.885 2.55 . . . . 0.0 117.885 -179.203 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.514 ' ND2' ' HD3' ' A' ' 45' ' ' ARG . 34.1 m-80 -146.22 -69.98 0.26 Allowed 'General case' 0 N--CA 1.515 2.82 0 N-CA-C 120.341 3.46 . . . . 0.0 120.341 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.11 -25.38 59.75 Favored Glycine 0 N--CA 1.506 3.352 0 N-CA-C 107.834 -2.107 . . . . 0.0 107.834 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.546 ' HA3' ' HB3' ' A' ' 14' ' ' CYS . . . -6.8 74.78 0.0 OUTLIER Glycine 0 N--CA 1.484 1.898 0 N-CA-C 118.842 2.297 . . . . 0.0 118.842 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 t -90.5 102.2 13.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 100.429 -3.915 . . . . 0.0 100.429 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ABA . . . . . 1.019 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.42 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 4.4 ptm -117.04 131.59 56.9 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 113.011 -1.904 . . . . 0.0 108.93 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -76.2 113.67 14.01 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -94.8 21.85 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.174 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.47 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.6 OUTLIER -37.63 -38.94 0.29 Allowed 'General case' 0 N--CA 1.514 2.764 0 CA-C-O 123.117 1.437 . . . . 0.0 109.267 -179.71 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -31.09 -43.63 0.05 Allowed 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 109.927 -3.306 . . . . 0.0 111.477 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.95 -38.18 3.11 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 111.152 -2.749 . . . . 0.0 109.998 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -145.98 -82.44 0.14 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 119.432 3.123 . . . . 0.0 119.432 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.1 p -150.95 -139.63 0.09 Allowed 'General case' 0 N--CA 1.509 2.495 0 C-N-CA 118.639 -1.224 . . . . 0.0 110.732 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.019 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -95.36 138.74 32.64 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 179.39 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.5 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.331 0.4 OUTLIER -150.47 178.79 8.71 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 112.2 -2.273 . . . . 0.0 110.332 -179.403 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.487 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -122.68 142.46 50.65 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.06 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.42 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 2.5 t-20 -102.84 110.75 22.79 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 100.867 -3.753 . . . . 0.0 100.867 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 76.2 m -84.27 -119.86 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.413 -1.315 . . . . 0.0 112.792 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.519 HG13 ' N ' ' A' ' 37' ' ' TYR . 9.1 p -144.07 165.05 14.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 122.646 1.212 . . . . 0.0 110.806 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -52.65 -18.83 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 CA-C-N 112.135 -2.302 . . . . 0.0 107.73 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -105.55 -15.17 19.8 Favored Glycine 0 N--CA 1.482 1.742 0 CA-C-O 117.563 -1.687 . . . . 0.0 115.716 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.519 ' N ' HG13 ' A' ' 34' ' ' VAL . 3.9 m-85 -131.87 123.96 28.57 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.587 ' H ' HG23 ' A' ' 44' ' ' THR . 7.9 t -132.73 -147.57 0.31 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 87.48 -50.08 3.99 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.412 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER 136.59 -9.53 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.025 0 O-C-N 126.923 2.19 . . . . 0.0 109.002 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.522 ' HD2' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -114.31 -26.07 8.16 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.3 -178.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 1.2 m 79.82 35.88 0.14 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.594 ' OE1' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -88.82 -24.71 22.51 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 110.702 -2.954 . . . . 0.0 105.97 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.594 HG22 ' OE1' ' A' ' 43' ' ' GLN . 1.0 OUTLIER -106.31 89.73 3.14 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 102.469 -3.16 . . . . 0.0 102.469 179.749 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.514 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 4.3 mtm180 -84.93 90.8 7.89 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 101.572 -3.492 . . . . 0.0 101.572 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' GLY . 29.3 t70 -59.25 -20.1 51.42 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 111.693 -2.503 . . . . 0.0 107.882 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 65.47 49.29 1.88 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.881 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.558 ' H ' ' CA ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 115.934 -1.984 . . . . 0.0 111.249 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.493 1.46 0 N-CA-C 109.835 -0.871 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 145.8 172.78 16.46 Favored Glycine 0 N--CA 1.499 2.858 0 C-N-CA 118.987 -1.578 . . . . 0.0 115.238 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ABA . . . . . 0.455 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.455 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 63.4 Cg_endo -83.07 9.62 4.01 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 123.647 2.898 . . . . 0.0 111.506 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.22 -20.87 47.18 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.829 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 t -158.08 133.25 8.69 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.537 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 3.4 p90 -128.5 36.99 4.19 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.742 1.258 . . . . 0.0 108.05 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -100.45 130.3 46.52 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 47.3 33.75 8.09 Favored Glycine 0 N--CA 1.506 3.338 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -91.77 -20.37 21.59 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 125.315 1.244 . . . . 0.0 112.315 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.462 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 34.2 m -118.56 158.31 25.65 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 103.318 -2.845 . . . . 0.0 103.318 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.525 HD12 ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -112.25 -36.69 5.24 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -146.77 -77.05 0.18 Allowed 'General case' 0 N--CA 1.51 2.57 0 N-CA-C 119.053 2.983 . . . . 0.0 119.053 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.16 -23.56 69.86 Favored Glycine 0 N--CA 1.507 3.425 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.476 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -3.01 67.63 0.0 OUTLIER Glycine 0 N--CA 1.488 2.126 0 N-CA-C 122.1 3.6 . . . . 0.0 122.1 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.44 95.26 5.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 1 N-CA-C 100.172 -4.01 . . . . 0.0 100.172 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ABA . . . . . 1.055 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.493 ' SD ' ' ND2' ' A' ' 32' ' ' ASN . 8.3 ptm -122.49 126.89 48.8 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 123.147 1.451 . . . . 0.0 109.166 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.675 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -68.16 117.56 10.15 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.647 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -101.01 23.65 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.544 -179.532 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.486 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.7 OUTLIER -29.07 -49.25 0.08 Allowed 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 123.353 1.549 . . . . 0.0 109.034 -179.678 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -26.12 -49.29 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 108.656 -3.884 . . . . 0.0 113.165 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.51 -34.52 5.83 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 111.768 -2.469 . . . . 0.0 109.339 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -146.95 -81.12 0.14 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 23' ' ' ILE . 3.4 p -156.15 -132.07 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.468 -1.293 . . . . 0.0 110.129 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.055 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -98.45 137.17 37.53 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 179.67 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.541 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -148.57 -175.93 5.12 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 125.818 1.949 . . . . 0.0 110.246 -179.456 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.476 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -125.9 152.93 44.92 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.493 ' ND2' ' SD ' ' A' ' 21' ' ' MET . 4.0 t-20 -109.88 119.82 40.55 Favored 'General case' 0 C--N 1.298 -1.665 1 N-CA-C 96.346 -5.428 . . . . 0.0 96.346 179.612 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 37' ' ' TYR . 72.6 m -96.06 -111.89 0.14 Allowed 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 118.684 -1.206 . . . . 0.0 110.385 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.598 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 4.2 p -146.92 161.29 8.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 C-N-CA 118.617 -1.233 . . . . 0.0 108.139 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.419 ' H ' HG22 ' A' ' 35' ' ' ILE . 0.6 OUTLIER -46.62 -25.37 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 112.125 -2.307 . . . . 0.0 109.157 179.5 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.567 ' HA3' ' H ' ' A' ' 48' ' ' ARG . . . -106.84 1.6 35.98 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 118.495 2.158 . . . . 0.0 118.495 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.598 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 5.5 m-30 -135.55 120.32 18.43 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 100.283 -3.969 . . . . 0.0 100.283 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.624 ' H ' HG23 ' A' ' 44' ' ' THR . 7.4 t -131.77 -150.41 0.42 Allowed 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.19 -40.12 3.0 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 122.59 4.23 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.563 0 C-N-CA 127.073 2.149 . . . . 0.0 107.945 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.525 ' NE ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -127.69 -21.74 3.7 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.265 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER 77.0 35.79 0.35 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 -179.462 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.651 ' OE1' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -88.61 -21.47 23.99 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 111.423 -2.626 . . . . 0.0 107.307 -179.606 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.651 HG22 ' OE1' ' A' ' 43' ' ' GLN . 1.7 t -113.5 87.85 2.7 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 102.117 -3.29 . . . . 0.0 102.117 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 8.3 mtm180 -84.3 88.31 7.24 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 101.504 -3.517 . . . . 0.0 101.504 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 36' ' ' GLY . 32.4 t70 -55.32 -27.35 46.42 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.787 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 75.5 mt 91.48 64.16 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.574 0 C-N-CA 128.101 2.56 . . . . 0.0 117.263 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.567 ' H ' ' HA3' ' A' ' 36' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 116.295 -1.812 . . . . 0.0 109.906 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.493 1.476 0 CA-C-O 123.329 1.304 . . . . 0.0 108.717 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -120.44 168.25 13.87 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 107.037 -2.425 . . . . 0.0 107.037 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ABA . . . . . 0.415 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 7.7 Cg_exo -68.37 -44.61 3.27 Favored 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 122.134 1.889 . . . . 0.0 108.542 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -19.82 -54.81 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 110.801 -2.909 . . . . 0.0 117.621 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.89 116.71 19.05 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.582 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 2.7 p90 -114.5 2.47 14.62 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -70.38 140.47 52.12 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.34 42.37 2.48 Favored Glycine 0 N--CA 1.505 3.3 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.412 ' CD1' ' CZ ' ' A' ' 29' ' ' TYR . 35.9 t80 -91.17 -19.12 23.42 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 125.177 1.163 . . . . 0.0 113.258 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.437 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 35.6 m -116.21 154.85 29.35 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.861 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -107.14 -35.72 6.77 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.642 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 3.5 m120 -141.35 -83.09 0.21 Allowed 'General case' 0 N--CA 1.51 2.571 0 N-CA-C 120.84 3.644 . . . . 0.0 120.84 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.87 -26.12 66.73 Favored Glycine 0 N--CA 1.508 3.48 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.61 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 6.97 65.68 0.01 OUTLIER Glycine 0 N--CA 1.481 1.649 0 CA-C-N 110.275 -2.963 . . . . 0.0 120.127 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -94.17 97.09 6.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 102.768 -3.049 . . . . 0.0 102.768 179.306 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ABA . . . . . 0.995 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.57 ' HE3' HD13 ' A' ' 23' ' ' ILE . 5.5 ptt? -137.6 171.85 13.84 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 102.815 -3.031 . . . . 0.0 102.815 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.432 ' CE1' ' HG2' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -111.16 127.73 55.68 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.602 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -105.53 14.06 7.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 123.911 0.757 . . . . 0.0 110.644 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -20.12 -56.93 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.631 0 CA-C-O 123.893 1.806 . . . . 0.0 111.652 -179.028 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -26.26 -49.14 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.034 1 CA-C-N 108.259 -4.064 . . . . 0.0 113.723 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.37 -36.34 6.54 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 111.424 -2.625 . . . . 0.0 109.149 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -146.53 -81.14 0.15 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.455 ' H ' HG22 ' A' ' 23' ' ' ILE . 8.2 p -157.32 -132.7 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.951 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.995 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -97.21 140.56 31.52 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.551 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.264 0.5 OUTLIER -152.59 -177.89 6.51 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 112.753 -2.021 . . . . 0.0 109.578 -179.272 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.61 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -117.6 156.67 27.73 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -108.08 100.46 9.79 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 100.633 -3.84 . . . . 0.0 100.633 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.431 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 57.3 m -86.83 160.2 18.84 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.677 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.796 HG12 ' CD2' ' A' ' 37' ' ' TYR . 14.6 p -61.71 160.71 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-O 123.197 1.475 . . . . 0.0 111.658 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.415 HG22 ' H ' ' A' ' 35' ' ' ILE . 2.0 tt -52.51 -19.49 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 111.423 -2.626 . . . . 0.0 109.946 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -101.91 -0.72 51.97 Favored Glycine 0 N--CA 1.491 2.328 0 CA-C-N 114.076 -1.42 . . . . 0.0 115.692 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.796 ' CD2' HG12 ' A' ' 34' ' ' VAL . 9.4 m-30 -133.67 118.59 18.34 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.459 ' C ' HG22 ' A' ' 44' ' ' THR . 35.3 t -132.44 -134.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.741 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 71.63 -10.81 3.65 Favored Glycine 0 N--CA 1.486 1.969 0 CA-C-O 117.709 -1.606 . . . . 0.0 111.634 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 17.7 t70 105.0 -8.24 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.144 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.443 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -138.35 -1.05 1.94 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.688 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 69.34 30.95 4.02 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 -179.199 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.861 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -89.04 -16.68 31.04 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.204 -1.816 . . . . 0.0 110.107 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.465 ' O ' HG23 ' A' ' 44' ' ' THR 0.258 5.1 t -118.4 92.9 3.94 Favored 'General case' 0 C--N 1.297 -1.692 1 N-CA-C 99.668 -4.197 . . . . 0.0 99.668 179.995 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 19.0 mtm180 -88.36 92.28 9.11 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 112.249 -2.25 . . . . 0.0 105.832 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 36' ' ' GLY . 28.6 t70 -56.2 -27.34 54.3 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 125.833 1.958 . . . . 0.0 109.914 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER 76.81 117.59 0.06 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 126.066 2.104 . . . . 0.0 113.662 179.556 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 115.802 -2.047 . . . . 0.0 110.41 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo . . . . . 0 N--CA 1.492 1.424 0 N-CA-C 109.778 -0.893 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.459 ' HA3' ' HB3' ' A' ' 28' ' ' SER . . . 129.67 -173.41 19.71 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.925 -1.131 . . . . 0.0 112.553 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ABA . . . . . 0.498 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.498 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 52.5 Cg_endo -83.85 28.08 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 124.265 3.31 . . . . 0.0 110.505 173.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 6' ' ' ABA . 33.2 t -100.72 -21.84 15.08 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.977 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.5 t -156.53 125.84 6.13 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.474 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 9.3 p90 -123.49 30.82 6.12 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.688 1.232 . . . . 0.0 110.568 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -100.41 134.08 43.88 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.31 29.28 52.55 Favored Glycine 0 N--CA 1.506 3.327 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -91.25 -24.15 19.95 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.292 -1.454 . . . . 0.0 112.965 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.565 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 17.7 m -119.78 150.43 40.43 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.788 HD12 ' HD2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -109.19 -37.5 5.77 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 -179.355 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -149.46 -67.71 0.21 Allowed 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.94 -20.41 79.73 Favored Glycine 0 N--CA 1.502 3.085 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.565 ' HA3' ' HB3' ' A' ' 14' ' ' CYS . . . -4.02 71.08 0.0 OUTLIER Glycine 0 N--CA 1.484 1.834 0 N-CA-C 121.748 3.459 . . . . 0.0 121.748 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.6 t -96.18 93.62 3.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 101.343 -3.577 . . . . 0.0 101.343 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ABA . . . . . 1.067 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.3 ptp -114.47 170.38 8.35 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.8 OUTLIER -108.2 123.14 48.29 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -103.2 18.61 4.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 124.635 1.21 . . . . 0.0 111.115 -179.741 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -25.94 -52.41 0.05 OUTLIER 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 123.8 1.762 . . . . 0.0 110.643 -179.402 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -25.83 -49.37 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 108.437 -3.983 . . . . 0.0 113.069 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.76 -34.91 6.12 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 111.233 -2.712 . . . . 0.0 110.246 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -147.2 -80.84 0.14 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 23' ' ' ILE . 9.6 p -159.34 -130.98 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.771 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.067 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -96.31 140.64 30.69 Favored 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.521 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -151.2 172.34 15.97 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.791 -179.217 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.454 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -116.32 131.45 56.94 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -89.49 121.83 32.09 Favored 'General case' 0 C--N 1.303 -1.443 1 N-CA-C 99.957 -4.09 . . . . 0.0 99.957 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 37' ' ' TYR . 82.2 m -90.95 -114.5 0.08 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 123.945 0.778 . . . . 0.0 112.215 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.555 HG12 ' CD2' ' A' ' 37' ' ' TYR . 7.2 p -153.77 164.58 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 C-N-CA 117.656 -1.618 . . . . 0.0 111.257 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -47.9 -24.26 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 112.052 -2.34 . . . . 0.0 107.41 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -99.92 -17.9 24.11 Favored Glycine 0 C--O 1.201 -1.951 0 CA-C-O 117.69 -1.616 . . . . 0.0 115.165 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.555 ' CD2' HG12 ' A' ' 34' ' ' VAL . 1.1 m-85 -128.46 128.56 44.65 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 121.697 2.749 . . . . 0.0 106.008 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.64 ' H ' HG23 ' A' ' 44' ' ' THR . 12.6 t -130.77 -146.66 0.31 Allowed 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 40' ' ' ASP . . . 90.95 -51.12 3.17 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 106.496 -2.642 . . . . 0.0 106.496 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER 128.32 4.97 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.663 0 O-C-N 127.958 2.799 . . . . 0.0 109.026 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.788 ' HD2' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -121.53 -27.98 4.67 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.651 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 1.9 m 85.54 37.73 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 104.327 -2.472 . . . . 0.0 104.327 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.624 ' HA ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -88.17 -23.32 23.64 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 111.514 -2.585 . . . . 0.0 107.157 -179.621 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.64 HG23 ' H ' ' A' ' 38' ' ' SER . 1.3 t -110.23 84.42 1.92 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 101.365 -3.569 . . . . 0.0 101.365 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -81.28 87.48 6.12 Favored 'General case' 0 C--N 1.299 -1.63 1 N-CA-C 99.28 -4.341 . . . . 0.0 99.28 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 36' ' ' GLY . 33.3 t70 -58.85 -25.66 63.46 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 112.111 -2.313 . . . . 0.0 107.355 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 80.58 -148.5 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.498 ' NH1' ' O ' ' A' ' 46' ' ' ASP . 8.7 mtt180 . . . . . 0 N--CA 1.504 2.256 0 CA-C-N 119.447 1.021 . . . . 0.0 110.572 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 N--CA 1.493 1.446 0 N-CA-C 108.551 -1.365 . . . . 0.0 108.551 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.26 147.5 19.12 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ABA . . . . . 0.751 ' H ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.751 ' HD3' ' H ' ' A' ' 6' ' ' ABA . 69.2 Cg_endo -77.09 19.1 0.71 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 123.551 2.834 . . . . 0.0 112.368 -163.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 6' ' ' ABA . 35.9 t -100.47 -20.97 15.52 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.424 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.9 t -156.9 130.57 8.17 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.56 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 3.2 p90 -123.03 2.7 9.33 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.404 0.621 . . . . 0.0 111.82 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.29 122.57 13.55 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.11 36.95 93.13 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.722 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.52 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 22.4 t80 -91.24 -17.63 25.7 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.619 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.555 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 30.9 m -115.02 151.63 33.87 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.981 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -108.31 -34.0 6.94 Favored 'General case' 0 N--CA 1.508 2.457 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.491 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 4.3 m120 -142.07 -82.21 0.21 Allowed 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 120.355 3.465 . . . . 0.0 120.355 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.68 6.32 77.19 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 108.421 -1.871 . . . . 0.0 108.421 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.621 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -51.2 95.87 0.01 OUTLIER Glycine 0 C--N 1.303 -1.265 0 CA-C-N 112.847 -1.676 . . . . 0.0 113.508 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER -91.73 106.63 17.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 102.85 -3.019 . . . . 0.0 102.85 179.103 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ABA . . . . . 0.983 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.532 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 4.3 ptm -134.12 167.61 20.34 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 102.343 -3.206 . . . . 0.0 102.343 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -110.3 126.56 54.33 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.548 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -104.51 14.19 7.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 124.329 1.018 . . . . 0.0 112.408 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -23.05 -56.81 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 122.889 1.328 . . . . 0.0 112.657 -179.095 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.7 m -28.03 -44.22 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 110.277 -3.147 . . . . 0.0 115.428 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.99 -37.0 5.5 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 111.428 -2.623 . . . . 0.0 109.834 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -145.19 -82.63 0.15 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 117.211 2.301 . . . . 0.0 117.211 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.544 ' H ' HG22 ' A' ' 23' ' ' ILE . 1.0 OUTLIER -156.3 -138.87 0.07 Allowed 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 119.259 -0.977 . . . . 0.0 109.953 -179.267 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.983 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -92.36 146.39 23.73 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 102.591 -3.115 . . . . 0.0 102.591 179.372 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.547 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -158.43 -176.43 5.89 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 125.793 1.933 . . . . 0.0 109.704 -179.607 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.621 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -121.37 153.41 37.82 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.772 -1.171 . . . . 0.0 108.446 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.532 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 53.5 t30 -106.85 85.45 2.15 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 59.5 m -60.72 167.27 2.82 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.513 -1.676 . . . . 0.0 112.04 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.669 HG12 ' CD2' ' A' ' 37' ' ' TYR . 11.1 p -71.98 161.64 4.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 117.804 -1.559 . . . . 0.0 108.92 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.428 ' H ' HG22 ' A' ' 35' ' ' ILE . 1.9 tt -51.68 -21.64 2.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-N 112.335 -2.211 . . . . 0.0 108.735 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -92.4 -27.55 15.04 Favored Glycine 0 C--O 1.2 -2.016 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.81 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.669 ' CD2' HG12 ' A' ' 34' ' ' VAL . 3.1 m-30 -110.57 142.4 42.44 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 121.476 2.638 . . . . 0.0 108.341 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.433 ' C ' ' H ' ' A' ' 40' ' ' ASP . 53.0 m -142.73 -137.18 0.1 Allowed 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.649 -1.22 . . . . 0.0 112.034 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 73.79 -16.98 2.31 Favored Glycine 0 N--CA 1.481 1.665 0 CA-C-O 116.623 -2.209 . . . . 0.0 110.356 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 17.6 t70 106.94 -6.83 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.133 0 O-C-N 125.126 1.133 . . . . 0.0 111.817 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.505 ' C ' ' SG ' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -135.52 -6.58 2.23 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -178.715 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.562 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 69.3 33.54 3.21 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 -179.325 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.981 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -88.1 -21.13 24.86 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 111.514 -2.584 . . . . 0.0 106.916 -179.669 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.401 ' O ' ' CG2' ' A' ' 44' ' ' THR . 10.9 t -114.87 114.27 25.29 Favored 'General case' 0 C--N 1.296 -1.754 1 N-CA-C 94.032 -6.285 . . . . 0.0 94.032 179.612 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.609 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 14.6 mtm180 -105.25 99.76 9.37 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 101.337 -3.579 . . . . 0.0 101.337 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 36' ' ' GLY . 44.5 t0 -85.54 70.34 10.75 Favored 'General case' 0 C--N 1.295 -1.769 1 N-CA-C 98.599 -4.593 . . . . 0.0 98.599 179.533 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.7 mt -46.72 70.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 117.829 2.529 . . . . 0.0 117.829 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 116.455 -1.736 . . . . 0.0 109.333 179.523 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo . . . . . 0 N--CA 1.494 1.515 0 N-CA-C 110.066 -0.782 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.535 ' HA3' ' CB ' ' A' ' 28' ' ' SER . . . 105.21 -146.83 16.13 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ABA . . . . . 0.573 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 93.9 Cg_endo -78.93 14.89 1.6 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 123.196 2.598 . . . . 0.0 109.973 -163.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.522 ' H ' ' C ' ' A' ' 6' ' ' ABA . 1.3 t -100.22 -22.14 15.25 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.983 -1.462 . . . . 0.0 107.827 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.5 p -151.63 121.53 7.08 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 118.092 -0.956 . . . . 0.0 108.809 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 29' ' ' TYR . 4.3 p90 -116.11 -5.05 11.92 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.41 116.32 3.26 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.686 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.37 26.73 60.89 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.111 -1.519 . . . . 0.0 109.702 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.597 ' CE1' ' HA ' ' A' ' 30' ' ' THR . 26.3 t80 -91.28 -12.46 35.05 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 118.854 -1.139 . . . . 0.0 109.992 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.62 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 17.5 m -126.41 142.07 51.66 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.763 HD12 ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -100.83 -59.57 1.68 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -179.434 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.469 ' HB2' ' CD2' ' A' ' 37' ' ' TYR . 6.4 m120 -134.72 -52.62 0.81 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 119.791 3.256 . . . . 0.0 119.791 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -100.85 -0.62 55.13 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.62 ' HA3' ' HB3' ' A' ' 14' ' ' CYS . . . -51.75 90.52 0.01 OUTLIER Glycine 0 N--CA 1.476 1.327 0 CA-C-O 123.976 1.876 . . . . 0.0 117.119 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER -87.82 99.98 9.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 1 N-CA-C 96.02 -5.548 . . . . 0.0 96.02 179.237 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ABA . . . . . 0.471 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.6 ptm -138.71 170.06 16.68 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.496 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -111.08 130.79 55.5 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 103.419 -2.808 . . . . 0.0 103.419 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.635 HD13 ' CG2' ' A' ' 30' ' ' THR . 0.4 OUTLIER -104.59 16.45 5.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 124.214 0.946 . . . . 0.0 112.084 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.496 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 1.0 OUTLIER -29.16 -50.91 0.1 Allowed 'General case' 0 N--CA 1.507 2.389 0 CA-C-O 122.582 1.182 . . . . 0.0 112.727 -179.161 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.8 m -31.31 -43.42 0.06 Allowed 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 111.087 -2.779 . . . . 0.0 113.804 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.61 -36.03 5.6 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 111.522 -2.581 . . . . 0.0 109.987 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -148.2 -83.55 0.11 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 118.846 2.906 . . . . 0.0 118.846 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.535 ' CB ' ' HA3' ' A' ' 5' ' ' GLY . 5.1 p -148.92 -136.04 0.07 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.525 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.51 ' HE1' ' CG ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -101.4 147.87 25.83 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-N 118.584 0.629 . . . . 0.0 109.941 -179.593 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.635 ' CG2' HD13 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -160.01 -173.72 4.21 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 118.587 2.81 . . . . 0.0 118.587 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.511 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -131.85 130.11 41.27 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.58 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -92.08 89.62 7.02 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 104.716 -2.328 . . . . 0.0 104.716 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.2 m -72.72 -178.35 2.65 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.247 1.023 . . . . 0.0 108.922 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.779 HG12 ' CD2' ' A' ' 37' ' ' TYR . 10.9 p -89.81 166.81 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-O 123.979 1.847 . . . . 0.0 113.458 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.574 HD11 ' NH2' ' A' ' 48' ' ' ARG . 2.5 tt -56.29 -15.74 2.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-N 112.096 -2.32 . . . . 0.0 108.271 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.586 ' H ' HG13 ' A' ' 34' ' ' VAL . . . -98.34 -12.63 44.57 Favored Glycine 0 N--CA 1.486 1.972 0 CA-C-N 113.929 -1.487 . . . . 0.0 113.716 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.779 ' CD2' HG12 ' A' ' 34' ' ' VAL . 1.3 m-85 -135.24 130.51 35.32 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.57 ' H ' HG23 ' A' ' 44' ' ' THR . 1.4 t -129.06 -161.23 1.09 Allowed 'General case' 0 N--CA 1.515 2.775 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 51.27 63.5 4.57 Favored Glycine 0 N--CA 1.499 2.865 0 N-CA-C 117.513 1.765 . . . . 0.0 117.513 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 43.71 -13.78 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.588 1 N-CA-C 122.16 4.133 . . . . 0.0 122.16 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.763 ' NE ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -113.82 -28.2 7.5 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.464 ' SG ' ' N ' ' A' ' 18' ' ' GLY . 2.7 m 82.01 43.86 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.728 ' NE2' HG22 ' A' ' 44' ' ' THR . 0.1 OUTLIER -88.8 -8.68 53.95 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 112.86 -1.973 . . . . 0.0 112.127 -179.235 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.728 HG22 ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -120.83 94.12 4.25 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 102.121 -3.289 . . . . 0.0 102.121 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.4 ' HA ' ' HD1' ' A' ' 37' ' ' TYR . 7.2 mtm180 -83.78 86.52 7.13 Favored 'General case' 0 C--N 1.305 -1.329 1 N-CA-C 98.408 -4.664 . . . . 0.0 98.408 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 36' ' ' GLY . 1.3 t70 -59.96 -12.95 9.01 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 112.098 -2.319 . . . . 0.0 109.342 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 57.91 12.96 1.92 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 127.581 2.353 . . . . 0.0 116.709 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.574 ' NH2' HD11 ' A' ' 35' ' ' ILE . 1.7 ptm85 . . . . . 0 N--CA 1.5 2.072 0 CA-C-O 117.271 -1.347 . . . . 0.0 113.818 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 N--CA 1.492 1.421 0 N-CA-C 107.865 -1.629 . . . . 0.0 107.865 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.72 -170.31 14.06 Favored Glycine 0 N--CA 1.497 2.748 0 C-N-CA 120.151 -1.023 . . . . 0.0 110.569 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ABA . . . . . 0.55 ' H ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.55 ' HD3' ' H ' ' A' ' 6' ' ' ABA . 2.9 Cg_exo -70.02 -41.55 3.86 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.87 2.38 . . . . 0.0 109.06 173.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -19.91 -49.84 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 111.061 -2.791 . . . . 0.0 116.555 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.2 t -139.78 127.41 21.73 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -123.57 34.06 5.19 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.05 130.9 46.25 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 104.678 -2.342 . . . . 0.0 104.678 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.81 40.31 2.17 Favored Glycine 0 N--CA 1.506 3.34 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.407 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 24.6 t80 -91.52 -22.08 20.55 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 126.098 1.705 . . . . 0.0 112.856 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.41 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 38.1 m -114.68 155.07 27.3 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.964 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -107.06 -37.14 6.39 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -179.575 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.609 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 4.7 m120 -141.51 -85.54 0.18 Allowed 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 119.981 3.326 . . . . 0.0 119.981 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.98 -26.33 55.21 Favored Glycine 0 N--CA 1.512 3.716 0 N-CA-C 108.486 -1.845 . . . . 0.0 108.486 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.535 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 6.25 65.42 0.01 OUTLIER Glycine 0 N--CA 1.484 1.843 0 N-CA-C 121.504 3.362 . . . . 0.0 121.504 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.33 97.4 6.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 100.944 -3.725 . . . . 0.0 100.944 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ABA . . . . . 1.059 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.55 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 7.3 ptm -121.9 122.28 39.05 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 123.128 1.442 . . . . 0.0 109.379 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.641 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -62.57 121.38 13.19 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 179.626 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.653 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -104.36 24.87 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 123.936 0.773 . . . . 0.0 110.31 -179.637 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.498 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.8 OUTLIER -34.77 -39.89 0.1 Allowed 'General case' 0 N--CA 1.509 2.487 0 CA-C-O 123.502 1.62 . . . . 0.0 110.195 -179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.401 ' N ' ' C ' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -32.61 -46.26 0.13 Allowed 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 110.055 -3.248 . . . . 0.0 111.477 179.245 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.53 -34.53 4.86 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 111.672 -2.513 . . . . 0.0 110.396 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -148.09 -81.98 0.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 23' ' ' ILE . 2.5 p -152.76 -131.54 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.149 -1.02 . . . . 0.0 109.378 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.059 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -100.16 137.42 38.63 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.595 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -148.58 -176.34 5.28 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 112.449 -2.159 . . . . 0.0 110.266 -179.396 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.535 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -122.02 155.75 34.94 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.55 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 45.6 t30 -109.21 104.33 13.46 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 100.346 -3.946 . . . . 0.0 100.346 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.449 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 60.8 m -89.22 169.86 11.09 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.499 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.707 HG12 ' CD2' ' A' ' 37' ' ' TYR . 8.9 p -68.79 159.56 5.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 123.264 1.507 . . . . 0.0 111.613 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.402 ' H ' HG22 ' A' ' 35' ' ' ILE . 1.2 tt -48.43 -21.71 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 111.177 -2.738 . . . . 0.0 109.914 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.554 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -106.64 3.73 36.72 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 118.026 1.971 . . . . 0.0 118.026 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.707 ' CD2' HG12 ' A' ' 34' ' ' VAL . 13.5 m-30 -133.44 116.81 16.47 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 100.461 -3.903 . . . . 0.0 100.461 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.493 ' C ' HG22 ' A' ' 44' ' ' THR . 39.9 t -132.54 -133.65 0.18 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 118.381 -1.328 . . . . 0.0 113.041 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 71.42 -9.87 4.12 Favored Glycine 0 N--CA 1.486 1.993 0 CA-C-O 117.764 -1.575 . . . . 0.0 111.293 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 19.6 t70 104.57 -5.24 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.073 0 O-C-N 124.967 1.039 . . . . 0.0 112.907 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.463 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -139.39 -2.96 1.56 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -178.754 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 71.17 30.9 2.56 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 -179.254 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.964 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -89.04 -15.02 35.09 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 113.119 -1.855 . . . . 0.0 110.191 -179.519 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.493 HG22 ' C ' ' A' ' 38' ' ' SER 0.26 6.0 t -118.99 83.07 1.96 Allowed 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 100.236 -3.987 . . . . 0.0 100.236 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 8.8 mtm-85 -77.51 89.87 3.87 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 111.115 -2.766 . . . . 0.0 104.057 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 36' ' ' GLY . 0.9 OUTLIER -62.34 -16.89 57.09 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 113.017 -1.901 . . . . 0.0 109.773 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mt 78.55 47.86 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.554 ' H ' ' HA3' ' A' ' 36' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 116.469 -1.729 . . . . 0.0 112.617 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 N--CA 1.493 1.447 0 N-CA-C 108.141 -1.523 . . . . 0.0 108.141 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.424 ' HA3' ' CB ' ' A' ' 28' ' ' SER . . . 139.27 -178.95 19.16 Favored Glycine 0 N--CA 1.491 2.305 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.128 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ABA . . . . . 0.539 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 3.2 Cg_exo -74.33 -23.75 15.05 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.762 2.308 . . . . 0.0 111.342 173.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.5 t -20.14 -51.91 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 O-C-N 124.95 1.406 . . . . 0.0 113.535 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -156.31 154.83 31.26 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 102.421 -3.177 . . . . 0.0 102.421 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.521 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -125.32 10.77 8.03 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 124.768 1.292 . . . . 0.0 109.581 179.724 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.99 135.27 57.2 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 37.52 41.55 0.83 Allowed Glycine 0 N--CA 1.511 3.651 0 O-C-N 124.08 0.863 . . . . 0.0 111.511 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.412 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 20.9 t80 -91.24 -17.21 26.37 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 125.231 1.195 . . . . 0.0 112.589 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.455 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 44.6 m -116.92 154.13 31.36 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.933 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -108.15 -36.47 6.29 Favored 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -179.666 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.674 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 4.5 m120 -140.58 -82.52 0.24 Allowed 'General case' 0 N--CA 1.51 2.555 0 N-CA-C 120.372 3.471 . . . . 0.0 120.372 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.82 -21.42 65.32 Favored Glycine 0 N--CA 1.508 3.462 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.575 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 2.95 67.46 0.0 OUTLIER Glycine 0 N--CA 1.481 1.696 0 N-CA-C 120.215 2.846 . . . . 0.0 120.215 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 19' ' ' VAL . 2.0 t -95.72 94.58 4.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 101.423 -3.547 . . . . 0.0 101.423 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ABA . . . . . 1.066 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.418 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 8.2 ptm -115.84 165.66 12.83 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.445 ' CE1' ' HG2' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -102.71 126.71 49.92 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.611 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -106.6 18.92 5.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 124.412 1.07 . . . . 0.0 109.913 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.487 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -27.47 -52.96 0.07 Allowed 'General case' 0 N--CA 1.512 2.636 0 CA-C-O 123.405 1.574 . . . . 0.0 109.742 -179.421 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -25.08 -46.98 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 108.964 -3.743 . . . . 0.0 114.323 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.78 -35.52 5.45 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 110.916 -2.856 . . . . 0.0 110.026 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -147.03 -81.62 0.14 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 23' ' ' ILE . 4.5 p -157.44 -131.77 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.582 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.066 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -97.73 141.5 30.67 Favored 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.576 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.266 0.5 OUTLIER -153.31 -176.73 5.92 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.384 -1.735 . . . . 0.0 110.446 -179.277 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.575 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -120.48 148.95 43.15 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.727 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.418 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 43.3 t30 -101.61 101.0 11.47 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 101.417 -3.549 . . . . 0.0 101.417 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.511 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 59.5 m -86.71 156.6 19.9 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.116 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.696 HG12 ' CD2' ' A' ' 37' ' ' TYR . 12.5 p -59.94 160.38 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 112.591 -2.095 . . . . 0.0 114.266 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.7 tt -50.72 -21.85 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 CA-C-N 110.845 -2.889 . . . . 0.0 109.243 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -99.61 -6.83 54.49 Favored Glycine 0 N--CA 1.49 2.261 0 CA-C-N 114.202 -1.363 . . . . 0.0 115.929 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.696 ' CD2' HG12 ' A' ' 34' ' ' VAL . 5.9 m-85 -132.59 120.8 22.29 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.497 ' C ' HG22 ' A' ' 44' ' ' THR . 26.4 t -131.7 -137.98 0.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.629 -1.228 . . . . 0.0 111.087 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 74.88 -10.66 8.74 Favored Glycine 0 N--CA 1.481 1.688 0 CA-C-O 117.075 -1.958 . . . . 0.0 111.339 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 19.2 t70 105.07 -8.88 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.261 0 O-C-N 125.039 1.082 . . . . 0.0 113.065 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.455 ' HD3' ' CA ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -137.86 -2.24 1.93 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -178.67 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 69.31 31.35 3.92 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 104.523 -2.399 . . . . 0.0 104.523 -179.254 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.933 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -88.81 -16.03 33.1 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 113.024 -1.898 . . . . 0.0 109.223 -179.39 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.497 HG22 ' C ' ' A' ' 38' ' ' SER . 3.4 t -119.45 88.84 3.01 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 101.397 -3.557 . . . . 0.0 101.397 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 24.9 mtp-105 -83.4 93.69 7.82 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 111.342 -2.663 . . . . 0.0 105.465 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 36' ' ' GLY . 26.0 t0 -62.07 -23.64 66.62 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 112.745 -2.025 . . . . 0.0 108.042 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 80.61 -144.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 112.789 -2.005 . . . . 0.0 107.686 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.312 0 O-C-N 124.334 1.021 . . . . 0.0 113.607 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 N--CA 1.494 1.526 0 N-CA-C 107.929 -1.604 . . . . 0.0 107.929 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.59 179.58 16.62 Favored Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.208 -1.472 . . . . 0.0 113.408 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ABA . . . . . 0.572 ' H ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.572 ' HD3' ' H ' ' A' ' 6' ' ' ABA . 1.5 Cg_endo -76.45 -35.5 2.15 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.753 2.302 . . . . 0.0 112.548 177.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -19.81 -54.21 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 125.956 2.035 . . . . 0.0 113.177 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.8 t -146.99 154.47 41.28 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 103.669 -2.715 . . . . 0.0 103.669 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.561 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -127.06 12.12 7.13 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.183 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -55.81 129.7 40.51 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 35.35 46.04 0.71 Allowed Glycine 0 N--CA 1.508 3.487 0 O-C-N 124.744 1.277 . . . . 0.0 111.017 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.411 ' HD1' ' HH ' ' A' ' 29' ' ' TYR . 29.3 t80 -91.08 -17.6 25.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 125.752 1.501 . . . . 0.0 113.007 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.411 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 50.9 m -116.72 153.38 32.48 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.941 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -106.28 -35.71 7.08 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -179.691 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.49 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 4.9 m120 -144.12 -83.23 0.16 Allowed 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 119.107 3.003 . . . . 0.0 119.107 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -57.34 -27.0 57.48 Favored Glycine 0 N--CA 1.51 3.614 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.561 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 7.96 63.14 0.01 OUTLIER Glycine 0 N--CA 1.48 1.607 0 N-CA-C 120.304 2.882 . . . . 0.0 120.304 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.93 94.92 4.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 100.464 -3.902 . . . . 0.0 100.464 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ABA . . . . . 1.063 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 6.3 ptm -122.03 121.28 36.65 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 123.094 1.426 . . . . 0.0 108.807 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.661 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -63.78 118.36 8.22 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.67 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -99.98 26.18 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 123.751 0.657 . . . . 0.0 110.305 -179.448 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.487 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 1.3 tm-20 -34.29 -41.86 0.12 Allowed 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 123.652 1.691 . . . . 0.0 109.713 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -31.19 -45.33 0.08 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 109.874 -3.33 . . . . 0.0 112.241 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.02 -33.73 4.63 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 111.841 -2.436 . . . . 0.0 110.305 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -149.32 -80.67 0.12 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 23' ' ' ILE . 2.4 p -153.86 -131.11 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 118.891 -1.124 . . . . 0.0 109.718 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.063 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.2 OUTLIER -100.84 135.94 41.48 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.543 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -147.14 -177.56 5.74 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 112.333 -2.212 . . . . 0.0 109.705 -179.391 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.561 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -122.8 154.51 38.11 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 179.576 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.535 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 54.6 t30 -108.82 101.89 10.96 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 101.093 -3.669 . . . . 0.0 101.093 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 62.9 m -82.84 170.39 15.05 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 113.747 -1.57 . . . . 0.0 109.853 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.69 HG12 ' CD2' ' A' ' 37' ' ' TYR . 12.9 p -72.33 160.51 5.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 123.14 1.448 . . . . 0.0 111.859 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.432 HG22 HG22 ' A' ' 34' ' ' VAL . 3.0 tt -51.02 -19.03 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 111.657 -2.519 . . . . 0.0 108.94 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -94.3 -25.71 15.7 Favored Glycine 0 C--O 1.203 -1.839 0 CA-C-O 117.898 -1.501 . . . . 0.0 112.766 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.69 ' CD2' HG12 ' A' ' 34' ' ' VAL . 2.4 m-30 -115.1 124.64 52.05 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 119.428 1.614 . . . . 0.0 108.193 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.415 ' C ' HG22 ' A' ' 44' ' ' THR . 23.1 t -131.62 -139.92 0.21 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.83 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 76.62 -12.62 10.08 Favored Glycine 0 N--CA 1.481 1.657 0 CA-C-O 117.555 -1.692 . . . . 0.0 110.1 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.522 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 31.0 t70 105.63 -6.11 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.062 0 O-C-N 125.04 1.082 . . . . 0.0 113.301 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.468 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -137.4 -4.17 1.88 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.814 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.515 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 72.2 32.4 1.73 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 -179.238 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.941 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -87.99 -20.07 26.34 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 113.328 -1.76 . . . . 0.0 110.575 -179.248 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.493 ' O ' HG23 ' A' ' 44' ' ' THR 0.256 6.1 t -113.67 83.5 1.86 Allowed 'General case' 0 C--N 1.295 -1.79 1 N-CA-C 98.893 -4.484 . . . . 0.0 98.893 179.955 . . . . . . . . 4 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.58 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -76.0 89.34 2.97 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 101.944 -3.354 . . . . 0.0 101.944 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 36' ' ' GLY . 30.4 t70 -83.41 46.22 1.12 Allowed 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 45' ' ' ARG . 41.1 mt 13.1 25.27 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 1 N-CA-C 122.114 4.116 . . . . 0.0 122.114 -179.584 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 46' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 115.168 -2.349 . . . . 0.0 109.845 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo . . . . . 0 N--CA 1.501 1.931 0 N-CA-C 110.093 -0.772 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.1 t -19.94 -43.56 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 126.252 2.22 . . . . 0.0 116.238 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 t -146.49 127.38 14.46 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.4 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 7.0 p90 -122.06 35.93 4.76 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.09 131.96 45.74 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.1 40.16 1.7 Allowed Glycine 0 N--CA 1.51 3.569 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.44 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 26.4 t80 -91.87 -15.2 28.47 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 125.756 1.504 . . . . 0.0 114.191 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.4 m -128.47 156.62 42.93 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.934 HD22 ' HA ' ' A' ' 43' ' ' GLN . 1.1 mp -104.49 -33.09 8.69 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.438 ' ND2' ' CD ' ' A' ' 45' ' ' ARG . 4.6 m-80 -144.92 -81.65 0.16 Allowed 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 120.109 3.374 . . . . 0.0 120.109 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.12 -29.6 65.76 Favored Glycine 0 N--CA 1.507 3.429 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.402 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 5.02 66.99 0.01 OUTLIER Glycine 0 N--CA 1.483 1.767 0 CA-C-N 110.085 -3.058 . . . . 0.0 119.809 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.301 -1.515 1 N-CA-C 99.175 -4.38 . . . . 0.0 99.175 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.943 ' SD ' HD12 ' A' ' 23' ' ' ILE . 2.5 ppp? . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 124.459 2.076 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -70.86 117.24 12.12 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 113.238 -1.801 . . . . 0.0 107.497 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.943 HD12 ' SD ' ' A' ' 21' ' ' MET . 0.1 OUTLIER -100.93 24.88 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.006 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.482 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 1.3 tm-20 -32.71 -46.84 0.15 Allowed 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 123.607 1.67 . . . . 0.0 108.458 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -26.11 -48.47 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 108.605 -3.907 . . . . 0.0 113.067 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.449 ' CD1' HG12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -115.08 -33.99 5.2 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 111.357 -2.656 . . . . 0.0 109.996 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -146.82 -81.5 0.14 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 23' ' ' ILE . 6.3 p -156.16 -127.73 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.108 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -101.15 137.06 40.01 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.544 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -146.87 -174.54 4.52 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 112.312 -2.222 . . . . 0.0 109.297 -179.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.402 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -125.34 156.28 38.95 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -108.47 117.9 35.36 Favored 'General case' 0 C--N 1.298 -1.633 1 N-CA-C 98.102 -4.777 . . . . 0.0 98.102 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.548 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 81.9 m -98.57 166.22 11.45 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.61 HG12 ' CD2' ' A' ' 37' ' ' TYR . 7.1 p -64.87 158.11 4.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 C-N-CA 117.67 -1.612 . . . . 0.0 112.707 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -42.38 -28.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 111.52 -2.582 . . . . 0.0 110.682 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -99.06 -17.24 28.07 Favored Glycine 0 C--O 1.203 -1.784 0 CA-C-N 114.198 -1.365 . . . . 0.0 115.484 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.61 ' CD2' HG12 ' A' ' 34' ' ' VAL . 6.0 m-30 -111.96 124.92 53.41 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.43 ' C ' ' H ' ' A' ' 40' ' ' ASP . 47.0 t -133.71 -130.38 0.17 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.237 -1.385 . . . . 0.0 112.362 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.501 ' C ' ' NE2' ' A' ' 43' ' ' GLN . . . 65.75 -2.56 3.5 Favored Glycine 0 N--CA 1.483 1.77 0 CA-C-O 117.699 -1.611 . . . . 0.0 109.815 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 8.8 t70 92.78 -2.48 0.13 Allowed 'General case' 0 N--CA 1.517 2.916 0 CA-C-N 118.268 1.034 . . . . 0.0 113.662 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.515 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -141.38 2.41 1.65 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.548 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 61.13 33.95 19.21 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 -179.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.934 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -88.71 -24.27 22.76 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 111.731 -2.486 . . . . 0.0 108.305 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 44' ' ' THR . 6.1 t -112.33 83.92 1.88 Allowed 'General case' 0 C--N 1.297 -1.678 1 N-CA-C 99.07 -4.418 . . . . 0.0 99.07 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.609 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 16.6 mtm180 -79.84 91.49 5.36 Favored 'General case' 0 C--N 1.296 -1.731 1 N-CA-C 100.11 -4.033 . . . . 0.0 100.11 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 36' ' ' GLY . 5.6 t70 -86.79 64.98 8.79 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.498 1.957 0 N-CA-C 117.929 2.566 . . . . 0.0 117.929 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 N--CA 1.501 1.943 0 CA-C-O 120.867 0.278 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -19.89 -53.83 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 125.332 1.645 . . . . 0.0 114.634 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 t -143.75 144.2 31.72 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 104.23 -2.508 . . . . 0.0 104.23 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.457 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 3.2 p90 -127.19 26.4 6.06 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 124.868 1.355 . . . . 0.0 109.845 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -100.06 133.26 44.7 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.37 24.69 61.77 Favored Glycine 0 N--CA 1.505 3.243 0 N-CA-C 107.662 -2.175 . . . . 0.0 107.662 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.428 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 10.2 t80 -91.1 -18.04 25.19 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 113.47 -1.365 . . . . 0.0 112.208 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.471 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 10.1 m -132.83 147.51 52.3 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.757 HD12 ' HD2' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -104.0 -34.7 8.36 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -179.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.483 ' ND2' ' HB3' ' A' ' 15' ' ' LEU . 53.9 m-80 -147.86 -76.02 0.18 Allowed 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 120.403 3.483 . . . . 0.0 120.403 -178.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.469 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -63.72 -26.35 69.82 Favored Glycine 0 N--CA 1.508 3.496 0 N-CA-C 108.155 -1.978 . . . . 0.0 108.155 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 14' ' ' CYS . . . -1.25 68.56 0.0 OUTLIER Glycine 0 N--CA 1.485 1.911 0 N-CA-C 120.672 3.029 . . . . 0.0 120.672 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 17' ' ' GLY . 2.8 t . . . . . 0 C--N 1.3 -1.565 0 N-CA-C 100.322 -3.955 . . . . 0.0 100.322 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.503 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 5.5 ptp . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 123.207 1.479 . . . . 0.0 108.984 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.668 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -72.41 113.35 9.35 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 103.406 -2.812 . . . . 0.0 103.406 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.67 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -95.38 27.14 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.113 -179.289 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.496 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.8 OUTLIER -37.84 -37.65 0.25 Allowed 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 123.439 1.59 . . . . 0.0 109.288 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.4 ' N ' ' C ' ' A' ' 23' ' ' ILE . 0.7 OUTLIER -33.31 -44.38 0.13 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 110.388 -3.097 . . . . 0.0 111.579 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.5 -32.98 4.18 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 111.659 -2.519 . . . . 0.0 111.1 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -149.5 -80.04 0.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 118.124 2.639 . . . . 0.0 118.124 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.9 p -153.46 -133.52 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 119.098 -1.041 . . . . 0.0 109.834 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.668 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -100.09 135.95 40.73 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 179.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.526 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -147.65 -176.42 5.25 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 112.841 -1.981 . . . . 0.0 109.994 -179.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.421 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -125.18 150.07 47.32 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.503 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 14.5 t30 -106.36 123.71 48.47 Favored 'General case' 0 C--N 1.299 -1.599 1 N-CA-C 97.348 -5.056 . . . . 0.0 97.348 179.366 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 37' ' ' TYR . 72.1 m -96.59 -117.73 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.582 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.606 HG12 ' CD2' ' A' ' 37' ' ' TYR . 7.4 p -149.52 166.84 3.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 117.815 -1.554 . . . . 0.0 111.151 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tt -50.74 -19.68 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 112.247 -2.251 . . . . 0.0 107.747 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -104.27 -14.11 25.02 Favored Glycine 0 C--O 1.202 -1.848 0 CA-C-N 113.521 -1.672 . . . . 0.0 115.285 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.606 ' CD2' HG12 ' A' ' 34' ' ' VAL . 1.9 m-85 -131.66 125.64 32.64 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.609 ' H ' HG23 ' A' ' 44' ' ' THR . 11.1 t -129.74 -148.27 0.36 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 40' ' ' ASP . . . 90.82 -48.15 3.01 Favored Glycine 0 N--CA 1.502 3.049 0 N-CA-C 106.89 -2.484 . . . . 0.0 106.89 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 0.5 OUTLIER 122.81 8.68 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 C-N-CA 129.788 3.235 . . . . 0.0 108.186 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.757 ' HD2' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -127.27 -7.18 5.88 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.366 0.603 . . . . 0.0 110.83 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.45 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 62.51 38.32 12.65 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 124.236 1.969 . . . . 0.0 107.564 -179.211 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.696 HE21 HG22 ' A' ' 44' ' ' THR . 0.5 OUTLIER -88.23 -38.26 15.4 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 109.236 -3.62 . . . . 0.0 105.76 -179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.696 HG22 HE21 ' A' ' 43' ' ' GLN . 1.9 t -96.35 85.33 3.91 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 102.048 -3.316 . . . . 0.0 102.048 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.487 ' CZ ' ' HB2' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -82.61 84.69 7.18 Favored 'General case' 0 C--N 1.299 -1.626 1 N-CA-C 99.791 -4.152 . . . . 0.0 99.791 179.886 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 36' ' ' GLY . 30.1 t70 -55.49 -28.91 57.47 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 112.192 -2.276 . . . . 0.0 108.4 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 C-N-CA 127.068 2.147 . . . . 0.0 108.209 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.502 1.986 0 CA-C-O 122.411 0.921 . . . . 0.0 112.679 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.1 t -100.68 -25.15 14.24 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 113.391 -1.731 . . . . 0.0 106.406 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.9 t -155.88 133.82 11.28 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.507 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 3.0 p90 -124.09 19.59 9.13 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 122.896 1.331 . . . . 0.0 108.579 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.69 129.85 40.23 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.406 ' O ' ' NH1' ' A' ' 41' ' ' ARG . . . 36.36 50.6 1.31 Allowed Glycine 0 N--CA 1.501 2.972 0 O-C-N 125.415 1.697 . . . . 0.0 109.595 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.614 ' HD1' ' HH ' ' A' ' 29' ' ' TYR . 48.4 t80 -92.45 -14.9 27.84 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.5 m -122.67 162.72 21.43 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.622 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -117.29 -37.31 3.55 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.524 ' ND2' ' HD3' ' A' ' 45' ' ' ARG . 18.0 m-80 -146.69 -67.63 0.27 Allowed 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 119.765 3.246 . . . . 0.0 119.765 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.75 -24.99 76.48 Favored Glycine 0 N--CA 1.506 3.325 0 N-CA-C 106.474 -2.651 . . . . 0.0 106.474 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.501 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 0.97 59.88 0.0 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 120.56 2.984 . . . . 0.0 120.56 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.304 -1.386 0 N-CA-C 101.22 -3.622 . . . . 0.0 101.22 179.319 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.536 ' HE3' HD13 ' A' ' 23' ' ' ILE . 14.6 ptt? . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -63.0 122.89 17.15 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 102.535 -3.135 . . . . 0.0 102.535 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.643 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -101.1 25.69 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 124.098 0.874 . . . . 0.0 109.96 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.494 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 1.1 tm-20 -34.15 -42.94 0.14 Allowed 'General case' 0 N--CA 1.509 2.518 0 CA-C-O 123.21 1.481 . . . . 0.0 109.516 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -29.93 -49.9 0.11 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 109.56 -3.473 . . . . 0.0 111.86 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.05 -28.45 6.99 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 111.383 -2.644 . . . . 0.0 112.122 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -149.89 -79.42 0.13 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 29' ' ' TYR . 3.5 p -156.05 -131.94 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.23 -1.804 . . . . 0.0 110.31 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.614 ' HH ' ' HD1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -101.64 135.68 42.76 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 123.012 1.387 . . . . 0.0 109.697 179.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.545 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -148.37 -176.59 5.36 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 112.23 -2.259 . . . . 0.0 111.951 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.501 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -125.63 154.34 42.45 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.446 ' CA ' ' HE2' ' A' ' 21' ' ' MET . 6.2 t-20 -109.64 98.24 7.64 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 37' ' ' TYR . 55.8 m -93.07 150.33 20.6 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.751 HG12 ' CD2' ' A' ' 37' ' ' TYR . 9.9 p -59.51 169.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 111.758 -2.474 . . . . 0.0 117.143 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.447 ' H ' HG22 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -58.42 -21.07 17.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 111.497 -2.592 . . . . 0.0 107.146 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -94.56 -8.84 59.36 Favored Glycine 0 N--CA 1.482 1.733 0 CA-C-N 114.218 -1.355 . . . . 0.0 113.161 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.751 ' CD2' HG12 ' A' ' 34' ' ' VAL . 1.4 m-85 -141.19 126.25 18.34 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 116.496 -1.716 . . . . 0.0 107.799 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.612 ' H ' HG23 ' A' ' 44' ' ' THR . 8.5 t -124.14 -144.43 0.33 Allowed 'General case' 0 N--CA 1.518 2.966 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 41' ' ' ARG . . . 35.97 69.81 0.23 Allowed Glycine 0 N--CA 1.501 2.999 0 C-N-CA 124.441 1.019 . . . . 0.0 114.237 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 29.92 8.91 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 119.547 3.165 . . . . 0.0 119.547 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -132.19 -25.16 2.02 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.794 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.447 ' HB3' ' CB ' ' A' ' 37' ' ' TYR . 1.8 m 76.8 40.53 0.2 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.873 ' NE2' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -88.74 -20.7 24.45 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 112.749 -2.023 . . . . 0.0 109.437 -179.464 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.873 HG22 ' NE2' ' A' ' 43' ' ' GLN . 0.6 OUTLIER -113.0 92.87 4.16 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 102.21 -3.255 . . . . 0.0 102.21 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.524 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 6.7 mtm180 -84.93 85.84 7.43 Favored 'General case' 0 C--N 1.299 -1.597 1 N-CA-C 99.238 -4.356 . . . . 0.0 99.238 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 36' ' ' GLY . 13.9 t0 -60.67 -12.97 11.9 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 112.531 -2.122 . . . . 0.0 109.264 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.878 0 C-N-CA 128.156 2.582 . . . . 0.0 117.751 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo . . . . . 0 N--CA 1.492 1.403 0 CA-C-O 122.591 0.996 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 t -100.57 -29.0 12.58 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 113.682 -1.599 . . . . 0.0 106.824 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -166.46 152.75 8.8 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.508 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -129.55 14.58 6.01 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 124.659 1.224 . . . . 0.0 110.411 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -63.35 137.83 58.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.36 37.99 1.29 Allowed Glycine 0 N--CA 1.511 3.672 0 O-C-N 124.258 0.974 . . . . 0.0 111.133 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.576 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 30.5 t80 -90.4 -8.35 50.86 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 113.597 -1.301 . . . . 0.0 112.815 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.7 m -137.07 152.45 50.05 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.64 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.3 OUTLIER -94.13 -72.75 0.6 Allowed 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.41 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.454 ' C ' ' H ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -121.81 -56.66 1.85 Allowed 'General case' 0 N--CA 1.512 2.674 0 N-CA-C 115.667 1.728 . . . . 0.0 115.667 -179.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.81 44.29 3.31 Favored Glycine 0 N--CA 1.503 3.115 0 N-CA-C 105.913 -2.875 . . . . 0.0 105.913 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.533 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -68.82 67.39 0.45 Allowed Glycine 0 C--N 1.29 -2.019 0 CA-C-N 112.479 -1.861 . . . . 0.0 116.084 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.2 t . . . . . 0 C--N 1.302 -1.471 0 N-CA-C 103.52 -2.77 . . . . 0.0 103.52 179.673 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.0 ptm . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.485 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -111.7 126.5 55.1 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.194 -1.402 . . . . 0.0 107.696 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.638 ' O ' HG23 ' A' ' 23' ' ' ILE . 1.0 OUTLIER -106.78 23.11 3.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 124.189 0.931 . . . . 0.0 111.308 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.485 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.4 OUTLIER -38.1 -37.31 0.26 Allowed 'General case' 0 N--CA 1.515 2.816 0 CA-C-O 123.421 1.582 . . . . 0.0 110.157 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -33.26 -43.27 0.11 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 110.227 -3.17 . . . . 0.0 111.914 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.35 -34.66 3.77 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 111.335 -2.666 . . . . 0.0 111.3 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -147.28 -82.47 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 23' ' ' ILE . 26.7 p -154.52 -125.59 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.831 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.517 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -98.76 139.44 34.45 Favored 'General case' 0 N--CA 1.51 2.547 0 CA-C-O 122.394 1.092 . . . . 0.0 110.199 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.517 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -148.56 178.96 8.17 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 112.843 -1.98 . . . . 0.0 111.438 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.533 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -115.12 154.6 28.63 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 103.09 -2.93 . . . . 0.0 103.09 179.269 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.88 86.59 2.31 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.664 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 34.8 m -59.38 151.91 22.56 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.913 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.608 HG13 ' H ' ' A' ' 37' ' ' TYR . 7.5 p -59.36 157.12 2.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 111.589 -2.55 . . . . 0.0 112.158 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tt -43.16 -25.61 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 112.344 -2.207 . . . . 0.0 110.063 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 34' ' ' VAL . . . -98.33 -24.1 11.78 Favored Glycine 0 N--CA 1.485 1.931 0 CA-C-N 114.6 -1.182 . . . . 0.0 115.256 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.608 ' H ' HG13 ' A' ' 34' ' ' VAL . 1.3 m-30 -111.57 133.05 54.1 Favored 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 102.862 -3.014 . . . . 0.0 102.862 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.6 t -139.2 -137.04 0.13 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 118.403 -1.319 . . . . 0.0 111.175 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 75.74 -10.5 13.06 Favored Glycine 0 N--CA 1.48 1.621 0 CA-C-O 117.905 -1.497 . . . . 0.0 109.513 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 21.6 t70 102.06 -15.66 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.048 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.651 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -134.43 6.9 3.56 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.216 -179.285 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.664 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 59.48 32.51 21.76 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.261 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.651 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -88.13 5.55 40.76 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.256 -179.426 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.452 ' O ' ' C ' ' A' ' 45' ' ' ARG . 12.1 t -130.08 22.33 5.3 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.518 -1.674 . . . . 0.0 113.632 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.452 ' C ' ' O ' ' A' ' 44' ' ' THR . 1.0 OUTLIER -16.56 90.32 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 O-C-N 125.36 1.662 . . . . 0.0 112.252 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 36' ' ' GLY . 23.3 t70 -74.79 2.62 9.69 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 117.844 -1.542 . . . . 0.0 111.002 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.907 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 29' ' ' TYR . 8.4 Cg_endo . . . . . 0 N--CA 1.495 1.589 0 CA-C-O 119.878 -0.134 . . . . 0.0 111.882 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -19.86 -53.7 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 126.542 2.401 . . . . 0.0 115.172 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.55 125.38 22.54 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.392 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.459 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 1.4 p90 -110.51 4.42 20.41 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.851 1.31 . . . . 0.0 110.747 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.65 129.2 38.16 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 113.607 -1.633 . . . . 0.0 106.974 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 34.46 46.17 0.53 Allowed Glycine 0 N--CA 1.511 3.637 0 O-C-N 124.423 1.077 . . . . 0.0 111.414 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.402 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 26.7 t80 -91.44 -20.26 21.96 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 125.935 1.609 . . . . 0.0 112.611 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.8 m -116.92 153.82 31.91 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.884 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.3 OUTLIER -100.58 -36.53 9.13 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -144.67 -82.05 0.16 Allowed 'General case' 0 N--CA 1.51 2.572 1 N-CA-C 121.876 4.028 . . . . 0.0 121.876 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.25 -31.9 59.78 Favored Glycine 0 N--CA 1.515 3.924 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.474 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 7.8 69.47 0.01 OUTLIER Glycine 0 N--CA 1.486 1.969 0 CA-C-N 109.67 -3.265 . . . . 0.0 120.847 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.301 -1.518 1 N-CA-C 98.67 -4.567 . . . . 0.0 98.67 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 13.5 ptt? . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 122.974 1.369 . . . . 0.0 108.497 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -64.59 119.58 10.76 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.638 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -101.18 20.93 2.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 123.513 0.508 . . . . 0.0 109.684 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -26.26 -50.51 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 123.097 1.427 . . . . 0.0 109.603 -179.457 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -25.9 -49.06 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 108.829 -3.805 . . . . 0.0 113.333 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.91 -33.82 5.95 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 111.476 -2.602 . . . . 0.0 110.405 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -146.84 -80.24 0.15 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.5 p -156.8 -132.13 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.762 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -99.02 137.94 36.82 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.564 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.267 0.6 OUTLIER -148.26 -174.73 4.66 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 112.863 -1.971 . . . . 0.0 109.419 -179.615 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.474 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -124.7 157.47 35.56 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -109.33 116.4 31.78 Favored 'General case' 0 C--N 1.298 -1.649 1 N-CA-C 96.069 -5.53 . . . . 0.0 96.069 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 66.0 m -94.62 -124.71 0.11 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 118.601 -0.714 . . . . 0.0 111.023 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.54 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 5.7 p -139.64 160.28 27.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 117.787 -1.565 . . . . 0.0 109.095 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -47.51 -24.0 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 111.895 -2.411 . . . . 0.0 108.1 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -97.37 -20.25 23.25 Favored Glycine 0 C--O 1.203 -1.833 0 CA-C-O 117.716 -1.602 . . . . 0.0 114.814 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.55 ' CD1' ' HA ' ' A' ' 45' ' ' ARG . 2.1 m-30 -123.74 125.84 45.45 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 120.764 2.282 . . . . 0.0 106.805 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.527 ' H ' HG23 ' A' ' 44' ' ' THR . 47.8 t -138.17 -131.34 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.487 -1.285 . . . . 0.0 111.334 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 68.89 -6.54 3.68 Favored Glycine 0 N--CA 1.487 2.042 0 CA-C-O 117.988 -1.451 . . . . 0.0 111.513 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 11.8 t70 102.14 -12.7 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.036 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.578 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.2 OUTLIER -133.8 4.01 3.55 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.54 -178.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 62.72 32.07 16.29 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.884 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.18 -19.91 24.87 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 112.743 -2.026 . . . . 0.0 107.099 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.527 HG23 ' H ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -106.94 82.15 1.65 Allowed 'General case' 0 N--CA 1.488 1.461 1 N-CA-C 100.144 -4.021 . . . . 0.0 100.144 179.543 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.55 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 12.8 mtm180 -76.47 89.3 3.24 Favored 'General case' 0 C--N 1.296 -1.757 1 N-CA-C 99.129 -4.396 . . . . 0.0 99.129 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 36' ' ' GLY . 25.1 t70 -62.81 -25.6 68.33 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 117.344 -1.742 . . . . 0.0 108.832 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 46' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.502 2.129 0 C-N-CA 128.042 2.537 . . . . 0.0 108.436 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.449 ' HA ' ' HB3' ' A' ' 29' ' ' TYR . 5.5 Cg_exo . . . . . 0 N--CA 1.503 2.04 0 N-CA-C 108.147 -1.52 . . . . 0.0 108.147 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -19.93 -51.42 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 110.066 -3.243 . . . . 0.0 118.251 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.2 p -126.44 108.88 11.6 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.286 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.535 ' HA ' ' HB2' ' A' ' 13' ' ' TYR . 18.4 p90 -115.08 0.9 13.77 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -85.26 89.45 7.66 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.987 1.375 . . . . 0.0 110.173 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.35 28.81 4.47 Favored Glycine 0 N--CA 1.501 2.97 0 N-CA-C 106.958 -2.457 . . . . 0.0 106.958 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.535 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 20.6 t80 -90.57 -11.07 41.13 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.579 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 60.5 m -126.8 151.21 48.58 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.943 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.3 OUTLIER -104.38 -38.31 6.88 Favored 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.435 ' HB2' ' CD2' ' A' ' 37' ' ' TYR . 38.3 m-80 -147.07 -66.66 0.27 Allowed 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 120.621 3.563 . . . . 0.0 120.621 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.97 19.59 52.55 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.636 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -65.56 96.02 0.24 Allowed Glycine 0 C--N 1.295 -1.726 0 CA-C-O 124.39 2.106 . . . . 0.0 115.826 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.287 -2.126 0 N-CA-C 101.08 -3.674 . . . . 0.0 101.08 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.52 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 4.3 ptm . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 101.9 -3.37 . . . . 0.0 101.9 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -103.99 127.94 51.54 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -105.79 21.07 3.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 123.918 0.761 . . . . 0.0 109.718 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -29.58 -49.29 0.09 Allowed 'General case' 0 N--CA 1.509 2.478 0 CA-C-O 123.528 1.632 . . . . 0.0 109.645 -179.303 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -26.88 -48.48 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.676 1 CA-C-N 108.362 -4.017 . . . . 0.0 113.34 179.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.85 -34.12 5.87 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 111.036 -2.802 . . . . 0.0 110.673 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -147.74 -79.87 0.15 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 29' ' ' TYR . 1.7 p -156.67 -134.48 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.806 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.57 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -97.55 138.56 34.78 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.57 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.273 0.5 OUTLIER -149.3 -179.17 6.85 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 112.875 -1.966 . . . . 0.0 111.757 -179.197 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.636 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -116.1 151.91 34.65 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.52 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 43.8 t30 -104.13 76.81 1.37 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.543 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 33.5 m -64.1 152.39 40.59 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.678 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.671 HG12 ' CD2' ' A' ' 37' ' ' TYR . 7.4 p -59.67 160.99 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 111.811 -2.449 . . . . 0.0 114.441 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.421 ' H ' HG22 ' A' ' 35' ' ' ILE . 1.6 tt -51.72 -21.6 2.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 111.51 -2.587 . . . . 0.0 108.784 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -95.34 -14.38 48.21 Favored Glycine 0 N--CA 1.491 2.366 0 CA-C-N 114.201 -1.363 . . . . 0.0 115.297 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.671 ' CD2' HG12 ' A' ' 34' ' ' VAL . 2.1 m-85 -131.89 127.41 36.4 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.443 ' C ' HG22 ' A' ' 44' ' ' THR . 47.3 t -136.81 -135.46 0.14 Allowed 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 118.304 -1.358 . . . . 0.0 108.744 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 69.52 0.94 26.83 Favored Glycine 0 N--CA 1.48 1.603 0 CA-C-O 116.707 -2.163 . . . . 0.0 111.701 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 5.1 t70 94.65 -11.7 0.11 Allowed 'General case' 0 N--CA 1.52 3.068 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.541 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -138.02 -2.65 1.86 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.543 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 67.85 31.47 5.75 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -179.462 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.943 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -89.04 -19.55 25.5 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 111.878 -2.419 . . . . 0.0 108.652 -179.755 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 44' ' ' THR 0.266 2.3 t -115.14 89.89 3.21 Favored 'General case' 0 C--N 1.296 -1.723 1 N-CA-C 98.541 -4.615 . . . . 0.0 98.541 179.863 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 16.5 mtm180 -87.61 93.25 9.37 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 101.77 -3.419 . . . . 0.0 101.77 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 36' ' ' GLY . 31.7 t70 -64.73 -20.31 66.27 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.0 -1.455 . . . . 0.0 108.114 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 N--CA 1.493 1.683 0 C-N-CA 126.414 1.886 . . . . 0.0 107.572 179.634 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 N--CA 1.488 1.176 0 CA-C-O 123.168 1.237 . . . . 0.0 108.943 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.6 t -100.99 -26.05 13.86 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.206 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.3 t -173.27 151.96 2.14 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.57 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -129.84 12.6 5.77 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 124.41 1.068 . . . . 0.0 110.744 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -62.27 136.33 57.88 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 37.95 41.54 0.97 Allowed Glycine 0 N--CA 1.512 3.741 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 29' ' ' TYR . 37.3 t80 -91.71 -13.77 31.12 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 125.591 1.406 . . . . 0.0 113.231 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.483 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 33.7 m -121.79 155.08 36.08 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.857 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -108.2 -37.91 5.9 Favored 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.561 HD21 ' CZ ' ' A' ' 45' ' ' ARG . 25.7 m-80 -143.12 -80.57 0.2 Allowed 'General case' 0 N--CA 1.514 2.752 0 N-CA-C 119.471 3.137 . . . . 0.0 119.471 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.05 -24.6 63.19 Favored Glycine 0 N--CA 1.51 3.61 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.626 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 4.55 63.92 0.0 OUTLIER Glycine 0 N--CA 1.481 1.662 0 N-CA-C 120.823 3.089 . . . . 0.0 120.823 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 19' ' ' VAL . 1.8 t . . . . . 0 C--N 1.307 -1.254 0 N-CA-C 102.4 -3.185 . . . . 0.0 102.4 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.487 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 9.6 ptm . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.439 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -109.34 129.0 55.54 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.58 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -106.09 13.94 7.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 124.039 0.837 . . . . 0.0 111.87 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -22.78 -54.88 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 124.815 1.322 . . . . 0.0 112.008 -179.41 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.6 m -26.52 -45.18 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 110.921 -2.854 . . . . 0.0 114.3 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.53 -36.98 5.61 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 111.361 -2.654 . . . . 0.0 109.939 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -147.96 -81.77 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.2 p -156.87 -133.25 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.436 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.57 ' CE2' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -96.25 139.48 32.33 Favored 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.474 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -147.92 178.72 8.28 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 113.073 -1.876 . . . . 0.0 109.95 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.626 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -118.15 146.64 44.03 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.487 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 56.9 t30 -99.55 104.61 16.42 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 101.558 -3.497 . . . . 0.0 101.558 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 61.6 m -84.13 177.38 8.25 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.988 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.644 HG12 ' CD2' ' A' ' 37' ' ' TYR . 14.5 p -80.3 159.54 4.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 123.003 1.383 . . . . 0.0 112.712 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -46.84 -22.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-N 111.618 -2.537 . . . . 0.0 108.99 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -97.2 -15.88 37.01 Favored Glycine 0 C--O 1.203 -1.783 0 CA-C-N 113.615 -1.63 . . . . 0.0 116.534 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.644 ' CD2' HG12 ' A' ' 34' ' ' VAL . 4.4 m-30 -123.52 121.41 35.59 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 103.535 -2.765 . . . . 0.0 103.535 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.444 ' C ' HG22 ' A' ' 44' ' ' THR . 15.2 t -130.1 -142.54 0.24 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.385 1.088 . . . . 0.0 113.306 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 40' ' ' ASP . . . 86.33 -47.84 3.82 Favored Glycine 0 C--N 1.301 -1.406 0 N-CA-C 106.514 -2.634 . . . . 0.0 106.514 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER 139.31 -6.68 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.983 0 O-C-N 126.807 2.122 . . . . 0.0 112.291 -179.569 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.695 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -134.58 -1.9 2.76 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.14 -178.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.54 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 69.64 35.36 2.45 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 104.991 -2.225 . . . . 0.0 104.991 -179.28 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.857 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.06 -13.74 37.98 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 112.599 -2.091 . . . . 0.0 108.846 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.512 ' O ' HG23 ' A' ' 44' ' ' THR . 5.0 t -122.54 92.62 3.75 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 103.07 -2.937 . . . . 0.0 103.07 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.561 ' CZ ' HD21 ' A' ' 16' ' ' ASN . 0.1 OUTLIER -83.94 97.18 9.1 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' GLY . 30.2 t70 -66.11 -29.58 69.92 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 116.633 -2.027 . . . . 0.0 108.474 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 mt . . . . . 0 N--CA 1.502 2.14 0 C-N-CA 127.523 2.329 . . . . 0.0 106.82 179.643 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.438 ' HA ' ' HB3' ' A' ' 29' ' ' TYR . 1.1 Cg_endo . . . . . 0 N--CA 1.496 1.674 0 N-CA-C 108.179 -1.508 . . . . 0.0 108.179 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.2 m -21.27 -41.58 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 111.597 -2.547 . . . . 0.0 117.614 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.2 m -145.06 119.93 9.94 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.428 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 4.0 p90 -114.48 15.48 17.84 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 122.379 1.085 . . . . 0.0 111.058 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.51 133.25 36.49 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.41 32.86 31.23 Favored Glycine 0 N--CA 1.506 3.347 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.481 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 23.9 t80 -90.37 -13.2 35.54 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 113.935 -1.133 . . . . 0.0 112.951 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.405 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 16.0 m -128.95 143.61 50.93 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.941 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.5 OUTLIER -97.62 -33.02 11.49 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 123.58 0.55 . . . . 0.0 112.41 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -149.08 -85.96 0.09 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 120.515 3.524 . . . . 0.0 120.515 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 33' ' ' CYS . . . -48.7 -32.69 11.29 Favored Glycine 0 N--CA 1.513 3.785 0 CA-C-O 123.136 1.409 . . . . 0.0 109.684 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.5 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 8.11 64.84 0.01 OUTLIER Glycine 0 N--CA 1.48 1.599 0 CA-C-N 109.521 -3.339 . . . . 0.0 121.198 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 19' ' ' VAL . 1.3 t . . . . . 0 C--N 1.3 -1.578 1 N-CA-C 99.885 -4.117 . . . . 0.0 99.885 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.3 ptp . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -101.79 123.74 46.26 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.628 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -102.54 22.78 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 124.757 1.286 . . . . 0.0 111.489 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -36.3 -37.55 0.12 Allowed 'General case' 0 N--CA 1.516 2.852 0 CA-C-O 123.79 1.757 . . . . 0.0 110.353 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.7 OUTLIER -34.91 -45.95 0.29 Allowed 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 110.077 -3.238 . . . . 0.0 111.44 179.172 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.59 -33.83 5.08 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 111.517 -2.583 . . . . 0.0 110.481 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.67 -79.97 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.0 OUTLIER -156.65 -135.47 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 118.38 -1.328 . . . . 0.0 109.855 -179.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -94.78 140.44 29.91 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.575 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -151.21 -174.5 4.83 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 113.097 -1.865 . . . . 0.0 110.712 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.5 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -125.42 153.45 43.43 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -105.9 118.47 36.68 Favored 'General case' 0 C--N 1.3 -1.548 1 N-CA-C 98.29 -4.707 . . . . 0.0 98.29 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.511 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 76.3 m -98.8 166.45 11.3 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.634 HG13 ' H ' ' A' ' 37' ' ' TYR . 3.4 p -65.24 157.43 5.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 C-N-CA 118.141 -1.424 . . . . 0.0 111.064 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -41.78 -24.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 111.864 -2.426 . . . . 0.0 111.934 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.413 ' H ' HG22 ' A' ' 34' ' ' VAL . . . -100.53 -27.39 7.63 Favored Glycine 0 N--CA 1.484 1.838 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.82 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.634 ' H ' HG13 ' A' ' 34' ' ' VAL . 4.2 m-30 -98.91 120.58 39.6 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 104.019 -2.585 . . . . 0.0 104.019 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.4 t -130.91 -135.54 0.2 Allowed 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 118.175 -1.41 . . . . 0.0 112.398 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.508 ' C ' ' NE2' ' A' ' 43' ' ' GLN . . . 69.99 -8.58 3.48 Favored Glycine 0 N--CA 1.483 1.802 0 CA-C-O 117.4 -1.778 . . . . 0.0 110.622 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 16.7 t70 100.11 -2.83 0.03 OUTLIER 'General case' 0 N--CA 1.523 3.209 0 C-N-CA 124.004 0.922 . . . . 0.0 113.184 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.567 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -140.66 1.41 1.72 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -178.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 64.39 33.91 10.86 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 -179.383 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.941 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -88.47 -23.86 23.14 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 111.993 -2.367 . . . . 0.0 110.737 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.494 ' O ' HG23 ' A' ' 44' ' ' THR . 5.9 t -112.23 86.6 2.38 Favored 'General case' 0 C--N 1.294 -1.806 1 N-CA-C 98.201 -4.741 . . . . 0.0 98.201 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 14.9 mtm180 -77.04 87.2 3.54 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 110.849 -2.887 . . . . 0.0 104.647 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 36' ' ' GLY . 5.9 t70 -83.7 67.05 9.33 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 mp . . . . . 0 N--CA 1.506 2.363 1 N-CA-C 122.885 4.402 . . . . 0.0 122.885 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.473 ' HA ' ' HB3' ' A' ' 29' ' ' TYR . 6.8 Cg_endo . . . . . 0 N--CA 1.502 2.026 0 N-CA-C 108.325 -1.452 . . . . 0.0 108.325 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m -20.15 -50.52 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 109.944 -3.298 . . . . 0.0 116.413 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.19 127.82 17.11 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.543 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 1.0 OUTLIER -117.14 8.97 13.42 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 124.02 0.825 . . . . 0.0 112.074 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -69.38 138.25 53.48 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 41.25 37.53 1.64 Allowed Glycine 0 N--CA 1.507 3.402 0 O-C-N 124.43 1.081 . . . . 0.0 110.775 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.426 ' CD1' ' CZ ' ' A' ' 29' ' ' TYR . 30.9 t80 -91.25 -17.22 26.35 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 114.063 -1.068 . . . . 0.0 113.813 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.455 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 41.5 m -116.85 154.68 30.34 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.983 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -107.71 -37.97 6.0 Favored 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 115.086 1.514 . . . . 0.0 115.086 -179.65 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.553 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 3.8 m-80 -139.19 -83.21 0.27 Allowed 'General case' 0 N--CA 1.509 2.513 0 N-CA-C 120.133 3.383 . . . . 0.0 120.133 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.75 -24.22 64.14 Favored Glycine 0 N--CA 1.511 3.669 0 N-CA-C 108.849 -1.701 . . . . 0.0 108.849 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.577 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 5.38 65.39 0.01 OUTLIER Glycine 0 N--CA 1.478 1.495 0 N-CA-C 120.449 2.94 . . . . 0.0 120.449 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.306 -1.308 0 N-CA-C 100.734 -3.802 . . . . 0.0 100.734 179.28 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.56 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 7.2 ptm . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 123.073 1.416 . . . . 0.0 109.089 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -63.31 120.44 11.58 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 179.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.647 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -102.78 23.69 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 123.714 0.634 . . . . 0.0 110.367 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.5 OUTLIER -33.5 -42.06 0.1 Allowed 'General case' 0 N--CA 1.511 2.607 0 CA-C-O 123.722 1.725 . . . . 0.0 109.696 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -30.89 -46.54 0.08 Allowed 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 109.632 -3.44 . . . . 0.0 111.992 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.49 -35.51 4.56 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 111.572 -2.558 . . . . 0.0 109.779 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -146.71 -82.82 0.13 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 117.419 2.377 . . . . 0.0 117.419 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.3 p -153.11 -131.39 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.594 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -100.3 135.84 41.11 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.531 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.25 0.6 OUTLIER -146.5 -179.05 6.5 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.103 -2.317 . . . . 0.0 109.119 -179.42 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.577 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -121.16 153.67 37.22 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.56 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 60.5 t30 -106.72 104.28 13.92 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 101.77 -3.419 . . . . 0.0 101.77 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 57.5 m -88.71 156.72 18.83 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.19 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.65 HG12 ' CD2' ' A' ' 37' ' ' TYR . 12.2 p -59.83 159.93 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 113.019 -1.9 . . . . 0.0 114.319 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -48.56 -22.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 110.884 -2.871 . . . . 0.0 109.126 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -98.39 -11.84 46.91 Favored Glycine 0 N--CA 1.485 1.933 0 CA-C-O 117.832 -1.538 . . . . 0.0 116.588 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.65 ' CD2' HG12 ' A' ' 34' ' ' VAL . 3.1 m-30 -126.8 121.7 32.66 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.451 ' C ' HG22 ' A' ' 44' ' ' THR . 48.2 t -132.32 -134.59 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.725 -1.19 . . . . 0.0 110.868 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 74.61 -13.12 5.31 Favored Glycine 0 N--CA 1.485 1.953 0 CA-C-O 117.894 -1.504 . . . . 0.0 110.166 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 27.9 t70 104.62 -7.57 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.884 0 C-N-CA 124.419 1.087 . . . . 0.0 113.672 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.612 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -137.28 -2.26 2.05 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.498 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 70.27 31.2 3.19 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 -179.248 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.983 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -88.38 -11.96 44.68 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 113.699 -1.592 . . . . 0.0 109.82 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 44' ' ' THR 0.253 5.3 t -121.54 85.95 2.49 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 101.545 -3.502 . . . . 0.0 101.545 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.45 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 1.2 mtm180 -78.35 88.68 4.37 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 36' ' ' GLY . 24.1 t70 -61.01 -20.61 62.7 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.247 -1.797 . . . . 0.0 108.544 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.499 1.976 0 O-C-N 124.905 1.378 . . . . 0.0 112.379 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo . . . . . 0 N--CA 1.496 1.625 0 CA-C-O 122.449 0.937 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.21 -21.62 17.19 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 113.381 -1.736 . . . . 0.0 109.071 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.0 t -150.09 121.21 7.75 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -121.38 29.03 7.45 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 123.291 1.519 . . . . 0.0 107.795 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -101.01 134.37 44.1 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.15 23.9 60.26 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -91.94 -26.12 18.57 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.786 -1.207 . . . . 0.0 113.252 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.589 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 33.8 m -124.23 150.34 45.4 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -111.07 -37.85 5.23 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -179.24 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.539 ' ND2' ' HD2' ' A' ' 45' ' ' ARG . 34.3 m-80 -149.82 -59.91 0.2 Allowed 'General case' 0 N--CA 1.509 2.508 0 N-CA-C 118.57 2.804 . . . . 0.0 118.57 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -107.2 18.71 35.79 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 106.875 -2.49 . . . . 0.0 106.875 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.615 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -72.46 94.73 0.66 Allowed Glycine 0 C--N 1.296 -1.661 0 CA-C-O 123.926 1.848 . . . . 0.0 113.631 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.294 -1.848 0 N-CA-C 102.779 -3.045 . . . . 0.0 102.779 179.412 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.474 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 21.8 ptt? . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 123.401 1.572 . . . . 0.0 108.863 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.8 OUTLIER -73.61 119.14 17.43 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.103 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.643 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -104.11 23.77 2.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 124.279 0.987 . . . . 0.0 111.025 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -38.84 -37.18 0.32 Allowed 'General case' 0 N--CA 1.514 2.755 0 CA-C-O 123.707 1.718 . . . . 0.0 109.262 -179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.402 ' N ' ' C ' ' A' ' 23' ' ' ILE . 1.3 m -32.78 -43.42 0.09 Allowed 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 110.035 -3.257 . . . . 0.0 111.902 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.454 HD11 HG12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -119.3 -36.58 3.34 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 111.358 -2.656 . . . . 0.0 110.949 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -144.49 -84.6 0.14 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 23' ' ' ILE . 11.2 p -149.8 -131.56 0.05 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.495 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -98.54 143.74 28.62 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 179.544 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.534 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.258 0.6 OUTLIER -151.13 175.01 12.55 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 125.776 1.923 . . . . 0.0 111.03 -179.374 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.615 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -118.95 136.61 54.0 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.474 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 50.5 t30 -93.16 77.23 4.6 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.108 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.434 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 65.9 m -61.26 146.67 47.07 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.516 1.15 . . . . 0.0 110.681 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.621 HG12 ' CD2' ' A' ' 37' ' ' TYR . 10.5 p -58.97 161.98 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 112.332 -2.213 . . . . 0.0 115.403 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tt -49.83 -20.12 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 111.541 -2.572 . . . . 0.0 109.315 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.59 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -98.98 -18.35 25.02 Favored Glycine 0 C--O 1.202 -1.851 0 CA-C-O 117.48 -1.733 . . . . 0.0 114.34 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.621 ' CD2' HG12 ' A' ' 34' ' ' VAL . 1.9 m-30 -123.31 129.81 51.86 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 120.27 2.035 . . . . 0.0 107.269 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.634 ' H ' HG23 ' A' ' 44' ' ' THR . 0.3 OUTLIER -125.29 -159.46 0.89 Allowed 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -179.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 88.59 -47.82 3.48 Favored Glycine 0 N--CA 1.494 2.529 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.288 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 27.7 t70 124.28 -0.42 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.038 0 O-C-N 126.719 2.07 . . . . 0.0 109.198 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -117.95 -28.67 5.85 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.434 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 3.0 m 82.7 37.86 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.931 ' NE2' HG22 ' A' ' 44' ' ' THR . 2.6 pp0? -88.96 -21.43 23.55 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 110.665 -2.971 . . . . 0.0 107.425 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.931 HG22 ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -110.01 83.34 1.74 Allowed 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 101.835 -3.394 . . . . 0.0 101.835 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.539 ' HD2' ' ND2' ' A' ' 16' ' ' ASN . 1.1 mtm180 -78.77 89.19 4.62 Favored 'General case' 0 C--N 1.299 -1.622 1 N-CA-C 98.906 -4.479 . . . . 0.0 98.906 179.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.59 ' N ' ' O ' ' A' ' 36' ' ' GLY . 29.2 t0 -58.51 -23.0 57.03 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 111.849 -2.432 . . . . 0.0 107.192 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 N--CA 1.497 1.908 0 CA-C-N 112.668 -2.06 . . . . 0.0 115.077 179.541 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo . . . . . 0 N--CA 1.498 1.77 0 CA-C-O 122.349 0.895 . . . . 0.0 111.478 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 t -100.99 -19.3 15.91 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.249 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.9 m -154.95 128.96 8.8 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.516 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 2.7 p90 -124.83 8.91 8.18 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -69.24 142.73 54.12 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 39.71 39.46 1.31 Allowed Glycine 0 N--CA 1.507 3.405 0 O-C-N 124.518 1.136 . . . . 0.0 110.87 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.477 ' HD1' ' HH ' ' A' ' 29' ' ' TYR . 38.6 t80 -91.34 -15.81 28.46 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 125.383 1.284 . . . . 0.0 113.414 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.484 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 58.2 m -119.72 157.19 29.06 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.902 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -110.72 -38.38 5.17 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.457 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 11.8 m-80 -140.58 -77.84 0.3 Allowed 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 121.486 3.884 . . . . 0.0 121.486 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.54 -17.76 73.05 Favored Glycine 0 N--CA 1.507 3.377 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.627 ' HA2' ' SG ' ' A' ' 31' ' ' CYS . . . 2.71 62.92 0.0 OUTLIER Glycine 0 C--N 1.302 -1.352 0 N-CA-C 120.091 2.796 . . . . 0.0 120.091 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 19' ' ' VAL . 1.6 t . . . . . 0 C--N 1.31 -1.125 0 N-CA-C 101.762 -3.421 . . . . 0.0 101.762 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.7 ptm . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 102.525 -3.139 . . . . 0.0 102.525 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -102.4 129.51 48.9 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.615 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -105.19 19.47 4.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 124.053 0.846 . . . . 0.0 112.309 -179.556 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -29.11 -49.87 0.08 Allowed 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 122.811 1.291 . . . . 0.0 112.008 -179.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.4 m -31.44 -43.64 0.06 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 110.99 -2.823 . . . . 0.0 114.151 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.59 -32.68 6.1 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 112.063 -2.335 . . . . 0.0 111.094 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -149.61 -80.14 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.5 p -158.33 -133.2 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.879 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -97.04 139.36 33.16 Favored 'General case' 0 N--CA 1.51 2.554 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.538 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 1.2 t -147.34 -171.34 3.77 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.305 -1.771 . . . . 0.0 112.914 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.627 ' SG ' ' HA2' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -125.46 151.28 46.47 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 179.275 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -107.82 103.17 12.37 Favored 'General case' 0 C--N 1.3 -1.577 1 N-CA-C 99.53 -4.248 . . . . 0.0 99.53 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 83.4 m -87.69 170.74 10.99 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.415 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.596 HG12 ' CD2' ' A' ' 37' ' ' TYR . 14.2 p -67.69 163.6 2.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-O 123.304 1.526 . . . . 0.0 112.582 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.463 ' H ' HG22 ' A' ' 35' ' ' ILE . 1.2 tt -53.34 -18.11 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 112.044 -2.343 . . . . 0.0 108.851 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -100.03 -22.21 12.4 Favored Glycine 0 C--O 1.199 -2.081 0 CA-C-N 113.507 -1.679 . . . . 0.0 114.16 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.596 ' CD2' HG12 ' A' ' 34' ' ' VAL . 2.8 m-30 -118.96 130.21 55.58 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 121.149 2.475 . . . . 0.0 104.676 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.404 ' C ' ' H ' ' A' ' 40' ' ' ASP . 22.9 t -142.07 -136.24 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 117.545 -1.662 . . . . 0.0 113.767 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 40' ' ' ASP . . . 86.64 -42.37 3.15 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 107.744 -2.142 . . . . 0.0 107.744 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 0.8 OUTLIER 137.68 -2.03 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.796 0 O-C-N 126.017 1.657 . . . . 0.0 110.135 -179.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.583 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -140.93 -7.06 1.08 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -178.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.49 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 73.79 35.07 0.85 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 -178.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.902 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.6 OUTLIER -88.39 -17.68 30.0 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 112.015 -2.357 . . . . 0.0 107.727 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.538 ' O ' HG23 ' A' ' 44' ' ' THR . 5.1 t -120.02 88.36 2.92 Favored 'General case' 0 C--N 1.299 -1.588 1 N-CA-C 99.745 -4.168 . . . . 0.0 99.745 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.412 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 13.7 mtm180 -83.46 96.34 8.55 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 101.841 -3.392 . . . . 0.0 101.841 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 36' ' ' GLY . 28.1 t70 -83.93 69.75 10.33 Favored 'General case' 0 C--N 1.294 -1.81 1 N-CA-C 99.926 -4.102 . . . . 0.0 99.926 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.405 HD12 ' CE1' ' A' ' 37' ' ' TYR . 3.4 mp . . . . . 0 N--CA 1.49 1.551 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.457 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 N--CA 1.496 1.631 0 CA-C-O 121.928 0.72 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.25 -23.82 20.06 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.778 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 t -153.25 126.77 8.7 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.567 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 4.1 p90 -121.38 20.01 11.29 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 122.146 0.974 . . . . 0.0 109.004 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -72.46 121.47 19.64 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.463 ' O ' ' NH2' ' A' ' 41' ' ' ARG . . . 53.13 40.99 60.16 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.433 ' OH ' ' HA ' ' A' ' 30' ' ' THR . 7.0 t80 -91.27 -16.17 28.0 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.546 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 4.7 m -122.61 161.49 23.66 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.522 HD12 ' HD2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -115.63 -37.17 4.03 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 117.885 2.55 . . . . 0.0 117.885 -179.203 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.514 ' ND2' ' HD3' ' A' ' 45' ' ' ARG . 34.1 m-80 -146.22 -69.98 0.26 Allowed 'General case' 0 N--CA 1.515 2.82 0 N-CA-C 120.341 3.46 . . . . 0.0 120.341 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.11 -25.38 59.75 Favored Glycine 0 N--CA 1.506 3.352 0 N-CA-C 107.834 -2.107 . . . . 0.0 107.834 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.546 ' HA3' ' HB3' ' A' ' 14' ' ' CYS . . . -6.8 74.78 0.0 OUTLIER Glycine 0 N--CA 1.484 1.898 0 N-CA-C 118.842 2.297 . . . . 0.0 118.842 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.302 -1.46 0 N-CA-C 100.429 -3.915 . . . . 0.0 100.429 179.617 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.42 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 4.4 ptm . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 123.193 1.473 . . . . 0.0 108.93 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -76.2 113.67 14.01 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -94.8 21.85 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.174 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.47 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.6 OUTLIER -37.63 -38.94 0.29 Allowed 'General case' 0 N--CA 1.514 2.764 0 CA-C-O 123.117 1.437 . . . . 0.0 109.267 -179.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -31.09 -43.63 0.05 Allowed 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 109.927 -3.306 . . . . 0.0 111.477 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.95 -38.18 3.11 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 111.152 -2.749 . . . . 0.0 109.998 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -145.98 -82.44 0.14 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 119.432 3.123 . . . . 0.0 119.432 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.1 p -150.95 -139.63 0.09 Allowed 'General case' 0 N--CA 1.509 2.495 0 C-N-CA 118.639 -1.224 . . . . 0.0 110.732 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -95.36 138.74 32.64 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 179.39 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.5 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.331 0.4 OUTLIER -150.47 178.79 8.71 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 112.2 -2.273 . . . . 0.0 110.332 -179.403 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.487 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -122.68 142.46 50.65 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.06 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.42 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 0.3 OUTLIER -102.84 110.75 22.79 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 100.867 -3.753 . . . . 0.0 100.867 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 76.2 m -84.27 -119.86 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.413 -1.315 . . . . 0.0 112.792 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.519 HG13 ' N ' ' A' ' 37' ' ' TYR . 9.1 p -144.07 165.05 14.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 122.646 1.212 . . . . 0.0 110.806 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -52.65 -18.83 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 CA-C-N 112.135 -2.302 . . . . 0.0 107.73 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -105.55 -15.17 19.8 Favored Glycine 0 N--CA 1.482 1.742 0 CA-C-O 117.563 -1.687 . . . . 0.0 115.716 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.519 ' N ' HG13 ' A' ' 34' ' ' VAL . 3.9 m-85 -131.87 123.96 28.57 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.587 ' H ' HG23 ' A' ' 44' ' ' THR . 7.9 t -132.73 -147.57 0.31 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 87.48 -50.08 3.99 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.412 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER 136.59 -9.53 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.025 0 O-C-N 126.923 2.19 . . . . 0.0 109.002 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.522 ' HD2' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -114.31 -26.07 8.16 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.3 -178.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 1.2 m 79.82 35.88 0.14 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.737 ' NE2' HG22 ' A' ' 44' ' ' THR . 2.9 pp0? -88.82 -24.71 22.51 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 110.702 -2.954 . . . . 0.0 105.97 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.737 HG22 ' NE2' ' A' ' 43' ' ' GLN . 1.0 OUTLIER -106.31 89.73 3.14 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 102.469 -3.16 . . . . 0.0 102.469 179.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.514 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 4.3 mtm180 -84.93 90.8 7.89 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 101.572 -3.492 . . . . 0.0 101.572 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' GLY . 29.3 t70 -59.25 -20.1 51.42 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 111.693 -2.503 . . . . 0.0 107.882 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.881 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo . . . . . 0 N--CA 1.499 1.817 0 CA-C-O 121.004 0.335 . . . . 0.0 111.506 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.22 -20.87 47.18 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.829 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 t -158.08 133.25 8.69 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.537 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 3.4 p90 -128.5 36.99 4.19 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.742 1.258 . . . . 0.0 108.05 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -100.45 130.3 46.52 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 47.3 33.75 8.09 Favored Glycine 0 N--CA 1.506 3.338 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -91.77 -20.37 21.59 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 125.315 1.244 . . . . 0.0 112.315 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.462 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 34.2 m -118.56 158.31 25.65 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 103.318 -2.845 . . . . 0.0 103.318 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.525 HD12 ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -112.25 -36.69 5.24 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.485 ' ND2' ' HD3' ' A' ' 45' ' ' ARG . 39.8 m-80 -146.77 -77.05 0.18 Allowed 'General case' 0 N--CA 1.51 2.57 0 N-CA-C 119.053 2.983 . . . . 0.0 119.053 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.16 -23.56 69.86 Favored Glycine 0 N--CA 1.507 3.425 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.476 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -3.01 67.63 0.0 OUTLIER Glycine 0 N--CA 1.488 2.126 0 N-CA-C 122.1 3.6 . . . . 0.0 122.1 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.303 -1.451 1 N-CA-C 100.172 -4.01 . . . . 0.0 100.172 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.493 ' SD ' ' ND2' ' A' ' 32' ' ' ASN . 8.3 ptm . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 123.147 1.451 . . . . 0.0 109.166 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.675 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -68.16 117.56 10.15 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.647 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -101.01 23.65 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.544 -179.532 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.486 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.7 OUTLIER -29.07 -49.25 0.08 Allowed 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 123.353 1.549 . . . . 0.0 109.034 -179.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -26.12 -49.29 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 108.656 -3.884 . . . . 0.0 113.165 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.51 -34.52 5.83 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 111.768 -2.469 . . . . 0.0 109.339 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -146.95 -81.12 0.14 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 23' ' ' ILE . 3.4 p -156.15 -132.07 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.468 -1.293 . . . . 0.0 110.129 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.675 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -98.45 137.17 37.53 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 179.67 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.541 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -148.57 -175.93 5.12 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 125.818 1.949 . . . . 0.0 110.246 -179.456 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.476 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -125.9 152.93 44.92 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.493 ' ND2' ' SD ' ' A' ' 21' ' ' MET . 4.0 t-20 -109.88 119.82 40.55 Favored 'General case' 0 C--N 1.298 -1.665 1 N-CA-C 96.346 -5.428 . . . . 0.0 96.346 179.612 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 37' ' ' TYR . 72.6 m -96.06 -111.89 0.14 Allowed 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 118.684 -1.206 . . . . 0.0 110.385 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.598 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 4.2 p -146.92 161.29 8.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 C-N-CA 118.617 -1.233 . . . . 0.0 108.139 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.419 ' H ' HG22 ' A' ' 35' ' ' ILE . 0.6 OUTLIER -46.62 -25.37 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 112.125 -2.307 . . . . 0.0 109.157 179.5 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -106.84 1.6 35.98 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 118.495 2.158 . . . . 0.0 118.495 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.598 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 5.5 m-30 -135.55 120.32 18.43 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 100.283 -3.969 . . . . 0.0 100.283 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.624 ' H ' HG23 ' A' ' 44' ' ' THR . 7.4 t -131.77 -150.41 0.42 Allowed 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.19 -40.12 3.0 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 122.59 4.23 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.563 0 C-N-CA 127.073 2.149 . . . . 0.0 107.945 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.525 ' NE ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -127.69 -21.74 3.7 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.265 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER 77.0 35.79 0.35 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 -179.462 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.818 ' NE2' HG22 ' A' ' 44' ' ' THR . 2.7 pp0? -88.61 -21.47 23.99 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 111.423 -2.626 . . . . 0.0 107.307 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.818 HG22 ' NE2' ' A' ' 43' ' ' GLN . 1.7 t -113.5 87.85 2.7 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 102.117 -3.29 . . . . 0.0 102.117 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.485 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 8.3 mtm180 -84.3 88.31 7.24 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 101.504 -3.517 . . . . 0.0 101.504 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 36' ' ' GLY . 32.4 t70 -55.32 -27.35 46.42 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.787 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 75.5 mt . . . . . 0 N--CA 1.51 2.574 0 C-N-CA 128.101 2.56 . . . . 0.0 117.263 179.268 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 N--CA 1.504 2.112 0 N-CA-C 108.542 -1.368 . . . . 0.0 108.542 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -19.82 -54.81 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 110.801 -2.909 . . . . 0.0 117.621 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.89 116.71 19.05 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.582 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 2.7 p90 -114.5 2.47 14.62 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -70.38 140.47 52.12 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.34 42.37 2.48 Favored Glycine 0 N--CA 1.505 3.3 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.412 ' CD1' ' CZ ' ' A' ' 29' ' ' TYR . 35.9 t80 -91.17 -19.12 23.42 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 125.177 1.163 . . . . 0.0 113.258 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.437 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 35.6 m -116.21 154.85 29.35 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.861 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -107.14 -35.72 6.77 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.642 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 2.1 m-80 -141.35 -83.09 0.21 Allowed 'General case' 0 N--CA 1.51 2.571 0 N-CA-C 120.84 3.644 . . . . 0.0 120.84 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.87 -26.12 66.73 Favored Glycine 0 N--CA 1.508 3.48 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.61 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 6.97 65.68 0.01 OUTLIER Glycine 0 N--CA 1.481 1.649 0 CA-C-N 110.275 -2.963 . . . . 0.0 120.127 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.305 -1.33 0 N-CA-C 102.768 -3.049 . . . . 0.0 102.768 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.57 ' HE3' HD13 ' A' ' 23' ' ' ILE . 5.5 ptt? . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 102.815 -3.031 . . . . 0.0 102.815 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.432 ' CE1' ' HG2' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -111.16 127.73 55.68 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.602 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -105.53 14.06 7.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 123.911 0.757 . . . . 0.0 110.644 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -20.12 -56.93 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.631 0 CA-C-O 123.893 1.806 . . . . 0.0 111.652 -179.028 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -26.26 -49.14 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.034 1 CA-C-N 108.259 -4.064 . . . . 0.0 113.723 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.37 -36.34 6.54 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 111.424 -2.625 . . . . 0.0 109.149 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -146.53 -81.14 0.15 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.455 ' H ' HG22 ' A' ' 23' ' ' ILE . 8.2 p -157.32 -132.7 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.951 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -97.21 140.56 31.52 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.551 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.264 0.5 OUTLIER -152.59 -177.89 6.51 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 112.753 -2.021 . . . . 0.0 109.578 -179.272 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.61 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -117.6 156.67 27.73 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -108.08 100.46 9.79 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 100.633 -3.84 . . . . 0.0 100.633 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.431 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 57.3 m -86.83 160.2 18.84 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.677 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.796 HG12 ' CD2' ' A' ' 37' ' ' TYR . 14.6 p -61.71 160.71 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-O 123.197 1.475 . . . . 0.0 111.658 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.415 HG22 ' H ' ' A' ' 35' ' ' ILE . 2.0 tt -52.51 -19.49 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 111.423 -2.626 . . . . 0.0 109.946 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -101.91 -0.72 51.97 Favored Glycine 0 N--CA 1.491 2.328 0 CA-C-N 114.076 -1.42 . . . . 0.0 115.692 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.796 ' CD2' HG12 ' A' ' 34' ' ' VAL . 9.4 m-30 -133.67 118.59 18.34 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.459 ' C ' HG22 ' A' ' 44' ' ' THR . 35.3 t -132.44 -134.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.741 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 71.63 -10.81 3.65 Favored Glycine 0 N--CA 1.486 1.969 0 CA-C-O 117.709 -1.606 . . . . 0.0 111.634 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 17.7 t70 105.0 -8.24 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.144 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.612 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -138.35 -1.05 1.94 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 69.34 30.95 4.02 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 -179.199 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.861 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -89.04 -16.68 31.04 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.204 -1.816 . . . . 0.0 110.107 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.465 ' O ' HG23 ' A' ' 44' ' ' THR 0.258 5.1 t -118.4 92.9 3.94 Favored 'General case' 0 C--N 1.297 -1.692 1 N-CA-C 99.668 -4.197 . . . . 0.0 99.668 179.995 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 19.0 mtm180 -88.36 92.28 9.11 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 112.249 -2.25 . . . . 0.0 105.832 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 36' ' ' GLY . 28.6 t70 -56.2 -27.34 54.3 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 125.833 1.958 . . . . 0.0 109.914 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.498 1.937 0 O-C-N 126.066 2.104 . . . . 0.0 113.662 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo . . . . . 0 N--CA 1.495 1.585 0 CA-C-O 122.316 0.882 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.2 t -100.72 -21.84 15.08 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.977 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.5 t -156.53 125.84 6.13 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.474 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 9.3 p90 -123.49 30.82 6.12 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.688 1.232 . . . . 0.0 110.568 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -100.41 134.08 43.88 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.31 29.28 52.55 Favored Glycine 0 N--CA 1.506 3.327 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -91.25 -24.15 19.95 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.292 -1.454 . . . . 0.0 112.965 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.565 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 17.7 m -119.78 150.43 40.43 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.788 HD12 ' HD2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -109.19 -37.5 5.77 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 -179.355 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -149.46 -67.71 0.21 Allowed 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.94 -20.41 79.73 Favored Glycine 0 N--CA 1.502 3.085 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.565 ' HA3' ' HB3' ' A' ' 14' ' ' CYS . . . -4.02 71.08 0.0 OUTLIER Glycine 0 N--CA 1.484 1.834 0 N-CA-C 121.748 3.459 . . . . 0.0 121.748 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 C--N 1.303 -1.42 0 N-CA-C 101.343 -3.577 . . . . 0.0 101.343 179.408 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.3 ptp . . . . . 0 N--CA 1.487 1.394 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.8 OUTLIER -108.2 123.14 48.29 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -103.2 18.61 4.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 124.635 1.21 . . . . 0.0 111.115 -179.741 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -25.94 -52.41 0.05 OUTLIER 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 123.8 1.762 . . . . 0.0 110.643 -179.402 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -25.83 -49.37 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 108.437 -3.983 . . . . 0.0 113.069 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.76 -34.91 6.12 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 111.233 -2.712 . . . . 0.0 110.246 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -147.2 -80.84 0.14 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 23' ' ' ILE . 9.6 p -159.34 -130.98 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.771 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -96.31 140.64 30.69 Favored 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.521 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -151.2 172.34 15.97 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.791 -179.217 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.454 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -116.32 131.45 56.94 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -89.49 121.83 32.09 Favored 'General case' 0 C--N 1.303 -1.443 1 N-CA-C 99.957 -4.09 . . . . 0.0 99.957 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 37' ' ' TYR . 82.2 m -90.95 -114.5 0.08 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 123.945 0.778 . . . . 0.0 112.215 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.555 HG12 ' CD2' ' A' ' 37' ' ' TYR . 7.2 p -153.77 164.58 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 C-N-CA 117.656 -1.618 . . . . 0.0 111.257 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -47.9 -24.26 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 112.052 -2.34 . . . . 0.0 107.41 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -99.92 -17.9 24.11 Favored Glycine 0 C--O 1.201 -1.951 0 CA-C-O 117.69 -1.616 . . . . 0.0 115.165 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.555 ' CD2' HG12 ' A' ' 34' ' ' VAL . 1.1 m-85 -128.46 128.56 44.65 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 121.697 2.749 . . . . 0.0 106.008 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.64 ' H ' HG23 ' A' ' 44' ' ' THR . 12.6 t -130.77 -146.66 0.31 Allowed 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 40' ' ' ASP . . . 90.95 -51.12 3.17 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 106.496 -2.642 . . . . 0.0 106.496 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER 128.32 4.97 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.663 0 O-C-N 127.958 2.799 . . . . 0.0 109.026 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.788 ' HD2' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -121.53 -27.98 4.67 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.651 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 1.9 m 85.54 37.73 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 104.327 -2.472 . . . . 0.0 104.327 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.714 ' NE2' HG22 ' A' ' 44' ' ' THR . 2.7 pp0? -88.17 -23.32 23.64 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 111.514 -2.585 . . . . 0.0 107.157 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.714 HG22 ' NE2' ' A' ' 43' ' ' GLN . 1.3 t -110.23 84.42 1.92 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 101.365 -3.569 . . . . 0.0 101.365 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -81.28 87.48 6.12 Favored 'General case' 0 C--N 1.299 -1.63 1 N-CA-C 99.28 -4.341 . . . . 0.0 99.28 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 36' ' ' GLY . 33.3 t70 -58.85 -25.66 63.46 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 112.111 -2.313 . . . . 0.0 107.355 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.423 ' HB3' ' HB3' ' A' ' 29' ' ' TYR . 69.2 Cg_endo . . . . . 0 N--CA 1.492 1.433 0 CA-C-O 122.031 0.763 . . . . 0.0 112.368 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.9 t -100.47 -20.97 15.52 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.424 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.9 t -156.9 130.57 8.17 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.56 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 3.2 p90 -123.03 2.7 9.33 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.404 0.621 . . . . 0.0 111.82 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.29 122.57 13.55 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.11 36.95 93.13 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.722 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.52 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 22.4 t80 -91.24 -17.63 25.7 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.619 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.555 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 30.9 m -115.02 151.63 33.87 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.981 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -108.31 -34.0 6.94 Favored 'General case' 0 N--CA 1.508 2.457 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.491 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 5.1 m-80 -142.07 -82.21 0.21 Allowed 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 120.355 3.465 . . . . 0.0 120.355 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.68 6.32 77.19 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 108.421 -1.871 . . . . 0.0 108.421 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.621 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -51.2 95.87 0.01 OUTLIER Glycine 0 C--N 1.303 -1.265 0 CA-C-N 112.847 -1.676 . . . . 0.0 113.508 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.291 -1.962 0 N-CA-C 102.85 -3.019 . . . . 0.0 102.85 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.532 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 4.3 ptm . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 102.343 -3.206 . . . . 0.0 102.343 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -110.3 126.56 54.33 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.548 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -104.51 14.19 7.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 124.329 1.018 . . . . 0.0 112.408 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -23.05 -56.81 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 122.889 1.328 . . . . 0.0 112.657 -179.095 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.7 m -28.03 -44.22 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 110.277 -3.147 . . . . 0.0 115.428 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.99 -37.0 5.5 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 111.428 -2.623 . . . . 0.0 109.834 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -145.19 -82.63 0.15 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 117.211 2.301 . . . . 0.0 117.211 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.544 ' H ' HG22 ' A' ' 23' ' ' ILE . 1.0 OUTLIER -156.3 -138.87 0.07 Allowed 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 119.259 -0.977 . . . . 0.0 109.953 -179.267 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.56 ' CE2' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -92.36 146.39 23.73 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 102.591 -3.115 . . . . 0.0 102.591 179.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.547 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -158.43 -176.43 5.89 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 125.793 1.933 . . . . 0.0 109.704 -179.607 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.621 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -121.37 153.41 37.82 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.772 -1.171 . . . . 0.0 108.446 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.532 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 53.5 t30 -106.85 85.45 2.15 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 59.5 m -60.72 167.27 2.82 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.513 -1.676 . . . . 0.0 112.04 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.669 HG12 ' CD2' ' A' ' 37' ' ' TYR . 11.1 p -71.98 161.64 4.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 117.804 -1.559 . . . . 0.0 108.92 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.428 ' H ' HG22 ' A' ' 35' ' ' ILE . 1.9 tt -51.68 -21.64 2.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-N 112.335 -2.211 . . . . 0.0 108.735 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -92.4 -27.55 15.04 Favored Glycine 0 C--O 1.2 -2.016 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.81 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.669 ' CD2' HG12 ' A' ' 34' ' ' VAL . 3.1 m-30 -110.57 142.4 42.44 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 121.476 2.638 . . . . 0.0 108.341 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.433 ' C ' ' H ' ' A' ' 40' ' ' ASP . 53.0 m -142.73 -137.18 0.1 Allowed 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.649 -1.22 . . . . 0.0 112.034 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 73.79 -16.98 2.31 Favored Glycine 0 N--CA 1.481 1.665 0 CA-C-O 116.623 -2.209 . . . . 0.0 110.356 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 17.6 t70 106.94 -6.83 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.133 0 O-C-N 125.126 1.133 . . . . 0.0 111.817 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.527 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -135.52 -6.58 2.23 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -178.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.562 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 69.3 33.54 3.21 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 -179.325 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.981 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -88.1 -21.13 24.86 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 111.514 -2.584 . . . . 0.0 106.916 -179.669 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.401 ' O ' ' CG2' ' A' ' 44' ' ' THR . 10.9 t -114.87 114.27 25.29 Favored 'General case' 0 C--N 1.296 -1.754 1 N-CA-C 94.032 -6.285 . . . . 0.0 94.032 179.612 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.609 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 14.6 mtm180 -105.25 99.76 9.37 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 101.337 -3.579 . . . . 0.0 101.337 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 36' ' ' GLY . 44.5 t0 -85.54 70.34 10.75 Favored 'General case' 0 C--N 1.295 -1.769 1 N-CA-C 98.599 -4.593 . . . . 0.0 98.599 179.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.7 mt . . . . . 0 N--CA 1.496 1.85 0 N-CA-C 117.829 2.529 . . . . 0.0 117.829 -179.384 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo . . . . . 0 N--CA 1.493 1.46 0 CA-C-O 122.232 0.847 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 t -100.22 -22.14 15.25 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.983 -1.462 . . . . 0.0 107.827 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.5 p -151.63 121.53 7.08 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 118.092 -0.956 . . . . 0.0 108.809 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 29' ' ' TYR . 4.3 p90 -116.11 -5.05 11.92 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.41 116.32 3.26 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.686 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.37 26.73 60.89 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.111 -1.519 . . . . 0.0 109.702 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.597 ' CE1' ' HA ' ' A' ' 30' ' ' THR . 26.3 t80 -91.28 -12.46 35.05 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 118.854 -1.139 . . . . 0.0 109.992 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.62 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 17.5 m -126.41 142.07 51.66 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.763 HD12 ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -100.83 -59.57 1.68 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -179.434 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.742 HD21 HD23 ' A' ' 15' ' ' LEU . 6.5 m-80 -134.72 -52.62 0.81 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 119.791 3.256 . . . . 0.0 119.791 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -100.85 -0.62 55.13 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.62 ' HA3' ' HB3' ' A' ' 14' ' ' CYS . . . -51.75 90.52 0.01 OUTLIER Glycine 0 N--CA 1.476 1.327 0 CA-C-O 123.976 1.876 . . . . 0.0 117.119 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.295 -1.785 1 N-CA-C 96.02 -5.548 . . . . 0.0 96.02 179.237 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.6 ptm . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.496 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -111.08 130.79 55.5 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 103.419 -2.808 . . . . 0.0 103.419 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.635 HD13 ' CG2' ' A' ' 30' ' ' THR . 0.4 OUTLIER -104.59 16.45 5.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 124.214 0.946 . . . . 0.0 112.084 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.496 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 1.0 OUTLIER -29.16 -50.91 0.1 Allowed 'General case' 0 N--CA 1.507 2.389 0 CA-C-O 122.582 1.182 . . . . 0.0 112.727 -179.161 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.8 m -31.31 -43.42 0.06 Allowed 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 111.087 -2.779 . . . . 0.0 113.804 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.61 -36.03 5.6 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 111.522 -2.581 . . . . 0.0 109.987 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -148.2 -83.55 0.11 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 118.846 2.906 . . . . 0.0 118.846 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.492 ' H ' HG22 ' A' ' 23' ' ' ILE . 5.1 p -148.92 -136.04 0.07 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.525 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.51 ' HE1' ' CG ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -101.4 147.87 25.83 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-N 118.584 0.629 . . . . 0.0 109.941 -179.593 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.635 ' CG2' HD13 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -160.01 -173.72 4.21 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 118.587 2.81 . . . . 0.0 118.587 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.511 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -131.85 130.11 41.27 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.58 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -92.08 89.62 7.02 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 104.716 -2.328 . . . . 0.0 104.716 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.2 m -72.72 -178.35 2.65 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.247 1.023 . . . . 0.0 108.922 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.779 HG12 ' CD2' ' A' ' 37' ' ' TYR . 10.9 p -89.81 166.81 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-O 123.979 1.847 . . . . 0.0 113.458 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.43 ' H ' HG22 ' A' ' 35' ' ' ILE . 2.5 tt -56.29 -15.74 2.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-N 112.096 -2.32 . . . . 0.0 108.271 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.586 ' H ' HG13 ' A' ' 34' ' ' VAL . . . -98.34 -12.63 44.57 Favored Glycine 0 N--CA 1.486 1.972 0 CA-C-N 113.929 -1.487 . . . . 0.0 113.716 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.779 ' CD2' HG12 ' A' ' 34' ' ' VAL . 1.3 m-85 -135.24 130.51 35.32 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.57 ' H ' HG23 ' A' ' 44' ' ' THR . 1.4 t -129.06 -161.23 1.09 Allowed 'General case' 0 N--CA 1.515 2.775 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 51.27 63.5 4.57 Favored Glycine 0 N--CA 1.499 2.865 0 N-CA-C 117.513 1.765 . . . . 0.0 117.513 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 43.71 -13.78 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.588 1 N-CA-C 122.16 4.133 . . . . 0.0 122.16 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.763 ' NE ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -113.82 -28.2 7.5 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.464 ' SG ' ' N ' ' A' ' 18' ' ' GLY . 2.7 m 82.01 43.86 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.728 ' NE2' HG22 ' A' ' 44' ' ' THR . 0.1 OUTLIER -88.8 -8.68 53.95 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 112.86 -1.973 . . . . 0.0 112.127 -179.235 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.728 HG22 ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -120.83 94.12 4.25 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 102.121 -3.289 . . . . 0.0 102.121 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.4 ' HA ' ' HD1' ' A' ' 37' ' ' TYR . 7.2 mtm180 -83.78 86.52 7.13 Favored 'General case' 0 C--N 1.305 -1.329 1 N-CA-C 98.408 -4.664 . . . . 0.0 98.408 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 36' ' ' GLY . 1.3 t70 -59.96 -12.95 9.01 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 112.098 -2.319 . . . . 0.0 109.342 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.903 0 C-N-CA 127.581 2.353 . . . . 0.0 116.709 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.503 2.059 0 N-CA-C 109.06 -1.169 . . . . 0.0 109.06 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -19.91 -49.84 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 111.061 -2.791 . . . . 0.0 116.555 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.2 t -139.78 127.41 21.73 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -123.57 34.06 5.19 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.05 130.9 46.25 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 104.678 -2.342 . . . . 0.0 104.678 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.81 40.31 2.17 Favored Glycine 0 N--CA 1.506 3.34 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.407 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 24.6 t80 -91.52 -22.08 20.55 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 126.098 1.705 . . . . 0.0 112.856 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.41 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 38.1 m -114.68 155.07 27.3 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.964 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -107.06 -37.14 6.39 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -179.575 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.609 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 3.5 m-80 -141.51 -85.54 0.18 Allowed 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 119.981 3.326 . . . . 0.0 119.981 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.98 -26.33 55.21 Favored Glycine 0 N--CA 1.512 3.716 0 N-CA-C 108.486 -1.845 . . . . 0.0 108.486 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.535 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 6.25 65.42 0.01 OUTLIER Glycine 0 N--CA 1.484 1.843 0 N-CA-C 121.504 3.362 . . . . 0.0 121.504 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.307 -1.261 0 N-CA-C 100.944 -3.725 . . . . 0.0 100.944 179.279 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.55 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 7.3 ptm . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 123.128 1.442 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.641 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -62.57 121.38 13.19 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 179.626 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.653 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -104.36 24.87 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 123.936 0.773 . . . . 0.0 110.31 -179.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.498 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.8 OUTLIER -34.77 -39.89 0.1 Allowed 'General case' 0 N--CA 1.509 2.487 0 CA-C-O 123.502 1.62 . . . . 0.0 110.195 -179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.401 ' N ' ' C ' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -32.61 -46.26 0.13 Allowed 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 110.055 -3.248 . . . . 0.0 111.477 179.245 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.53 -34.53 4.86 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 111.672 -2.513 . . . . 0.0 110.396 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -148.09 -81.98 0.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 23' ' ' ILE . 2.5 p -152.76 -131.54 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.149 -1.02 . . . . 0.0 109.378 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -100.16 137.42 38.63 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.595 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -148.58 -176.34 5.28 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 112.449 -2.159 . . . . 0.0 110.266 -179.396 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.535 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -122.02 155.75 34.94 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.55 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 45.6 t30 -109.21 104.33 13.46 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 100.346 -3.946 . . . . 0.0 100.346 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.449 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 60.8 m -89.22 169.86 11.09 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.499 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.707 HG12 ' CD2' ' A' ' 37' ' ' TYR . 8.9 p -68.79 159.56 5.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 123.264 1.507 . . . . 0.0 111.613 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.402 ' H ' HG22 ' A' ' 35' ' ' ILE . 1.2 tt -48.43 -21.71 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 111.177 -2.738 . . . . 0.0 109.914 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.554 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -106.64 3.73 36.72 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 118.026 1.971 . . . . 0.0 118.026 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.707 ' CD2' HG12 ' A' ' 34' ' ' VAL . 13.5 m-30 -133.44 116.81 16.47 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 100.461 -3.903 . . . . 0.0 100.461 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.493 ' C ' HG22 ' A' ' 44' ' ' THR . 39.9 t -132.54 -133.65 0.18 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 118.381 -1.328 . . . . 0.0 113.041 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 71.42 -9.87 4.12 Favored Glycine 0 N--CA 1.486 1.993 0 CA-C-O 117.764 -1.575 . . . . 0.0 111.293 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 19.6 t70 104.57 -5.24 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.073 0 O-C-N 124.967 1.039 . . . . 0.0 112.907 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.578 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -139.39 -2.96 1.56 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -178.754 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 71.17 30.9 2.56 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 -179.254 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.964 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -89.04 -15.02 35.09 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 113.119 -1.855 . . . . 0.0 110.191 -179.519 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.493 HG22 ' C ' ' A' ' 38' ' ' SER 0.26 6.0 t -118.99 83.07 1.96 Allowed 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 100.236 -3.987 . . . . 0.0 100.236 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 8.8 mtm-85 -77.51 89.87 3.87 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 111.115 -2.766 . . . . 0.0 104.057 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 36' ' ' GLY . 0.9 OUTLIER -62.34 -16.89 57.09 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 113.017 -1.901 . . . . 0.0 109.773 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mt . . . . . 0 N--CA 1.507 2.388 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 179.205 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.496 1.626 0 N-CA-C 111.342 -0.292 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.5 t -20.14 -51.91 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 O-C-N 124.95 1.406 . . . . 0.0 113.535 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -156.31 154.83 31.26 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 102.421 -3.177 . . . . 0.0 102.421 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.521 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -125.32 10.77 8.03 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 124.768 1.292 . . . . 0.0 109.581 179.724 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.99 135.27 57.2 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 37.52 41.55 0.83 Allowed Glycine 0 N--CA 1.511 3.651 0 O-C-N 124.08 0.863 . . . . 0.0 111.511 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.412 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 20.9 t80 -91.24 -17.21 26.37 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 125.231 1.195 . . . . 0.0 112.589 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.455 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 44.6 m -116.92 154.13 31.36 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.933 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -108.15 -36.47 6.29 Favored 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -179.666 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.674 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 3.7 m-80 -140.58 -82.52 0.24 Allowed 'General case' 0 N--CA 1.51 2.555 0 N-CA-C 120.372 3.471 . . . . 0.0 120.372 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.82 -21.42 65.32 Favored Glycine 0 N--CA 1.508 3.462 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.575 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 2.95 67.46 0.0 OUTLIER Glycine 0 N--CA 1.481 1.696 0 N-CA-C 120.215 2.846 . . . . 0.0 120.215 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 19' ' ' VAL . 2.0 t . . . . . 0 C--N 1.305 -1.351 0 N-CA-C 101.423 -3.547 . . . . 0.0 101.423 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.418 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 8.2 ptm . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.445 ' CE1' ' HG2' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -102.71 126.71 49.92 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.611 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -106.6 18.92 5.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 124.412 1.07 . . . . 0.0 109.913 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.487 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -27.47 -52.96 0.07 Allowed 'General case' 0 N--CA 1.512 2.636 0 CA-C-O 123.405 1.574 . . . . 0.0 109.742 -179.421 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -25.08 -46.98 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 108.964 -3.743 . . . . 0.0 114.323 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.78 -35.52 5.45 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 110.916 -2.856 . . . . 0.0 110.026 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -147.03 -81.62 0.14 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 23' ' ' ILE . 4.5 p -157.44 -131.77 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.582 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -97.73 141.5 30.67 Favored 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.576 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.266 0.5 OUTLIER -153.31 -176.73 5.92 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.384 -1.735 . . . . 0.0 110.446 -179.277 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.575 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -120.48 148.95 43.15 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.418 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 43.3 t30 -101.61 101.0 11.47 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 101.417 -3.549 . . . . 0.0 101.417 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.511 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 59.5 m -86.71 156.6 19.9 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.116 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.696 HG12 ' CD2' ' A' ' 37' ' ' TYR . 12.5 p -59.94 160.38 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 112.591 -2.095 . . . . 0.0 114.266 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.7 tt -50.72 -21.85 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 CA-C-N 110.845 -2.889 . . . . 0.0 109.243 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -99.61 -6.83 54.49 Favored Glycine 0 N--CA 1.49 2.261 0 CA-C-N 114.202 -1.363 . . . . 0.0 115.929 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.696 ' CD2' HG12 ' A' ' 34' ' ' VAL . 5.9 m-85 -132.59 120.8 22.29 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.497 ' C ' HG22 ' A' ' 44' ' ' THR . 26.4 t -131.7 -137.98 0.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.629 -1.228 . . . . 0.0 111.087 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 74.88 -10.66 8.74 Favored Glycine 0 N--CA 1.481 1.688 0 CA-C-O 117.075 -1.958 . . . . 0.0 111.339 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 19.2 t70 105.07 -8.88 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.261 0 O-C-N 125.039 1.082 . . . . 0.0 113.065 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.605 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -137.86 -2.24 1.93 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -178.67 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 69.31 31.35 3.92 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 104.523 -2.399 . . . . 0.0 104.523 -179.254 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.933 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -88.81 -16.03 33.1 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 113.024 -1.898 . . . . 0.0 109.223 -179.39 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.497 HG22 ' C ' ' A' ' 38' ' ' SER . 3.4 t -119.45 88.84 3.01 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 101.397 -3.557 . . . . 0.0 101.397 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 24.9 mtp-105 -83.4 93.69 7.82 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 111.342 -2.663 . . . . 0.0 105.465 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 36' ' ' GLY . 26.0 t0 -62.07 -23.64 66.62 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 112.745 -2.025 . . . . 0.0 108.042 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-N 112.789 -2.005 . . . . 0.0 107.686 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo . . . . . 0 N--CA 1.498 1.747 0 CA-C-O 119.676 -0.218 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -19.81 -54.21 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 125.956 2.035 . . . . 0.0 113.177 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.8 t -146.99 154.47 41.28 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 103.669 -2.715 . . . . 0.0 103.669 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.561 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -127.06 12.12 7.13 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.183 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -55.81 129.7 40.51 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 35.35 46.04 0.71 Allowed Glycine 0 N--CA 1.508 3.487 0 O-C-N 124.744 1.277 . . . . 0.0 111.017 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.411 ' HD1' ' HH ' ' A' ' 29' ' ' TYR . 29.3 t80 -91.08 -17.6 25.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 125.752 1.501 . . . . 0.0 113.007 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.411 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 50.9 m -116.72 153.38 32.48 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.941 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -106.28 -35.71 7.08 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -179.691 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.49 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 4.3 m-80 -144.12 -83.23 0.16 Allowed 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 119.107 3.003 . . . . 0.0 119.107 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -57.34 -27.0 57.48 Favored Glycine 0 N--CA 1.51 3.614 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.561 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 7.96 63.14 0.01 OUTLIER Glycine 0 N--CA 1.48 1.607 0 N-CA-C 120.304 2.882 . . . . 0.0 120.304 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.307 -1.262 0 N-CA-C 100.464 -3.902 . . . . 0.0 100.464 179.323 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 6.3 ptm . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 123.094 1.426 . . . . 0.0 108.807 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.661 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -63.78 118.36 8.22 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.67 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -99.98 26.18 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 123.751 0.657 . . . . 0.0 110.305 -179.448 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.487 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 1.3 tm-20 -34.29 -41.86 0.12 Allowed 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 123.652 1.691 . . . . 0.0 109.713 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -31.19 -45.33 0.08 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 109.874 -3.33 . . . . 0.0 112.241 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.02 -33.73 4.63 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 111.841 -2.436 . . . . 0.0 110.305 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -149.32 -80.67 0.12 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 23' ' ' ILE . 2.4 p -153.86 -131.11 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 118.891 -1.124 . . . . 0.0 109.718 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.661 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -100.84 135.94 41.48 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.543 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -147.14 -177.56 5.74 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 112.333 -2.212 . . . . 0.0 109.705 -179.391 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.561 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -122.8 154.51 38.11 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 179.576 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.535 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 54.6 t30 -108.82 101.89 10.96 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 101.093 -3.669 . . . . 0.0 101.093 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 62.9 m -82.84 170.39 15.05 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 113.747 -1.57 . . . . 0.0 109.853 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.69 HG12 ' CD2' ' A' ' 37' ' ' TYR . 12.9 p -72.33 160.51 5.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 123.14 1.448 . . . . 0.0 111.859 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.432 HG22 HG22 ' A' ' 34' ' ' VAL . 3.0 tt -51.02 -19.03 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 111.657 -2.519 . . . . 0.0 108.94 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -94.3 -25.71 15.7 Favored Glycine 0 C--O 1.203 -1.839 0 CA-C-O 117.898 -1.501 . . . . 0.0 112.766 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.69 ' CD2' HG12 ' A' ' 34' ' ' VAL . 2.4 m-30 -115.1 124.64 52.05 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 119.428 1.614 . . . . 0.0 108.193 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.415 ' C ' HG22 ' A' ' 44' ' ' THR . 23.1 t -131.62 -139.92 0.21 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.83 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 76.62 -12.62 10.08 Favored Glycine 0 N--CA 1.481 1.657 0 CA-C-O 117.555 -1.692 . . . . 0.0 110.1 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.522 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 31.0 t70 105.63 -6.11 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.062 0 O-C-N 125.04 1.082 . . . . 0.0 113.301 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.611 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -137.4 -4.17 1.88 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.515 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 72.2 32.4 1.73 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 -179.238 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.941 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -87.99 -20.07 26.34 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 113.328 -1.76 . . . . 0.0 110.575 -179.248 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.493 ' O ' HG23 ' A' ' 44' ' ' THR 0.256 6.1 t -113.67 83.5 1.86 Allowed 'General case' 0 C--N 1.295 -1.79 1 N-CA-C 98.893 -4.484 . . . . 0.0 98.893 179.955 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.58 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -76.0 89.34 2.97 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 101.944 -3.354 . . . . 0.0 101.944 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 36' ' ' GLY . 30.4 t70 -83.41 46.22 1.12 Allowed 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 45' ' ' ARG . 41.1 mt . . . . . 0 N--CA 1.504 2.27 1 N-CA-C 122.114 4.116 . . . . 0.0 122.114 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo . . . . . 0 N--CA 1.493 1.474 0 N-CA-C 108.692 -1.311 . . . . 0.0 108.692 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.97 173.43 13.42 Favored Glycine 0 N--CA 1.498 2.807 0 C-N-CA 119.506 -1.331 . . . . 0.0 114.232 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ABA . . . . . 0.776 ' H ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.776 ' HD3' ' H ' ' A' ' 6' ' ' ABA . 23.0 Cg_exo -58.2 -44.07 41.96 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 123.536 2.824 . . . . 0.0 110.093 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.1 t -19.94 -43.56 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 126.252 2.22 . . . . 0.0 116.238 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 t -146.49 127.38 14.46 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.4 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 7.0 p90 -122.06 35.93 4.76 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.09 131.96 45.74 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.1 40.16 1.7 Allowed Glycine 0 N--CA 1.51 3.569 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.44 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 26.4 t80 -91.87 -15.2 28.47 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 125.756 1.504 . . . . 0.0 114.191 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.4 m -128.47 156.62 42.93 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.934 HD22 ' HA ' ' A' ' 43' ' ' GLN . 1.1 mp -104.49 -33.09 8.69 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.438 ' ND2' ' CD ' ' A' ' 45' ' ' ARG . 4.6 m-80 -144.92 -81.65 0.16 Allowed 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 120.109 3.374 . . . . 0.0 120.109 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.12 -29.6 65.76 Favored Glycine 0 N--CA 1.507 3.429 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.402 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 5.02 66.99 0.01 OUTLIER Glycine 0 N--CA 1.483 1.767 0 CA-C-N 110.085 -3.058 . . . . 0.0 119.809 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 t -96.11 96.71 5.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 1 N-CA-C 99.175 -4.38 . . . . 0.0 99.175 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ABA . . . . . 1.055 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.943 ' SD ' HD12 ' A' ' 23' ' ' ILE . 2.5 ppp? -122.26 132.6 54.5 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 124.459 2.076 . . . . 0.0 109.964 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -70.86 117.24 12.12 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 113.238 -1.801 . . . . 0.0 107.497 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.943 HD12 ' SD ' ' A' ' 21' ' ' MET . 0.1 OUTLIER -100.93 24.88 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.006 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.482 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 1.3 tm-20 -32.71 -46.84 0.15 Allowed 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 123.607 1.67 . . . . 0.0 108.458 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -26.11 -48.47 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 108.605 -3.907 . . . . 0.0 113.067 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.449 ' CD1' HG12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -115.08 -33.99 5.2 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 111.357 -2.656 . . . . 0.0 109.996 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -146.82 -81.5 0.14 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 23' ' ' ILE . 6.3 p -156.16 -127.73 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.108 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.055 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -101.15 137.06 40.01 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.544 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -146.87 -174.54 4.52 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 112.312 -2.222 . . . . 0.0 109.297 -179.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.402 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -125.34 156.28 38.95 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -108.47 117.9 35.36 Favored 'General case' 0 C--N 1.298 -1.633 1 N-CA-C 98.102 -4.777 . . . . 0.0 98.102 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.548 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 81.9 m -98.57 166.22 11.45 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.61 HG12 ' CD2' ' A' ' 37' ' ' TYR . 7.1 p -64.87 158.11 4.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 C-N-CA 117.67 -1.612 . . . . 0.0 112.707 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -42.38 -28.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 111.52 -2.582 . . . . 0.0 110.682 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -99.06 -17.24 28.07 Favored Glycine 0 C--O 1.203 -1.784 0 CA-C-N 114.198 -1.365 . . . . 0.0 115.484 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.61 ' CD2' HG12 ' A' ' 34' ' ' VAL . 6.0 m-30 -111.96 124.92 53.41 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.43 ' C ' ' H ' ' A' ' 40' ' ' ASP . 47.0 t -133.71 -130.38 0.17 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.237 -1.385 . . . . 0.0 112.362 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.501 ' C ' ' NE2' ' A' ' 43' ' ' GLN . . . 65.75 -2.56 3.5 Favored Glycine 0 N--CA 1.483 1.77 0 CA-C-O 117.699 -1.611 . . . . 0.0 109.815 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 8.8 t70 92.78 -2.48 0.13 Allowed 'General case' 0 N--CA 1.517 2.916 0 CA-C-N 118.268 1.034 . . . . 0.0 113.662 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.515 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -141.38 2.41 1.65 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.548 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 61.13 33.95 19.21 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 -179.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.934 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -88.71 -24.27 22.76 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 111.731 -2.486 . . . . 0.0 108.305 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 44' ' ' THR . 6.1 t -112.33 83.92 1.88 Allowed 'General case' 0 C--N 1.297 -1.678 1 N-CA-C 99.07 -4.418 . . . . 0.0 99.07 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.609 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 16.6 mtm180 -79.84 91.49 5.36 Favored 'General case' 0 C--N 1.296 -1.731 1 N-CA-C 100.11 -4.033 . . . . 0.0 100.11 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 36' ' ' GLY . 5.6 t70 -86.79 64.98 8.79 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -10.76 62.23 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 117.929 2.566 . . . . 0.0 117.929 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 46' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.264 -1.351 . . . . 0.0 112.575 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 0 N--CA 1.493 1.444 0 CA-C-O 121.643 0.601 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.34 164.53 9.92 Favored Glycine 0 N--CA 1.5 2.9 0 C-N-CA 119.999 -1.096 . . . . 0.0 113.202 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ABA . . . . . 0.46 ' H ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.46 ' HD3' ' H ' ' A' ' 6' ' ' ABA . 7.9 Cg_exo -71.33 -35.08 8.9 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.944 2.43 . . . . 0.0 111.497 171.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -19.89 -53.83 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 125.332 1.645 . . . . 0.0 114.634 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 t -143.75 144.2 31.72 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 104.23 -2.508 . . . . 0.0 104.23 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.457 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 3.2 p90 -127.19 26.4 6.06 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 124.868 1.355 . . . . 0.0 109.845 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -100.06 133.26 44.7 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.37 24.69 61.77 Favored Glycine 0 N--CA 1.505 3.243 0 N-CA-C 107.662 -2.175 . . . . 0.0 107.662 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.428 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 10.2 t80 -91.1 -18.04 25.19 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 113.47 -1.365 . . . . 0.0 112.208 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.471 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 10.1 m -132.83 147.51 52.3 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.757 HD12 ' HD2' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -104.0 -34.7 8.36 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -179.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.483 ' ND2' ' HB3' ' A' ' 15' ' ' LEU . 53.9 m-80 -147.86 -76.02 0.18 Allowed 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 120.403 3.483 . . . . 0.0 120.403 -178.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.469 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -63.72 -26.35 69.82 Favored Glycine 0 N--CA 1.508 3.496 0 N-CA-C 108.155 -1.978 . . . . 0.0 108.155 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 14' ' ' CYS . . . -1.25 68.56 0.0 OUTLIER Glycine 0 N--CA 1.485 1.911 0 N-CA-C 120.672 3.029 . . . . 0.0 120.672 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 17' ' ' GLY . 2.8 t -95.46 96.37 5.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 100.322 -3.955 . . . . 0.0 100.322 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ABA . . . . . 1.043 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.503 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 5.5 ptp -116.61 126.64 53.54 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 123.207 1.479 . . . . 0.0 108.984 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.668 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -72.41 113.35 9.35 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 103.406 -2.812 . . . . 0.0 103.406 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.67 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -95.38 27.14 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.113 -179.289 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.496 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.8 OUTLIER -37.84 -37.65 0.25 Allowed 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 123.439 1.59 . . . . 0.0 109.288 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.4 ' N ' ' C ' ' A' ' 23' ' ' ILE . 0.7 OUTLIER -33.31 -44.38 0.13 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 110.388 -3.097 . . . . 0.0 111.579 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.5 -32.98 4.18 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 111.659 -2.519 . . . . 0.0 111.1 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -149.5 -80.04 0.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 118.124 2.639 . . . . 0.0 118.124 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.9 p -153.46 -133.52 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 119.098 -1.041 . . . . 0.0 109.834 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.043 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -100.09 135.95 40.73 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 179.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.526 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -147.65 -176.42 5.25 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 112.841 -1.981 . . . . 0.0 109.994 -179.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.421 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -125.18 150.07 47.32 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.503 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 14.5 t30 -106.36 123.71 48.47 Favored 'General case' 0 C--N 1.299 -1.599 1 N-CA-C 97.348 -5.056 . . . . 0.0 97.348 179.366 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 37' ' ' TYR . 72.1 m -96.59 -117.73 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.582 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.606 HG12 ' CD2' ' A' ' 37' ' ' TYR . 7.4 p -149.52 166.84 3.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 117.815 -1.554 . . . . 0.0 111.151 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tt -50.74 -19.68 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 112.247 -2.251 . . . . 0.0 107.747 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -104.27 -14.11 25.02 Favored Glycine 0 C--O 1.202 -1.848 0 CA-C-N 113.521 -1.672 . . . . 0.0 115.285 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.606 ' CD2' HG12 ' A' ' 34' ' ' VAL . 1.9 m-85 -131.66 125.64 32.64 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.609 ' H ' HG23 ' A' ' 44' ' ' THR . 11.1 t -129.74 -148.27 0.36 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 40' ' ' ASP . . . 90.82 -48.15 3.01 Favored Glycine 0 N--CA 1.502 3.049 0 N-CA-C 106.89 -2.484 . . . . 0.0 106.89 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 0.5 OUTLIER 122.81 8.68 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 C-N-CA 129.788 3.235 . . . . 0.0 108.186 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.757 ' HD2' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -127.27 -7.18 5.88 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.366 0.603 . . . . 0.0 110.83 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.45 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 62.51 38.32 12.65 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 124.236 1.969 . . . . 0.0 107.564 -179.211 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.696 HE21 HG22 ' A' ' 44' ' ' THR . 0.5 OUTLIER -88.23 -38.26 15.4 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 109.236 -3.62 . . . . 0.0 105.76 -179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.696 HG22 HE21 ' A' ' 43' ' ' GLN . 1.9 t -96.35 85.33 3.91 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 102.048 -3.316 . . . . 0.0 102.048 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.487 ' CZ ' ' HB2' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -82.61 84.69 7.18 Favored 'General case' 0 C--N 1.299 -1.626 1 N-CA-C 99.791 -4.152 . . . . 0.0 99.791 179.886 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 36' ' ' GLY . 30.1 t70 -55.49 -28.91 57.47 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 112.192 -2.276 . . . . 0.0 108.4 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 88.32 -139.03 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 127.068 2.147 . . . . 0.0 108.209 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.7 ptm85 . . . . . 0 N--CA 1.509 2.511 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -179.829 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo . . . . . 0 N--CA 1.493 1.442 0 N-CA-C 107.441 -1.792 . . . . 0.0 107.441 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.07 177.6 15.12 Favored Glycine 0 N--CA 1.499 2.882 0 C-N-CA 119.054 -1.546 . . . . 0.0 112.26 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ABA . . . . . 0.587 ' H ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.587 ' HD3' ' H ' ' A' ' 6' ' ' ABA . 73.6 Cg_endo -76.47 23.09 0.49 Allowed 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 123.746 2.964 . . . . 0.0 112.679 -167.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.523 ' H ' ' C ' ' A' ' 6' ' ' ABA . 5.1 t -100.68 -25.15 14.24 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 113.391 -1.731 . . . . 0.0 106.406 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.9 t -155.88 133.82 11.28 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.507 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 3.0 p90 -124.09 19.59 9.13 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 122.896 1.331 . . . . 0.0 108.579 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.69 129.85 40.23 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.406 ' O ' ' NH1' ' A' ' 41' ' ' ARG . . . 36.36 50.6 1.31 Allowed Glycine 0 N--CA 1.501 2.972 0 O-C-N 125.415 1.697 . . . . 0.0 109.595 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.614 ' HD1' ' HH ' ' A' ' 29' ' ' TYR . 48.4 t80 -92.45 -14.9 27.84 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.5 m -122.67 162.72 21.43 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.622 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -117.29 -37.31 3.55 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.524 ' ND2' ' HD3' ' A' ' 45' ' ' ARG . 18.0 m-80 -146.69 -67.63 0.27 Allowed 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 119.765 3.246 . . . . 0.0 119.765 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.75 -24.99 76.48 Favored Glycine 0 N--CA 1.506 3.325 0 N-CA-C 106.474 -2.651 . . . . 0.0 106.474 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.501 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 0.97 59.88 0.0 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 120.56 2.984 . . . . 0.0 120.56 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.1 95.21 5.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 101.22 -3.622 . . . . 0.0 101.22 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ABA . . . . . 0.962 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.536 ' HE3' HD13 ' A' ' 23' ' ' ILE . 14.6 ptt? -128.23 113.79 16.13 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -63.0 122.89 17.15 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 102.535 -3.135 . . . . 0.0 102.535 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.643 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -101.1 25.69 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 124.098 0.874 . . . . 0.0 109.96 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.494 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 1.1 tm-20 -34.15 -42.94 0.14 Allowed 'General case' 0 N--CA 1.509 2.518 0 CA-C-O 123.21 1.481 . . . . 0.0 109.516 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -29.93 -49.9 0.11 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 109.56 -3.473 . . . . 0.0 111.86 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.05 -28.45 6.99 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 111.383 -2.644 . . . . 0.0 112.122 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -149.89 -79.42 0.13 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 29' ' ' TYR . 3.5 p -156.05 -131.94 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.23 -1.804 . . . . 0.0 110.31 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.962 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.5 OUTLIER -101.64 135.68 42.76 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 123.012 1.387 . . . . 0.0 109.697 179.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.545 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -148.37 -176.59 5.36 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 112.23 -2.259 . . . . 0.0 111.951 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.501 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -125.63 154.34 42.45 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.446 ' CA ' ' HE2' ' A' ' 21' ' ' MET . 6.2 t-20 -109.64 98.24 7.64 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 37' ' ' TYR . 55.8 m -93.07 150.33 20.6 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.751 HG12 ' CD2' ' A' ' 37' ' ' TYR . 9.9 p -59.51 169.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 111.758 -2.474 . . . . 0.0 117.143 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.447 ' H ' HG22 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -58.42 -21.07 17.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 111.497 -2.592 . . . . 0.0 107.146 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -94.56 -8.84 59.36 Favored Glycine 0 N--CA 1.482 1.733 0 CA-C-N 114.218 -1.355 . . . . 0.0 113.161 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.751 ' CD2' HG12 ' A' ' 34' ' ' VAL . 1.4 m-85 -141.19 126.25 18.34 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 116.496 -1.716 . . . . 0.0 107.799 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.612 ' H ' HG23 ' A' ' 44' ' ' THR . 8.5 t -124.14 -144.43 0.33 Allowed 'General case' 0 N--CA 1.518 2.966 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 41' ' ' ARG . . . 35.97 69.81 0.23 Allowed Glycine 0 N--CA 1.501 2.999 0 C-N-CA 124.441 1.019 . . . . 0.0 114.237 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 29.92 8.91 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 119.547 3.165 . . . . 0.0 119.547 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -132.19 -25.16 2.02 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.794 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.447 ' HB3' ' CB ' ' A' ' 37' ' ' TYR . 1.8 m 76.8 40.53 0.2 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.873 ' NE2' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -88.74 -20.7 24.45 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 112.749 -2.023 . . . . 0.0 109.437 -179.464 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.873 HG22 ' NE2' ' A' ' 43' ' ' GLN . 0.6 OUTLIER -113.0 92.87 4.16 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 102.21 -3.255 . . . . 0.0 102.21 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.524 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 6.7 mtm180 -84.93 85.84 7.43 Favored 'General case' 0 C--N 1.299 -1.597 1 N-CA-C 99.238 -4.356 . . . . 0.0 99.238 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 36' ' ' GLY . 13.9 t0 -60.67 -12.97 11.9 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 112.531 -2.122 . . . . 0.0 109.264 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.17 -29.46 0.18 Allowed 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 128.156 2.582 . . . . 0.0 117.751 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 . . . . . 0 N--CA 1.511 2.579 0 O-C-N 126.261 2.226 . . . . 0.0 114.112 179.894 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 N--CA 1.492 1.402 0 N-CA-C 108.882 -1.238 . . . . 0.0 108.882 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 124.97 -169.15 16.93 Favored Glycine 0 N--CA 1.499 2.843 0 C-N-CA 120.414 -0.898 . . . . 0.0 110.875 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ABA . . . . . 0.534 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 39.2 Cg_endo -81.87 33.99 0.54 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.911 2.407 . . . . 0.0 110.274 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.517 ' H ' ' C ' ' A' ' 6' ' ' ABA . 5.4 t -100.57 -29.0 12.58 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 113.682 -1.599 . . . . 0.0 106.824 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -166.46 152.75 8.8 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.508 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -129.55 14.58 6.01 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 124.659 1.224 . . . . 0.0 110.411 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -63.35 137.83 58.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.36 37.99 1.29 Allowed Glycine 0 N--CA 1.511 3.672 0 O-C-N 124.258 0.974 . . . . 0.0 111.133 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.576 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 30.5 t80 -90.4 -8.35 50.86 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 113.597 -1.301 . . . . 0.0 112.815 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.7 m -137.07 152.45 50.05 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.64 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.3 OUTLIER -94.13 -72.75 0.6 Allowed 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.41 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.454 ' C ' ' H ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -121.81 -56.66 1.85 Allowed 'General case' 0 N--CA 1.512 2.674 0 N-CA-C 115.667 1.728 . . . . 0.0 115.667 -179.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.81 44.29 3.31 Favored Glycine 0 N--CA 1.503 3.115 0 N-CA-C 105.913 -2.875 . . . . 0.0 105.913 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.533 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -68.82 67.39 0.45 Allowed Glycine 0 C--N 1.29 -2.019 0 CA-C-N 112.479 -1.861 . . . . 0.0 116.084 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.2 t -90.67 85.27 2.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 103.52 -2.77 . . . . 0.0 103.52 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ABA . . . . . 1.009 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.0 ptm -120.25 -179.28 3.9 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.485 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -111.7 126.5 55.1 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.194 -1.402 . . . . 0.0 107.696 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.638 ' O ' HG23 ' A' ' 23' ' ' ILE . 1.0 OUTLIER -106.78 23.11 3.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 124.189 0.931 . . . . 0.0 111.308 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.485 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.4 OUTLIER -38.1 -37.31 0.26 Allowed 'General case' 0 N--CA 1.515 2.816 0 CA-C-O 123.421 1.582 . . . . 0.0 110.157 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -33.26 -43.27 0.11 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 110.227 -3.17 . . . . 0.0 111.914 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.35 -34.66 3.77 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 111.335 -2.666 . . . . 0.0 111.3 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -147.28 -82.47 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 23' ' ' ILE . 26.7 p -154.52 -125.59 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.831 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.009 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -98.76 139.44 34.45 Favored 'General case' 0 N--CA 1.51 2.547 0 CA-C-O 122.394 1.092 . . . . 0.0 110.199 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.517 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -148.56 178.96 8.17 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 112.843 -1.98 . . . . 0.0 111.438 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.533 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -115.12 154.6 28.63 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 103.09 -2.93 . . . . 0.0 103.09 179.269 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.88 86.59 2.31 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.664 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 34.8 m -59.38 151.91 22.56 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.913 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.608 HG13 ' H ' ' A' ' 37' ' ' TYR . 7.5 p -59.36 157.12 2.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 111.589 -2.55 . . . . 0.0 112.158 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tt -43.16 -25.61 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 112.344 -2.207 . . . . 0.0 110.063 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 34' ' ' VAL . . . -98.33 -24.1 11.78 Favored Glycine 0 N--CA 1.485 1.931 0 CA-C-N 114.6 -1.182 . . . . 0.0 115.256 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.608 ' H ' HG13 ' A' ' 34' ' ' VAL . 1.3 m-30 -111.57 133.05 54.1 Favored 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 102.862 -3.014 . . . . 0.0 102.862 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.6 t -139.2 -137.04 0.13 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 118.403 -1.319 . . . . 0.0 111.175 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 75.74 -10.5 13.06 Favored Glycine 0 N--CA 1.48 1.621 0 CA-C-O 117.905 -1.497 . . . . 0.0 109.513 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 21.6 t70 102.06 -15.66 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.048 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.651 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -134.43 6.9 3.56 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.216 -179.285 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.664 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 59.48 32.51 21.76 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.261 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.651 ' NE2' ' H ' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -88.13 5.55 40.76 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.256 -179.426 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.452 ' O ' ' C ' ' A' ' 45' ' ' ARG . 12.1 t -130.08 22.33 5.3 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.518 -1.674 . . . . 0.0 113.632 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.452 ' C ' ' O ' ' A' ' 44' ' ' THR . 1.0 OUTLIER -16.56 90.32 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 O-C-N 125.36 1.662 . . . . 0.0 112.252 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 36' ' ' GLY . 23.3 t70 -74.79 2.62 9.69 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 117.844 -1.542 . . . . 0.0 111.002 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 mt 67.63 -152.05 0.18 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.241 0 CA-C-O 114.14 -2.838 . . . . 0.0 113.112 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.493 1.496 0 N-CA-C 110.505 -0.613 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -119.99 161.79 14.29 Favored Glycine 0 N--CA 1.496 2.679 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.83 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ABA . . . . . 0.478 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 29' ' ' TYR . 8.4 Cg_endo -73.39 -42.68 0.85 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.42 2.08 . . . . 0.0 111.882 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -19.86 -53.7 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 126.542 2.401 . . . . 0.0 115.172 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.55 125.38 22.54 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.392 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.459 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 1.4 p90 -110.51 4.42 20.41 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.851 1.31 . . . . 0.0 110.747 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.65 129.2 38.16 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 113.607 -1.633 . . . . 0.0 106.974 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 34.46 46.17 0.53 Allowed Glycine 0 N--CA 1.511 3.637 0 O-C-N 124.423 1.077 . . . . 0.0 111.414 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.402 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 26.7 t80 -91.44 -20.26 21.96 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 125.935 1.609 . . . . 0.0 112.611 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.8 m -116.92 153.82 31.91 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.884 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.3 OUTLIER -100.58 -36.53 9.13 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -144.67 -82.05 0.16 Allowed 'General case' 0 N--CA 1.51 2.572 1 N-CA-C 121.876 4.028 . . . . 0.0 121.876 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.25 -31.9 59.78 Favored Glycine 0 N--CA 1.515 3.924 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.474 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 7.8 69.47 0.01 OUTLIER Glycine 0 N--CA 1.486 1.969 0 CA-C-N 109.67 -3.265 . . . . 0.0 120.847 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.7 t -97.84 96.53 5.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 1 N-CA-C 98.67 -4.567 . . . . 0.0 98.67 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ABA . . . . . 1.081 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 13.5 ptt? -119.88 121.72 39.67 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 122.974 1.369 . . . . 0.0 108.497 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -64.59 119.58 10.76 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.638 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -101.18 20.93 2.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 123.513 0.508 . . . . 0.0 109.684 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -26.26 -50.51 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 123.097 1.427 . . . . 0.0 109.603 -179.457 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -25.9 -49.06 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 108.829 -3.805 . . . . 0.0 113.333 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.91 -33.82 5.95 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 111.476 -2.602 . . . . 0.0 110.405 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -146.84 -80.24 0.15 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.5 p -156.8 -132.13 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.762 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.081 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -99.02 137.94 36.82 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.564 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.267 0.6 OUTLIER -148.26 -174.73 4.66 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 112.863 -1.971 . . . . 0.0 109.419 -179.615 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.474 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -124.7 157.47 35.56 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -109.33 116.4 31.78 Favored 'General case' 0 C--N 1.298 -1.649 1 N-CA-C 96.069 -5.53 . . . . 0.0 96.069 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 66.0 m -94.62 -124.71 0.11 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 118.601 -0.714 . . . . 0.0 111.023 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.54 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 5.7 p -139.64 160.28 27.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 117.787 -1.565 . . . . 0.0 109.095 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -47.51 -24.0 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 111.895 -2.411 . . . . 0.0 108.1 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -97.37 -20.25 23.25 Favored Glycine 0 C--O 1.203 -1.833 0 CA-C-O 117.716 -1.602 . . . . 0.0 114.814 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.55 ' CD1' ' HA ' ' A' ' 45' ' ' ARG . 2.1 m-30 -123.74 125.84 45.45 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 120.764 2.282 . . . . 0.0 106.805 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.527 ' H ' HG23 ' A' ' 44' ' ' THR . 47.8 t -138.17 -131.34 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.487 -1.285 . . . . 0.0 111.334 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 68.89 -6.54 3.68 Favored Glycine 0 N--CA 1.487 2.042 0 CA-C-O 117.988 -1.451 . . . . 0.0 111.513 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 11.8 t70 102.14 -12.7 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.036 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.578 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.2 OUTLIER -133.8 4.01 3.55 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.54 -178.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 62.72 32.07 16.29 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.884 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.18 -19.91 24.87 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 112.743 -2.026 . . . . 0.0 107.099 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.527 HG23 ' H ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -106.94 82.15 1.65 Allowed 'General case' 0 N--CA 1.488 1.461 1 N-CA-C 100.144 -4.021 . . . . 0.0 100.144 179.543 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.55 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 12.8 mtm180 -76.47 89.3 3.24 Favored 'General case' 0 C--N 1.296 -1.757 1 N-CA-C 99.129 -4.396 . . . . 0.0 99.129 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 36' ' ' GLY . 25.1 t70 -62.81 -25.6 68.33 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 117.344 -1.742 . . . . 0.0 108.832 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 46' ' ' ASP . 0.2 OUTLIER 89.28 -157.71 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 128.042 2.537 . . . . 0.0 108.436 179.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.509 2.492 0 CA-C-O 116.054 -1.927 . . . . 0.0 110.541 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo . . . . . 0 N--CA 1.491 1.369 0 N-CA-C 109.265 -1.09 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -119.55 167.38 13.38 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 107.068 -2.413 . . . . 0.0 107.068 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ABA . . . . . 0.593 ' H ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.593 ' HD3' ' H ' ' A' ' 6' ' ' ABA . 5.5 Cg_exo -65.91 -47.33 3.81 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 122.049 1.833 . . . . 0.0 108.147 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -19.93 -51.42 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 110.066 -3.243 . . . . 0.0 118.251 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.2 p -126.44 108.88 11.6 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.286 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.535 ' HA ' ' HB2' ' A' ' 13' ' ' TYR . 18.4 p90 -115.08 0.9 13.77 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -85.26 89.45 7.66 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.987 1.375 . . . . 0.0 110.173 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.35 28.81 4.47 Favored Glycine 0 N--CA 1.501 2.97 0 N-CA-C 106.958 -2.457 . . . . 0.0 106.958 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.535 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 20.6 t80 -90.57 -11.07 41.13 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.579 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 60.5 m -126.8 151.21 48.58 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.943 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.3 OUTLIER -104.38 -38.31 6.88 Favored 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.435 ' HB2' ' CD2' ' A' ' 37' ' ' TYR . 38.3 m-80 -147.07 -66.66 0.27 Allowed 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 120.621 3.563 . . . . 0.0 120.621 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.97 19.59 52.55 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.636 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -65.56 96.02 0.24 Allowed Glycine 0 C--N 1.295 -1.726 0 CA-C-O 124.39 2.106 . . . . 0.0 115.826 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER -92.05 102.98 14.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 101.08 -3.674 . . . . 0.0 101.08 179.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ABA . . . . . 0.976 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.52 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 4.3 ptm -134.88 161.3 35.61 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 101.9 -3.37 . . . . 0.0 101.9 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -103.99 127.94 51.54 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -105.79 21.07 3.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 123.918 0.761 . . . . 0.0 109.718 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -29.58 -49.29 0.09 Allowed 'General case' 0 N--CA 1.509 2.478 0 CA-C-O 123.528 1.632 . . . . 0.0 109.645 -179.303 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -26.88 -48.48 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.676 1 CA-C-N 108.362 -4.017 . . . . 0.0 113.34 179.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.85 -34.12 5.87 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 111.036 -2.802 . . . . 0.0 110.673 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -147.74 -79.87 0.15 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 29' ' ' TYR . 1.7 p -156.67 -134.48 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.806 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.976 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -97.55 138.56 34.78 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.57 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.273 0.5 OUTLIER -149.3 -179.17 6.85 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 112.875 -1.966 . . . . 0.0 111.757 -179.197 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.636 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -116.1 151.91 34.65 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.52 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 43.8 t30 -104.13 76.81 1.37 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.543 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 33.5 m -64.1 152.39 40.59 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.678 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.671 HG12 ' CD2' ' A' ' 37' ' ' TYR . 7.4 p -59.67 160.99 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 111.811 -2.449 . . . . 0.0 114.441 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.421 ' H ' HG22 ' A' ' 35' ' ' ILE . 1.6 tt -51.72 -21.6 2.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 111.51 -2.587 . . . . 0.0 108.784 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -95.34 -14.38 48.21 Favored Glycine 0 N--CA 1.491 2.366 0 CA-C-N 114.201 -1.363 . . . . 0.0 115.297 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.671 ' CD2' HG12 ' A' ' 34' ' ' VAL . 2.1 m-85 -131.89 127.41 36.4 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.443 ' C ' HG22 ' A' ' 44' ' ' THR . 47.3 t -136.81 -135.46 0.14 Allowed 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 118.304 -1.358 . . . . 0.0 108.744 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 69.52 0.94 26.83 Favored Glycine 0 N--CA 1.48 1.603 0 CA-C-O 116.707 -2.163 . . . . 0.0 111.701 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 5.1 t70 94.65 -11.7 0.11 Allowed 'General case' 0 N--CA 1.52 3.068 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.541 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -138.02 -2.65 1.86 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.543 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 67.85 31.47 5.75 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -179.462 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.943 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -89.04 -19.55 25.5 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 111.878 -2.419 . . . . 0.0 108.652 -179.755 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 44' ' ' THR 0.266 2.3 t -115.14 89.89 3.21 Favored 'General case' 0 C--N 1.296 -1.723 1 N-CA-C 98.541 -4.615 . . . . 0.0 98.541 179.863 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 16.5 mtm180 -87.61 93.25 9.37 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 101.77 -3.419 . . . . 0.0 101.77 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 36' ' ' GLY . 31.7 t70 -64.73 -20.31 66.27 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.0 -1.455 . . . . 0.0 108.114 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 mt 75.64 -145.51 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 126.414 1.886 . . . . 0.0 107.572 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.39 0 CA-C-O 113.645 -3.074 . . . . 0.0 113.676 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo . . . . . 0 N--CA 1.496 1.647 0 CA-C-O 122.111 0.796 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 124.35 -169.35 16.41 Favored Glycine 0 N--CA 1.499 2.859 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ABA . . . . . 0.514 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.514 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 95.5 Cg_endo -85.68 36.68 0.54 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 123.323 2.682 . . . . 0.0 108.943 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 6' ' ' ABA . 47.6 t -100.99 -26.05 13.86 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.206 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.3 t -173.27 151.96 2.14 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.57 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -129.84 12.6 5.77 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 124.41 1.068 . . . . 0.0 110.744 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -62.27 136.33 57.88 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 37.95 41.54 0.97 Allowed Glycine 0 N--CA 1.512 3.741 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 29' ' ' TYR . 37.3 t80 -91.71 -13.77 31.12 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 125.591 1.406 . . . . 0.0 113.231 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.483 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 33.7 m -121.79 155.08 36.08 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.857 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -108.2 -37.91 5.9 Favored 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.561 HD21 ' CZ ' ' A' ' 45' ' ' ARG . 25.7 m-80 -143.12 -80.57 0.2 Allowed 'General case' 0 N--CA 1.514 2.752 0 N-CA-C 119.471 3.137 . . . . 0.0 119.471 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.05 -24.6 63.19 Favored Glycine 0 N--CA 1.51 3.61 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.626 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 4.55 63.92 0.0 OUTLIER Glycine 0 N--CA 1.481 1.662 0 N-CA-C 120.823 3.089 . . . . 0.0 120.823 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 19' ' ' VAL . 1.8 t -94.24 96.32 5.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 102.4 -3.185 . . . . 0.0 102.4 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ABA . . . . . 1.043 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.487 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 9.6 ptm -122.08 172.92 7.89 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.439 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -109.34 129.0 55.54 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.58 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -106.09 13.94 7.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 124.039 0.837 . . . . 0.0 111.87 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -22.78 -54.88 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 124.815 1.322 . . . . 0.0 112.008 -179.41 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.6 m -26.52 -45.18 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 110.921 -2.854 . . . . 0.0 114.3 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.53 -36.98 5.61 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 111.361 -2.654 . . . . 0.0 109.939 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -147.96 -81.77 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.2 p -156.87 -133.25 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.436 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.043 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -96.25 139.48 32.33 Favored 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.474 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -147.92 178.72 8.28 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 113.073 -1.876 . . . . 0.0 109.95 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.626 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -118.15 146.64 44.03 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.487 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 56.9 t30 -99.55 104.61 16.42 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 101.558 -3.497 . . . . 0.0 101.558 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 61.6 m -84.13 177.38 8.25 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.988 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.644 HG12 ' CD2' ' A' ' 37' ' ' TYR . 14.5 p -80.3 159.54 4.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 123.003 1.383 . . . . 0.0 112.712 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -46.84 -22.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-N 111.618 -2.537 . . . . 0.0 108.99 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -97.2 -15.88 37.01 Favored Glycine 0 C--O 1.203 -1.783 0 CA-C-N 113.615 -1.63 . . . . 0.0 116.534 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.644 ' CD2' HG12 ' A' ' 34' ' ' VAL . 4.4 m-30 -123.52 121.41 35.59 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 103.535 -2.765 . . . . 0.0 103.535 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.444 ' C ' HG22 ' A' ' 44' ' ' THR . 15.2 t -130.1 -142.54 0.24 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.385 1.088 . . . . 0.0 113.306 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 40' ' ' ASP . . . 86.33 -47.84 3.82 Favored Glycine 0 C--N 1.301 -1.406 0 N-CA-C 106.514 -2.634 . . . . 0.0 106.514 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER 139.31 -6.68 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.983 0 O-C-N 126.807 2.122 . . . . 0.0 112.291 -179.569 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.695 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -134.58 -1.9 2.76 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.14 -178.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.54 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 69.64 35.36 2.45 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 104.991 -2.225 . . . . 0.0 104.991 -179.28 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.857 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.06 -13.74 37.98 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 112.599 -2.091 . . . . 0.0 108.846 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.512 ' O ' HG23 ' A' ' 44' ' ' THR . 5.0 t -122.54 92.62 3.75 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 103.07 -2.937 . . . . 0.0 103.07 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.561 ' CZ ' HD21 ' A' ' 16' ' ' ASN . 0.1 OUTLIER -83.94 97.18 9.1 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' GLY . 30.2 t70 -66.11 -29.58 69.92 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 116.633 -2.027 . . . . 0.0 108.474 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 mt 96.64 -147.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 127.523 2.329 . . . . 0.0 106.82 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.506 2.355 0 CA-C-O 115.003 -2.427 . . . . 0.0 111.322 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.493 1.468 0 N-CA-C 110.25 -0.712 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.77 -179.8 16.05 Favored Glycine 0 N--CA 1.498 2.816 0 C-N-CA 120.031 -1.081 . . . . 0.0 110.473 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ABA . . . . . 0.619 ' H ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.619 ' HD3' ' H ' ' A' ' 6' ' ' ABA . 1.1 Cg_endo -68.74 -47.97 1.15 Allowed 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.109 1.872 . . . . 0.0 108.179 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.2 m -21.27 -41.58 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 111.597 -2.547 . . . . 0.0 117.614 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.2 m -145.06 119.93 9.94 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.428 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 4.0 p90 -114.48 15.48 17.84 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 122.379 1.085 . . . . 0.0 111.058 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.51 133.25 36.49 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.41 32.86 31.23 Favored Glycine 0 N--CA 1.506 3.347 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.481 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 23.9 t80 -90.37 -13.2 35.54 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 113.935 -1.133 . . . . 0.0 112.951 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.405 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 16.0 m -128.95 143.61 50.93 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.941 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.5 OUTLIER -97.62 -33.02 11.49 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 123.58 0.55 . . . . 0.0 112.41 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -149.08 -85.96 0.09 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 120.515 3.524 . . . . 0.0 120.515 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 33' ' ' CYS . . . -48.7 -32.69 11.29 Favored Glycine 0 N--CA 1.513 3.785 0 CA-C-O 123.136 1.409 . . . . 0.0 109.684 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.5 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 8.11 64.84 0.01 OUTLIER Glycine 0 N--CA 1.48 1.599 0 CA-C-N 109.521 -3.339 . . . . 0.0 121.198 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 19' ' ' VAL . 1.3 t -95.14 95.02 4.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 1 N-CA-C 99.885 -4.117 . . . . 0.0 99.885 179.273 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ABA . . . . . 1.039 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.3 ptp -119.31 161.11 21.0 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -101.79 123.74 46.26 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.628 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -102.54 22.78 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 124.757 1.286 . . . . 0.0 111.489 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -36.3 -37.55 0.12 Allowed 'General case' 0 N--CA 1.516 2.852 0 CA-C-O 123.79 1.757 . . . . 0.0 110.353 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 23' ' ' ILE . 0.7 OUTLIER -34.91 -45.95 0.29 Allowed 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 110.077 -3.238 . . . . 0.0 111.44 179.172 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.59 -33.83 5.08 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 111.517 -2.583 . . . . 0.0 110.481 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.67 -79.97 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.0 OUTLIER -156.65 -135.47 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 118.38 -1.328 . . . . 0.0 109.855 -179.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.039 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.2 OUTLIER -94.78 140.44 29.91 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.575 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -151.21 -174.5 4.83 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 113.097 -1.865 . . . . 0.0 110.712 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.5 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -125.42 153.45 43.43 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -105.9 118.47 36.68 Favored 'General case' 0 C--N 1.3 -1.548 1 N-CA-C 98.29 -4.707 . . . . 0.0 98.29 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.511 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 76.3 m -98.8 166.45 11.3 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.634 HG13 ' H ' ' A' ' 37' ' ' TYR . 3.4 p -65.24 157.43 5.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 C-N-CA 118.141 -1.424 . . . . 0.0 111.064 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -41.78 -24.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 111.864 -2.426 . . . . 0.0 111.934 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.413 ' H ' HG22 ' A' ' 34' ' ' VAL . . . -100.53 -27.39 7.63 Favored Glycine 0 N--CA 1.484 1.838 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.82 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.634 ' H ' HG13 ' A' ' 34' ' ' VAL . 4.2 m-30 -98.91 120.58 39.6 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 104.019 -2.585 . . . . 0.0 104.019 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.4 t -130.91 -135.54 0.2 Allowed 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 118.175 -1.41 . . . . 0.0 112.398 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.508 ' C ' ' NE2' ' A' ' 43' ' ' GLN . . . 69.99 -8.58 3.48 Favored Glycine 0 N--CA 1.483 1.802 0 CA-C-O 117.4 -1.778 . . . . 0.0 110.622 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 16.7 t70 100.11 -2.83 0.03 OUTLIER 'General case' 0 N--CA 1.523 3.209 0 C-N-CA 124.004 0.922 . . . . 0.0 113.184 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.567 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -140.66 1.41 1.72 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -178.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 64.39 33.91 10.86 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 -179.383 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.941 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -88.47 -23.86 23.14 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 111.993 -2.367 . . . . 0.0 110.737 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.494 ' O ' HG23 ' A' ' 44' ' ' THR . 5.9 t -112.23 86.6 2.38 Favored 'General case' 0 C--N 1.294 -1.806 1 N-CA-C 98.201 -4.741 . . . . 0.0 98.201 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 14.9 mtm180 -77.04 87.2 3.54 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 110.849 -2.887 . . . . 0.0 104.647 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 48' ' ' ARG . 5.9 t70 -83.7 67.05 9.33 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 mp -2.64 31.02 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 1 N-CA-C 122.885 4.402 . . . . 0.0 122.885 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.474 ' N ' ' O ' ' A' ' 46' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 116.494 -1.717 . . . . 0.0 113.179 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo . . . . . 0 N--CA 1.49 1.293 0 N-CA-C 108.026 -1.567 . . . . 0.0 108.026 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.32 -170.01 13.84 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ABA . . . . . 0.663 ' H ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.663 ' HD3' ' H ' ' A' ' 6' ' ' ABA . 6.8 Cg_endo -68.82 -41.77 5.28 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 122.529 2.152 . . . . 0.0 108.325 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m -20.15 -50.52 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 109.944 -3.298 . . . . 0.0 116.413 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.19 127.82 17.11 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.543 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 1.0 OUTLIER -117.14 8.97 13.42 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 124.02 0.825 . . . . 0.0 112.074 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -69.38 138.25 53.48 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 41.25 37.53 1.64 Allowed Glycine 0 N--CA 1.507 3.402 0 O-C-N 124.43 1.081 . . . . 0.0 110.775 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.426 ' CD1' ' CZ ' ' A' ' 29' ' ' TYR . 30.9 t80 -91.25 -17.22 26.35 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 114.063 -1.068 . . . . 0.0 113.813 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.455 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 41.5 m -116.85 154.68 30.34 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.983 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -107.71 -37.97 6.0 Favored 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 115.086 1.514 . . . . 0.0 115.086 -179.65 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.553 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 3.8 m-80 -139.19 -83.21 0.27 Allowed 'General case' 0 N--CA 1.509 2.513 0 N-CA-C 120.133 3.383 . . . . 0.0 120.133 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.75 -24.22 64.14 Favored Glycine 0 N--CA 1.511 3.669 0 N-CA-C 108.849 -1.701 . . . . 0.0 108.849 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.577 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 5.38 65.39 0.01 OUTLIER Glycine 0 N--CA 1.478 1.495 0 N-CA-C 120.449 2.94 . . . . 0.0 120.449 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.73 96.5 5.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 100.734 -3.802 . . . . 0.0 100.734 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ABA . . . . . 1.055 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.56 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 7.2 ptm -121.25 121.2 37.21 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 123.073 1.416 . . . . 0.0 109.089 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -63.31 120.44 11.58 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 179.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.647 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -102.78 23.69 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 123.714 0.634 . . . . 0.0 110.367 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.5 OUTLIER -33.5 -42.06 0.1 Allowed 'General case' 0 N--CA 1.511 2.607 0 CA-C-O 123.722 1.725 . . . . 0.0 109.696 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -30.89 -46.54 0.08 Allowed 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 109.632 -3.44 . . . . 0.0 111.992 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.49 -35.51 4.56 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 111.572 -2.558 . . . . 0.0 109.779 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -146.71 -82.82 0.13 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 117.419 2.377 . . . . 0.0 117.419 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.3 p -153.11 -131.39 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.594 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.055 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -100.3 135.84 41.11 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.531 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.25 0.6 OUTLIER -146.5 -179.05 6.5 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.103 -2.317 . . . . 0.0 109.119 -179.42 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.577 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -121.16 153.67 37.22 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.56 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 60.5 t30 -106.72 104.28 13.92 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 101.77 -3.419 . . . . 0.0 101.77 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 57.5 m -88.71 156.72 18.83 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.19 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.65 HG12 ' CD2' ' A' ' 37' ' ' TYR . 12.2 p -59.83 159.93 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 113.019 -1.9 . . . . 0.0 114.319 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -48.56 -22.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 110.884 -2.871 . . . . 0.0 109.126 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -98.39 -11.84 46.91 Favored Glycine 0 N--CA 1.485 1.933 0 CA-C-O 117.832 -1.538 . . . . 0.0 116.588 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.65 ' CD2' HG12 ' A' ' 34' ' ' VAL . 3.1 m-30 -126.8 121.7 32.66 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.451 ' C ' HG22 ' A' ' 44' ' ' THR . 48.2 t -132.32 -134.59 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.725 -1.19 . . . . 0.0 110.868 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 74.61 -13.12 5.31 Favored Glycine 0 N--CA 1.485 1.953 0 CA-C-O 117.894 -1.504 . . . . 0.0 110.166 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 27.9 t70 104.62 -7.57 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.884 0 C-N-CA 124.419 1.087 . . . . 0.0 113.672 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.612 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -137.28 -2.26 2.05 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.498 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 70.27 31.2 3.19 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 -179.248 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.983 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -88.38 -11.96 44.68 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 113.699 -1.592 . . . . 0.0 109.82 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 44' ' ' THR 0.253 5.3 t -121.54 85.95 2.49 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 101.545 -3.502 . . . . 0.0 101.545 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.45 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 1.2 mtm180 -78.35 88.68 4.37 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 36' ' ' GLY . 24.1 t70 -61.01 -20.61 62.7 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.247 -1.797 . . . . 0.0 108.544 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 72.49 25.59 2.69 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 124.905 1.378 . . . . 0.0 112.379 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.429 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo . . . . . 0 N--CA 1.493 1.463 0 N-CA-C 110.642 -0.561 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.54 157.0 7.13 Favored Glycine 0 N--CA 1.497 2.726 0 C-N-CA 119.979 -1.105 . . . . 0.0 111.937 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ABA . . . . . 0.466 ' C ' ' H ' ' A' ' 8' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 62.3 Cg_endo -84.18 18.03 1.61 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.377 2.718 . . . . 0.0 110.058 -172.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 6' ' ' ABA . 0.5 OUTLIER -97.21 -21.62 17.19 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 113.381 -1.736 . . . . 0.0 109.071 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.0 t -150.09 121.21 7.75 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -121.38 29.03 7.45 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 123.291 1.519 . . . . 0.0 107.795 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -101.01 134.37 44.1 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.15 23.9 60.26 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -91.94 -26.12 18.57 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.786 -1.207 . . . . 0.0 113.252 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.589 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 33.8 m -124.23 150.34 45.4 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -111.07 -37.85 5.23 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -179.24 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.539 ' ND2' ' HD2' ' A' ' 45' ' ' ARG . 34.3 m-80 -149.82 -59.91 0.2 Allowed 'General case' 0 N--CA 1.509 2.508 0 N-CA-C 118.57 2.804 . . . . 0.0 118.57 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -107.2 18.71 35.79 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 106.875 -2.49 . . . . 0.0 106.875 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.615 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -72.46 94.73 0.66 Allowed Glycine 0 C--N 1.296 -1.661 0 CA-C-O 123.926 1.848 . . . . 0.0 113.631 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.6 t -91.88 103.1 14.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 102.779 -3.045 . . . . 0.0 102.779 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ABA . . . . . 0.995 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.474 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 21.8 ptt? -116.57 129.69 56.32 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 123.401 1.572 . . . . 0.0 108.863 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.8 OUTLIER -73.61 119.14 17.43 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.103 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.643 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -104.11 23.77 2.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 124.279 0.987 . . . . 0.0 111.025 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -38.84 -37.18 0.32 Allowed 'General case' 0 N--CA 1.514 2.755 0 CA-C-O 123.707 1.718 . . . . 0.0 109.262 -179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.402 ' N ' ' C ' ' A' ' 23' ' ' ILE . 1.3 m -32.78 -43.42 0.09 Allowed 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 110.035 -3.257 . . . . 0.0 111.902 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.454 HD11 HG12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -119.3 -36.58 3.34 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 111.358 -2.656 . . . . 0.0 110.949 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -144.49 -84.6 0.14 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 23' ' ' ILE . 11.2 p -149.8 -131.56 0.05 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.495 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.995 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -98.54 143.74 28.62 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 179.544 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.534 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.258 0.6 OUTLIER -151.13 175.01 12.55 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 125.776 1.923 . . . . 0.0 111.03 -179.374 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.615 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -118.95 136.61 54.0 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.474 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 50.5 t30 -93.16 77.23 4.6 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.108 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.434 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 65.9 m -61.26 146.67 47.07 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.516 1.15 . . . . 0.0 110.681 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.621 HG12 ' CD2' ' A' ' 37' ' ' TYR . 10.5 p -58.97 161.98 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 112.332 -2.213 . . . . 0.0 115.403 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tt -49.83 -20.12 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 111.541 -2.572 . . . . 0.0 109.315 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.59 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -98.98 -18.35 25.02 Favored Glycine 0 C--O 1.202 -1.851 0 CA-C-O 117.48 -1.733 . . . . 0.0 114.34 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.621 ' CD2' HG12 ' A' ' 34' ' ' VAL . 1.9 m-30 -123.31 129.81 51.86 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 120.27 2.035 . . . . 0.0 107.269 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.634 ' H ' HG23 ' A' ' 44' ' ' THR . 0.3 OUTLIER -125.29 -159.46 0.89 Allowed 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -179.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 88.59 -47.82 3.48 Favored Glycine 0 N--CA 1.494 2.529 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.288 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 27.7 t70 124.28 -0.42 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.038 0 O-C-N 126.719 2.07 . . . . 0.0 109.198 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -117.95 -28.67 5.85 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.434 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 3.0 m 82.7 37.86 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.931 ' NE2' HG22 ' A' ' 44' ' ' THR . 2.6 pp0? -88.96 -21.43 23.55 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 110.665 -2.971 . . . . 0.0 107.425 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.931 HG22 ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -110.01 83.34 1.74 Allowed 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 101.835 -3.394 . . . . 0.0 101.835 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.539 ' HD2' ' ND2' ' A' ' 16' ' ' ASN . 1.1 mtm180 -78.77 89.19 4.62 Favored 'General case' 0 C--N 1.299 -1.622 1 N-CA-C 98.906 -4.479 . . . . 0.0 98.906 179.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.59 ' N ' ' O ' ' A' ' 36' ' ' GLY . 29.2 t0 -58.51 -23.0 57.03 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 111.849 -2.432 . . . . 0.0 107.192 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 mt 62.98 6.17 2.12 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 112.668 -2.06 . . . . 0.0 115.077 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.588 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.42 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 N--CA 1.496 1.624 0 N-CA-C 110.197 -0.732 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' A' ' 28' ' ' SER . . . 139.54 -178.56 19.55 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 119.564 -1.303 . . . . 0.0 112.597 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ABA . . . . . 0.632 ' H ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.632 ' HD3' ' H ' ' A' ' 6' ' ' ABA . 69.1 Cg_endo -78.21 16.76 1.14 Allowed 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.708 2.272 . . . . 0.0 111.478 -173.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.522 ' H ' ' C ' ' A' ' 6' ' ' ABA . 6.0 t -100.99 -19.3 15.91 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.249 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.9 m -154.95 128.96 8.8 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.516 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 2.7 p90 -124.83 8.91 8.18 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -69.24 142.73 54.12 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 39.71 39.46 1.31 Allowed Glycine 0 N--CA 1.507 3.405 0 O-C-N 124.518 1.136 . . . . 0.0 110.87 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.477 ' HD1' ' HH ' ' A' ' 29' ' ' TYR . 38.6 t80 -91.34 -15.81 28.46 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 125.383 1.284 . . . . 0.0 113.414 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.484 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 58.2 m -119.72 157.19 29.06 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.902 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -110.72 -38.38 5.17 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.457 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 11.8 m-80 -140.58 -77.84 0.3 Allowed 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 121.486 3.884 . . . . 0.0 121.486 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.54 -17.76 73.05 Favored Glycine 0 N--CA 1.507 3.377 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.627 ' HA2' ' SG ' ' A' ' 31' ' ' CYS . . . 2.71 62.92 0.0 OUTLIER Glycine 0 C--N 1.302 -1.352 0 N-CA-C 120.091 2.796 . . . . 0.0 120.091 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 19' ' ' VAL . 1.6 t -91.6 96.56 6.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 101.762 -3.421 . . . . 0.0 101.762 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ABA . . . . . 0.923 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.7 ptm -137.51 159.87 40.74 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 102.525 -3.139 . . . . 0.0 102.525 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -102.4 129.51 48.9 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.615 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -105.19 19.47 4.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 124.053 0.846 . . . . 0.0 112.309 -179.556 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -29.11 -49.87 0.08 Allowed 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 122.811 1.291 . . . . 0.0 112.008 -179.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.4 m -31.44 -43.64 0.06 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 110.99 -2.823 . . . . 0.0 114.151 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.59 -32.68 6.1 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 112.063 -2.335 . . . . 0.0 111.094 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -149.61 -80.14 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.43 ' CB ' ' HA3' ' A' ' 5' ' ' GLY . 1.5 p -158.33 -133.2 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.879 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.923 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -97.04 139.36 33.16 Favored 'General case' 0 N--CA 1.51 2.554 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.538 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 1.2 t -147.34 -171.34 3.77 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.305 -1.771 . . . . 0.0 112.914 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.627 ' SG ' ' HA2' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -125.46 151.28 46.47 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 179.275 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -107.82 103.17 12.37 Favored 'General case' 0 C--N 1.3 -1.577 1 N-CA-C 99.53 -4.248 . . . . 0.0 99.53 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 83.4 m -87.69 170.74 10.99 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.415 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.596 HG12 ' CD2' ' A' ' 37' ' ' TYR . 14.2 p -67.69 163.6 2.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-O 123.304 1.526 . . . . 0.0 112.582 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.463 ' H ' HG22 ' A' ' 35' ' ' ILE . 1.2 tt -53.34 -18.11 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 112.044 -2.343 . . . . 0.0 108.851 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -100.03 -22.21 12.4 Favored Glycine 0 C--O 1.199 -2.081 0 CA-C-N 113.507 -1.679 . . . . 0.0 114.16 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.596 ' CD2' HG12 ' A' ' 34' ' ' VAL . 2.8 m-30 -118.96 130.21 55.58 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 121.149 2.475 . . . . 0.0 104.676 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.404 ' C ' ' H ' ' A' ' 40' ' ' ASP . 22.9 t -142.07 -136.24 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 117.545 -1.662 . . . . 0.0 113.767 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 40' ' ' ASP . . . 86.64 -42.37 3.15 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 107.744 -2.142 . . . . 0.0 107.744 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 0.8 OUTLIER 137.68 -2.03 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.796 0 O-C-N 126.017 1.657 . . . . 0.0 110.135 -179.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.583 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -140.93 -7.06 1.08 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -178.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.49 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 73.79 35.07 0.85 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 -178.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.902 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.6 OUTLIER -88.39 -17.68 30.0 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 112.015 -2.357 . . . . 0.0 107.727 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.538 ' O ' HG23 ' A' ' 44' ' ' THR . 5.1 t -120.02 88.36 2.92 Favored 'General case' 0 C--N 1.299 -1.588 1 N-CA-C 99.745 -4.168 . . . . 0.0 99.745 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.412 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 13.7 mtm180 -83.46 96.34 8.55 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 101.841 -3.392 . . . . 0.0 101.841 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 36' ' ' GLY . 28.1 t70 -83.93 69.75 10.33 Favored 'General case' 0 C--N 1.294 -1.81 1 N-CA-C 99.926 -4.102 . . . . 0.0 99.926 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.405 HD12 ' CE1' ' A' ' 37' ' ' TYR . 3.4 mp -44.37 120.25 2.13 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.457 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 116.792 -1.575 . . . . 0.0 111.483 179.936 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 N--CA 1.499 1.823 0 CA-C-O 120.386 0.078 . . . . 0.0 111.951 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.47 ' HA3' ' CB ' ' A' ' 28' ' ' SER . . . 124.65 175.21 14.23 Favored Glycine 0 N--CA 1.505 3.286 0 CA-C-O 119.01 -0.883 . . . . 0.0 112.689 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ABA . . . . . 0.682 ' H ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.682 ' HD3' ' H ' ' A' ' 6' ' ' ABA . 95.2 Cg_endo -76.41 11.86 1.74 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 123.591 2.861 . . . . 0.0 111.777 -159.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.476 ' H ' ' C ' ' A' ' 6' ' ' ABA . 0.1 OUTLIER -91.25 -23.82 20.06 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.778 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 t -153.25 126.77 8.7 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.567 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 4.1 p90 -121.38 20.01 11.29 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 122.146 0.974 . . . . 0.0 109.004 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -72.46 121.47 19.64 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.463 ' O ' ' NH2' ' A' ' 41' ' ' ARG . . . 53.13 40.99 60.16 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.433 ' OH ' ' HA ' ' A' ' 30' ' ' THR . 7.0 t80 -91.27 -16.17 28.0 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.546 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 4.7 m -122.61 161.49 23.66 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.522 HD12 ' HD2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -115.63 -37.17 4.03 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 117.885 2.55 . . . . 0.0 117.885 -179.203 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.514 ' ND2' ' HD3' ' A' ' 45' ' ' ARG . 34.1 m-80 -146.22 -69.98 0.26 Allowed 'General case' 0 N--CA 1.515 2.82 0 N-CA-C 120.341 3.46 . . . . 0.0 120.341 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.11 -25.38 59.75 Favored Glycine 0 N--CA 1.506 3.352 0 N-CA-C 107.834 -2.107 . . . . 0.0 107.834 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.546 ' HA3' ' HB3' ' A' ' 14' ' ' CYS . . . -6.8 74.78 0.0 OUTLIER Glycine 0 N--CA 1.484 1.898 0 N-CA-C 118.842 2.297 . . . . 0.0 118.842 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 t -90.5 102.2 13.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 100.429 -3.915 . . . . 0.0 100.429 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ABA . . . . . 1.019 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.42 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 4.4 ptm -117.04 131.59 56.9 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 113.011 -1.904 . . . . 0.0 108.93 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -76.2 113.67 14.01 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -94.8 21.85 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.174 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.47 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.6 OUTLIER -37.63 -38.94 0.29 Allowed 'General case' 0 N--CA 1.514 2.764 0 CA-C-O 123.117 1.437 . . . . 0.0 109.267 -179.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -31.09 -43.63 0.05 Allowed 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 109.927 -3.306 . . . . 0.0 111.477 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.95 -38.18 3.11 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 111.152 -2.749 . . . . 0.0 109.998 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -145.98 -82.44 0.14 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 119.432 3.123 . . . . 0.0 119.432 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.1 p -150.95 -139.63 0.09 Allowed 'General case' 0 N--CA 1.509 2.495 0 C-N-CA 118.639 -1.224 . . . . 0.0 110.732 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.019 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -95.36 138.74 32.64 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 179.39 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.5 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.331 0.4 OUTLIER -150.47 178.79 8.71 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 112.2 -2.273 . . . . 0.0 110.332 -179.403 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.487 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -122.68 142.46 50.65 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.06 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.42 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 0.3 OUTLIER -102.84 110.75 22.79 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 100.867 -3.753 . . . . 0.0 100.867 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 76.2 m -84.27 -119.86 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.413 -1.315 . . . . 0.0 112.792 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.519 HG13 ' N ' ' A' ' 37' ' ' TYR . 9.1 p -144.07 165.05 14.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 122.646 1.212 . . . . 0.0 110.806 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -52.65 -18.83 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 CA-C-N 112.135 -2.302 . . . . 0.0 107.73 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -105.55 -15.17 19.8 Favored Glycine 0 N--CA 1.482 1.742 0 CA-C-O 117.563 -1.687 . . . . 0.0 115.716 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.519 ' N ' HG13 ' A' ' 34' ' ' VAL . 3.9 m-85 -131.87 123.96 28.57 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.587 ' H ' HG23 ' A' ' 44' ' ' THR . 7.9 t -132.73 -147.57 0.31 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 87.48 -50.08 3.99 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.412 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER 136.59 -9.53 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.025 0 O-C-N 126.923 2.19 . . . . 0.0 109.002 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.522 ' HD2' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -114.31 -26.07 8.16 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.3 -178.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 1.2 m 79.82 35.88 0.14 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.737 ' NE2' HG22 ' A' ' 44' ' ' THR . 2.9 pp0? -88.82 -24.71 22.51 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 110.702 -2.954 . . . . 0.0 105.97 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.737 HG22 ' NE2' ' A' ' 43' ' ' GLN . 1.0 OUTLIER -106.31 89.73 3.14 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 102.469 -3.16 . . . . 0.0 102.469 179.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.514 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 4.3 mtm180 -84.93 90.8 7.89 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 101.572 -3.492 . . . . 0.0 101.572 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' GLY . 29.3 t70 -59.25 -20.1 51.42 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 111.693 -2.503 . . . . 0.0 107.882 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 65.47 49.29 1.88 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.881 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.558 ' H ' ' CA ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 115.934 -1.984 . . . . 0.0 111.249 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.493 1.46 0 N-CA-C 109.835 -0.871 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 145.8 172.78 16.46 Favored Glycine 0 N--CA 1.499 2.858 0 C-N-CA 118.987 -1.578 . . . . 0.0 115.238 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ABA . . . . . 0.455 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.455 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 63.4 Cg_endo -83.07 9.62 4.01 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 123.647 2.898 . . . . 0.0 111.506 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.22 -20.87 47.18 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.829 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 t -158.08 133.25 8.69 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.537 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 3.4 p90 -128.5 36.99 4.19 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.742 1.258 . . . . 0.0 108.05 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -100.45 130.3 46.52 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 47.3 33.75 8.09 Favored Glycine 0 N--CA 1.506 3.338 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -91.77 -20.37 21.59 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 125.315 1.244 . . . . 0.0 112.315 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.462 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 34.2 m -118.56 158.31 25.65 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 103.318 -2.845 . . . . 0.0 103.318 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.525 HD12 ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -112.25 -36.69 5.24 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.485 ' ND2' ' HD3' ' A' ' 45' ' ' ARG . 39.8 m-80 -146.77 -77.05 0.18 Allowed 'General case' 0 N--CA 1.51 2.57 0 N-CA-C 119.053 2.983 . . . . 0.0 119.053 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.16 -23.56 69.86 Favored Glycine 0 N--CA 1.507 3.425 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.476 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -3.01 67.63 0.0 OUTLIER Glycine 0 N--CA 1.488 2.126 0 N-CA-C 122.1 3.6 . . . . 0.0 122.1 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.44 95.26 5.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 1 N-CA-C 100.172 -4.01 . . . . 0.0 100.172 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ABA . . . . . 1.055 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.493 ' SD ' ' ND2' ' A' ' 32' ' ' ASN . 8.3 ptm -122.49 126.89 48.8 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 123.147 1.451 . . . . 0.0 109.166 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.675 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -68.16 117.56 10.15 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.647 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -101.01 23.65 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.544 -179.532 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.486 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.7 OUTLIER -29.07 -49.25 0.08 Allowed 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 123.353 1.549 . . . . 0.0 109.034 -179.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -26.12 -49.29 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 108.656 -3.884 . . . . 0.0 113.165 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.51 -34.52 5.83 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 111.768 -2.469 . . . . 0.0 109.339 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -146.95 -81.12 0.14 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 23' ' ' ILE . 3.4 p -156.15 -132.07 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.468 -1.293 . . . . 0.0 110.129 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.055 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -98.45 137.17 37.53 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 179.67 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.541 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -148.57 -175.93 5.12 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 125.818 1.949 . . . . 0.0 110.246 -179.456 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.476 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -125.9 152.93 44.92 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.493 ' ND2' ' SD ' ' A' ' 21' ' ' MET . 4.0 t-20 -109.88 119.82 40.55 Favored 'General case' 0 C--N 1.298 -1.665 1 N-CA-C 96.346 -5.428 . . . . 0.0 96.346 179.612 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 37' ' ' TYR . 72.6 m -96.06 -111.89 0.14 Allowed 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 118.684 -1.206 . . . . 0.0 110.385 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.598 ' CG1' ' CD2' ' A' ' 37' ' ' TYR . 4.2 p -146.92 161.29 8.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 C-N-CA 118.617 -1.233 . . . . 0.0 108.139 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.419 ' H ' HG22 ' A' ' 35' ' ' ILE . 0.6 OUTLIER -46.62 -25.37 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 112.125 -2.307 . . . . 0.0 109.157 179.5 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.567 ' HA3' ' H ' ' A' ' 48' ' ' ARG . . . -106.84 1.6 35.98 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 118.495 2.158 . . . . 0.0 118.495 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.598 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 5.5 m-30 -135.55 120.32 18.43 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 100.283 -3.969 . . . . 0.0 100.283 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.624 ' H ' HG23 ' A' ' 44' ' ' THR . 7.4 t -131.77 -150.41 0.42 Allowed 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.19 -40.12 3.0 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 122.59 4.23 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.563 0 C-N-CA 127.073 2.149 . . . . 0.0 107.945 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.525 ' NE ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -127.69 -21.74 3.7 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.265 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER 77.0 35.79 0.35 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 -179.462 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.818 ' NE2' HG22 ' A' ' 44' ' ' THR . 2.7 pp0? -88.61 -21.47 23.99 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 111.423 -2.626 . . . . 0.0 107.307 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.818 HG22 ' NE2' ' A' ' 43' ' ' GLN . 1.7 t -113.5 87.85 2.7 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 102.117 -3.29 . . . . 0.0 102.117 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.485 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 8.3 mtm180 -84.3 88.31 7.24 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 101.504 -3.517 . . . . 0.0 101.504 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 36' ' ' GLY . 32.4 t70 -55.32 -27.35 46.42 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.787 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 75.5 mt 91.48 64.16 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.574 0 C-N-CA 128.101 2.56 . . . . 0.0 117.263 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.567 ' H ' ' HA3' ' A' ' 36' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 116.295 -1.812 . . . . 0.0 109.906 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.493 1.476 0 CA-C-O 123.329 1.304 . . . . 0.0 108.717 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -120.44 168.25 13.87 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 107.037 -2.425 . . . . 0.0 107.037 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ABA . . . . . 0.415 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 7.7 Cg_exo -68.37 -44.61 3.27 Favored 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 122.134 1.889 . . . . 0.0 108.542 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -19.82 -54.81 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 110.801 -2.909 . . . . 0.0 117.621 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.89 116.71 19.05 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.582 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 2.7 p90 -114.5 2.47 14.62 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -70.38 140.47 52.12 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.34 42.37 2.48 Favored Glycine 0 N--CA 1.505 3.3 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.412 ' CD1' ' CZ ' ' A' ' 29' ' ' TYR . 35.9 t80 -91.17 -19.12 23.42 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 125.177 1.163 . . . . 0.0 113.258 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.437 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 35.6 m -116.21 154.85 29.35 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.861 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -107.14 -35.72 6.77 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.642 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 2.1 m-80 -141.35 -83.09 0.21 Allowed 'General case' 0 N--CA 1.51 2.571 0 N-CA-C 120.84 3.644 . . . . 0.0 120.84 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.87 -26.12 66.73 Favored Glycine 0 N--CA 1.508 3.48 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.61 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 6.97 65.68 0.01 OUTLIER Glycine 0 N--CA 1.481 1.649 0 CA-C-N 110.275 -2.963 . . . . 0.0 120.127 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -94.17 97.09 6.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 102.768 -3.049 . . . . 0.0 102.768 179.306 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ABA . . . . . 0.995 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.57 ' HE3' HD13 ' A' ' 23' ' ' ILE . 5.5 ptt? -137.6 171.85 13.84 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 102.815 -3.031 . . . . 0.0 102.815 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.432 ' CE1' ' HG2' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -111.16 127.73 55.68 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.602 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -105.53 14.06 7.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 123.911 0.757 . . . . 0.0 110.644 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -20.12 -56.93 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.631 0 CA-C-O 123.893 1.806 . . . . 0.0 111.652 -179.028 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -26.26 -49.14 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.034 1 CA-C-N 108.259 -4.064 . . . . 0.0 113.723 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.37 -36.34 6.54 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 111.424 -2.625 . . . . 0.0 109.149 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -146.53 -81.14 0.15 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.455 ' H ' HG22 ' A' ' 23' ' ' ILE . 8.2 p -157.32 -132.7 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.951 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.995 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -97.21 140.56 31.52 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.551 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.264 0.5 OUTLIER -152.59 -177.89 6.51 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 112.753 -2.021 . . . . 0.0 109.578 -179.272 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.61 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -117.6 156.67 27.73 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -108.08 100.46 9.79 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 100.633 -3.84 . . . . 0.0 100.633 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.431 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 57.3 m -86.83 160.2 18.84 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.677 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.796 HG12 ' CD2' ' A' ' 37' ' ' TYR . 14.6 p -61.71 160.71 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-O 123.197 1.475 . . . . 0.0 111.658 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.415 HG22 ' H ' ' A' ' 35' ' ' ILE . 2.0 tt -52.51 -19.49 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 111.423 -2.626 . . . . 0.0 109.946 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -101.91 -0.72 51.97 Favored Glycine 0 N--CA 1.491 2.328 0 CA-C-N 114.076 -1.42 . . . . 0.0 115.692 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.796 ' CD2' HG12 ' A' ' 34' ' ' VAL . 9.4 m-30 -133.67 118.59 18.34 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.459 ' C ' HG22 ' A' ' 44' ' ' THR . 35.3 t -132.44 -134.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.741 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 71.63 -10.81 3.65 Favored Glycine 0 N--CA 1.486 1.969 0 CA-C-O 117.709 -1.606 . . . . 0.0 111.634 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 17.7 t70 105.0 -8.24 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.144 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.612 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -138.35 -1.05 1.94 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 69.34 30.95 4.02 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 -179.199 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.861 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -89.04 -16.68 31.04 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.204 -1.816 . . . . 0.0 110.107 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.465 ' O ' HG23 ' A' ' 44' ' ' THR 0.258 5.1 t -118.4 92.9 3.94 Favored 'General case' 0 C--N 1.297 -1.692 1 N-CA-C 99.668 -4.197 . . . . 0.0 99.668 179.995 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 19.0 mtm180 -88.36 92.28 9.11 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 112.249 -2.25 . . . . 0.0 105.832 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 36' ' ' GLY . 28.6 t70 -56.2 -27.34 54.3 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 125.833 1.958 . . . . 0.0 109.914 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER 76.81 117.59 0.06 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 126.066 2.104 . . . . 0.0 113.662 179.556 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 115.802 -2.047 . . . . 0.0 110.41 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo . . . . . 0 N--CA 1.492 1.424 0 N-CA-C 109.778 -0.893 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.459 ' HA3' ' HB3' ' A' ' 28' ' ' SER . . . 129.67 -173.41 19.71 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.925 -1.131 . . . . 0.0 112.553 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ABA . . . . . 0.498 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.498 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 52.5 Cg_endo -83.85 28.08 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 124.265 3.31 . . . . 0.0 110.505 173.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 6' ' ' ABA . 33.2 t -100.72 -21.84 15.08 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.977 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.5 t -156.53 125.84 6.13 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.474 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 9.3 p90 -123.49 30.82 6.12 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.688 1.232 . . . . 0.0 110.568 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -100.41 134.08 43.88 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.31 29.28 52.55 Favored Glycine 0 N--CA 1.506 3.327 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -91.25 -24.15 19.95 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.292 -1.454 . . . . 0.0 112.965 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.565 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 17.7 m -119.78 150.43 40.43 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.788 HD12 ' HD2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -109.19 -37.5 5.77 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 -179.355 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -149.46 -67.71 0.21 Allowed 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.94 -20.41 79.73 Favored Glycine 0 N--CA 1.502 3.085 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.565 ' HA3' ' HB3' ' A' ' 14' ' ' CYS . . . -4.02 71.08 0.0 OUTLIER Glycine 0 N--CA 1.484 1.834 0 N-CA-C 121.748 3.459 . . . . 0.0 121.748 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.6 t -96.18 93.62 3.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 101.343 -3.577 . . . . 0.0 101.343 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ABA . . . . . 1.067 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.3 ptp -114.47 170.38 8.35 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.8 OUTLIER -108.2 123.14 48.29 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -103.2 18.61 4.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 124.635 1.21 . . . . 0.0 111.115 -179.741 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -25.94 -52.41 0.05 OUTLIER 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 123.8 1.762 . . . . 0.0 110.643 -179.402 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -25.83 -49.37 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 108.437 -3.983 . . . . 0.0 113.069 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.76 -34.91 6.12 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 111.233 -2.712 . . . . 0.0 110.246 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -147.2 -80.84 0.14 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 23' ' ' ILE . 9.6 p -159.34 -130.98 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.771 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.067 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -96.31 140.64 30.69 Favored 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.521 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -151.2 172.34 15.97 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.791 -179.217 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.454 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -116.32 131.45 56.94 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -89.49 121.83 32.09 Favored 'General case' 0 C--N 1.303 -1.443 1 N-CA-C 99.957 -4.09 . . . . 0.0 99.957 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 37' ' ' TYR . 82.2 m -90.95 -114.5 0.08 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 123.945 0.778 . . . . 0.0 112.215 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.555 HG12 ' CD2' ' A' ' 37' ' ' TYR . 7.2 p -153.77 164.58 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 C-N-CA 117.656 -1.618 . . . . 0.0 111.257 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -47.9 -24.26 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 112.052 -2.34 . . . . 0.0 107.41 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -99.92 -17.9 24.11 Favored Glycine 0 C--O 1.201 -1.951 0 CA-C-O 117.69 -1.616 . . . . 0.0 115.165 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.555 ' CD2' HG12 ' A' ' 34' ' ' VAL . 1.1 m-85 -128.46 128.56 44.65 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 121.697 2.749 . . . . 0.0 106.008 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.64 ' H ' HG23 ' A' ' 44' ' ' THR . 12.6 t -130.77 -146.66 0.31 Allowed 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 40' ' ' ASP . . . 90.95 -51.12 3.17 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 106.496 -2.642 . . . . 0.0 106.496 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER 128.32 4.97 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.663 0 O-C-N 127.958 2.799 . . . . 0.0 109.026 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.788 ' HD2' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -121.53 -27.98 4.67 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.651 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 1.9 m 85.54 37.73 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 104.327 -2.472 . . . . 0.0 104.327 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.714 ' NE2' HG22 ' A' ' 44' ' ' THR . 2.7 pp0? -88.17 -23.32 23.64 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 111.514 -2.585 . . . . 0.0 107.157 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.714 HG22 ' NE2' ' A' ' 43' ' ' GLN . 1.3 t -110.23 84.42 1.92 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 101.365 -3.569 . . . . 0.0 101.365 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -81.28 87.48 6.12 Favored 'General case' 0 C--N 1.299 -1.63 1 N-CA-C 99.28 -4.341 . . . . 0.0 99.28 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 36' ' ' GLY . 33.3 t70 -58.85 -25.66 63.46 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 112.111 -2.313 . . . . 0.0 107.355 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 80.58 -148.5 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.498 ' NH1' ' O ' ' A' ' 46' ' ' ASP . 8.7 mtt180 . . . . . 0 N--CA 1.504 2.256 0 CA-C-N 119.447 1.021 . . . . 0.0 110.572 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 N--CA 1.493 1.446 0 N-CA-C 108.551 -1.365 . . . . 0.0 108.551 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.26 147.5 19.12 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ABA . . . . . 0.751 ' H ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.751 ' HD3' ' H ' ' A' ' 6' ' ' ABA . 69.2 Cg_endo -77.09 19.1 0.71 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 123.551 2.834 . . . . 0.0 112.368 -163.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 6' ' ' ABA . 35.9 t -100.47 -20.97 15.52 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.424 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.9 t -156.9 130.57 8.17 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.56 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 3.2 p90 -123.03 2.7 9.33 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.404 0.621 . . . . 0.0 111.82 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.29 122.57 13.55 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.11 36.95 93.13 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.722 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.52 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 22.4 t80 -91.24 -17.63 25.7 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.619 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.555 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 30.9 m -115.02 151.63 33.87 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.981 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -108.31 -34.0 6.94 Favored 'General case' 0 N--CA 1.508 2.457 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.491 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 5.1 m-80 -142.07 -82.21 0.21 Allowed 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 120.355 3.465 . . . . 0.0 120.355 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.68 6.32 77.19 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 108.421 -1.871 . . . . 0.0 108.421 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.621 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . -51.2 95.87 0.01 OUTLIER Glycine 0 C--N 1.303 -1.265 0 CA-C-N 112.847 -1.676 . . . . 0.0 113.508 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER -91.73 106.63 17.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 102.85 -3.019 . . . . 0.0 102.85 179.103 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ABA . . . . . 0.983 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.532 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 4.3 ptm -134.12 167.61 20.34 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 102.343 -3.206 . . . . 0.0 102.343 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -110.3 126.56 54.33 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.548 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -104.51 14.19 7.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 124.329 1.018 . . . . 0.0 112.408 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -23.05 -56.81 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 122.889 1.328 . . . . 0.0 112.657 -179.095 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.7 m -28.03 -44.22 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 110.277 -3.147 . . . . 0.0 115.428 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.99 -37.0 5.5 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 111.428 -2.623 . . . . 0.0 109.834 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -145.19 -82.63 0.15 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 117.211 2.301 . . . . 0.0 117.211 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.544 ' H ' HG22 ' A' ' 23' ' ' ILE . 1.0 OUTLIER -156.3 -138.87 0.07 Allowed 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 119.259 -0.977 . . . . 0.0 109.953 -179.267 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.983 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -92.36 146.39 23.73 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 102.591 -3.115 . . . . 0.0 102.591 179.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.547 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -158.43 -176.43 5.89 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 125.793 1.933 . . . . 0.0 109.704 -179.607 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.621 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -121.37 153.41 37.82 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.772 -1.171 . . . . 0.0 108.446 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.532 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 53.5 t30 -106.85 85.45 2.15 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 59.5 m -60.72 167.27 2.82 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.513 -1.676 . . . . 0.0 112.04 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.669 HG12 ' CD2' ' A' ' 37' ' ' TYR . 11.1 p -71.98 161.64 4.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 117.804 -1.559 . . . . 0.0 108.92 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.428 ' H ' HG22 ' A' ' 35' ' ' ILE . 1.9 tt -51.68 -21.64 2.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-N 112.335 -2.211 . . . . 0.0 108.735 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -92.4 -27.55 15.04 Favored Glycine 0 C--O 1.2 -2.016 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.81 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.669 ' CD2' HG12 ' A' ' 34' ' ' VAL . 3.1 m-30 -110.57 142.4 42.44 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 121.476 2.638 . . . . 0.0 108.341 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.433 ' C ' ' H ' ' A' ' 40' ' ' ASP . 53.0 m -142.73 -137.18 0.1 Allowed 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.649 -1.22 . . . . 0.0 112.034 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 73.79 -16.98 2.31 Favored Glycine 0 N--CA 1.481 1.665 0 CA-C-O 116.623 -2.209 . . . . 0.0 110.356 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 17.6 t70 106.94 -6.83 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.133 0 O-C-N 125.126 1.133 . . . . 0.0 111.817 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.527 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -135.52 -6.58 2.23 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -178.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.562 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 69.3 33.54 3.21 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 -179.325 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.981 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -88.1 -21.13 24.86 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 111.514 -2.584 . . . . 0.0 106.916 -179.669 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.401 ' O ' ' CG2' ' A' ' 44' ' ' THR . 10.9 t -114.87 114.27 25.29 Favored 'General case' 0 C--N 1.296 -1.754 1 N-CA-C 94.032 -6.285 . . . . 0.0 94.032 179.612 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.609 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 14.6 mtm180 -105.25 99.76 9.37 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 101.337 -3.579 . . . . 0.0 101.337 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 36' ' ' GLY . 44.5 t0 -85.54 70.34 10.75 Favored 'General case' 0 C--N 1.295 -1.769 1 N-CA-C 98.599 -4.593 . . . . 0.0 98.599 179.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.7 mt -46.72 70.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 117.829 2.529 . . . . 0.0 117.829 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 116.455 -1.736 . . . . 0.0 109.333 179.523 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo . . . . . 0 N--CA 1.494 1.515 0 N-CA-C 110.066 -0.782 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.535 ' HA3' ' CB ' ' A' ' 28' ' ' SER . . . 105.21 -146.83 16.13 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ABA . . . . . 0.573 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 93.9 Cg_endo -78.93 14.89 1.6 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 123.196 2.598 . . . . 0.0 109.973 -163.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.522 ' H ' ' C ' ' A' ' 6' ' ' ABA . 1.3 t -100.22 -22.14 15.25 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.983 -1.462 . . . . 0.0 107.827 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.5 p -151.63 121.53 7.08 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 118.092 -0.956 . . . . 0.0 108.809 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 29' ' ' TYR . 4.3 p90 -116.11 -5.05 11.92 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.41 116.32 3.26 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.686 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.37 26.73 60.89 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.111 -1.519 . . . . 0.0 109.702 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.597 ' CE1' ' HA ' ' A' ' 30' ' ' THR . 26.3 t80 -91.28 -12.46 35.05 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 118.854 -1.139 . . . . 0.0 109.992 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.62 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 17.5 m -126.41 142.07 51.66 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.763 HD12 ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -100.83 -59.57 1.68 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -179.434 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.742 HD21 HD23 ' A' ' 15' ' ' LEU . 6.5 m-80 -134.72 -52.62 0.81 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 119.791 3.256 . . . . 0.0 119.791 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -100.85 -0.62 55.13 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.62 ' HA3' ' HB3' ' A' ' 14' ' ' CYS . . . -51.75 90.52 0.01 OUTLIER Glycine 0 N--CA 1.476 1.327 0 CA-C-O 123.976 1.876 . . . . 0.0 117.119 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER -87.82 99.98 9.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 1 N-CA-C 96.02 -5.548 . . . . 0.0 96.02 179.237 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ABA . . . . . 0.471 ' CG ' ' CE2' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.6 ptm -138.71 170.06 16.68 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.496 ' CE1' ' HB2' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -111.08 130.79 55.5 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 103.419 -2.808 . . . . 0.0 103.419 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.635 HD13 ' CG2' ' A' ' 30' ' ' THR . 0.4 OUTLIER -104.59 16.45 5.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 124.214 0.946 . . . . 0.0 112.084 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.496 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 1.0 OUTLIER -29.16 -50.91 0.1 Allowed 'General case' 0 N--CA 1.507 2.389 0 CA-C-O 122.582 1.182 . . . . 0.0 112.727 -179.161 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.8 m -31.31 -43.42 0.06 Allowed 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 111.087 -2.779 . . . . 0.0 113.804 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.61 -36.03 5.6 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 111.522 -2.581 . . . . 0.0 109.987 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -148.2 -83.55 0.11 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 118.846 2.906 . . . . 0.0 118.846 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.535 ' CB ' ' HA3' ' A' ' 5' ' ' GLY . 5.1 p -148.92 -136.04 0.07 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.525 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.51 ' HE1' ' CG ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -101.4 147.87 25.83 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-N 118.584 0.629 . . . . 0.0 109.941 -179.593 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.635 ' CG2' HD13 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -160.01 -173.72 4.21 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 118.587 2.81 . . . . 0.0 118.587 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.511 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -131.85 130.11 41.27 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.58 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -92.08 89.62 7.02 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 104.716 -2.328 . . . . 0.0 104.716 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.2 m -72.72 -178.35 2.65 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.247 1.023 . . . . 0.0 108.922 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.779 HG12 ' CD2' ' A' ' 37' ' ' TYR . 10.9 p -89.81 166.81 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-O 123.979 1.847 . . . . 0.0 113.458 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.574 HD11 ' NH2' ' A' ' 48' ' ' ARG . 2.5 tt -56.29 -15.74 2.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-N 112.096 -2.32 . . . . 0.0 108.271 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.586 ' H ' HG13 ' A' ' 34' ' ' VAL . . . -98.34 -12.63 44.57 Favored Glycine 0 N--CA 1.486 1.972 0 CA-C-N 113.929 -1.487 . . . . 0.0 113.716 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.779 ' CD2' HG12 ' A' ' 34' ' ' VAL . 1.3 m-85 -135.24 130.51 35.32 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.57 ' H ' HG23 ' A' ' 44' ' ' THR . 1.4 t -129.06 -161.23 1.09 Allowed 'General case' 0 N--CA 1.515 2.775 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 51.27 63.5 4.57 Favored Glycine 0 N--CA 1.499 2.865 0 N-CA-C 117.513 1.765 . . . . 0.0 117.513 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 43.71 -13.78 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.588 1 N-CA-C 122.16 4.133 . . . . 0.0 122.16 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.763 ' NE ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -113.82 -28.2 7.5 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.464 ' SG ' ' N ' ' A' ' 18' ' ' GLY . 2.7 m 82.01 43.86 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.728 ' NE2' HG22 ' A' ' 44' ' ' THR . 0.1 OUTLIER -88.8 -8.68 53.95 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 112.86 -1.973 . . . . 0.0 112.127 -179.235 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.728 HG22 ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -120.83 94.12 4.25 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 102.121 -3.289 . . . . 0.0 102.121 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.4 ' HA ' ' HD1' ' A' ' 37' ' ' TYR . 7.2 mtm180 -83.78 86.52 7.13 Favored 'General case' 0 C--N 1.305 -1.329 1 N-CA-C 98.408 -4.664 . . . . 0.0 98.408 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 36' ' ' GLY . 1.3 t70 -59.96 -12.95 9.01 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 112.098 -2.319 . . . . 0.0 109.342 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 57.91 12.96 1.92 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 127.581 2.353 . . . . 0.0 116.709 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.574 ' NH2' HD11 ' A' ' 35' ' ' ILE . 1.7 ptm85 . . . . . 0 N--CA 1.5 2.072 0 CA-C-O 117.271 -1.347 . . . . 0.0 113.818 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 N--CA 1.492 1.421 0 N-CA-C 107.865 -1.629 . . . . 0.0 107.865 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.72 -170.31 14.06 Favored Glycine 0 N--CA 1.497 2.748 0 C-N-CA 120.151 -1.023 . . . . 0.0 110.569 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ABA . . . . . 0.55 ' H ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.55 ' HD3' ' H ' ' A' ' 6' ' ' ABA . 2.9 Cg_exo -70.02 -41.55 3.86 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.87 2.38 . . . . 0.0 109.06 173.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -19.91 -49.84 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 111.061 -2.791 . . . . 0.0 116.555 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.2 t -139.78 127.41 21.73 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -123.57 34.06 5.19 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.05 130.9 46.25 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 104.678 -2.342 . . . . 0.0 104.678 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.81 40.31 2.17 Favored Glycine 0 N--CA 1.506 3.34 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.407 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 24.6 t80 -91.52 -22.08 20.55 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 126.098 1.705 . . . . 0.0 112.856 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.41 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 38.1 m -114.68 155.07 27.3 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.964 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -107.06 -37.14 6.39 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -179.575 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.609 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 3.5 m-80 -141.51 -85.54 0.18 Allowed 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 119.981 3.326 . . . . 0.0 119.981 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.98 -26.33 55.21 Favored Glycine 0 N--CA 1.512 3.716 0 N-CA-C 108.486 -1.845 . . . . 0.0 108.486 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.535 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 6.25 65.42 0.01 OUTLIER Glycine 0 N--CA 1.484 1.843 0 N-CA-C 121.504 3.362 . . . . 0.0 121.504 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.33 97.4 6.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 100.944 -3.725 . . . . 0.0 100.944 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ABA . . . . . 1.059 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.55 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 7.3 ptm -121.9 122.28 39.05 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 123.128 1.442 . . . . 0.0 109.379 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.641 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -62.57 121.38 13.19 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 179.626 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.653 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -104.36 24.87 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 123.936 0.773 . . . . 0.0 110.31 -179.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.498 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 0.8 OUTLIER -34.77 -39.89 0.1 Allowed 'General case' 0 N--CA 1.509 2.487 0 CA-C-O 123.502 1.62 . . . . 0.0 110.195 -179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.401 ' N ' ' C ' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -32.61 -46.26 0.13 Allowed 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 110.055 -3.248 . . . . 0.0 111.477 179.245 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.53 -34.53 4.86 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 111.672 -2.513 . . . . 0.0 110.396 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -148.09 -81.98 0.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 23' ' ' ILE . 2.5 p -152.76 -131.54 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.149 -1.02 . . . . 0.0 109.378 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.059 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -100.16 137.42 38.63 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.595 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -148.58 -176.34 5.28 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 112.449 -2.159 . . . . 0.0 110.266 -179.396 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.535 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -122.02 155.75 34.94 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.55 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 45.6 t30 -109.21 104.33 13.46 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 100.346 -3.946 . . . . 0.0 100.346 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.449 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 60.8 m -89.22 169.86 11.09 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.499 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.707 HG12 ' CD2' ' A' ' 37' ' ' TYR . 8.9 p -68.79 159.56 5.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 123.264 1.507 . . . . 0.0 111.613 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.402 ' H ' HG22 ' A' ' 35' ' ' ILE . 1.2 tt -48.43 -21.71 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 111.177 -2.738 . . . . 0.0 109.914 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.554 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -106.64 3.73 36.72 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 118.026 1.971 . . . . 0.0 118.026 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.707 ' CD2' HG12 ' A' ' 34' ' ' VAL . 13.5 m-30 -133.44 116.81 16.47 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 100.461 -3.903 . . . . 0.0 100.461 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.493 ' C ' HG22 ' A' ' 44' ' ' THR . 39.9 t -132.54 -133.65 0.18 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 118.381 -1.328 . . . . 0.0 113.041 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 71.42 -9.87 4.12 Favored Glycine 0 N--CA 1.486 1.993 0 CA-C-O 117.764 -1.575 . . . . 0.0 111.293 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 19.6 t70 104.57 -5.24 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.073 0 O-C-N 124.967 1.039 . . . . 0.0 112.907 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.578 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -139.39 -2.96 1.56 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -178.754 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 71.17 30.9 2.56 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 -179.254 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.964 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -89.04 -15.02 35.09 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 113.119 -1.855 . . . . 0.0 110.191 -179.519 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.493 HG22 ' C ' ' A' ' 38' ' ' SER 0.26 6.0 t -118.99 83.07 1.96 Allowed 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 100.236 -3.987 . . . . 0.0 100.236 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 8.8 mtm-85 -77.51 89.87 3.87 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 111.115 -2.766 . . . . 0.0 104.057 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 36' ' ' GLY . 0.9 OUTLIER -62.34 -16.89 57.09 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 113.017 -1.901 . . . . 0.0 109.773 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mt 78.55 47.86 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.554 ' H ' ' HA3' ' A' ' 36' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 116.469 -1.729 . . . . 0.0 112.617 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 N--CA 1.493 1.447 0 N-CA-C 108.141 -1.523 . . . . 0.0 108.141 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.424 ' HA3' ' CB ' ' A' ' 28' ' ' SER . . . 139.27 -178.95 19.16 Favored Glycine 0 N--CA 1.491 2.305 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.128 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ABA . . . . . 0.539 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 6' ' ' ABA . 3.2 Cg_exo -74.33 -23.75 15.05 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.762 2.308 . . . . 0.0 111.342 173.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.5 t -20.14 -51.91 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 O-C-N 124.95 1.406 . . . . 0.0 113.535 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -156.31 154.83 31.26 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 102.421 -3.177 . . . . 0.0 102.421 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.521 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -125.32 10.77 8.03 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 124.768 1.292 . . . . 0.0 109.581 179.724 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.99 135.27 57.2 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 37.52 41.55 0.83 Allowed Glycine 0 N--CA 1.511 3.651 0 O-C-N 124.08 0.863 . . . . 0.0 111.511 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.412 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 20.9 t80 -91.24 -17.21 26.37 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 125.231 1.195 . . . . 0.0 112.589 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.455 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 44.6 m -116.92 154.13 31.36 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.933 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -108.15 -36.47 6.29 Favored 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -179.666 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.674 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 3.7 m-80 -140.58 -82.52 0.24 Allowed 'General case' 0 N--CA 1.51 2.555 0 N-CA-C 120.372 3.471 . . . . 0.0 120.372 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.82 -21.42 65.32 Favored Glycine 0 N--CA 1.508 3.462 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.575 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 2.95 67.46 0.0 OUTLIER Glycine 0 N--CA 1.481 1.696 0 N-CA-C 120.215 2.846 . . . . 0.0 120.215 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 19' ' ' VAL . 2.0 t -95.72 94.58 4.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 101.423 -3.547 . . . . 0.0 101.423 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ABA . . . . . 1.066 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.418 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 8.2 ptm -115.84 165.66 12.83 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.445 ' CE1' ' HG2' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -102.71 126.71 49.92 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.611 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -106.6 18.92 5.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 124.412 1.07 . . . . 0.0 109.913 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.487 ' C ' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -27.47 -52.96 0.07 Allowed 'General case' 0 N--CA 1.512 2.636 0 CA-C-O 123.405 1.574 . . . . 0.0 109.742 -179.421 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -25.08 -46.98 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 108.964 -3.743 . . . . 0.0 114.323 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.78 -35.52 5.45 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 110.916 -2.856 . . . . 0.0 110.026 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -147.03 -81.62 0.14 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 23' ' ' ILE . 4.5 p -157.44 -131.77 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.582 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.066 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.1 OUTLIER -97.73 141.5 30.67 Favored 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.576 ' N ' ' CD1' ' A' ' 29' ' ' TYR 0.266 0.5 OUTLIER -153.31 -176.73 5.92 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.384 -1.735 . . . . 0.0 110.446 -179.277 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.575 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -120.48 148.95 43.15 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.418 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 43.3 t30 -101.61 101.0 11.47 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 101.417 -3.549 . . . . 0.0 101.417 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.511 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 59.5 m -86.71 156.6 19.9 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.116 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.696 HG12 ' CD2' ' A' ' 37' ' ' TYR . 12.5 p -59.94 160.38 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 112.591 -2.095 . . . . 0.0 114.266 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.7 tt -50.72 -21.85 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 CA-C-N 110.845 -2.889 . . . . 0.0 109.243 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -99.61 -6.83 54.49 Favored Glycine 0 N--CA 1.49 2.261 0 CA-C-N 114.202 -1.363 . . . . 0.0 115.929 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.696 ' CD2' HG12 ' A' ' 34' ' ' VAL . 5.9 m-85 -132.59 120.8 22.29 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.497 ' C ' HG22 ' A' ' 44' ' ' THR . 26.4 t -131.7 -137.98 0.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.629 -1.228 . . . . 0.0 111.087 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 74.88 -10.66 8.74 Favored Glycine 0 N--CA 1.481 1.688 0 CA-C-O 117.075 -1.958 . . . . 0.0 111.339 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 19.2 t70 105.07 -8.88 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.261 0 O-C-N 125.039 1.082 . . . . 0.0 113.065 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.605 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -137.86 -2.24 1.93 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -178.67 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 69.31 31.35 3.92 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 104.523 -2.399 . . . . 0.0 104.523 -179.254 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.933 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -88.81 -16.03 33.1 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 113.024 -1.898 . . . . 0.0 109.223 -179.39 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.497 HG22 ' C ' ' A' ' 38' ' ' SER . 3.4 t -119.45 88.84 3.01 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 101.397 -3.557 . . . . 0.0 101.397 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 24.9 mtp-105 -83.4 93.69 7.82 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 111.342 -2.663 . . . . 0.0 105.465 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 36' ' ' GLY . 26.0 t0 -62.07 -23.64 66.62 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 112.745 -2.025 . . . . 0.0 108.042 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 80.61 -144.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 112.789 -2.005 . . . . 0.0 107.686 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.312 0 O-C-N 124.334 1.021 . . . . 0.0 113.607 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 N--CA 1.494 1.526 0 N-CA-C 107.929 -1.604 . . . . 0.0 107.929 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.59 179.58 16.62 Favored Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.208 -1.472 . . . . 0.0 113.408 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ABA . . . . . 0.572 ' H ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.572 ' HD3' ' H ' ' A' ' 6' ' ' ABA . 1.5 Cg_endo -76.45 -35.5 2.15 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.753 2.302 . . . . 0.0 112.548 177.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -19.81 -54.21 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 125.956 2.035 . . . . 0.0 113.177 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.8 t -146.99 154.47 41.28 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 103.669 -2.715 . . . . 0.0 103.669 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.561 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -127.06 12.12 7.13 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.183 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -55.81 129.7 40.51 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 35.35 46.04 0.71 Allowed Glycine 0 N--CA 1.508 3.487 0 O-C-N 124.744 1.277 . . . . 0.0 111.017 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.411 ' HD1' ' HH ' ' A' ' 29' ' ' TYR . 29.3 t80 -91.08 -17.6 25.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 125.752 1.501 . . . . 0.0 113.007 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.411 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 50.9 m -116.72 153.38 32.48 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.941 HD22 ' HA ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -106.28 -35.71 7.08 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -179.691 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.49 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 4.3 m-80 -144.12 -83.23 0.16 Allowed 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 119.107 3.003 . . . . 0.0 119.107 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -57.34 -27.0 57.48 Favored Glycine 0 N--CA 1.51 3.614 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.561 ' C ' ' SG ' ' A' ' 31' ' ' CYS . . . 7.96 63.14 0.01 OUTLIER Glycine 0 N--CA 1.48 1.607 0 N-CA-C 120.304 2.882 . . . . 0.0 120.304 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.93 94.92 4.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 100.464 -3.902 . . . . 0.0 100.464 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ABA . . . . . 1.063 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 32' ' ' ASN . 6.3 ptm -122.03 121.28 36.65 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 123.094 1.426 . . . . 0.0 108.807 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.661 ' HA ' ' HA ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -63.78 118.36 8.22 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.67 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -99.98 26.18 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 123.751 0.657 . . . . 0.0 110.305 -179.448 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.487 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . 1.3 tm-20 -34.29 -41.86 0.12 Allowed 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 123.652 1.691 . . . . 0.0 109.713 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -31.19 -45.33 0.08 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 109.874 -3.33 . . . . 0.0 112.241 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.02 -33.73 4.63 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 111.841 -2.436 . . . . 0.0 110.305 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -149.32 -80.67 0.12 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 23' ' ' ILE . 2.4 p -153.86 -131.11 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 118.891 -1.124 . . . . 0.0 109.718 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.063 ' CE1' ' HG3' ' A' ' 20' ' ' ABA . 0.2 OUTLIER -100.84 135.94 41.48 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.543 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.6 OUTLIER -147.14 -177.56 5.74 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 112.333 -2.212 . . . . 0.0 109.705 -179.391 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.561 ' SG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -122.8 154.51 38.11 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 179.576 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.535 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 54.6 t30 -108.82 101.89 10.96 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 101.093 -3.669 . . . . 0.0 101.093 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 42' ' ' CYS . 62.9 m -82.84 170.39 15.05 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 113.747 -1.57 . . . . 0.0 109.853 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.69 HG12 ' CD2' ' A' ' 37' ' ' TYR . 12.9 p -72.33 160.51 5.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 123.14 1.448 . . . . 0.0 111.859 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.432 HG22 HG22 ' A' ' 34' ' ' VAL . 3.0 tt -51.02 -19.03 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 111.657 -2.519 . . . . 0.0 108.94 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 46' ' ' ASP . . . -94.3 -25.71 15.7 Favored Glycine 0 C--O 1.203 -1.839 0 CA-C-O 117.898 -1.501 . . . . 0.0 112.766 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.69 ' CD2' HG12 ' A' ' 34' ' ' VAL . 2.4 m-30 -115.1 124.64 52.05 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 119.428 1.614 . . . . 0.0 108.193 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.415 ' C ' HG22 ' A' ' 44' ' ' THR . 23.1 t -131.62 -139.92 0.21 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.83 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 76.62 -12.62 10.08 Favored Glycine 0 N--CA 1.481 1.657 0 CA-C-O 117.555 -1.692 . . . . 0.0 110.1 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.522 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 31.0 t70 105.63 -6.11 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.062 0 O-C-N 125.04 1.082 . . . . 0.0 113.301 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.611 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -137.4 -4.17 1.88 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.515 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER 72.2 32.4 1.73 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 -179.238 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.941 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -87.99 -20.07 26.34 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 113.328 -1.76 . . . . 0.0 110.575 -179.248 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.493 ' O ' HG23 ' A' ' 44' ' ' THR 0.256 6.1 t -113.67 83.5 1.86 Allowed 'General case' 0 C--N 1.295 -1.79 1 N-CA-C 98.893 -4.484 . . . . 0.0 98.893 179.955 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.58 ' HA ' ' CD1' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -76.0 89.34 2.97 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 101.944 -3.354 . . . . 0.0 101.944 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 36' ' ' GLY . 30.4 t70 -83.41 46.22 1.12 Allowed 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 45' ' ' ARG . 41.1 mt 13.1 25.27 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 1 N-CA-C 122.114 4.116 . . . . 0.0 122.114 -179.584 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 46' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 115.168 -2.349 . . . . 0.0 109.845 179.648 . . . . . . . . 2 2 . 1 stop_ save_